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Abstract 
Streptococcus equi subspecies equi (S. equi) is a host-restricted pathogen of horses and the 
aetiological agent of strangles. Available evidence suggests that S. equi evolved from 
Streptococcus equi subspecies zooepidemicus (S. zooepidemicus), a versatile bacterium 
that is often isolated from the equine respiratory tract, but can cause opportunistic disease 
in horses and other animals. A comparison of the genomes of S. equi 4047 and S. 
zooepidemicus H70 and the screening of diverse S. equi and S. zooepidemicus strains 
uncovered the genetic events that have shaped the evolution of S. equi, and led to its 
emergence as a niche-adapted pathogen. This analysis provides evidence of functional 
loss, changes in the organisation and sequence of genes, and pathogenic specialisation 
through the acquisition of prophage encoding a phospholipase A2 toxin, and 4 
superantigens, and an integrative conjugative element carrying a novel siderophore-like 
nonribosomal peptide synthetase (NRPS) system. The NRPS shares similarity with the 
yersiniabactin system found in the high pathogenicity island of Yersinia pestis and is the 
first of its kind to be identified in streptococci. As this genetic feature is absent from the S. 
zooepidemicus popUlation, its gain is considered to have been a key event in the emergence 
of S. equi. Further work determined a role for the NRPS in iron acquisition, and through 
its heterologous reconstitution in Escherichia coli and/or the analysis of allelic replacement 
mutants in S. equi, identified biosynthetic genes, transporters involved in efflux and import 
of the NRPS product(s), salicylate as a substrate for the NRPS and its regulation by a novel 
iron-dependent IdeR-like repressor, using various in vitro growth assays, including 
sensitivity to streptonigrin and 55Fe accumulation. Possible vaccine targets were identified 
in both subspecies and existing diagnostic tools were improved, which included the 
development of a quantitative peR test for the detection of S. equi. 
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Preface 
Streptococcus equi subspecies equi (S. equi) is a highly specialised host-restricted bacterial 
pathogen and the aetiological agent of strangles, one of the most prevalent infectious 
diseases of horses worldwide. Strangles is best known for the painful abscessation 
associated with the disease, which has a major impact on equine welfare. In addition, it is 
responsible for significant economic loss to the equine industry. Evidence points toward 
the evolution of S. equi from an ancestral strain of Streptococcus equi subspecies 
zooepidemicus (S. zooepidemicus). However, unlike S. equi, S. zooepidemicus is generally 
considered as an opportunistic pathogen. The diverse number of host environments in 
which S. zooepidemicus colonises or causes disease is reflected in the diversity of its 
genetic make-up. 
It was not until 1887 that a distinction between streptococci responsible for strangles and 
other infections was recognised (Evans, 1936). Since then research has contributed a much 
better understanding of the popUlation structure of these veterinary pathogens and 
improved our knowledge of S. equi pathogenesis. Some important virulence determinants 
of S. equi have been revealed often through the identification of factors unique to S. equi 
when compared with S. zooepidemicus. Given the gravity of strangles, the main driving 
force for research in this field has come from a need to better contain, diagnose, treat and 
prevent this disease. However, S. zooepidemicus has also received some attention for its 
association with inflammatory airway disease (lAD) in racehorses and its zoonotic 
capabilities, as well its role in a range of other diseases in many different species. A need 
may arise for vaccines or diagnostic tests to combat S. zooepidemicus infections, 
particularly if certain virulent strains are linked to specific disease types. 
My research project exploited the newly available genome sequences of S. equi strain 4047 
(Se4047) and S. zooepidemicus strain H70 (SzH70). The main aim of the study was to 
v 
identify the genetic differences that delineate these two closely related subspecies and to 
uncover the molecular basis for the evolution of S. equi into a specialised pathogen from an 
opportunistic and generally less pathogenic ancestor. This analysis has the applied 
objective of identifying novel virulence factors and components for the development of 
diagnostic tests and vaccines. 
Each chapter (2-5) in this thesis includes an introduction, specific aims, methods, results 
and discussions, and finishes with conclusions. The introductory chapter introduces the 
pathogenesis and epidemiology of diseases associated with S. zooepidemicus infection in 
horses, including current knowledge regarding their treatment and prevention. Given the 
versatile nature of S. zooepidemicus, diseases associated with infection by this bacterium in 
other animals are also highlighted. Chapter 1 then describes strangles, the pathogenesis of 
S. equi and the current state of play with regards to treatments, diagnostics and vaccines. 
The latter part of chapter 1 outlines the phylogenetic relationship of S. equi, which is 
largely clonal within the S. zooepidemicus popUlation. 
Chapter 2 introduces the molecular processes that generally shape the emergence of 
specialised pathogens from more flexible non-pathogenic progenitors. Pre-existing 
knowledge of virulence factors and genetic determinants that are shared between S. equi 
and S. zooepidemicus or that distinguish S. equi from its proposed ancestor are highlighted. 
The core of Chapter 2 presents the genetic diversification of these two subspecies 
following an alignment of the Se4047 and SzH70 genomes, gene prevalence screening to 
establish the true species-specific disparities and some functional analyses to back-up 
assigned putative functions. 
Chapter 3 focuses on the bioinformatic and functional characterisation of ICESe2, a novel 
S. equi-specific integrative and conjugative element (ICE). The acquisition of ICESe2 is 
vi 
proposed to have been a key event in the speciation of S. equi and encodes a novel non-
ribosomal peptide synthetase (NRPS) system involved in iron acquisition. A novel cation-
dependant repressor EqbA regulates the ICESe2 NRPS locus. The analysis of recombinant 
EqbA by gel mobility shift assays is addressed in the latter part of Chapter 3. 
Reconstitution of the ICESe2 NRPS product 'equibactin' was performed using Escherichia 
coli (Chapter 4) and a new strangles diagnostic PCR (polymerase chain reaction) test based 
on this locus was developed (Chapter 5). Overall conclusions and suggestions for future 
work are presented in Chapter 6. 
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Chapter 1 General introduction 
1.1 S. zooepidemicus infection in horses: clinical disease, pathogenesis 
and epidemiology 
S. zooepidemicus is generally considered a commensal organism of horses and is often 
isolated from the skin, upper respiratory mucosa, tonsil and associated pharyngeal 
lymphoid tissues of healthy individuals (Woolcock, 1975). However, S. zooepidemicus 
can cause opportunistic disease given the appropriate conditions, which although poorly 
understood, are likely to be multifactorial and involve changes or differences in both host 
and bacterium. A molecular basis for differences in pathogenicity between S. 
zooepidemicus isolates has not yet been reported, but situations arise that appear to render 
the host more susceptible to disease associated with S. zooepidemicus infection. For 
example, stresses that can occur following training, virus infection, transportation, 
overcrowding, debilitation, anaesthesia, tissue injury and poor air hygiene have been 
implicated as a prelude to S. zooepidemicus infection. As a result, S. zooepidemicus is a 
common cause of wound infection (cellulitis and abscesses), conjunctivitis and ulcerative 
keratitis (Brooks et al., 2000), and is the most frequently isolated pyogen from equine 
joints, lymph nodes (LNs), nasal cavities, and lungs (Hoffman et al., 1993; McGorum, 
2006; Timoney, 2004). In mares, cervicitis and endometritis has been associated with S. 
zooepidemicus infection. This might be a sequel to vulvar deformity or to injury during 
parturition. Abortion can occur when S. zooepidemicus is carried in the bloodstream to the 
placenta or enters the uterus from the distal genital tract (Giles et aI., 1993; Hong et aI., 
1993; Smith et aI., 2003; Timoney, 1988). 
Young horses are particularly susceptible to opportunistic disease associated with S. 
zooepidemicus infection probably as a result of inadequate immunity, including poor 
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maternal transfer of antibodies. S. zooepidemicus is a common cause of septicaemia in 
foals and can invade the umbilical stump, causing inflammation of the umbilical veins 
(omphalophlebitis), bacteraemia and polyarthritis (Timoney, 1988). Bronchopneumonia in 
foals and pneumonia/pleuropneumonia (including equine shipping fever) in adults, have 
been associated with mixed infections, although S. zooepidemicus is the bacterium most 
frequently isolated (McGorum, 2006; Raphel & Beech, 1982; Sweeney et ai., 1985; 
Sweeney et ai., 1991; Welsh, 1984; Yoshikawa et ai., 2003). The disease progresses 
rapidly and is associated with extensive cellular damage (epithelial desquamation, 
necrosis), haemorrhage, interstitial changes, and pulmonary consolidation (McGorum, 
2006; Oikawa et ai., 1994; Yoshikawa et ai., 2003). Consequently, although cases of 
pneumonia are sporadic and have low morbidity, they have a high mortality rate 
(McGorum, 2006). 
Young racehorses also appear more prone to inflammatory airway disease (lAD) (Newton 
et ai., 2003), although time spent in training (and exposure to the new training 
environment) may be more important than age in determining susceptibility to this 
condition (Cardwell, 2007). Suffice it to say, lAD is a common problem faced by 
racehorses early on in their training and has been referred to as a clinical or subclinical 
lower respiratory tract disease characterised by endoscopically visible tracheal mucus and 
cytologically evident neutrophilic inflammation (Newton et ai., 2003). Poor performance, 
exercise intolerance and/or coughing are frequent manifestations of IAD. Because 
respiratory disease has a major impact on racehorses in training (Bailey et ai., 1999; 
leffcott et ai., 1982; Rossdale et ai., 1985) and is frequently publicly attributed as the cause 
of prolonged periods of poor overall racing performance in yards (Newton et ai., 2003), S. 
zooepidemicus has received particular attention for its role in lAD. Epidemiological 
studies have shown statistically significant associations between infection with S. 
zooepidemicus (and other bacterial species) of the lower airways and both IAD (Burrell et 
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aI., 1996; Cardwell, 2007; Chapman et aI., 2000; Newton et aI., 2003; Wood et al., 1993; 
Wood et aI., 2oo5a; Wood et al., 2oo5b; Wood, 1999) and coughing (Christley et aI., 
2001). Due to the ubiquitous nature of S. zooepidemicus and the non-availability of 
specific-pathogen-free foals to this organism, there is a lack of evidence for S. 
zooepidemicus satisfying Koch's postulates of infectious causality (Newton, 2002). 
However, 7 out of 9 criteria for causal association of S. zooepidemicus with lAD have been 
met, namely strength of association, consistency, biological gradient, biological 
plausibility, coherence, some limited experimental evidence, and analogy with other 
species (Cardwell, 2007; Newton et aI., 2003; Wood, 1994). In addition, although most 
studies identified S. zooepidemicus as an important, but not absolutely exclusive infectious 
factor in this disease syndrome (Burrell et aI., 1996; Chapman et al., 2000; Newton et aI., 
2003; Wood et al., 1993; Wood et aI., 2oo5a; Wood et aI., 2oo5b; Wood, 1999), a study in 
National Hunt racehorses revealed S. zooepidemicus as the only bacterial species 
associated with lAD in multivariable analysis (Cardwell, 2007). With the exception of 
influenza virus, which has low prevalence in vaccinated populations, virus infection 
(including equine herpesvirus-1 and -4, equine rhinovirus-1 and equine adenovirus) has not 
been associated with clinically apparent respiratory disease in young racehorses (Newton 
et aI., 2003). S. zooepidemicus-associated lAD is therefore unlikely to occur as strictly 
secondary to primary viral infection, which has been the traditional view. 
It is likely that the aetiology of lAD involves stresses associated with the lifestyle of the 
racehorse, including those that arise from stabling (Christley et al., 2001). However, lower 
airway disease has also been observed in recently weaned ponies entering new premises, 
suggesting that non-Thoroughbreds kept at pasture undergo a form of lAD clinically 
similar to that seen in racehorses (Newton et aI., 2007). This natural clinical respiratory 
disease has been characterised predominantly by mucoid nasal discharge, coughing and 
occasionally pyrexia, dyspnoea and pneumonia. S. zooepidemicus is one of the bacterial 
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species most commonly isolated from the lungs of affected animals and an epidemiological 
study found that higher clinical scores were associated with higher colony numbers of S. 
zooepidemicus in tracheal wash (TW) samples (dose response), which was consistent with 
previous studies of both clinical disease and airway inflammation (Newton et at., 2007). 
Interestingly, ponies suffering naturally occurring respiratory disease occasionally present 
submandibular lymphadenopathy (Newton, 2002; Newton et ai., 2007) (unpublished 
observations). These LNs become enlarged and hardened and may become abscessed, 
which often occurs during S. equi infection, although abscessation associated with S. 
zooepidemicus infection is much less frequent. Unlike pneumonia, less severe lAD occurs 
as outbreaks with high morbidity and very low mortality, possibly because horses in 
training or immunologically naive youngsters experience less severe compromise to their 
respiratory tract defences than sick foals or adults subject to greater stress, such as 
anaesthesia (McGorum, 2006). 
The molecular epidemiology of S. zooepidemicus respiratory infection has been studied in 
detail in 2 different equine popUlations: Thoroughbred racehorses in training and Welsh 
mountain ponies with naturally occurring respiratory disease following their recent 
weaning and transportation to new premises (Barquero et ai., 2009; Newton et at., 2008). 
Both studies typed strains of S. zooepidemicus based on the characterisation of the SZp-
adhesin hypervariable region (Walker & Timoney, 1998) and the 16S-23S rRNA gene 
intergenic spacer (Chanter et at., 1997) so that the prevalence of different S. zooepidemicus 
types at different locations in the respiratory tract could be assessed over the study period 
(10 months in the Thoroughbred study and 10 weeks in the pony study). 
S. zooepidemicus infection was highly prevalent during the pony study, being isolated from 
94% of TW samples and 88% of nasopharyngeal (NP) swabs (Newton et ai., 2008), but 
was markedly less prevalent in the Thoroughbred study (22 to 23% of TW and NP 
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samples), which sampled an older population (Barquero et ai., 2009). A wide diversity of 
S. zooepidemicus types were identified in both equine populations, with 24 different types 
isolated from 198 Thoroughbreds and 39 types recovered from 29 ponies, although 10 
types accounted for > 80% of all isolates recovered from the 2 populations. Some 
similarities were seen in the most common types isolated, with Al types being the most 
prevalent in both study populations. The S. zooepidemicus genome sequencing strain 
(SzH70) is type AIHV4, which was the 5th most prevalent type isolated from tracheal and 
NP samples in the pony study (Newton et aI., 2008), the most prevalent type isolated from 
NP samples in the Thoroughbred racehorses and the 2nd most prevalent type isolated from 
TWs in the same Thoroughbred population (Barquero et ai., 2009). However, differences 
in the occurrence and prevalence of types were apparent between the 2 different study 
populations and also between different Thoroughbred yards (Barquero et ai., 2009; 
Newton et ai., 2008). In both studies, more types were isolated from the trachea (23 to 33) 
than the nasopharynx (15 to 27) but temporal patterns of bacterial prevalence for the 
respective 4 most prevalent types were similar in TW and NP samples. These data suggest 
that, counter to the observations previously reported (Timoney et ai., 1997a), the trachea 
acts as a source of S. zooepidemicus for the upper respiratory tract due to the clearance of 
mucus, bacteria and debris proximally with mucociliary action. Different S. zooepidemicus 
strains may also be adapted to differences in conditions for colonisation between the upper 
and lower airways (Barquero et ai., 2009; Newton et ai., 2008). It was noted that in 
individual animals NP S. zooepidemicus types were not necessarily predictive of types 
isolated from the trachea (Newton et ai., 2008). More S. zooepidemicus isolates were 
cultured from TW relative to NP samples, which may also have contributed to more types 
arising from the former (Barquero et ai., 2009; Newton et ai., 2008). 
Different S. zooepidemicus types varied markedly in their prevalence over time with some 
appearing dominant at times and many others never becoming well established (Newton et 
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ai., 2008). The appearance and disappearance of the different types over time in the pony 
population suggested that there was clonal succession of S. zooepidemicus types amongst 
the group of ponies (Newton et ai., 2008). A 3rd study assessed the infection/colonisation 
patterns of S. zooepidemicus strains (typed by multilocus sequence typing (MLST» in 
National Hunt racehorses and provided preliminary evidence for recurrent or persistent 
infection with the same strains, clonal succession within individual animals and sequential 
new infection with different strains (Cardwell, 2007). 
There is emerging evidence that horse genotype plays a role in S. zooepidemicus disease 
susceptibility, possibly related to transferrin haplotype. In the pony study of naturally 
occurring equine respiratory disease, ponies with transferrin haplotypes D were at 
significantly decreased risk of disease and S. zooepidemicus infection, whereas those with 
haplotype F2 were at significantly increased risk (Newton et al., 2008). Similarly, in a 
study of the effect of transferrin haplotype on susceptibility to IAD in young racehorses, 
individuals with haplotype D had a significantly lower prevalence and duration of IAD 
compared to those without this haplotype (Newton, 2003). Since transferrin is a host 
glycoprotein involved in sequestering free iron, these data suggest that the availability of 
iron to S. zooepidemicus during in vivo infection may differ depending on host transferrin 
genotype and impact on the ability of S. zooepidemicus to cause disease. Alternatively, 
another host factor genetically linked to transferrin haplotype may be important in disease 
susceptibility. Similar trends have been observed in horses infected with other bacterial 
species (Mousel et al., 2003; Newton, 2003), although a study of lAD in National Hunt 
racehorses showed that whilst increased odds of tracheal mucus were associated with the 
possession of haplotype F, the risk of nasal discharge was increased in horses with 
haplotype D (Cardwell, 2007). The apparently contradictory effect of haplotype D 
compared with other studies may have been related to the predominance of DfF 
heterozygotes in the study (Cardwell, 2007). 
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1.1.1 Immunity, vaccines, diagnostics and treatment 
Most horses carry precipitating antibodies to S. zooepidemicus, probably as a consequence 
of NP carriage of the organism and serum antibodies can cross-react with S. zooepidemicus 
antigens shared by S. equi (Timoney & Trachman, 1985). Antibodies to the hypervariable 
adhesin of S. zooepidemicus (Szp) have been detected in equine serum (Timoney et at., 
1995). During the development of a strangles blood test at the Animal Health Trust 
(AHT), serum antibodies specific to a number of antigens present in S. zooepidemicus, as 
well as S. equi, were present in negative control samples collected from horses with no 
history of S. equi infection (Nicola Butcher, unpublished observations). Another strangles 
blood test based on the S. equi SeM anti-phagocytic surface antigen requires a pre-
absorption step with heat killed S. zooepidemicus to reduce cross-reactivity from antibodies 
raised to the S. zooepidemicus variant of the SeM protein (Timoney, 1997). These data 
point to the development of humoral immune responses following S. zooepidemicus 
infection, but these have not been well studied for their role in clearing the bacterium. 
Antisera raised against Szp in rabbits elicited a protective opsonic activity against S. 
zooepidemicus in vitro (Timoney et ai., 1995). In addition, mice vaccinated with an E. coli 
lysate containing recombinant Szp were significantly protected against S. zooepidemicus 
infection following intraperitoneal challenge (Timoney et al., 1995). However, because 
this antigen of S. zooepidemicus is highly variable, immunity may not be cross-protective 
against other S. zooepidemicus strains. Antibodies and complement in uterine fluids have 
also been shown to be effective in enhancing phagocytosis and clearance of S. 
zooepidemicus (Asbury et ai., 1984). 
The presence of S. zooepidemicus as a normal resident of the equine upper respiratory tract 
and its regular isolation from adult horses, suggests that this organism is able to persist in 
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the respiratory tract despite the development of host immunity, which may in part be 
explained by the diversity of this bacterium. The sequential infection with different types 
of S. zooepidemicus previously observed (described above) (Cardwell, 2007; Newton et 
aI., 2008), suggests that continuous S. zooepidemicus infection does not necessarily reflect 
continuous colonisation by a single type, but instead may be due to clonal succession with 
non-cross-immunising subtypes of S. zooepidemicus. In support of this there is evidence 
that equine sera can be highly discriminating in their ability to opsonise S. zooepidemicus 
isolates (Causey et al., 1995). The predisposition of young horses to S. zooepidemicus 
associated disease (described above) indicates the importance of immunity, probably to a 
wide range of subtypes, in preventing these opportunistic infections. 
No vaccmes are currently available to protect against diseases associated with S. 
zooepidemicus infection and the development of an efficacious vaccine is likely to be 
hampered by the diversity of this SUbspecies. An attempt was made to protect recently 
weaned ponies from natural respiratory tract infection with S. zooepidemicus using 
inactivated, alum adjuvanted vaccine containing 2 strains each of S. zooepidemicus and 
Actinobacillus equuli (Newton et al., 2007). However, this vaccine failed maybe in part 
due to failure of challenge by the specific SUbtypes of the bacteria in the vaccine combined 
with an absence of cross-protective immunity conveyed between SUbtypes and an 
overwhelming mixed infection challenge (Newton et al., 2007). Future vaccme 
development may require the targeting of SUbtypes and conserved virulence factors linked 
to specific disease types. Immunisation of mares with bacterial protein extracts provided 
some resistance to endometritis caused by S. zooepidemicus, although vaccination resulted 
in adverse reactions at the injection site in some horses (Widders et ai., 1995). 
Culture analysis from relevant swab or wash samples can be used to identify S. 
zooepidemicus. This relies on the isolation of ~-haemolytic streptococci that agglutinate 
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latex particles coated with antibodies to Lancefield group C polysaccharide cell wall 
antigen and ferment sorbitol, lactose, ribose (most strains) but not trehalose (Bannister et 
aI., 1985). A multiplex PCR test, based on a S. equi subspecies-specific region of the 
superoxide dismutase gene sodA and the S. equi-specific mitogenic toxin gene seeI, has 
been developed with the potential to detect S. zooepidemicus and distinguish this bacterium 
from S. equi in test samples (Alber et aI., 2004). However, PCR testing is not commonly 
used to diagnose S. zooepidemicus infections at present, although Zoologix is currently 
marketing a qualitative PCR test to identify S. zooepidemicus as a tool in the detection and 
prevention of haemorrhagic pneumonia in dogs (see below) 
(http://www.zoologix.comldogcatJDatasheets/StreptococcusZooepidemicus.htm. accessed 
23.06.09). 
S. zooepidemicus is generally sensitive to penicillin and related antibiotics and also a 
variety of other antibiotics including tetracyclines, trimethoprim-sulfonamide combinations 
and peptide antibiotics (McGorum, 2006). Antibiotics have been used to treat S. 
zooepidemicus infections and also as a preventive measure to predisposing medical 
conditions or stressors (e.g. uterine fluid accumulation). Limiting stress through suitable 
management practices is equally important in preventing opportunistic disease. 
1.2 Diseases associated with S. zooepidemicus infection in other 
animals 
Unlike S. equi, S. zooepidemicus is not restricted to the horse and is an opportunistic 
pathogen of many other animal hosts including cattle, sheep, goats, foxes, birds, rabbits, 
guinea pigs, dogs, pigs and monkeys (Chalker et ai., 2003; Pesavento et ai., 2008; 
Stableforth, 1959). Associated diseases include mastitis, polyarthritis, bronchopneumonia, 
pleuritis, epicarditis, endocarditis, and meningitis (Las Heras et ai., 2002; Salasia et aI., 
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2004; Sharp et aI., 1995; Soedannanto et aI., 1996; Stevenson, 1974). Distinct strains of S. 
zooepidemicus appear to be associated with certain disease types (Webb et aI., 2008). 
Related S. zooepidemicus strains have been isolated from recent outbreaks of fatal 
haemorrhagic pneumonia in dogs in the USA and the UK (Webb et aI., 2008). A single 
virulent clone appears to be associated with a disease outbreak in 1994 in Indonesia among 
pigs and monkeys (Soedannanto et aI., 1996). On rare occasions, S. zooepidemicus can 
cause invasive infections in humans including bacteraemia and meningitis. These 
infections usually originate following zoonotic transmission from domesticated animals to 
humans (Barnham et aI., 1987; Bradley et al., 1991; Downar et al., 2001; Hashikawa et aI., 
2004; Korman et al., 2004; Latorre et aI., 1993; Pati et aI., 2007). Epidemic outbreaks 
have been associated with the consumption of unpasteurised dairy products, and many of 
these episodes have been complicated with post-streptococcal glomerulonephritis (Bordes-
Benitez et al., 2006; Francis et al., 1993; Kuusi et al., 2006), also a sequela of S. 
zooepidemicus infection in horses (Divers et al., 1992). Immune reactant renal disease has 
been associated with IgG antibody and streptococcal antigens (Divers et al., 1992). 
1.3 Strangles 
Strangles is one of the oldest recorded equine diseases. Giordano Ruffo, farrier to Emperor 
Frederick II of Italy, and Albertus Magnus, a Dominican bishop, described the acute 
clinical disease strangles (strangulina) in the earliest surviving European veterinary 
manuscripts dated from the 13th century (Slater, 2003). Caused by infection with the 
bacterium S. equi, strangles is a disease of the upper respiratory tract and draining LNs. 
Abrupt onset of fever is followed by acute swelling with subsequent abscess formation in 
the submandibular and retropharyngeal LNs and sometimes other LNs of the rostral neck 
(parotid and cranial cervical). This lymphadenopathy is a major clinical sign of the 
disease. Mature LN abscesses rupture, internally or externally, to release sometimes 
profuse quantities of creamy pus. Early on in the disease, pharyngitis and laryngitis may 
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contribute to serous nasal secretions, whilst later on the internal drainage of a ruptured 
abscess is characterised by a mucopurulent nasal discharge. Ocular discharge can also 
occur. The retropharyngeal LNs may drain into and cause empyema of the guttural pouch 
(GP). Throughout the course of the infection horses may demonstrate dysphagia and 
general depression as a result of fever and/or pain from inflammation of the respiratory 
tract, the development of abscesses and GP empyema. A soft moist cough sometimes 
accompanies these manifestations. Complications and severe sequelae to strangles 
infection often result in fatality - an 8% fatality rate was reported in one study (Sweeney et 
ai., 1987). 
1.3.1 Pathogenesis 
S. equi enters via the nose and mouth and attaches to the mucosa associated lymphoid 
tissues (MALT) of the oro- and nasopharynx. There is no evidence for colonisation prior 
to invasion. After infection, the bacterium is difficult to detect on the mucosal surface but 
small numbers appear in the tonsillar crypts, in the adjacent follicular subepithelium and 
underlying lymphoid follicles (Sweeney et ai., 2005; Timoney & Kumar, 2008). 
Translocation occurs in a few hours to the efferent LNs that drain the pharyngeal and 
tonsillar region. Intracellular and extracellular multiplication of S. equi has been detected 
in the tonsillar lymphoid tissue and LNs (Timoney & Kumar, 2008). Once inside the LNs, 
large numbers of polymorphonuclear neutrophils (PMNs) are attracted by complement-
derived chemotactic factors, but fail to phagocytose and kill the streptococci. 
Consequently, extracellular streptococci accumulate in long chains surrounded by large 
numbers of degenerating neutrophils (Sweeney et aI., 2005; Timoney & Kumar, 2008). 
Final disposal of these organisms is dependent on lysis of the abscess capsule and 
evacuation of its contents, which usually occurs within 7 to 14 days after the first clinical 
signs of disease. Fever develops between 3 and 14 days after exposure and blood 
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fibrinogen concentrations, white blood cell counts and neutrophil counts increase. The 
progression of strangles and severity of disease depends on the dose of S. equi received 
(the larger the dose, the shorter the incubation period) and depends on the immune status of 
the horse (e.g. more severe disease may be seen in young and elderly horses) (Sweeney et 
ai., 2005; Timoney & Kumar, 2008). 
Severe LN enlargement may lead to complications. The name strangles was coined 
because affected horses can be suffocated by enlarged LNs that caused dyspnea. This may 
occur through restriction of the airway (compression of the pharynx, larynx or trachea) or 
may result from damage to laryngeal nerves (Sweeney et al., 2005). Resultant respiratory 
distress and/or dysfunction of the swallow reflex as a result of nerve damage (Jeremy 
Kemp-Symonds, personal communication) can cause aspiration pneumonia (Sweeney et 
ai., 1987; Sweeney et ai., 2005). 
Metastasis of S. equi can result in abscess formation in other locations such as the lungs, 
brain, thoracic or abdominal LNs. This condition referred to with the archaic term 'bastard 
strangles' is almost always fatal. Spread is presumed to occur mainly via lymphatic 
channels as bacteraemia is rare (Evers, 1968) and LNs are usually involved alongside solid 
organs in the disseminated disease (e.g. splenic LNs and the spleen or mesenteric LNs and 
the intestine) (Ken Smith, personal communication). However, haematogenous 
dissemination of antigens may contribute to the development of purpura haemorrhagica, 
another sequela of strangles. 
Purpura haemorrhagica (also triggered by other streptococcal infections) is an immune-
system mediated aseptic vasculitis characterised by subcutaneous oedema, which is 
frequently fatal. Interestingly, this condition is also associated with the vaccination of 
horses with strangles vaccines containing the anti phagocytic S. equi surface protein SeM 
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(Pusterla et a!., 2003). Affected horses have characteristically very high levels of anti-
SeM-protein antibodies and it is thought that these generate SeM-protein immune 
complexes that deposit in blood vessel walls to cause a type 3 hypersensitivity reaction 
(Galan & Timoney, 1985b). An alternative mechanism for this state has been proposed 
based on the activation of host neutrophils by the binding of M-protein-fibrinogen 
complexes to P2 integrin receptors (Waller, 2007). This occurs in Streptococcus pyogenes 
mediated streptococcal toxic shock syndrome in humans and results in the release of an 
inflammatory mediator (heparin binding protein) by activated neutrophils with subsequent 
vascular leakage, oedema and toxic shock. In a mouse model of S. pyogenes infection, 
severe pulmonary damage caused by vascular leakage was substantially reduced by 
treatment with a P2 integrin antagonist (Herwald et aI., 2004). 
1.3.2 Transmission and persistent carriage 
Discharge from nasal secretions and ruptured abscesses provides a source of S. equi that 
can be transmitted directly to other horses through normal social behaviour or indirectly· 
through shared housing, water and feed sources, and other equipment or the clothing of 
handlers, farriers or veterinarians. Transmission may occur when horses show no obvious 
clinical signs of disease, for example during the early infection phase or after the clinical 
signs have disappeared. A moderate proportion of horses continue to harbour S. equi for 
several weeks after clinical signs have gone, even though the organism is no longer 
detectable in the majority 4 to 6 weeks after apparent recovery (Sweeney et aI., 2005). 
Incomplete drainage of exudates from the GPs (and more rarely the sinuses), which are 
known to become infected in the early phase of infection and following rupture of the 
adjacent retropharyngeal LNs, contributes to the prolonged intermittent shedding of S. equi 
(Newton et at., 1997; Sweeney et aI., 2005). Drying and hardening of exudates leads to 
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the fonnation of discrete bodies called chondroids that can remain in the GP for several 
years. Consequently, up to 10% of horses that have apparently recovered from strangles 
can continue to harbor S. equi for many months or years (Newton et aI., 1997) and transmit 
the infection to naive horses. The existence of carriers is undoubtedly important (Fintl et 
aI., 2000; Judy et al., 1999; Newton et al., 1997; Newton et al., 2000; Timoney et aI., 
1998) and probably critical to the success of S. equi. 
S. equi does not readily survive in the presence of soil-borne microflora and prolonged 
environmental persistence of S. equi is unproven (Sweeney et ai., 2005). One laboratory-
based study demonstrated survival on wood for 63 days at 2°C but did not include co-
infection with common environmental bacteria (Jonn, 1992). The inability of S. equi to 
persist in the environment suggests that carriers play a key role in the recurrence of 
strangles outbreaks. 
1.3.3 Diagnosis, control and treatment 
Careful management, treatment and diagnostic testing enable S. equi transmission to be 
contained and can prevent the initiation of new outbreaks. Horses that are new to premises 
or are suspected of being infectious and any individuals that they have been in contact with 
can be kept in isolation until further tests and/or time reveals the risk they pose to others. 
Monitoring body temperature can identify the onset of fever, an early clinical sign of 
strangles. Prompt treatment with antibiotics during the early acute phase may abort the 
infection but does not prevent re-infection if the animal is re-exposed once the treatment is 
withdrawn (Sweeney et al., 2(05). S. equi is sensitive to the majority of antibiotics in 
vitro, but antibiotic therapy is usually ineffective once external lymphadenopathy is 
detected probably due to the lack of sufficient vascularity in the abscess to enable 
antibiotic penetration to therapeutic levels (Harrington et aI., 2002). Management is then 
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limited to isolation, careful monitoring (particularly for complications associated with 
strangles) and palliative care until the abscesses have ruptured and the horse's own 
immunity has cleared the infection. 
PCR and culture analysis of NP swabs or wash samples are useful tools to identify S. equi 
infection, particularly where clinical signs of disease are not obvious (e.g. during the early 
and late phases of disease, mild disease or asymptomatic carriage) (Newton et al., 2000; 
Sweeney et aI., 2005; Timoney & Artiushin, 1997). Culture analysis relies on the isolation 
of ~-haemolytic streptococci that agglutinate latex particles coated with antibodies to 
Lancefield group C polysaccharide cell wall antigen and are unable to ferment trehalose, 
sorbitol, lactose or ribose (Bannister et ai., 1985). Unfortunately the growth of S. equi on 
agar plates can be outcompeted or masked by other bacteria particularly if S. equi is 
present as the minority. PCR can help to overcome this limitation but both tests require S. 
equi to be present in the respiratory tract at the moment of sampling. As S. equi shedding 
is usually intermittent, a prolonged quarantine period with or without repeated testing is , 
often necessary. In the past, an individual has been considered clear of infection on the 
collection of 3 consecutive negative NP swabs over a 2 week period (George et at., 1983). 
Currently there is an increasing trend toward blood testing (see below) and GP endoscopy. 
Endoscopy is used to look for signs of pathology in the GP, to collect lavage samples for 
analysis by culturelPCR and to clear any chondroids or contaminating material (often 
followed by antibiotic treatment to kill residual bacteria). 
Blood tests bestow a significant advancement in the detection of S. equi as they do not 
require an animal to be shedding S. equi at the time of testing. An ELISA test is currently 
used by practitioners in the USA (http://www.idexx.com/eguinellaboratory/segui elisa!. 
Accessed 28.10.08). Unfortunately, overlapping breakpoints in normal and convalescent 
horses often complicates the interpretation of results from this SeM-protein-based test. 
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SzM, a near identical partial homologue to SeM is present in S. zooepidemicus (Kelly et 
ai., 2006) and antibodies raised to SzM are likely to cross-react with the SeM antigen. Pre-
absorption of cross-reacting antibodies by incubation of sera with heat killed S. 
zooepidemicus improves the reliability of the SeM ELISA, although at the expense of 
assay sensitivity (Timoney, 1997; Waller & Jolley, 2007). 
A new ELISA test was recently developed in the UK 
(http://www.aht.org.uklbact blood.html. Accessed 28.10.08), which has a sensitivity of 
91.5% and specificity of 90.2% and enables the robust detection of horses that have been 
recently exposed to S. equi. The antigens used in this test were chosen from among the 
array of coding sequences in the early Se4047 genome sequence predicted by 
bioinformatics to encode proteins likely to be exposed to the host immune system. This 
current study further revealed the antigens to be a specific feature of S. equi and absent 
from the S. zooepidemicus population (SEQ2190 and See!, Figure 2.6, Chapter 2). 
Blood sampling is generally well tolerated by horses and large numbers of animals can be 
screened by this method, which has a 24 hour turnaround time. However, antibody levels 
take 2-3 weeks to build up post infection and can remain elevated for up to 6 months once 
the horse has recovered and eliminated S. equi. The blood test is therefore a suitable pre-
screen procedure to complement good management, GP endoscopy, PCR and culture 
analysis. 
1.3.4 Vaccines 
Most horses develop immunity during recovery from strangles that may persist for 5 years 
or longer (Hamlen et ai., 1994; Sweeney et ai., 2005; Waller & Jolley, 2007). This 
indicates that stimulation of a high level of immunity is biologically feasible given the 
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appropriate presentation of protective immunogens. Despite this, progress in the 
development of an effective strangles vaccine has been slow. Bacterin type vaccines 
produced by moderate heat inactivation of logarithmic phase cultures were introduced in 
Australia in the 1940s and then in the USA in the 1960s (Timoney, 2004). Unfortunately, 
unacceptable severe adverse reactions occurred at the injection site, including 
inflammation and abscess formation. Extract vaccines prepared by hot acid or mutanolysin 
plus detergent treatment to release acid-resistant or surface proteins were better tolerated 
than bacterins and were marketed in the USA in the 1970s and 1980s. However, these 
conventional vaccines have shown disappointing efficacy, with little published data to 
support significant protection (Jorm, 1990; Sweeney et al., 2005; Timoney & Eggers, 
1985). 
More recent progress has seen the application of live attenuated S. equi vaccines. The first, 
Pinnacle IN, is administered via the intranasal route and has been widely used in the USA 
since its launch in 1998. However, the attenuating mutations in this strain were introduced 
through chemically-induced random mutagenesis and therefore, except for a resultant lack 
of capsule production and defects in carbohydrate utilisation, the mutations have not been 
defined. Point mutations are prone to back mutation and thus to reversion to full virulence 
and although this vaccine may protect up to 100% of horses (Timoney, 1993; Walker & 
Timoney, 2002; Waller & Jolley, 2007) it has not been licensed for sale in Europe due to 
safety concerns. These include residual virulence with formation of slowly developing 
submandibular abscesses in a small percentage of vaccinates, nasal discharge and 
occasional cases of purpura haemorrhagica (Sweeney et aI., 2005). The Pinnacle strain has 
since been refined to improve the genetic stability of its acapsular phenotype by deletion of 
part of the hasA and hasB genes, which encode hyaluronate (HA) synthase and uridine 
diphosphate (UDP)-glucose dehydrogenase, respectively (Pinnacle HasNeg) (Walker & 
Timoney, 2002). Both enzymes are involved in HA capsule biosynthesis. It is, however, 
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not clear if this new strain has replaced the original vaccine strain in the commercial 
product (Meeusen et aI., 2007) or what this modification offers in terms of improved 
safety. 
In 2004, the Equilis StrepE vaccine, a live recombinant strain TW928 was licensed for use 
in Europe (Jacobs et aI., 2000; Waller & Jolley, 2007). This strain, created by deletion of 
the aroA gene (Kelly et al., 2006), was 104-fold attenuated in intraperitoneal mouse 
challenge studies (Waller & Jolley, 2007). Originally developed for intranasal application, 
protection was only accomplished in horses by intramuscular injection and an unusual 
route of subcutaneous administration into the upper lip (Jacobs et aI., 2000). As seen with 
the conventional vaccines, intramuscular inoculation caused undesirable adverse reactions, 
including local swelling of muscle tissue and the formation of abscesses. Small pustules 
also occurred at the injection site following subcutaneous inoculation in the lip. However, 
the scale of the immune response to vaccination and persistence of the attenuated organism 
at the injection site appeared to correlate with protection. Intramuscular vaccination 
conferred 100% protection from subsequent S. equi challenge, whilst lip inoculation 
protected 50% of horses from the development of LN abscesses and a further 25% of 
vaccinates had reduced clinical signs of disease, albeit for a limited (3-month) duration of 
immunity. On dose reduction, reduced lip reactions further correlated with decreased 
protection (Jacobs et aI., 2000). 
To reduce side effects and at the expense of efficacy, Equilis StrepE is administered via the 
lip route and recommended for use in horses of high or moderate risk of strangles where 
acquisition of a short duration of immunity is advantageous. Booster vaccination of horses 
inoculated up to 6 months previously in the face of an outbreak has bee~ shown to improve 
clinical outcome (Waller & Jolley, 2007). However, bacterial replication of TW928 and 
abscess formation has been reported in a retropharyngeal LN following vaccination 
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(Kemp-Symonds et ai., 2007) and like the Pinnacle vaccine, contamination during 
concurrent immunisation with other vaccines has resulted in inadvertent adverse reactions 
at parenteral injection sites. Equilis StrepE is currently unavailable due to quality control 
problems and new safe methods of immunisation against strangles are being investigated 
with the use of novel recombinant strains (Andrew Waller, unpublished data) and subunit 
vaccines. 
Vaccines that target the SeM protein of S. equi specifically, showed promise in mouse 
vaccination challenge studies, but failed to demonstrate significant protection in horses 
despite the generation of SeM reactive antibodies (Hoffman et ai., 1991; Meehan et ai., 
1998; Sheoran et ai., 2002; Timoney & Mukhtar, 1993; Timoney et ai., 1997b). Similarly, 
a recombinant S. equi hyaluronate associated protein (HAP) vaccine, was partially 
protective in mice (Chanter et ai., 1999) but failed to prevent the development of strangles 
in horses despite the generation of serum and mucosal antibodies to this protein (Neil 
Chanter, unpublished data). 
A recent study assessed 2 mUlti-component subunit vaccines comprising 5 to 6 
recombinant surface exposed or secreted S. equi proteins that are immunogenic and 
recognised by the host immune system during experimental infection with S. equi. These 
included cell wall-anchored surface proteins (SzPSe, Cne, Se46.8, Se51.9), a lipoprotein 
(Se44.2) and a secreted protein (Se42.0) with functions as diverse as fibrinogen binding, 
collagen binding, adhesion, immunoglobulin (Jg) and platelet binding and methionine 
sulfoxide reductase activity. Subcutaneous immunisations yielded strong serum antibody 
responses to each protein component but failed to provide any protection against strangles 
(Timoney et ai., 2007). 
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Another group has successfully identified a mUlticomponent recombinant protein vaccine 
that confers some protection from strangles in horses (Waller et al., 2007) (Table 1.1). 
This group used a mouse model to assess the suitability of different protein combinations 
in vaccines to protect against S. equi infection (Table 1.1). Their early results 
demonstrated that a combination of 3 proteins Fnz (cell wall-attached fibronectin binding 
protein), Sfs (secreted fibronectin binding protein) and Eag (u2-macroglobulin, albumin 
and JgG binding protein) conferred improved protection of mice when compared with 
vaccination with Eag alone. In addition, vaccination with the collagen binding protein Cne 
or a collagen-like protein Sc1C conferred partial protection which was enhanced on 
vaccination with a combination of Cne and Eag (Flock et al., 2006). Picking the right 
combination of vaccine components to generate a synergistic and protective immune 
response appears to be important. Intranasal and intramuscular immunisation of horses 
with a combination of Eag, Cne and Sc1C resulted in significantly reduced nasal discharge 
and bacterial growth from NP swabs and a lower rate of empyaema or scarring of the GPs 
following intranasal challenge of horses with S. equi (Waller et al., 2007). 
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Table 1.1 Potential subunit vaccine components to protect against strangles 
Protein Function Features Protection against S. equi infection 
following recombinant protein vaccination 
Fnz CL- andFn- Surface protein Partial protection in mice when combined 
binding with Sfs and Eag 
Sfs Fn- binding Secreted protein Partial protection in mice when combined 
with Fnz and Eag 
Eag IgG-, O,2M-, Surface protein Partial protection in mice enhanced when 
albumin-binding used in combination Fnz and Sfs, also partial 
protection in mice when used in combination 
with Cne 
Partial protection in horses in combination 
with Cne and Sc1C 
Cne CL- binding Surface protein Partial protection in mice enhanced when 
used in combination with Eag 
Partial protection in horses in combination 
with Eag and Sc1C 
Sc1C Unknown CL-like surface Partial protection in mice 
protein Partial protection in horses in combination 
with Eag and Cne 
CL: collagen, Fn: fibronectin, a2M: a2-macroglobulin 
1.3.5 Immunity 
The basis for protection against S. equi infection is not fully understood. Humoral 
immunity is presumed to be an important aspect of defence as serum antibodies specific to 
S. equi antigens have been observed in horses that are resistant to S. equi infection as a 
result of previous exposure or vaccination (Galan & Timoney, 1985a; Timoney et al., 
2007). Convalescent sera contain antibodies raised against a wide range of S. equi antigens 
(Andrew Waller, unpublished data), (Artiushin et ai., 2002; Timoney et al., 2008). 
However, a strong vaccine-induced antibody response often does not correlate with 
protection (see above), which may depend on the target(s) or type of vaccine chosen or a 
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failure to elicit a suitable antibody response or as yet unknown mechanisms of immunity 
(e.g. cell mediated immunity). The exact mechanism of action of antibodies has rarely been 
addressed but is proposed to depend on the blocking of function and/or opsonisation. For 
example, Cne mediates bacterial adherence to collagen, a component of host extracellular 
matrix (ECM) (Lannergard et al., 2003) and serum antibodies against Cne are able to block 
adherence of S. equi to immobilized collagen in vitro (Flock et ai., 2006). Antibody-
mediated blockage of adherence in vivo might therefore hamper the infectious process and 
contribute to the partial protection observed in animals vaccinated with Cne as a 
component ofmuti-subunit vaccines (see above). Convalescent ponies or those immunized 
with recombinant S. equi mitogen SeeI (SePE-I) are protected from the pyrogenic effect of 
subsequent SeeI administration most probably through a neutralising antibody response 
(Artiushin et al., 2002). Neutralising antibodies to streptococcal superantigens appear 
important in resistance of humans to severe group A streptococcal disease (Kotb, 1995). 
Opsonophagocytosis of S. equi has been demonstrated indirectly using in vitro bactericidal 
assays and sera collected following S. equi infection or vaccination with M protein, extract 
or bacterin vaccines (Sheoran et al., 1997; Timoney & Eggers, 1985). Ig subclasses 
capable of eliciting this effector function have been defined with the aid of genomic 
identification. IgGl, IgG3, IgG4, IgG5 and IgG7, but not IgG2 and IgG6, are able to elicit 
a strong respiratory burst from equine peripheral blood leukocytes suggesting that these 
subclasses are able to interact with Fc receptors on effector cells. IgGl, IgG3, IgG4 and 
IgG7, but not IgG2, IgG5 and IgG6, are able to bind complement Clq and activate 
complement via the classical pathway (Lewis et al., 2008b). Of the originally described 
IgG subclasses, IgGa corresponds to IgGl, IgGb to IgG4 and IgG7, IgGc to IgG6, and 
IgG(T) to both IgG3 and IgG5 (Wagner et al., 2002; Wagner et al., 2004). Purified IgGa 
(IgGl) and IgGb (IgG4 and IgG7) but not IgGc (IgG6) or IgG(T) (IgG3 and IgG5) from 
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sera collected after vaccination with S. equi protein extract killed S. equi in vitro in the 
presence of complement and phagocytes (Sheoran et ai., 1997). 
A protective antibody response might therefore contain a predominance of Ig sub-isotypes 
that contribute to the clearance of bacteria via these mechanisms and some antigen-specific 
Ig subclass responses to infection and vaccination have been measured. One study 
demonstrated a predominant and prolonged serum SeM-specific IgGb (IgG4 and IgG7) 
response to infection but also significant increases in IgGa (IgG 1), IgG(T) (IgG3 and 
IgG5) and a small increase in IgGc (IgG6). In comparison, a poor response by IgG 1 
(IgGa) to immunisation may have contributed to the failure of an extract vaccination to 
protect horses from subsequent S. equi challenge (Sheoran et al., 1997). However, in vitro 
bactericidal activity of serum Ig does not necessarily indicate in vivo protection (Sheoran et 
ai., 1997; Timoney & Eggers, 1985). 
Although IgG is the principal antibody in serum, serum IgA also contributes to the in vitro 
opsonophagocytosis of S. equi (Sheoran et ai., 1997) and secretory IgA is the predominant 
antibody in nasal secretions of adult horses (Sheoran et al., 2000). SeM, Se18.9 and IdeE-
specific mucosal IgA have been detected following clinical strangles and show a similar 
pattern of response to infection as serum IgG, peaking at 3 to 6 weeks post exposure and 
gradually declining over 4 to 6 months (Sheoran et ai., 1997; Timoney et ai., 2008; Tiwari 
et al., 2007). Mucosal IgA may therefore contribute to immunity against S. equi infection, 
although a failure to react with a number of S. equi proteins has been noted (Galan & 
Timoney, 1985a). Ponies that received intranasal (and intramuscular) vaccination with 
mixed protein antigens, which conferred some protection from S. equi infection, generated 
antigen-specific IgG but only low concentrations of antigen-specific ~gA in NP wash 
samples (Flock et ai., 2006). Mucosal IgG antibodies may therefore playa role in 
immunity and the failure of an extract vaccine to provide protection against strangles could 
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in part be due to the lack of an adequate mucosal IgG or IgA response (Sheoran et ai., 
1997). 
Since the port of S. equi entry is the naso- and oropharyngeal tonsils it is conceivable that a 
first defence would be most effective at the mucosal surface. One group of researchers, 
with some success, have focused their vaccine approach to block (at least in part) the 
function of adhesins that might be important in early adhesion and invasion events (Waller 
et ai., 2007). Immune horses appear to rapidly clear intranasally inoculated S. equi and 
also show no boost in serum antibody concentrations to some antigens previously 
recognised from S. equi infection, which may suggest that convalescent protective 
immunity occurs early on in the infectious process (Timoney et ai., 2007). 
Immunity to S. equi infection may prove to be a complex process with many contributing 
facets as both intramuscular and intranasal routes of vaccination have demonstrated 
efficacy (Jacobs et aI., 2000; Timoney, 1993; Walker & Timoney, 2002). S. 
zooepidemicus is a normal commensal resident of the equine tonsil and very closely related 
to S. equi, but does not stimulate immunity that is cross-protective against S. equi infection 
(Bazely, 1942). For this reason, protective immunogens of S. equi are presumed, at least in 
part to be specific to this subspecies and more recent research into multi-component 
subunit vaccines has focused on the use of recombinant protein mixes that contain at least 
some S. equi unique components (Timoney et ai., 2007; Waller et ai., 2007). Comparative 
genomic analysis between S. equi and S. zooepidemicus will highlight potential vaccine 
targets that are specific to the former and this approach could reduce the time and cost 
associated with future vaccine development. 
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1.4 Phylogenetics of Streptococcus zooepidemicus and Streptococcus 
equi 
The classification of streptococci has come a long way since 1903 when streptococci were 
first classified as either ~-haemolytic or non-~-haemolytic according to their phenotype on 
blood agar. In 1933, Lancefield differentiated the ~-haemolytic streptococci using 
serological tests based on carbohydrate 'group' antigens (Lancefield, 1933). In 1937 
Sherman proposed a scheme for placing the streptococci into four categories based on the 
Lancefield typing and fermentation/tolerance profiles (Sherman, 1937). These were the 
pyogenic (pus forming) group (including the ~-haemolytic streptococci Lancefield groups 
A-G), the viridans (oral) group (now viridans streptococci), the lactic group (now 
lactococcus) and the enterococci. This division of the streptococci is not appreciably 
different from that of today's identification systems except that now only the 2 first groups 
remain in the genus Streptococcus; the lactococcus and enterococci have been reclassified 
as separate genera. 
The ~-haemolytic streptococci have been separated into species and subspecies using a 
variety of techniques including DNA-DNA reassociation, 16s rRNA gene sequencing, 
whole-cell protein analysis, multilocus enzyme electrophoresis (MLEE), and phenotypic 
characteristics (Facklam, 2002). With the progression of DNA sequencing, multilocus 
sequence typing (MLST) has become established as a powerful molecular typing 
methodology to discriminate streptococcal isolates. 
The pyogenic group of streptococci include several species of significant medical and 
veterinary importance. Streptococcus agalactiae (group B Streptococcus (GBS» is the 
most common cause of neonatal sepsis (Facldam, 2002). Streptococcus pyogenes (group A 
Streptococcus (GAS» causes bacterial pharyngitis, impetigo and a host of other infections 
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in man including severe invasive diseases. Streptococcus canis has the Lancefield group G 
antigen and, as the name suggests, is isolated frequently from dogs (Facklam, 2002). S. 
equi and S. zooepidemicus belong to the Lancefield group C p-hemolytic group of 
pyogenic streptococci and, based on 16s rRNA sequence, are most closely related to S. 
pyogenes and S. canis (Figure 1.1). 
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Figure 1.1 A maximum likelihood tree based on 16s rRNA showing the diversity of the 
streptococci 
Figure reproduced with kind permission from Matt Holden, Sanger Institute. The S. equi 
subspecies share the same branch of the tree. 
27 
1.4.1 Streptococcus equi subspecies 
S. equi and S. zooepidemicus are officially designated S. equi subspecies equi and S. equi 
subspecies zooepidemicus because S. equi was regarded as the archetype for S. 
zooepidemicus, based on DNA hybridisation studies (Farrow & Collins, 1984). However, 
later examinations using MLEE (Jorm et ai., 1994) and sequence analysis of 16S and 23S 
rRNA intergenic spacers (Chanter et al., 1997) suggest the reverse scenario: that in fact S. 
zooepidemicus is the ancestor of S. equi. MLST provides the most compelling evidence 
yet to confirm S. equi as a descendant of S. zooepidemicus (Webb et al., 2008) and a 
reclassification of these two subspecies seems appropriate to accurately reflect their 
origins. 
A novel subspecies S. equi subspecies ruminatorum was recently isolated from milk 
samples from small ruminants with mastitis (Fernandez et aI., 2004). Based on 16S rRNA 
gene sequencing, S. equi and S. zooepidemicus are the closest phylogenetic relatives to S. 
ruminatorum with 98% DNA sequence identity. S. ruminatorum is ~-haemolytic and 
possesses the Lancefield group C antigen but it does not correspond to S. equi or S. 
zooepidemicus in terms of its rRNA gene restriction patterns or biochemical reactions 
(Fernandez et al., 2004). Unlike S. equi and S. zooepidemicus, S. ruminatorum is able to 
perform synergistic haemolysis with Staphylococcus aureus (Christie-Atkins-Munch-
Petersen (CAMP) reaction) and hydrolyses hippurate but fails to acidify sucrose or methyl 
~-D-glucopyranoside. S. ruminatorum does however ferment lactose, sorbitol and ribose, a 
feature of S. zooepidemicus in > 90% , > 90% and 80-89% of strains respectively, but not 
a feature of S. equi (Holt, 1994). Like S. equi and S. zooepidemicus, S. ruminatorum is 
unable to ferment trehalose. 
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1.4.2 Population structure of Streptococcus equi and Streptococcus zooepidemicus 
MLEE and MLST have highlighted the diverse population structure of S. zooepidemicus 
and the near clonal nature of the S. equi population. Using 247 Australian isolates cultured 
from horses (70 S. equi and 177 S. zooepidemicus), 3 clusters of 40 electrophoretic types 
(ET) of S. zooepidemicus and a unique ET -12 typical of S. equi were identified (Jorm et 
aI., 1994). Webb et al (Webb et aI., 2008) identified 130 unique sequence types (STs) 
from 277 isolates of varied geographical and temporal origin (Figure 1.2). All S. equi 
isolates were ST-179 or its single locus variant ST-151. An online MLST database is 
maintained at the University of Oxford (http://pubmlst.orglszooepidemicus), which 
currently holds 220 STs for S. zooepidemicus (n = 462) and 2 STs for S. equi (ST-179, n = 
'25, ST-151, n = 2, accessed 02.04.09) (Jolley et aI., 2004). 
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Figure 1.2 A majority-rules consensus tree 
Tree generated from 12 independent runs of ClonalFrame, each with 250 000 iterations, 
and imported into MEGA to display as a radial tree (Webb et ai., 2008). The ST-1511179 
cluster represents all S. equi isolates, including Se4047 (ST-179). The ST-71 cluster 
represents mostly S. zooepidemicus respiratory isolates (87%, n = 46), including SzH70 
(ST-1). Each ST in the ST-1511179 and ST-71 clusters is a single locus variant of the 
primary founder ST-179 and ST-71, respectively. *Isolates from outbreaks of acute fatal 
haemorrhagic pneumonia in dogs (Webb et al., 2008). Figure reproduced with kind 
permission from Keith Jolley, Oxford University. 
A propensity for recombination appears to be a feature of the S. zooepidemicus popUlation 
and a contributing factor to the genetic diversity of this SUbspecies (Webb et al., 2008). 
The eBURST diagrammatic representation of the S. zooepidemicus popUlation based on 
MLST analysis (Figure 1.3) (Webb et al., 2008) resembles similar popUlation snapshots 
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generated for highly recombining species such as Helicobacter pylori (Turner et al., 2007). 
Statistical tests of congruence show that the topologies of maximum-likelihood trees 
constructed using data from individual MLST loci are significantly different (Webb et al., 
2008) contrary to the phylogenetic congruence that occurs under entirely clonal evolution . 
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Clusters of related STs and individual unlinked STs within the study sample are displayed 
as a single eBURST diagram (Webb et al., 2008). Clusters of linked isolates correspond to 
clonal complexes. Primary founders (blue) are positioned centrally in each cluster, and 
subgroup founders are shown in red. 
MLEE showed S. equi to be ET-12 (69 of 70 isolates), closely related to the S. 
zooepidemicus ET -13 and belonging to the electromorph cluster B with types 4 to 22 
comprising 109 of 177 S. zooepidemicus isolates (Jorm et al. , 1994). MLST analysis 
revealed that some related S. zooepidemicus strains associated with particular disease types 
and surprisingly, isolates of S. equi shared a recent evolutionary ancestor with S. 
zooepidemicus isolates that were significantly associated with cases of uterine infection or 
abortion in horses (P < 0.001, Fischer's exact test, n = 145). S. equi clustered with 10 
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independent S. zooepidemicus isolates, 8 (80%) of which were associated with uterine 
infection and abortion. This cluster accounted for 18% (8 of 44) of all independent isolates 
from uterine infection or abortion in the MLST study compared with only 1 % (2 of 203) of 
other independent S. zooepidemicus isolates studied (Figure 1.2) (Webb et aI., 2008). 
S. zooepidemicus respiratory isolates formed 5 distinct phylogenetic clusters and included 
40 of 46 isolates in the ST -71 complex, 13 of 17 isolates in the ST -8 cluster, 16 of 17 
isolates in the ST-106/164 cluster, all 8 isolates in the ST-103 complex, all 11 isolates in 
the ST-119 complex and all 5 isolates in the ST-117/148 cluster (Figure 1.2 (Webb et aI., 
2008». Of a total of 145 S. zooepidemicus isolates associated with disease, a significantly 
higher proportion of isolates in the ST -71 cluster were recovered from cases of respiratory 
infection (rather than from other disease types) compared with those isolates that did not 
cluster in the ST-71 complex (P < 0.001, Fischer's exact test) (Webb et aI., 2008). A lack 
of association with respiratory colonisers does provide a possible explanation for the lack 
of evidence for colonisation of the equine respiratory tract by S. equi prior to invasion 
(Sweeney et at., 2005). The sequenced S. zooepidemicus genome SzH70 is ST-l and 
clusters in the ST-71 respiratory complex, which contains independent isolates from the 
UK and USA collected over a long time period. This strain was chosen for genome 
sequence analysis before MLST data were available and is more distantly related to S. equi 
compared with other types. SzH70 was chosen as a prevalent rRNA intergenic spacerlM-
protein PeR-type AIHVI (Newton et at., 2008) isolated from a nasal swab taken from a 
healthy racehorse in Newmarket, England, in 2000 (Webb et aI., 2008). Se4047 , ST-179, 
was isolated from a horse with strangles in the New Forest, England, in 1990 (Kelly et aI., 
2006). 
S. zooepidemicus STs associated with disease in dogs also often clustered together (Figure 
1.2), including isolates from 3 UK outbreaks of acute fatal haemorrhagic pneumonia and 
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from 3 outbreaks of this disease in the USA. Some strain types isolated from dogs were 
also able to infect horses (Webb et ai., 2008). 
1.4.3 Differentiation of Streptococcus equi strains 
The absence of variation in housekeeping genes has required alternative methods to 
distinguish strains of S. equi. In the past, S. equi isolates were differentiated by peR using 
enterobacterial repetitive intergenic consensus primers (Al-Ghamdi et ai., 2000). More 
recently sequence variation of the SeM gene, most likely driven by immune selection from 
the host, has allowed the discrimination of S. equi isolates (Anzai et at., 2005; Kelly et at., 
2006). SeM is a virulence determinant involved in evasion of phagocytosis (Boschwitz & 
Timoney, 1994a; Galan & Timoney, 1987; Meehan et ai., 1998; Timoney et ai., 1997b). 
The short term variability of virulence genes or hypervariable genes has been used by 
others to enhance the discrimination of bacteria that lack variation in constitutive genes 
(van Loo et at., 2002). 
An online database (http://pubmlst.orglszooepidemicus/seM/) holds information on a total 
of 64 S. equi SeM alleles (accessed 02.04.09) including 43 reassigned in 2007 from two 
studies conducted in 2005 and 2006 (Anzai et at., 2005; Kelly et at., 2006; Waller & 
Jolley, 2007). Figure 1.4 shows the split decomposition analysis of the amino acid 
sequences of these 43 SeM alleles (Waller & Jolley, 2007). Both studies showed that 
groups of related isolates tended to be recovered from particular geographical locations, 
with allelic-types characteristic of North America and European outbreaks apparent. The 
SeM alleles of isolates from Brazil (alleles 40 and 41) and Australia (allele 15) were 
similar to those from European isolates, whereas SeM alleles of the majority of isolates 
from Japan (alleles 18, 19, 20 and 21) were related to alleles present in strains from the 
USA (alleles 24 and 25) (Waller & Jolley, 2007). This matched reports suggesting that an 
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outbreak of strangles in Tokachi, Japan originated from the transport of horses from 
Indiana, USA (Anzai et aI., 2005). SeM allele 9 is the most frequently identified allele 
type. The sequenced S. equi genome Se4047 has SeM allele type 3 which has been 
identified in 4 UK outbreaks and clusters with the European types (Kelly et at., 2006). 
SeM gene sUbtyping has been used to determine the source of new outbreaks, to follow 
changes in SeM sequence during the course of an outbreak and to differentiate between a 
vaccine strain and field strains of S. equi responsible for concurrent disease (Andrew 
Waller, unpublished data, (Kelly et aI., 2006». 
USA 
Europe 
• Japan 
~ Brazil 
• Australia 
Figure 1.4 Split decomposition analysis of the amino acid sequences of 43 SeM alleles 
Figure reproduced with kind permission from Andrew Waller, AHT and Keith Jolley, 
Oxford University (Waller & Jolley, 2007). 
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Chapter 2 Comparative and functional genomic analysis of 
Streptococcus equi and Streptococcus zooepidemicus 
2.1 Introduction 
2.1.1 Comparative genomic analysis 
Comparative genomic analysis refers to the sequencing and comparison of multiple 
genomes of closely related organisms in order to identify differences in their gene content 
that may indicate the events that shaped their evolution. This technology has been applied 
to a wide genera of bacteria, including several human pathogens and their ancestral 
relatives. Common themes underpining the evolution of bacterial pathogens include gene 
gain, gene loss, gene change and often a combination of all three (Pallen & Wren, 2007). 
For example, Yersinia pestis (aetiological agent of plague) and Shigella flexneri 
demonstrate all three aspects of molecular divergence in their adaptation to new highly 
specialised niches, either as a successful blood-borne parasite of fleas and rodents (and 
occasionally humans) or as an intracellular pathogen of human intestinal epithelial cells, 
respectively (Parkhill et al., 2001b; Wei et at., 2(03). Y. pestis has gained virulence 
factors that aid colonisation and persistence in the flea gut that have clearly contributed to 
its shift in host and transmission pathway, whilst S. flexneri has gained coding sequences 
(CDSs) on a large virulence plasmid, which have conferred the ability to invade epithelial 
cells (Sansonetti et at., 1982; Wei et al., 2003). Many other differences distinguish the 
. genomes of Y. pestis and S. flexneri from their ancestors (Yersinia pseudotuberculosis and 
E. coli, respectively) including genome rearrangements and gene decay. For example, loss 
of gene function has contributed to a loss in the motility of both species (Parkhill et at., 
2001b; Wei et at., 2(03). 
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2.1.1.1 Gene gain 
Horizontal gene transfer (HGT) is a potent source of gene gain and genomic variability 
between closely related bacteria. The extent of HGT was a revelation to the scientific 
community; however bacteria, inhabitants of the planet for over three and half billion 
years, have evolved a number of mechanisms to facilitate the uptake of foreign DNA in 
order to expand their potential for genetic adaptation. Genes can be acquired directly from 
other bacteria through contact-mediated transfer of DNA (conjugation), indirectly from 
bacteriophage vectors (transduction) or via the uptake of naked DNA from the 
surroundings (transformation). The ability to acquire DNA through these three 
mechanisms depends on the genetic make-up of the individual and in itself may be an 
adaptation of a particular species. 
The genome of Clostridium difficile, for instance, contains a large proportion of integrative 
and conjugative elements (ICEs). As the name suggests, these mobile elements were 
putatively acquired by conjugation and encode an extensive array of genes likely to be 
involved in antimicrobial resistance as well as virulence, host interaction and the 
production of surface structures (Sebaihia et aI., 2006). Virulent, multidrug-resistant 
strains of C. difficile have been responsible for recent outbreaks of antibiotic-associated 
diarrhoea. Related ICEs often share the same integration sites, and thereby increase the 
variability at such sites within both bacterial species and genera (Burrus & Waldor, 2004). 
Often the genes encoding the apparatus enabling conjugation are located on plasmids. 
Transduction has played an important role in the emergence of highly virulent clones of 
GAS and many other pathogens (Brussow et al., 2004; Canchaya et al., 2003). GAS infect 
humans only and are a common cause of pharyngitis ('strep throat'), but more severe 
forms of group A streptococcal disease (e.g. necrotizing fasciitis or 'flesh-eating disease' 
and streptococcal toxic shock syndrome) re-emerged in the 1980s. Comparative genomic 
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analyses revealed a large array of prophage in the genomes of the more virulent M-types of 
GAS associated with these outbreaks of severe invasive disease (Aziz et aI., 2005; Beres et 
al., 2002; Ikebe et aI., 2002; Nakagawa et al., 2003). The prophage elements carry genes 
that are superfluous for bacteriophage replication within distinct 'cargo compartments' at 
one end of the prophage genome, which encode DNAses, streptococcal phospholipase A2 
(Sla) and streptococcal pyrogenic exotoxins. The latter are superantigen-like extracellular 
proteins, which elicit a massive non-specific immunological response in the host and 
contribute to pathogenesis. 
Bacteriophage have also contributed genetic diversity to pathogens as distinct as E. coli 
(shiga toxin and type-Ill secretion effectors), Corynebacterium diphtheriae (diphtheria 
toxin), Vibrio cholerae (cholera toxin) and S. aureus (staphylococcal enterotoxin A, 
exfoliatin A and Panton-Valentine leukocidin) (Pallen & Wren, 2007). Interestingly, 
recombination between phage modules appears common (Brussow et aI., 2004; Canchaya 
et al., 2003) and so the potential for mobilization of cargo carried by phage is increased, 
which adds an extra dynamic to the fluidity of these phage-encoded genes among bacterial 
pathogens. 
Regions of atypical nucleotide content indicative of HGT are referred to as genomic 
islands where clusters of contiguous genes are present in some related strains or species but 
not in others. These may encode integrases (enzymes that integrate the island into the host 
DNA) and are often associated with transfer RNA loci. Pathogenicity islands (PIs) encode 
proteins that contribute a virulence phenotype (Pallen & Wren, 2007). However, the 
mechanism of mobilization of these genomic islands is not always apparent. The PIs of S. 
au reus are thought to have arisen following a misrecombination event that could have led 
to the replacement of a segment of phage DNA with a chromosomal segment (Feng et aI., 
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2008; Yarwood et aI., 2002). These loci require 'helper' phage for their mobilisation and 
can be transduced at a very high frequency (Lindsay et aI., 1998; Ruzin et aI., 2001). 
In Salmonella, the causative agent of food-borne gastroenteritis and typhoid fever, the 
presence of virulence genes on numerous PIs has conferred the ability of these organisms 
to invade and survive in eUkaryotic cells, and to cause disease (Whittam & Bumbaugh, 
2002). E. coli 0157:H7, implicated in major food-borne outbreaks of disease, has over 1.4 
Mb of specific DNA relative to the laboratory commensal strain E. coli K-12. This 
0157:H7 specific DNA is organised into approximately 180 discrete regions (O-islands) 
with the potential to encode over 1500 proteins, approximately 10% of which are assumed 
to have virulence-related functions (Hayashi et at., 2001; Perna et aI., 2001; Whittam & 
Bumbaugh, 2002). 
Plasmids and chromosomal elements have shaped the evolution of Y. pestis. Like its close 
relatives Y. pseudotuberculosis and Yersinia enterocolitica, Y. pestis is host to a 70 kb 
virulence plasmid pYV/pCDI. In addition, it also carries two other plasmids, pPst/pPCPl 
and pFralpMTI which are not present in the other Yersinia species. Together, these 
plasmids, and a high pathogenicity island (HPI), encode virulence factors involved in 
bacterial adhesion, injection of proteins into the host cell (type-III secretion molecules), 
invasion (plasminogen activator PIa), and the production of a siderophore yersiniabactin, 
important for iron acquisition (Bearden et aI., 1997; Cowan et aI., 2000; Parkhill et at., 
2001b). 
Evidence for gene duplication, another source of gene gain, has been identified in the 
genomes of S. equi and S. zooepidemicus, which contain 2 near-identical paralogues of 
hasC and glmU, genes encoding enzymes involved in the biosynthesis of hyaluronate (HA) 
capsule prescursors (Blank et aI., 2008). This duplication event is likely to improve HA 
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productivity by gene dosage. Similar gene expansion events are likely to have contributed 
to the evolution of S. equi (Karlstrom et aI., 2006) and are evident in many bacterial 
species encoding a diverse set of functions (Hollingshead et al., 1994; Tettelin et aI., 
2001). Half of the genes (52%) present in Mycobacterium tuberculosis arose from gene-
duplication events leading to extensive functional redundancy (Tekaia et aI., 1999). 
Expansion of insertion sequence (IS) elements is a defining feature of organisms that have 
encountered an 'evolutionary bottleneck'. This is common to many recently emerged 
pathogens that have entered a new niche with a decreased population size. In any 
population, ISs transpose through the genome to novel sites, but many of the resultant 
insertions disrupt CDSs or regulatory components and may confer a selective 
disadvantage. In normal circumstances, bacteria carrying them are often outcompeted by 
others in the population. However, for those that have encountered an 'evolutionary 
bottleneck' the selective disadvantage may not exist in the new environment andlor the 
mutation may be less likely to be competed out or repaired through recombination due to a 
small population size. The result is a build up of ISs in the population. Accumulation of 
ISs is particularly evident in Y. pestis (140 ISs), B. pertussis (261 ISs), B. mallei (171 ISs) 
and Shigella flexneri (314 ISs) (Jin et al., 2002; Nierman et al., 2004; Parkhill et al., 
2001b; Parkhill et al., 2003). 
2.1.1.2 Gene loss 
Despite the widespread occurrence of HOT, bacterial genomes tend to remain about the 
same size. This is because gene gain is usually accompanied by gene loss as genes 
unnecessary for survival in a new niche are no longer maintained by natural selection. 
This phenomenon of genome reduction is well demonstrated by the recently emerged 
pathogens that have changed lifestyle and often moved from a more diverse existence to 
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occupy a more restricted host-associated niche. For example, the genomes of Salmonella 
enterica serovar typhi, Y. pestis, Bordetella pertussis, Burkholderia mallei and 
Mycobacterium leprae show substantial genome decay when compared to their more 
flexible ancestors (Cole et al., 2001; Maurelli, 2007; Nierman et ai., 2004; Parkhill et ai., 
2001a; Parkhill et al., 2001b; Parkhill et al., 2003); the latter 3 species have evolved almost 
solely through gene loss. In most cases, the loss of gene function appears to have occurred 
relatively recently as small mutations have introduced frame shifts or early stop codons 
(pseudogenes). With time, larger regions of the gene or genome are lost. An abundance of 
ISs contributes to gene loss following recombination between these perfect repeat 
elements. M. leprae demonstrates extreme genome downsizing relative to other 
mycobacteria with less than half of the genome encoding functional protein-coding 
sequences. Gene deletion and decay have eliminated many important metabolic activities 
including siderophore production, part of the oxidative and most of the microaerophilic 
and anaerobic respiratory chains, and numerous catabolic systems and their regulatory 
circuits (Cole et al., 2001). Similar severe decay is seen in other obligate intracellular 
parasites (Andersson et al., 1998), which suggests that these organisms encode 'just 
enough' activity to permit intracellular growth. 
Situations are likely to arise where gene decay results from positive selection. This 
concept falls under the umbrella of 'pathoadaptation' (Maurelli, 2007). A newly minted 
pathogen, freshly equipped with virulence factors may require further modifications in 
order to better survive a new niche. Genes that are no longer compatible with the novel 
lifestyle of the pathogen are selectively altered or inactivated. These have been referred to 
as 'antivirulence genes' when the gene in question affects the pathogenicity of the 
organism (Maurelli, 2007). As an example, strains of shigella lack ompT; a gene present 
in closely related non-pathogenic E. coli. Introduction of ompT, which encodes a surface 
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protease, suppresses shigella virulence by disrupting intercellular spread (Nakata et aI., 
1993). 
2.1.1.3 Gene change 
Gene change refers to modifications that affect the sequences or order of the existing 
genes. A common feature of IS accumulation, in addition to gene decay, is genome 
rearrangement and translocation (Turlan & Chandler, 1995). Bordetella pertussis, Y. 
pestis, S. jlexneri 5b and Burkholderia mallei all demonstrate varying amounts of 
chromosomal rearrangement mediated by ISs. B. pertussis, in comparison to Bordetella 
bronchoseptica, has nearly 150 individual rearrangements, unprecedented for congeneric 
bacteria. Recombinations between ISs in Y. pestis are reflected by striking anomalies in 
GC bias and also occur during the growth of the organism in vitro. The effects of these 
frequent intra-genomic recombination events is a fluid genome but their influence on the 
biology of the organism is unknown (Parkhill et al., 2001b). 
Adaptation to a new niche is a continuous process. Newly acquired virulence traits, along 
with the pre-existing core genes, continue to undergo selection. Mutations within 
individual genes must also contribute to the initial development of gene functions as well 
as their subsequent fine tuning. Nonsynonymous changes and natural selection of the 
encoded proteins most likely determines the fate of new alleles. 
High levels of polymorphism have been observed at loci involved with host-pathogen 
interactions in many different bacterial species (Marciel et aI., 1997; McShan et al., 2008; 
Nassif et ai., 1993; Perna et aI., 1998; Salama et aI., 2000; Theisen et aI., 1995; Zhang & 
Wise, 1996). Genetic variation often occurs in surface adhesins. Uropathogenic E. coli 
express a variant form of FimH, a fimbrial adhesin, which confers an advantage for 
colonisation of the bladder through increased binding to mannosylated glycoproteins 
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(Sokurenko et ai., 1998). S. zooepidemicus demonstrates hyper-variability in the sequence 
of a protective adhesin (Fan et al., 2008; Timoney et al., 1995; Timoney et ai., 1997b). 
Where organisms such as S. zooepidemicus and S. equi have evolved a transmission pattern 
that relies on persistent infection, mechanisms for evading the host adaptive immunity are 
particularly important. The ratio of nonsynonymous to synonymous nucleotide changes in 
the seM gene of S. equi is extremely high suggesting that strong immune selection is 
directed against epitopes in the N-terminus of the antiphagocytic SeM protein (Kelly et ai., 
2006). Moreover, sequence changes occurred over time (Kelly et ai., 2006) and in some 
cases truncations arose in this region of seM in S. equi isolates that remained in the GPs of 
asymptomatic carriers for prolonged periods of time (Chanter et ai., 2000). 
Sequence changes can be introduced by random mutation; however recombination between 
closely related sequences in closely related strains may also contribute. Recombination is 
a predominant feature of S. zooepidemicus (Webb et al., 2008), Helicobacter pylori (Aras 
et ai., 2003) and other species such as Neisseria meningitidis, Haemophilus injluenzae and 
Streptococcus pneumoniae that are naturally competent and display hyper-variable 
chromosomal regions (AIm et ai., 1999; Nassif et al., 1993; Read et ai., 2000). Not all 
variation is expected to be adaptive. Some may present neutral variation between strains. 
Still others may be deleterious but either have not yet been eliminated by selection or 
cannot be eliminated because of linkage constraints. 
Many mechanisms of antigen and phase variation exist that allow bacteria to undergo 
frequent and usually reversible phenotypic changes resulting from genetic or, more rarely, 
epigenetic alterations at specific genetic loci. Borrelia burgdoiferi, the causal agent of 
Lyme disease, escapes the humoral immune system by generating variants expressing 
different antigenic forms of the VIsE surface lipoprotein. A functional copy of visE can 
recombine with anyone of 15 silent cassettes to create new versions of the lipoprotein 
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(gene conversion) (Bankhead & Chaconas, 2007; Wisniewski-Dye & Vial, 2008; Zhang & 
Norris, 1998). 
A mechanism of phase variation displayed by S. pyogenes switches the production of the 
adhesin SclB on and off through a process of slipped-strand misrepairing in 
pentanucleotide coding repeats (Rasmussen & Bjorck, 2001), a process that throws the 
CDS in and out of frame. Site-specific inversion of an element that usually contains a 
promoter and is flanked by short inverted repeat sequences can be catalysed by 
recombinases. The inversion event acts as a switch triggering the expression of a gene 
initially silent or impeding the expression of a gene initially expressed (Wisniewski-Dye & 
Vial, 2008). Bacteroides fragilis uses DNA inversion to modulate more than 20 genetic 
loci, which contain genes that encode bacterial surface proteins, polysaccharides and 
components of regulatory systems (Cerdeno-Tarraga et aI., 2005). Phase variation can 
have more far reaching effects by impacting on global regulation (van der Woude & 
Baumler, 2004). Coordinate phase variation of key S. pyogenes surface proteins is 
achieved through change in the central regulator, mga, required for expression of M 
protein and C5a peptidase (Bormann & Cleary, 1997). 
2.1.2 Genetic variation and virulence: Streptococcus equi and Streptococcus zooepidemicus 
This introduction describes the pre-existing knowledge of genetic determinants and 
putative virulence factors that are shared between S. equi and S. zooepidemicus or 
distinguish S. equi from its closely related proposed ancestor (Table 2.1). To relate these 
molecular factors to the processes of infection these are described under 3 headings, i) 
adhesion, ii) immune evasion and iii) tissue damage, dissemination and nutrient 
acquisition. However, many presented attributes offer functions covering more than one 
category and have been explained accordingly. 
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Table 2.1 Genetic determinants and potential virulence factors of S. equi and S. 
zooepidemicus 
Protein/factor 
S. equi S. zooepidemicus Function Features Protection against S. 
(Se) (Sz) equi infection 
following protein 
vaccination 
Fne Fnz CL- andFn- Surface protein in Sz, Partial protection in 
binding secreted, truncated mice when combined 
protein in Se with Sfs and Eag 
FneB Fnz2 CL- andFn- Surface protein No protection in mice 
binding 
Sfs Sfs (detected in Fn- binding Secreted protein Partial protection in 
85% strains only, mice when combined 
n=48) with Fnz and Eag 
Cne Cne CL- binding Surface protein Partial protection in 
mice enhanced when 
used in combination 
with Eag, partial 
protection in horses in 
combination with Eag 
and SelC 
FneC ? CL- binding Surface protein Not tested 
FneD ? CL- binding secreted, truncated Not tested 
protein in Se 
FneE ? CL- andFn- Surface protein Not tested 
binding 
FneF ? CL- binding Surface protein Not tested 
SelC ? Unknown CL-like surface Partial protection in 
protein mice, partial 
protection in horses in 
combination with Eag 
andCne 
SelD ? Unknown CL-like surface Not tested 
protein 
SelE ? Unknown CL-like surface Not tested 
protein 
SelF ? Unknown CL-like surface Not tested 
protein 
Sc1G ? Unknown CL-like surface Not tested 
protein 
Sc1H ? Unknown CL-like surface Not tested 
protein 
Sell ? Unknown CL-like surface Not tested 
protein 
SeM SzM SeM: Surface protein No protection in 
Antiphagocytic, horses 
IgG-, Fg-
binding, 
adherence 
SzM: unknown 
SzPSe Szp SzPSe: Fg- Surface protein Not tested 
binding 
SzP: adhesin 
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Table 2.1 continued 
Protein/factor 
S. equi S. zooepidemicus Function Features Protection against S. 
(Se) (Sz) equi infection 
following protein 
vaccination 
Se18.9 - Fg- and factor Secreted protein that Not tested 
H-binding, also associates with 
antiphagocytic the cell surface 
Hyaluronate capsule Antiphagocytic, Capsular Non-immunogenic 
adherence? polysaccharide 
SeeH - Superantigen Phage associated Not tested 
exotoxin: induces 
equinePBMC 
proliferation* and 
pyrexia in rabbits 
See! - Superantigen Phage associated Protection against the 
exotoxin: induces pyrogenic effects of 
equinePBMC See! but not tested for 
proliferation and protection against S. 
pyrexia in equi infection 
rabbitslhorses 
SeeL SeeL (only Superantigen Phage associated Not tested 
detected in 1 exotoxin 
strain out of 31 
strains tested) 
SeeM SeeM (only Superantigen Phage associated Not tested 
detected in 1 exotoxin 
strain out of 31 
strains tested) 
Eag Zag IgG-, U2M-, Surface protein Partial protection in 
albumin-binding mice enhanced when 
used in combination 
with Fnz and Sfs, also 
partial protection in 
mice when used in 
combination with Cne, 
partial protection in 
horses in combination 
with Cne and Sc1C 
IdeE IdeZ Antiphagocytic Secreted protein Not tested 
IgG 
endopeptidase 
(not active 
against equine 
IgG4) 
SLS SLS ~-haemolysis Secreted streptolysin Not tested 
S-like toxin 
Shp ? Haem-binding Surface protein Not tested 
and transfer 
HtsABC ? Haem-binding ABC transporter Not tested 
and uptake . 
transfer 
MtsABC MtsABC Putative MnlFe ABC transporter Not tested 
binding and 
uptake 
45 
Table 2.1 continued 
Protein/factor 
S. equi S. zooepidemicus Function Features Protection against S. 
(Se) (Sz) equi infection 
following protein 
vaccination 
Hpr Hpr Putative Histidine containing Not tested 
regulation of phosphocarrier 
sugar uptake protein of the 
streptococcal 
phosphotransferase 
system 
LppC LppC Acid Lipoprotein Not tested 
phosphatase 
Pst Pst Putative Phosphoenolpyruvate Not tested 
regulation of -protein 
sugar uptake phosphotransferase 
HAP HAP Putative ecto Hyaluronate Partial protection in 
threonine associated mice but no protection 
kinase, putative lipoprotein in horses 
regulatory role 
in hyaluronate 
capsule 
shedding 
through auto-
phosphorylation 
CL: collagen; Fn: fibronectin; Fg: fibrinogen; (l2M: (l2-macroglobulin. * Not shown to 
induce proliferation of equine PBMCs in this study. 
2.1.2.1 Adhesion 
Attachment to host cell surfaces is an essential first step in bacterial infection, which in 
Gram-positive bacteria is largely mediated by cell wall-anchored surface proteins that bind 
to components of the ECM such as fibronectin, collagen and fibrinogen (Patti et al., 1994). 
S. equi and S. zooepidemicus are likely to share factors that contribute to this early 
adhesive event. However, whilst S. zooepidemicus can remain at the respiratory surface 
for some time as evidenced by the regular isolation of this subspecies from the equine 
nasopharynx, S. equi rapidly invades the epithelium and subepithelial follicles before being 
translocated within a few hours to the efferent LNs. Differences there{ore exist in the 
invasive capabilities of these 2 subspecies and possibly their competence for persistent 
colonisation, at least of the mucosal surface in the oro- and nasopharynx. Fibronectin-
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binding proteins of S. pyogenes and S. au reus contribute to integrin-mediated cellular 
invasion (Hauck & Ohlsen, 2006; Schwarz-Linek et al., 2004) but such events have yet to 
be proven in S. equi. Fne produced by S. equi has been shown to re-shape host cells 
through an interaction with host integrins and ECM components (see below and section on 
immune evasion). S. equi may therefore use an as yet undetermined active process to 
mediate the early invasion event (possibly through factors described here) and/or it may 
rely on an indirect process of dissemination (see tissue damage, dissemination and nutrient 
acquisition below). 
Both S. equi and S. zooepidemicus harbor at least 3 genes encoding fibronectin-binding 
proteins (Table 2.1). In subspecies zooepidemicus, 2 of these proteins, Fnz (Lindmark et 
ai., 1996) and Fnz2 (Hong, 2005), are cell wall bound while the 3rd, Sfs (Lindmark & 
Guss, 1999) has characteristics of a secreted protein. In subspecies equi, the corresponding 
proteins are denoted Fne (Lindmark et ai., 2001), FneB (Lannergard et al., 2005) and Sfs. 
However, a frameshift mutation has occurred in the fne gene during the evolution of S. 
equi and as a result Fne is truncated relative to Fnz. Consequently, Fne does not have a 
cell wall anchor and is secreted from the cell but also lacks the 2nd fibronectin-binding 
domain of Fnz, which reduces the opportunity for fibronectin binding by S. equi via 2 
potential mechanisms. Firstly, by a reduced surface bound fibronectin binding capacity 
and secondly, because Fne is released into the extracellular environment fewer free 
fibronectin targets may be available for binding. Sfs may act in a similar fashion to reduce 
the availability of fibronectin ligands and although sis is a constant feature of S. equi (n = 
50), 15% of S. zooepidemicus strains (n = 48) lack this gene (Lindmark & Guss, 1999). S. 
equi strains typically bind significantly lower quantities of fibronectin than those of S. 
zooepidemicus (Lindmark et aI., 2001). A recombinant form of another predicted cell 
wall-anchored protein FneE identified in S. equi also binds fibronectin (Table· 2.1) 
(Lannergard, 2006), although fibronectin binding by S. equi appears to be mostly mediated 
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by the cell wall bound FneB (Lannergard et al., 2005). However, mice vaccinated with 
FneB were not protected against S. equi infection (Flock et al., 2006), although vaccination 
with Fnz and Sfs in combination with one other protein did confer some protection (Flock 
et al., 2004). It is worth noting that reduced fibronectin-binding capacity of GAS has 
resulted in increased virulence through enhanced bacterial dissemination (Nyberg et al., 
2004) and the same may apply for S. equi. 
FnzlFne and Fnz2IFneB also bind collagen, the most abundant structural component of 
ECM. Secretion of Fne may therefore also reduce the ability of S. equi relative to S. 
zooepidemicus to directly interact with host tissue via collagen binding. Another 5 S. equi 
putative cell wall-anchored proteins are involved in collagen binding: Cne, FneC, FneD, 
FneE and FneF (Table 2.1) (Lannergard et al., 2003; Lannergard, 2006), although FneD, 
like Fne, is interrupted by an early stop codon and is likely to be secreted as a truncated 
product. Cne belongs to the Cna family of collagen-binding proteins (Nallapareddy et al., 
2003; Patti et al., 1992; Rich et al., 1999; Sato et al., 2004; Xu et al., 2004) and contributes 
to 35% of the collagen binding activity of S. equi in vitro. The cne gene was a feature of 
all strains of S. equi (n = 13) and also all strains of S. zooepidemicus (n = 13). Cne as a 
subunit vaccine alone or in combination with 2 other recombinant proteins conferred 
partial protection against S. equi infection in mice and horses respectively (Flock et al., 
2006; Waller et al., 2007). FneC, FneD, FneE and FneF were identified as putative 
paralogues of Fne by BLAST analysis of the publicly accessible Se4047 genome and their 
presence in SzH70 is addressed in the results section of this chapter. 
A family of 7 collagen-like cell surface proteins (SclC - Scll) have also been identified in 
2 strains of S. equi, Se4047 and 1866 (Karlstrom et al., 2004; Karlstrom et al., 2006) but 
their presence in S. zooepidemicus has not been previously examined (Table 2.1). A 
common feature of these proteins are GXY -triplet repeats (collagen-like) and variable N-
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terminal regions (V regions) that show no similarity to known proteins. The biological 
role of these ScI proteins in S. equi is yet to be investigated but a collagen-like protein of S. 
pyogenes interacts with mammalian collagen-binding integrins (Humtsoe et ai., 2005) and 
similar host interactions may occur through this expanded family of ScIs in S. equi. Sera 
from horses previously diagnosed with strangles have antibodies against these proteins 
suggesting their expression by S. equi during infection (Karlstrom et ai., 2006). In 
addition, ScIC as a subunit vaccine alone or in combination with 2 other recombinant 
proteins conferred partial protection against S. equi infection in mice and horses, 
respectively (Flock et aI., 2006; Waller et al., 2007). 
Fibrinogen is an abundant plasma protein that increases in concentration during the acute 
phase of S. equi infection and can serve as a substrate for bacterial adhesins by coating 
trauma sites or as a component of the ECM. S. equi produces 2 cell wall-anchored proteins 
SeM (also known as FgBP) and SzPSe that bind strongly to equine fibrinogen (Table 2.1) 
(Meehan et ai., 2002; Timoney et al., 1997b), although pre-treatment of S. equi with SeM-
specific antibodies reduces fibrinogen binding by about 70% (Boschwitz & Timoney, 
1994b) and S. equi mutants lacking SeM fail to bind fibrinogen (Meehan et al., 2001), 
suggesting that SeM is more important for fibrinogen binding than SzPSe. The adherence 
of S. equi to cheek and tongue cells isolated from adult ponies could be inhibited by pre-
incubation of cells with purified SeM and antiserum raised to SeM inhibited adherence to 
the same extent as antiserum raised against whole S. equi cells (Srivastava & Barnum, 
1983). 
Both SzPSe and SeM have homologues in S. zooepidemicus named Szp and SzM, 
respectively (Table 2.1). SzPSe is an allelic variant of Szp, a hypervariable protective 
typing antigen of S. zooepidemicus (Timoney et aI., 1995; Timoney et ai., 1997b) that 
functions as an adhesin and mediates the binding of S. zooepidemicus to HEp-2 cells (Fan 
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et al., 2008). SeM has a unique N-terminal domain relative to its allelic variant in SzH70 
(Kelly et al., 2006). As this N-terminal region is necessary for the binding of SeM to 
fibrinogen (and. IgG), the replacement or modification of this region may represent an 
important evolutionary adaptation by S. equi and may have contributed to its increased 
virulence over S. zooepidemicus (Galan & Timoney, 1987; Timoney et al., 1997b). S. equi 
SeM mutants show decreased virulence in a mouse model (Meehan et al., 2001) while the 
contribution of SzPSe to the virulence of S. equi has not been investigated. Se18.9 is a 
secreted fibrinogen-binding protein (and factor H-binding protein) that is unique to S. equi 
and absent from S. zooepidemicus (Table 2.1). However, this protein also associates with 
the cell surface through an unknown mechanism (Tiwari et al., 2007). 
The HA capsule of S. zooepidemicus and S. equi may influence adherence of these bacteria 
to host cells, although conflicting data showed that higher levels of HA increased binding 
to HeLa cells by S. zooepidemicus (Wibawan et al., 1999) and decreased binding to tongue 
cells of ponies by S. equi (Srivastava & Barnum, 1983). An acapsular S. equi HA synthase 
deletion mutant (JhasA) did however show reduced clearance from in vitro air-interface 
respiratory epithelium cultures (Josh Slater, unpublished data). HA capsule may act as a 
direct ligand for host receptors (Harrington et al., 2002; Wessels, 2000), mask the active 
sites of adhesins or exert an influence through its negative charge on the conformation and 
functionality of surface exposed proteins involved in adhesion (Timoney, 2004). 
2.1.2.2 Immune evasion 
Fever, neutrophilia and increased plasma fibrinogen are symptoms of acute phase strangles 
that may be triggered as a consequence of superantigen production, which is a feature of S. 
equi but not generally S. zooepidemicus (Anzai et al., 1999a). By screening a S. equi 
chromosomal phage library for super antigen activity, 2 superantigens (SeeH and SeeI, 
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initially referred to as sePE-H and sePE-l) were identified in strain CF32 (Table 2.1) 
(Artiushin et al., 2002). SeeH and Seer are near identical orthologues of SpeH and Sper, 
the pyrogenic superantigens of S. pyogenes. seeH and see! were present in 7 out of 7 S. 
equi strains (Artiushin et aI., 2002) but absent from all S. zooepidemicus strains tested (n = 
7). Later, 2 orthologues of the S. pyogenes superantigens SpeL and SpeM were identified 
by data mining of the Se4047 genome (Table 2.1) (Alber et aI., 2005) and proved to be a 
consistent feature of S. equi strains (n = 17). An earlier study failed to detect these CDSs 
in 8 strains of S. equi but did not classify the subspecies of the investigated S. equi isolates 
(Proft et aI., 2003). Genes encoding SeeL and SeeM were identified in one strain of S. 
zooepidemicus (out of 31 screened) isolated from bovine mastitis (Alber et al., 2005) and 
another S. zooepidemicus isolate recovered from a human with toxic shock-like syndrome 
gave evidence of superantigen production although the isolate was not screened for seeL or 
seeM (Korman et al., 2004). The location of seeH + see! is adjacent to putative phage 
genes similar to those found in a defective phage sequence in S. pyogenes M1 and seeL + 
seeM are next to a putative phage encoded cell wall hydrolase, which points to their 
acquisition via phage mediated horizontal transfer (Alber et aI., 2005; Artiushin et aI., 
2002). Greater than 98% amino acid sequence identity with the S. pyogenes counterparts 
suggests that an exchange of superantigens has occurred between these different species of 
streptococci. 
Bacterial superantigens are small secreted toxins that simultaneously bind and cross-link 
major histocompatibility class (MHC) II antigens (outside of the normal antigen-binding 
interface) and T cell receptors leading to a non-specific stimulation of large numbers of T 
cells, a resultant pro-inflammatory cytokine storm and corruption of the innate and 
adaptive immune response (Fraser & Proft, 2008). This is likely to represent an important 
mechanism employed by S. equi during the early stages of infection to avoid host 
responses that might normally reduce the pathogen load. Superantigen production may 
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also enhance abscess development. SeeH and SeeI both induced strong mitogenic 
responses in horse peripheral blood mononuclear cells (PBMCs) and pyrexia in rabbits, 
however only SeeI was pyrogenic in horses. Horses immunised with SeeI or recently 
recovered from strangles had serum antibodies specific to this mitogen (and SeeH in 
convalescents) and were resistant to the pyrogenic effects of SeeI (Artiushin et al., 2002). 
Studies with S. pyogenes demonstrated stimulation of pro-inflammatory cytokines 
following interaction of M-protein with PMNs and monocytes (pahlman et al., 2006). 
SeM (see above) might prove to misdirect the immune response in a similar fashion. As 
the major cell wall-associated protein of S. equi cells grown in vitro (Meehan et aI., 1998), 
SeM contributes significantly to the resistance of S. equi to phagocytosis (Boschwitz & 
Timoney, 1994a; Boschwitz & Timoney, 1994b; Chanter, 1994; Meehan et aI., 2001; 
Timoney et aI., 1997b), a particular feature of this bacterium which is demonstrated by the 
accumulation of long chains of extracellular streptococci surrounded by large numbers of 
degenerating neutrophils in the abscesses of strangles. The antiphagocytic action of SeM 
results from the binding of fibrinogen and the Fc domain of IgG; the latter inhibits 
deposition of C3b on the bacterial surface. SeM binds specifically to IgG4 and IgG7, the 
most prevalent forms of IgG in serum and mucosal secretions (Sheoran et aI., 2000) to 
inhibit complement activation via the classical pathway (Lewis et al., 2008a). Since IgG4 
and IgG7 are likely to interact with Fc receptors on effector cells, SeM may also inhibit 
phagocytosis directly (Lewis et aI., 2008b). Fibrinogen-binding inhibits fixation of C3 on 
human streptococci (Chhatwal et al., 1985), but a similar inhibitory effect was not 
demonstrated in S. equi (Boschwitz & Timoney, 1994b) and so the process used by 
fibrinogen binding to protect against phagocytosis is unclear. The promotion of bacterial 
aggregation by SeM offers another mechanism to avoid phagocytosis (Meehan et aI., 
2001), a property critical for resistance to phagocytosis (and adherence) in S. pyogenes 
(Frick et aI., 2000). 
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Another IgG-binding protein has been identified in both S. equi (Eag) and S. 
zooepidemicus (Zag) that could contribute to immune evasion in a similar way to SeM 
(Table 2.1). Zag binds horse IgG with a much higher affinity than SeM and also binds IgG 
from a broader range of host species (Jonsson et al., 1995). S. equi and some isolates of S. 
zooepidemicus bind low levels of IgG compared to other members of the S. zooepidemicus 
population (Lindmark et al., 1999). The reasons for these phenotypic differences are 
unknown and may be numerous although variation in regulatory control might account for 
some. Eag/Zag are multiple ligand binding proteins that also bind the host protease 
inhibitor (l2-macroglobulin «l2M) and albumin (Jonsson et al., 1995). Binding of (l2M to 
cells of group C streptococci has been reported to inhibit phagocytosis in vitro (Valentin-
Weigand et al., 1990) possibly by protecting antiphagocytic surface structures from 
proteolytic degradation (Rasmussen et ai., 1999). Horses naturally infected with S. equi 
mount an antibody response to Eag confirming its production in vivo (Flock et ai., 2004). 
Immunisation with Eag as a subunit vaccine alone or in combination with 2 other 
recombinant proteins conferred partial protection against S. equi infection in mice and 
horses, respectively (Flock et al., 2004; Flock et ai., 2006; Waller et ai., 2007). 
Near identical proteins with homology to the Mac (IdeS) proteins of S. pyogenes were 
identified in S. zooepidemicus (IdeZ) and S. equi (IdeE) (Table 2.1) (Lannergard & Guss, 
2006; Lei et ai., 2003). GAS Mac proteins bind to PMN Fc receptors and block antibody 
mediated opsonophagocytosis by these immune cells (Lei et ai., 2002a; Lei et ai., 2003). 
IdeE bound to neutrophils, particularly a subpopulation of these leukocytes that 
presumably expressed a distinct integrin and inhibited the phagocytosis of S. equi by 
PMNs (Timoney et al., 2008). IdeE and IdeZ, like other streptococcal Mac proteins, also 
demonstrated IgG endopeptidase activity (Lannergard & Guss, 2006). Removal of surface 
bound IgG by this activity has been suggested as another potential mechanism for 
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avoidance of phagocytosis (von Pawel-Rammingen et aI., 2002). However, this function 
had little impact on Macsoos-mediated resistance to phagocytosis (Lei et aI., 2002a) and 
IgG degradation may be a less critical feature of IdeE since S. equi is an obligate parasite 
of horses and IdeE failed to cleave equIne IgG efficiently due to a lack of a distinct 
substrate site in the m<;>st prevalent equine subclass IgG4. These Mac proteins do not 
contain a wall anchor domain and are predicted to be secreted from the cell, although 
levels of IdeElIdeZ detected in culture supernatants were slightly higher in S. equi 
compared to S. zooepidemicus and they also associated with the cell wall (Timoney et aI., 
2008). When grown in the presence of serum, S. equi, but not S. zooepidemicus, degraded 
equine IgG (including IgG4) suggesting that an unidentified factor is produced by the 
former that contributes to the proteolysis of IgG. A continual removal of surface bound 
IgG through proteolysis is presumably an important housekeeping function to allow the 
pathogen to continue to bind and neutralise specific IgG capable of eliciting a complement 
cascade and phagocytosis (Soderberg & von Pawel-Rammingen, 2008). 
The secreted S. equi unique Se18.9 significantly reduces the bactericidal activity of equine 
neutrophils toward this pathogen. The antiphagocytic properties of Se18.9 may depend, at 
least in part, on its ability to subvert the host's regulatory control of the complement 
, 
cascade. Se18.9 binds to the complement regulator factor H, which serves as a cofactor for 
factor I-mediated cleavage of cell-bound C3b to inactive C3b and reduces the amplification 
of C3b via the alternative pathway. C3b deposition on S. equi was reduced following the 
addition of Se18.9 and increased when Se18.9 antiserum was added (Tiwari et al., 2007). 
Both S. equi and S. zooepidemicus direct a considerable proportion of carbon toward the 
production of a HA capsule which, due to the ubiquitous presence of HA in the ECM of 
vertebrates, is nonimmunogenic and serves to camouflage the bacteria from the host 
immune system. HA capsule confers resistance to phagocytosis in both subspecies (Anzai 
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et al., 1999b),(Wibawan et aI., 1999), (unpublished data) and, although not directly proven 
through gene inactivation, the presence of HA has been associated with virulence in S. equi 
(Anzai et al., 1999b; Harrington et al., 2002). Most S. equi isolates have a large colony 
phenotype on blood agar plates suggestive of a constitutive production of HA in vitro, 
whilst the recombinant LlhasA mutant has a much smaller colony size (Carl Robinson, 
unpublished data). S. zooepidemicus strains however display considerable diversity in 
colony size and demonstrate phase variation in their degree of encapsulation (Soedarmanto 
et al., 1996; Wibawan et aI., 1999). 
Fne (see above) stimulates cell-mediated collagen gel contraction in vitro directed by the 
endothelial cell receptor aV~3. By simultaneously binding collagen and fibronectin, Fne is 
thought to form a molecular bridge between collagen fibers and cell surface fibronectin 
that is in tum bound by aV~3 integrin resulting in gel contraction (Liden et al., 2008). As 
interstitial fluid pressure (IFP) can be lowered or normalised by a number of agents that 
also inhibit or stimulate collagen gel contraction in vitro respectively, this in vitro assay 
models IFP regulation during inflammation in vivo. Fne was shown to restore dermal IFP 
in mice, lowered as a result of anaphylaxis. Fne could therefore provide a novel virulence 
mechanism to protect S. equi from the innate immune response by inducing a compacted 
connective tissue, thereby counteracting a lowering of IFP and the resulting oedema 
formation that would usually enhance clearance of infectious organisms. This process may 
help to encapsulate S. equi infection and hinder the diffusion of macromolecules such as 
IgG, cytokines and inflammatory cells. The homologous N terminal portion of Fnz (FnzN) 
in S. zooepidemicus is also proven to mediate collagen gel contraction (Liden et aI., 2006), 
however, Fnz is proposed to be unlikely to have this activity because it is anchored to the 
bacterial cell wall (Liden et al., 2008). 
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2.1.2.3 Tissue damage, dissemination and nutrient acquisition 
Bacteria cannot survive and proliferate in vivo without access to nutrient sources, but the 
host has its own measures to deprive invading microorganisms of macro- and 
micronutrients. To counteract these defences bacteria use systems to sabotage host stores 
and actively take up nutrients. Many of the putative virulence factors already described 
(EaglZag), including those specific to S. equi (superantigens, SeM) could contribute to 
tissue breakdown in the host with a resultant release of valuable nutrients. Damage to the 
host might be thought of as a by-product of the organisms' nutrient-questing behaviour 
although improved invasion and dissemination are other possible consequences of cell 
degradation. 
By binding a.2M via the multiple ligand binding proteins Zag and Eag, S. zooepidemicus 
and S. equi may protect their own surface structures from proteolytic degradation but a 
resultant depletion of surrounding protease inhibitors could also increase the amount of 
free proteases and enhance tissue destruction during the infection process (Rasmussen & 
Bjorck, 2002). Streptokinase, a secreted product of both subspecies activates the 
conversion of plasminogen to plasmin, a serine protease that can degrade fibrin clots and 
the ECM (McCoy et al., 1991). The acquisition of superantigens by S. equi during its 
evolution from a S. zooepidemicus progenitor may have contributed to the more invasive 
nature of S. equi as a result of increased cell damage associated with an overzealous 
inflammatory response. Streptococcal exotoxins are implicated in severe group A 
streptococcal infections of man including scarlet fever and streptococcal toxic shock 
syndrome (epithelial damage leads to capillary leakage and hypotension) (Fraser & Proft, 
2008). SeeH and SeeI enhanced the susceptibility of rabbits to lipopolysaccharide-induced 
endotoxic shock (Artiushin et al., 2002). The speL gene has been recently acquired by 
M3ff3 S. pyogenes isolates in Japan (sometime from 1973 to 1992) that have caused more 
than 10% of streptococcal toxic shock-like syndrome cases reported from 1992 to 2002 
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(Ikebe et aI., 2002). In addition, the presence of the speL gene is highly associated with S. 
pyogenes M89, a serotype linked to outbreaks of rheumatic fever in New Zealand (Proft et 
ai., 2003). 
S. equi and S. zooepidemicus also secrete a potent ~-haemolytic toxin, characterised in S. 
equi to be streptolysin S-like (Flanagan et aI., 1998) (Table 2.1). Streptolysin S creates 
holes in the cell membrane of erythrocytes and many other mammalian cells resulting in 
their osmotic lysis and the release of nutrients, including haemoproteins which offer a rich 
source of iron to the invading pathogen. S. equi has a surface protein Shp and a lipoprotein 
HtsA that bind and transfer haem ready for its presumed uptake by the htsABC encoded 
ABC transporter (Nygaard et ai., 2006) (Table 2.1). Genes encoding this iron acquisition 
system are present in a conserved region of the S. equi genome relative to S. pyogenes and 
are shown from this study to exist in SzH70 also. 
A homologue of MtsABC, the manganese and iron transporter of S. pyogenes (Janulczyk et 
aI., 2003) has also been identified in S. equi (Harrington et aI., 2000) (Table 2.1). The 
gene encoding the lipoprotein component was identified in all of 10 disparate S. equi (n = 
5) and S. zooepidemicus isolates (n = 5). The S. equi cell surface displays various protein 
components (HPr, LppC, Pst, HAP) that can either transfer, release or bind/transport 
phosphate groups at the extracytoplasmicsurface, although their exact functions and 
contributions to virulence (if any) are unknown and may serve nutritional purposes by 
scavenging phosphate and organic phosphoesters and/or regulatory roles through 
environmental sensing (Dixon et ai., 2001; Hamilton et aI., 2000; Harrington et aI., 2002) 
(Table 2.1). Genes encoding these proteins are also present in SzH70. HAP is 
hypothesised to playa role in HA capsule maintenance and was partially protective against 
S. equi and S. zooepidemicus infection in mice (Chanter et aI., 1999; Nickel et ai., 1998) 
but failed to prevent the development of strangles in ponies. 
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Prior to this study, very few differences have been highlighted in the capacity of S. equi 
and S. zooepidemicus to acquire carbon or nitrogen sources and essential trace elements. S. 
zooepidemicus is able to utilise lactose and sorbitol but S. equi lacks this ability, which 
allows these 2 subspecies to be differentiated biochemically. Carbohydrate catabolism has 
received more interest recently as an important participant in bacterial infection; specific 
mechanisms of carbohydrate usage appear to enhance the colonising potential of 
streptococci (Shelburne et al., 2008a). 
2.2 Aims 
The overall aim of the work presented in this chapter was to investigate the genetic factors 
that separate S. equi and S. zooepidemicus in order to reveal the functional differences 
resulting from gene gain, gene loss and gene change that have contributed to the evolution 
of the more virulent, less versatile, host and niche-adapted pathogen S. equi from its 
presumed ancestor S. zooepidemicus. An applied objective was to identify potential 
vaccine and diagnostic targets, primarily to aid in the prevention and diagnosis of 
strangles. These aims were achieved using the following specific objectives:-
1. To identify genetic differences that delineate Se4047 and SzH70 using the Artemis 
Comparison Tool (ACT). 
2. To use bioinformatic and in some cases in vitro analysis to establish the function or 
putative function of proteins encoded by these novel gene loci. 
3. To use PCR to establish the prevalence of some important genetic loci across a 
diverse selection of S. equi and S. zooepidemicus strains in order to clarify the true 
subspecies-specific genetic factors that have contributed to the spe~ialization of S. 
equi (and/or subsets of the S. zooepidemicus population). 
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2.3 Methods 
2.3.1 Bacterial strains 
Se4047 , ST -179 and SeM allele type 3, was isolated in 1990 from the submandibular 
abscess of a New Forest pony in Hampshire (Kelly et aI., 2006). SzH70, ST-1, was 
isolated in 2000 from a Thoroughbred racehorse in Newmarket (Webb et aI., 2008). A set 
of 26 S. equi strains and 140 S. zooepidemicus strains representative of diverse SeM allele 
types and MLST STs, respectively were used for gene prevalence screening and functional 
analysis (Appendix Table A.1). The relatedness of MLST STs was determined by Katy 
Webb (ART) and Keith Jolley (Oxford University) using ClonalFrame [58]. 
2.3.2 Identification of genetic differences between Se4047 and SzH70 
Genetic differences were identified following a pairwise comparison of the Se4047 and 
SzH70 genomes by reciprocal TBLASTX analysis (cut off score of 100). The genomes 
were aligned and analysed using ACT (Carver et ai., 2005). Early investigation of the 
subspecies-specific DNA loci identified in the incomplete genomes of Se4047 and SzH70 
involved the use of ORPHEUS (Frishman et aI., 1998) and GLIMMER (Salzberg et aI., 
1998) to aid the manual prediction of potential CDSs. The predicted protein sequences 
were searched against a non-redundant protein database using BLASTP and FASTA to 
assist the assignment of putative functions. Annotation was based, wherever possible, on 
characterised proteins and graphical display features of ACT were used to aid the 
identification of protein characteristics (assisted by the use of online tools such as SignalP 
(Emanuelsson et aI., 2007) and TMHMM http://www.cbs.dtu.dklservicesffMHMM-2.0/ 
accessed 18.11.08). Predicted proteins were also compared against the PFAM database of 
protein domain hidden Markov models (Bateman et aI., 2002). The completed genomes 
were later annotated by Matt Holden (Sanger Institute) as described previously (Parkhill et 
aI., 2000; Parkhill et aI., 2003). Orthologous proteins were identified as reciprocal best 
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matches using FASTA with subsequent manual curation. Orthology inferred from 
positional information was investigated using ACT. Pseudo genes had one or more 
mutations that would prevent correct translation; each of the inactivating mutations was 
subsequently checked against the original sequencing data. The sequence and annotation 
of the Se4047 and SzH70 genomes are deposited in the EMBL database under accession 
numbers FM204883 and FM204884, respectively. 
Sequences used by Matt Holden for comparative genomic analysis were: S. zooepidemicus 
MGCS10565 (CPOO1129) (Beres et al., 2008), S. uberis 0140J (AM946015) (Ward et aI., 
2009), S. pyogenes Manfredo (AM295007) (Holden et aI., 2007), S. thermophilus 
CNRZ1066 (CP000024) (Bolotin et ai., 2004), S. suis Pl/7 
(http://www.sanger.ac.uklProjects/S_suis/). S. pneumoniae TIGR4 (AE005672) (Tettelin et 
al., 2001), S. sanguinis SK.36 (CP000387) (Xu et al., 2007), S. mutans UA159 
(AEOI4133) (Ajdic et al., 2002), S. agalactiae NEM316 (AL732656) (Glaser et ai., 2002), 
S. gordonii str. Challis substr. CHI (CPOOO725) (Vickerman et ai., 2007) and Lactococcus 
lactis subsp. lactis IL1403 (AE005176) (Bolotin et ai., 2001). 
2.3.3 Gene prevalence studies 
Strains were cultured from single colonies on COBA strep select plates (bioMerieux) and 
DNA was purified from colony material using GenElute spin columns according to 
manufacturer's instructions (Sigma). Gene prevalence was then determined by 
quantitative PCR (QPCR) using a SYBR green based method with a Techne Quantica 
instrument. For the QPCR, DNA diluted 1/100 was mixed with 0.3 11M forward and 
reverse primers (Table 2.2) and Ix ABsolute QPCR SYBR green mix (Abgene) in a total 
volume of 20 III and subjected to thermocycling at 95°C for 15 min, followed by 40 cycles 
of 95°C for 15 s, 55°C for 30 s and 72°C for 30 s. Dissociation curves were analysed 
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following a final ramp step from 60°C to 90°C with reads at 0.5°C increments to rule out 
non-specific amplification. Positive, negative and no-template controls were included on 
each run. Data were analysed using Quansoft software (Techne). Crossing point values 
relative to those for the gyrA house-keeping gene were used to determine gene presence or 
absence. Supervised assistance was received for the set up of QPCR reactions by Karen 
Steward, Fern Ainslie and Melanie Osborne (AHT). Fischer's exact test was used to test 
the null hypothesis that there was no statistically significant difference in the prevalence of 
gene loci between S. equi subspecies or between S. zooep(demicus isolates associated with 
particular disease, tissue or gene types. Statistical significance was set at P ~ 0.05. 
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Table 2.2 Oligonucleotide primers used to screen diverse strains of S. equi and S. 
zooepidemicus for the presence of genes and a large inter-replichore inversion event, to 
conduct quantitative reverse transcription-PCR analysis and to PCR across the junction of 
a circular form of ICESe2 
Primer Sequence (5'-3') Gene I region 
zm457 GGGTTAATGAGCCGATACTCTTTG lacE (SZO 15230) 
zm458 CGTTCCTAATACCAAGCCAAGC lacE (SZOlS230) 
18f CGATGTAGCTAAGTTGGCTG rbsD (SZOISI40) 
I8r AGGTGTATCCTCTCCTGTTC rbsD (SZOIS140) 
28f CGGGTAAGACAGTGATTGTC sorD (SZOOI7S0) 
28r ACCAAAATGCGCCCAACAGC sorD (SZOOI7S0) 
66f AACGCTTGTGGCTTTCTCC hysA (SZ006680) 
66r ACTCTTTGCCCCTCTTGATC hysA (SZ006680) 
zm49 GACGAATTCAGAGTATGCGCGAATGCTAG srtC2 - mC3 (SZO 18280 -
SZ018270) 
zm50 GACGATATCACCAAGCATCATCAAAAGGTAG srtC2 - srtC3 (SZOI8280-
SZ018270) 
24f GTATTTGGAACAGTAGCACCG SZ008S60 
24r CATCCTTAACATGCTTCGCC SZ008S60 
zm492 CAGCAACCTTTCATTACCAAATTACC esaA 
zm493 AACAAAGACTTCAAATCAATCACAGC esaA 
zm432 GTGTGTTGATTATGGCCAGC Conserved hypothetical protein 
CRISPR locus (SZ0l4370) 
zm433 TATCAGAACGCCCTAGTGTC Conserved hypothetical protein 
CRISPR locus (SZOI4370) 
If CAGATGATGTTCTAGAGATGGG slaA (SEQ0849) 
lr CTCTAATAGCATCGGCTACG slaA (SEQ0849) 
zm381 CAAGTGCAACTATGGCAACAG slaB (SEQ21SS) 
zm382 ATCCTGCCTTGAAATACTTTCG slaB (SEQ2155) 
zm4S5 TTAATACGGATGAAAATACTACAGTTTGG seeL (SEQ 1728) 
zm4S6 CAACATTAAACATTCTTTCCTGTGAAG seeL (SEQ 1728) 
4f CTGTTAGGATGGTTTCTGCG seeM (SEQ 1727) 
4r TCAGCCGATAATGCAAGACC seeM (SEQ 1727) 
ISf CAAGAGGCTTGTGAATGTCC seeH (SEQ2036) 
ISr CATGCTATTAAAGTCTCCATTGCC seeH (SEQ2036) 
ISaf TTGGAGTATTCTCCTCCCTG seel (SEQ2037) 
ISar AGCATACTCTCTCTGTCACC seel (SEQ2037) 
eqbEf AAGATATAGCAGCATCGTATCG eqbE(SEQI242) 
eqbEr TCTAAATCTCTATTAAATAGCGGTATATTG eqbE (SEQ 1242) 
zm340 ACTGATATTGAAGAAGCTTGAAG se18.9 (SEQ023S) 
zm341 GCATAGGTGTCAGTCAAAGC se18.9 (SEQ023S) 
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Table 2.2 continued 
Primer Sequence (5'-3') Gene I region 
gyrAf AAGGCGGGATTCCTAAAATC gyrA (SEQ 1 170, SZ009430) 
gyrAr GATAAGTAAGCCCTCTAAAATGTG gyrA (SEQ 1170, SZ009430) 
zm235 ATTGGGAACACCTTGCAAGG across junction of circular ICESe2 
zm236 TTTTTTCTTCTTCCCACTGGC across junction of circular ICESe2 
zm473F TTAGTTTCTTTGCTTGTATTTGGAACAG SZ008560 
zm474R TCTGCGTGTTTACTTCATCAGTATTATC SZ008560 
zm475R CTTTTCTCTCATATATCCCTTTTCTTG Recombinase (SZ008550) 
zm476F AGGAGCAAAGCTTCTTGATG Recombinase (SZ008550) 
zm490 CAGACAAGGTAGCCTAGTAC across junction of large inter-
replichore inversion in SzH70 
zm49 I AACTCCTCATAGCACTCACG across junction of large inter-
replichore inversion in SzH70 
2.3.4 Sugar fermentation 
The ability of isolates to ferment lactose, ribose and sorbitol was determined in Purple 
broth (Difco) using microtitre plates (ThermoScientific). Individual colonies were 
inoculated into Todd Hewitt broth (THB, Sigma), cultured overnight at 37°C with 5% C02 
and subsequently sub-cultured 115 into Purple broth (3.1 %) supplemented with 1 % sugar 
(Sigma) and 5% horse serum (Oxoid). Following a second overnight incubation at 37°C 
with 5% C02, the ability to ferment the sugar tested was noted based on the presence or 
absence of a colour change from blue to yellow. 
2.3.5 Mitogenicity assays 
Mitogenicity assays were performed by Romain Paillot (ART). Filter sterilized culture 
supernatants were prepared following the overnight culture of S. equi or S. zooepidemicus 
strains in THB (Sigma) at 37°C with 5% C02. Equine PBMCs were purified from 
heparinised blood by centrifugation on a Ficoll density gradient. PBMCs 'were incubated 
with S. equi or S. zooepidemicus culture supernatants diluted 1120. PBMC proliferation 
was detected by overnight incorporation of 3H thymidine after 3 days of culture. Equine 
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PBMC proliferation is expressed as stimulation index (SI) calculated as follows 
(experimental response/control response). A SI ~ 2 was considered as positive. 
2.3.6 Reverse transcription and quantitative real-time peR for recombinase activity 
The potential for inversion of the promoter region downstream of the recombinase was 
assessed by comparison of SZ008560 mRNA transcript levels (produced when the 
promoter region is in the forward orientation) with reverse strand SZ008550 mRNA 
transcript levels (produced when the promoter region is inverted) in SzH70. This analysis 
was performed by Karen Steward under my supervision. 
Total RNA was extracted from bacteria using RNAprotect, RNeasy and DNase Kits 
according to the manufacturer's instructions (Qiagen). SzH70 bacteria grown to log phase 
in THB (Sigma) with 10% horse serum (Oxoid) were pelleted by centrifugation for 10 min 
at 5000 g. The pellet was resuspended in 200 III of TE buffer (10 roM Tris-Cl, 1 mM 
EDTA; pH 8.0) containing 3 mg lysozyme (Sigma) and 500 U mutanolysin (Sigma). After 
incubation at room temperature for 45 min with repeated vortexing, 700 III of RLT buffer 
containing ~-mercaptoethanol was added, and the tube was vortexed. The mixture was 
transferred to a 2 m1 reaction tube containing 0.05 g of 100 11m-diameter acid-washed glass 
beads (Sigma) and vortexed for 5 min. The mixture was then centrifuged and total RNA 
was extracted from the supernatant using an RNeasy Midi Kit. 5 Ilg of recovered RNA was 
treated with DNase to remove any contaminating DNA followed by clean up on an RNeasy 
mini column. The quantity and purity of RNA was determined by optical density 
measurements at 260 and 280 nm using a NanoDropR ND1000 spectrophotometer 
(NanoDrop Technologies). 
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A quantitative two-step reverse transcription (RT) PCR procedure was used to analyse 
levels of SZ008560 and reverse strand SZ008550 transcription relative to the 
housekeeping gene gyrA. RT was performed using the Verso cDNA kit (Abgene). The 
RT reaction mixture (20 ~l) contained 100 ng total RNA, 2 ~M gene-specific primer 
(ZM474R or ZM476F) (Table 2.2), 500 ~M dNTP mix, Ix cDNA synthesis buffer, 1 ~l 
RT enhancer and 1 ~l Verso enzyme mix. RT was performed at 50°C for 30 min and 
terminated by heating to 95°C for 2 min. QPCR was performed with a Techne Quantica 
instrument and data analysed using Quansoft software (Techne). For the QPCR, 6 ~l RT 
reaction mixture diluted 1/1000 was mixed with 0.3 ~M forward and reverse primers 
(Table 2.2), and Ix ABsolute QPCR SYBR green mix (Abgene) in a total volume of 20 ~l 
and subjected to thermocycling at 95°C for 15 min, followed by 40 cycles of 95°C for 15 s, 
55°C for 30 s and 72°C for 30 s. Dissociation curves were analysed, following a final ramp 
step from 60°C to 90°C with reads at 0.5°C increments, to rule out non-specific 
amplification. No-template negative controls were included and reverse transcriptase 
negative controls to confirm the absence of contaminating DNA from RNA samples. 
Standard curves (Crossing point (Cp) vs. log gene copy number) were generated from 
genomic DNA for each target gene and used to calculate transcript copy number in cDNA 
samples. SZ008560 and reverse strand SZ008550 transcript copy numbers were 
normalised to gyrA reference gene copy number to correct for differences in the amount of 
starting material. Data were expressed as fold difference in normalised SZ008560 
transcript level relative to reverse strand SZ008550 transcript level. 
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2.4 Results 
2.4.1 Genome alignment of Se4047 and SzH70 using the Artemis Comparison Tool: 
identification and prevalence of novel gene loci 
2.4.1.1 Overview 
MLST has provided evidence of the close genetic relationship of S. equi and S. 
zooepidemicus (Webb et al., 2008). The genomes of Se4047 (ST-179) and SzH70 (ST-1) 
support the overall relatedness, but also reveal evidence of genome plasticity that has 
generated notable diversity. The two genomes are similar in size: the Se4047 genome 
consists of a circular chromosome of 2,253,793 bp (Figure 2.1A) encoding 2,137 predicted 
CDSs, and the SzH70 genome contains a chromosome of 2,149,866 bp (Figure 2.1B), 
encoding 1,960 predicted CDSs (Holden, 2009). Much of the Se4047 genome is 
orthologous to the SzH70 genome: 1671 Se4047 CDSs have SzH70 orthologs. Of the 
remaining 466 non-orthologous Se4047 CDSs, 422 are found on mobile genetic elements 
(MGEs) (Holden, 2009). For details of the regions of variation in the Se4047 and SzH70 
genomes see Appendix Table A.2. 
Recently, the genome sequence of S. zooepidemicus strain MGCS 10565 (SzMGCS 10565) 
was published (Beres et aI., 2008). This strain was isolated from a human case of nephritis 
that was part of a severe epidemic in Brazil (Balter et al., 2000). MLST 
(http://pubmlst.org/szooepidemicus/) analysis indicates that SzH70 and SzMGCS 10565 
(ST-72) are genetically distinct from each other and Se4047. Comparative analysis reveals 
that the number of orthologs in the Se4047 genome is slightly higher for SzH70 (78.2%) 
than for SzMGCS10565 (77.4%); 76.3% of the Se4047 CDSs have matches in both S. 
zooepidemicus strains (Holden, 2009). The following analysis has primarily focused on 
the comparison of the equine isolates, Se4047 with SzH70 but some details of 
SzMGCS10565 are included for comparison. 
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Figure 2.1 Schematic circular diagrams of the Se4047 (A) and SzH70 genomes (B) 
Figure reproduced with kind permission from Matt Holden, Sanger Institute (Holden, 
2009). Key for the circular diagrams (outside to inside): scale (in Mb); annotated CDSs 
coloured according to predicted function represented on a pair of concentric circles, 
representing both coding strands; orthologue matches shared with the streptococcal 
species, Se4047 or SzH70, SzMGCS10565, S. uberis 0140J, S. pyogenes Manfredo, S. 
mutans UA159, S. gordonii Challis CHI, S. sanguinis SK36, S. pneumoniae TIGR4, S. 
agalactiae NEM316, S. suis PIn, S. thermophilus CNRZI066, blue; orthologue matches 
shared with Lactococcus lactis sUbspecies lactis, green; G + C% content plot; G + C 
deviation plot (> 0% olive, < 0% purple). Colour coding for CDS functions: dark blue; 
pathogenicity/adaptation, black; energy metabolism, red; information transfer, dark green; 
surface associated, cyan; degradation of large molecules, magenta; degradation of small 
molecules, yellow; central/intermediary metabolism, pale green; unknown, pale blue; 
regulators, orange; conserved hypothetical, brown; pseudogenes, pink; phage and IS 
elements, grey; miscellaneous. The positions of the 4 prophage and 2 ICESe present in the 
Se4047 genome, and 2 ICESz in the SzH70 genome are indicated. 
Comparison of the predicted functions of the proteins encoded in the Se4047 and SzH70 
genomes revealed that Se4047 has the same number, or fewer CDSs, in each of the 
functional classes with the exception of protective responses and adaptation and laterally 
acquired elements (Figure 2.2A) (Holden, 2009). The number of pseudogenes in Se4047 is 
also elevated in comparison to SzH70 (Figures 2.2A and 2.2B). 
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Figure 2.2 Distribution of CDSs belonging to different functional classes in the Se4047 
and SzH70 genomes 
Figure reproduced with kind permission from Matt Holden, Sanger Institute (Holden, 
2009). (A) Functional CDSs of Se4047 and SzH70. (B) Partially deleted or pseudo genes 
in the Se4047 and SzH70 genomes. 
Closer examination of the genomes revealed (excluding IS elements) 31 and 37 novel 
genetic loci encoding 336 and 247 predicted proteins in Se4047 and SzH70, respectively 
68 
when compared to each other (Appendix Tables A.2A and A.2B, Figure 2.3). At least 80% 
of the Se4047-specific CDSs have been gained through the integration of 4 prophages 
(q>Seql - 4), an ICE (ICESe2), and 2 other genetic loci (Figures 2.1A and 2.4A), whilst 
deletion events in Se4047 relative to SzH70 account for at least 35% of the CDSs specific 
to the latter (Figure 2.4B). Loss of function through gene inactivation is also more 
prevalent in Se4047 , which has 136 pseudogenes (including 58 partially deleted genes) 
compared to 91 (including 62 partially deleted genes) in SzH70 (Appendix Tables A.2D 
and A.2E). In the shared core genome, 72% of pseudogenes identified in Se4047 are intact 
in SzH70, while 57% of SzH70 pseudogenes are also dysfunctional in Se4047 (Appendix 
Tables A.2D and A.2E). In particular, Se4047 is enriched for mutations associated with 
catabolic metabolism, transport, and the cell envelope (Figure 2.2B) (Holden, 2009). 
Overall, these data suggest that the evolution of S. equi has been shaped by gene gain and 
loss. 
SzH70 has acquired its own set of novel loci through gene gain when compared with the 
Se4047 genome, a feature that is likely to reflect the genetic diversity in the S. 
zooepidemicus population and the more distant relationship of this ST to S. equi compared 
with other S. zooepidemicus strain types (Webb et aI., 2008). Although no prophage are 
present in SzH70 (or SzMGCS10565), 18% of its unique CDSs (excluding ISs) have been 
gained through the insertion of a novel ICE (ICESz2) and one genomic island (Figures 
2.1B and 2.4B). Many of the novel DNA loci have atypical GC content (Appendix Table 
A.2) compared to the genome as a whole (Se4047: 41.28%; SzH70: 41.53%), but only 
those that encode a putative integrase and/or are flanked by duplicated repeat elements 
have been referred to as genomic islands. In a number of cases it was not possible to 
ascertain whether insertion or deletion events were responsible for the gain or loss of CDSs 
in one genome relative to the other (Figure 2.4). However, Figure 2.4A demonstrates the 
low occurrence of obvious deletion events in SzH70 when compared to Se4047. 
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One ICE is shared between the 2 genomes (ICESel and ICESzl) but these elements in 
Se4047 and SzH70 have a mosaic structure relative to one another and display variation in 
their N-terminal and C-terminal regions possibly due to recombination events. A number 
of other regions shared between Se4047 and SzH70 show significant divergence in their 
number and/or sequence of genes (Appendix Tables A.2A-C) . 
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Figure 2.3 Distribution of subspecies-specific DNA loci 
Bar chart shows the number of CDSs present on DNA loci that are novel to Se4047 or 
SzH70 and the total number of novel DNA loci in each SUbspecies. 
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Figure 2.4 Pie charts showing the proportion of species-specific CDSs (not including ISs) 
in (A) Se4047 and (B) SzH70 that are present through insertion, deletion or unknown 
events in each genome relative to the other 
2.4.1.2 IS eLements 
Both genomes contain IS elements of 5 or more families, although a considerable 
expansion of the IS3 family is a particular feature of Se4047 , which contains 73 ISs 
compared to 30 in SzH70 (Table 2.3) (Holden, 2009). 
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Table 2.3 Composition of insertion sequences in the SzH70 and Se4047 genomes 
Insertion element SzH70 Se4047 Family 
ISSzo 1 (IS Seq 1) 4 4 ISL3 
ISSzo2 (ISSeq2) 5 3 ISNCY 
ISSzo3 (ISSeq3) 4 40 IS3 
ISSzo4 (ISSeq4) 5 11 IS1634 
ISSzo5 (ISSeq5) 2 8 IS3 
ISSzo6 1 0 IS30 
ISSzo7 3 0 IS3 
ISSzo8 (ISSeq8) 2 2 IS200/IS605 
ISSzo9 (ISSeq9) 1 1 IS200/IS605 
ISSzoI0 2 0 ISAsl 
ISSzoll (ISSeqll) 1 I ISL3 
ISSeql4 0 1 ISL3 
ISSeqI5* 0 1 IS3 
Total 30 73 
Table reproduced with kind permission from Matt Holden, Sanger Institute (Holden, 
2009). IS elements were grouped into separate isoforms (IS elements with DNA sequence 
more than 95% identity), numbered accordingly, and given a specific 3 letter identifier to 
designate the species of origin. Truncated IS elements lacking either the 3-prime or 5-
prime ends were not included in the table. *chimeric IS element that appears to have been 
generated from recombination between ISSeq3 and ISSeq5 elements. 
2.4.1.3 Genome rearrangements 
The Se4047 and SzH70 chromosomes are generally collinear except for 2 inversions 
around the origin of replication (Figure 2.5). The smaller central inversion (spanning 119 
kb) is due to recombination events in Se4047 between identical conversely orientated 
ISSeq3 elements on opposite replichores. This inversion event relocates part of a 
bacteriocin gene cluster (SEQ 1226 - SEQ1223) and an ABC transporter CDS (SEQI276), 
both of which were already disrupted by insertion of the ISSeq3 elements and other DNA 
sequences (including ICESe2). The larger rearrangement is due to an inter-replichore 
inversion in SzH70 of unknown origin. 2 parts of a putative nudix gene that had already 
been disrupted by the insertion of a novel ICE (ICESz2), have been separated by this 
inversion event. PCR across one of the flanking sequences suggests a similar 
reorganization in 21 % of S. zooepidemicus isolates (n = 140, Figure 2.6), although this 
inversion has not occurred in the genome of SzMGCS 10565. The inversion was not 
detected in any isolate of S. equi tested by PCR (n = 26), which highlights a statistically 
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significant difference III the genome organisation of these 2 subspecies (P = 0.0088, 
Fischer' s exact test). Both the Se4047 and SzH70 genomes contain two copies of hasC 
which encode UDP-glucose pyrophosphorylases (Blank et ai., 2008). In SzH70 one copy 
of hasC (SZ017510) has been translocated to the opposite replichore by the previously 
mentioned large reciprocal inversion. There is also a small intra-replichore inversion (14 
kb) in Se4047 between the 2 copies of hasC (SEQ0271 and SEQ0289), which rearranges 
the genes associated with capsule production (Blank et at., 2008). 
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Figure 2.5 Pairwise comparison of the chromosomes of Se4047 and SzH70 using ACT 
Figure reproduced with kind permission from Matt Holden, Sanger Institute (Holden, 
2009). The sequences have been aligned from the predicted replication origins (oriC; 
right). The coloured bars separating each genome (red and blue) represent similarity 
matches identified by reciprocal TBLASTX analysis, with a score cut off of 100. Red 
lines link matches in the same orientation; blue lines link matches in the reverse 
orientation. The prophage (pink) and ICE (purple) are highlighted as coloured boxes. 
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Figure 2.6 ClonalFrame analysis of MLST alleles of 26 S. equi and 140 S. zooepidemicus 
isolates and its relationship with the prevalence of selected clifferences between the Se4047 
and SzH70 genomes 
The ClonalFrame tree (on the left) is reproduced with kind permission from Keith lolley, 
Oxford University. Genes examined were lacE, rbsD, sorD, SZ014690 (encoding a 
putative branched chain amino acid transporter), SZ006680 (encocling a putative HA lyase 
and specific to the 4 bp missing from SEQ1479), srtC.2/srtC.3, SZ008560 (encoding 
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Listeria-Bacteroides repeat Pfam domains (PF09479», esaA, SZ014370 (within the 
CRISPR locus), slaA, slaB, seeL, seeM, seeH, seeI, eqbE (within the equibactin locus), 
SEQ0235 (encoding Se18.9), SEQ2190 (encoding a cell-wall anchored protein), inversion 
(large inter-replichore inversion SZ001800 - SZ018031) and gyrA. Functional assays 
determined the ability of different isolates to ferment lactose, ribose and sorbitol and to 
induce mitogenic responses in equine PBMCs. The number of isolates representing each 
ST is indicated. STs where all isolates contained the gene or possessed functional activity 
are shown in red, STs where all isolates lacked the gene or functionality are shown in blue 
and STs containing some isolates containing the gene or functionality and some that did 
not are coloured in yellow. The position of S. equi isolates and SzH70 are indicated. With 
the exception of slaB and gyrA, which were present in all isolates of S. equi and all isolates 
of S. zooepidemicus, the prevalence of each gene, function or event was significantly 
different between the 2 subspecies (P = 0.0088 for the large inter-replichore inversion 
SZ001800 - SZ018031 and P < 0.0001 in all other cases, Fischer's exact test). 
SzMGCS 10565 is a single locus variant of ST -10 (ST -72; not shown), and had an identical 
gene prevalence profile to the ST-lO isolates based on in silico analysis of its genome 
sequence (Beres et al., 2008). 
2.4.1.4 Mobile genetics elements 
The increased size of the Se4047 genome compared to the genome of SzH70 is due to the 
acquisition of a large number of CDSs from MGEs. Together these make up a total of 
16.4% of the Se4047 genome. In contrast 7.5% of the SzH70 genome is composed of 
MGEs. Several of the MGEs in Se4047 carry notable virulence determinants absent in 
SzH70. 
2.4.1.4.1 Prophages and associated exotoxins 
Se4047 is polylysogenic, however prophage are absent from both the SzH70 and 
SzMGCS10565 genomes. Comparison of the sequences of each of the 4 Se4047 prophage 
with each other showed only limited mosaic similarity. However, comparison with 
prophage sequences in the public databases revealed more extensive similarity with 
prophage from S. pyogenes. Clustering analysis has demonstrated that the individual S. 
equi prophage are more related to phage in the other sequenced S. pyogenes genomes than 
they are to each other (Holden, 2009), suggesting commonality in the phage pool of these 
pathogens. 
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The first of the 4 Se4047 prophage, q>Seq1, is 39 kb in size, contains the CDSs SEQ0133-
SEQ0197 and is integrated immediately after the tRNA-Cys gene. The CDSs of q>Seq1 do 
not have homology to known virulence factors. However, examination of the Se4047 
genome sequencing reads revealed evidence that induction of q>Seq 1 prophage may occur 
(Nicholas Thompson, Sanger Institute). Re-circularised q>Seq 1 has since been amplified by 
PCR following phage induction by mitomycin C treatment and preparation of phage 
particles present in cultures of Se4047 (Holden, 2009). 
The 41 kb q>Seq2 (SEQ0787-SEQ0851) is integrated into the putative C-terminal sequence 
of an ATP-dependent DNA helicase (SEQ0786) and contains a CDS (SEQ0849) that 
shares 98% predicted amino acid sequence identity with the phospholipase A2, SlaA, of S. 
pyogenes M3 MGAS315 (Beres et al., 2002). slaA was present in all 26 strains of S. equi 
and 44 out of 140 S. zooepidemicus isolates tested by QPCR (Figure 2.6). This difference 
in prevalence of slaA between the 2 subspecies was statistically significant (P < 0.0001) 
using Fischer's exact test. Another homologue of slaA, denoted slaB, was identified at a 
different genome location in both Se4047 (SEQ2155) and SzH70 (SZ018670), adjacent to 
a single prophage gene (SEQ2154/SZ018660). SlaB shares 70% amino acid sequence 
identity with SlaA of S. pyogenes and was present in all strains of S. equi and S. 
zooepidemicus examined (Figure 2.6). 
The 30 kb q>Seq3 is integrated into SEQ1725 (a putative late competence protein CDS) and 
contains CDSs SEQ1727-SEQ1765 including two cargo CDSs encoding the superantigens 
SeeL and SeeM, which share 97% and 96% amino acid sequence identity with SpeL and 
SpeM of S. pyogenes MGAS8232, respectively (Alber et al., 2005; Proft et al., 2003). 
seeL and seeM were present in all strains of S. equi and 4 isolates (ST-106, ST-118, ST-
120) of S. zooepidemicus (of 140 isolates examined) that were recovered from the same 
outbreak of respiratory disease in 1996 (Figure 2.6). 
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Finally, the 40 kb <pSeq4 is inserted into SEQ2035, resulting in the truncation of this 
putative transcriptional repressor. <pSeq4 contains cargo CDSs encoding the previously 
described superantigens SeeH (SEQ2036) and SeeI (SEQ2037), which share 98% and 99% 
amino acid sequence identity with SpeH and SpeI, respectively (Artiushin et ai., 2002). 
<pSeq4 is very closely related to <pMan3 of S. pyogenes Manfredo (Figure 2.7, Matt 
Holden). Although seeH and seel were present in all strains of S. equi tested, no strains of 
S. zooepidemicus have yet been shown to contain these genes. 
To provide functional evidence for the production of superantigens by different strains of 
S. equi and S. zooepidemicus, Romain Paillot (ART) assayed the culture supernatants of 
our strain collection. This analysis confirmed that all strains of S. equi and the strains of S. 
zooepidemicus containing seeL and seeM possessed significant mitogenic activity. 
However, the supernatants of 25 additional strains of S. zooepidemicus also had mitogenic 
activity. Several of these strains were related genetically by MLST, and clustered into 
three related groups (ST-123, ST-127 and ST-141; ST-7, ST-48, ST-70, ST-5 and ST-53; 
ST-8, ST-46 and ST-1l3) (Figure 2.6). Overall, mitogenic activity was exhibited by a 
significantly higher proportion of S. equi isolates (100%, n = 26) compared to S. 
zooepidemicus isolates (21%, n = 140, P < 0.0001, Fischer's exact test). In addition, 
mitogenic activity was significantly more prevalent in respiratory isolates of S. 
zooepidemicus (30%, n = 73) compared to other S. zooepidemicus isolates (9%, n = 65, P = 
0.0027, Fischer's exact test). 
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Figure 2.7 Pairwise comparison of Se4047 <pSeq.4 and <pMan.3 from S. pyogenes 
Manfredo displayed using ACT 
Figure reproduced with kind permission from Matt Holden, Sanger Institute. Se4047 
<pSeq.4 is shown at the top of the alignment and <pMan.3 from S. pyogenes Manfredo is 
shown at the bottom of the alignment. The red bars separating each sequence represent 
similarity matches identified by TBLASTX analysis. The locations of seel, seeH, spel and 
speH are indicated. 
2.4.1.4.2 Integrative and conjugative elements (ICEs) 
Both the SzH70 and Se4047 genomes contain distinct ICE regions (Appendix Table A.2). 
ICESei (SEQ0730a to SEQ0763) and ICESzi (SZ012981 to SZ012560) are homologous 
ICE elements of the Se4047 and SzH70 genomes, respectively, and are integrated adjacent 
to a putative RNA methyltransferase gene (SZ012990/SEQ0729). These ICEs display 
heterogeneity in their N- and C-terminal regions, with a novel putative modification 
methylase (SEQ0757) and type-II restriction enzyme (SEQ0758) encoded by ICESei . 
BLAST analysis showed that ICESei and ICESzi share most homology with the 
conjugation modules of CDTn2 and CDTn5 in C. difficile (Sebaihia et aI., 2006), and also 
some homology with the conjugation CDSs of ICE MGAS10750-RD.2 of S. pyogenes 
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strain MGAS10750 (Beres & Musser, 2007). These ICEs carry transporters of unknown 
function in C. difficile and the erythromycin ribosome dimethyltransferase ennA (erm(TR» 
gene in S. pyogenes, which provides co-resistance to macrolide (including erythromycin), 
lincosamide, and streptogramin B antibiotics (MLSB resistance) through a modification of 
the target bacterial 23S rRNA (Sebaihia et ai., 2006; Seppala et ai., 1998). ICE 
MGAS10750-RD.2 also carries genes that potentially confer resistance to spectinomycin 
and tetronasin (Beres & Musser, 2007). CDTn2 and CDTn5 have a conjugation module 
related to that of Tn1549, a conjugative transposon responsible for vancomycin resistance 
in Enterococcus species (Garnier et aI., 2000; Sebaihia et ai., 2006). 
Similarities also exist between the conjugation modules of ICESellICESzl and ICESe2, 
the second ICE in the Se4047 genome, which also has features related to ICE 
MGAS10750-RD.2 (Figure 3.3, Chapter 3), CDTn21CDTn5 and Tn1549 in Enterococcus 
spp (Figure 3.2, Chapter 3). However, ICESe2 encodes a unique siderophore-like non-
ribosomal peptide synthesis system responsible for the production of a secreted product 
involved in iron acquisition (Chapter 3). A biosynthetic gene from this region of ICESe2 
was present in all of the S. equi isolates, but in none of the diverse collection of S. 
zooepidemicus isolates examined by QPCR (Figure 2.6). A putative bacteriocin locus is 
also present outside of the predicted conjugation module in ICESe2. An upstream putative 
two-component sensor histidine kinase is truncated at its N terminus, which may affect the 
regulatory control of this bacteriocin gene cluster., ICESe2 is integrated adjacent to an IS3 
element, which is associated with a 119 kb inter-replichore inversion in the centre of the 
Se4047 chromosome. 108mer flanking inverted repeats of ICESe2 extend into this IS and 
into a truncated hypothetical protein at the other end of the element. This hypothetical 
protein (SEQI273) and 2 other CDSs (SEQI274, SEQ1274) are also novel to the Se4047 
genome. ICESe2 was present in the same genome location in all S. equi strains tested 
(Chapter 3). 
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A unique ICE in SzH70 (ICESz2: SZOlS030 to SZ017561), which has integrated into a 
putative nudix hydrolase (SZOlS031-SZ001S11), is related to regions of probable ICEs in 
the genomes of S. agaZactiae (NC_004116.1, NC_00436S.1) and S. suis (NC_009442.1, 
NC_009443.1). ICESz2 encodes a number of proteins that may offer a selective advantage 
to this strain, including a multi-antimicrobial extrusion (MATE) family transporter 
(SZ017690), a putative glue an-binding protein (SZ017S00) and a C-5 cytosine-specific 
DNA methylase (SZ017990). ICEs are absent from the genome of SzMGCSI0565 (Beres 
et aI., 200S). 
2.4.1.5 A clustered regularly inters paced short palindromic repeat (CRISPR) array 
A 23 kb region of the SzH70 genome has been deleted in Se4047 through recombination 
between ISSeqll elements (Table 2.3, Appendix Table A.2). 24 CDSs are present in this 
part of the SzH70 genome including 7 CRISPR-associated genes (SZ014330-SZ014470) 
and a CRISPR array (Figure 2.S). 
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Figure 2.8 The clustered, regularly interspaced short palindromic repeat (CRISPR) locus 
of SzH70 
An AT-rich leader sequence separates the short palindromic repeat sequences interspersed 
with unique spacer sequences from the putative CRISPR-associated genes. The predicted 
secondary structure of the type 1 and type 2 repeats is shown using RNAfold (Gruber et 
at-, 2008). 
CRISPR systems are a recently discovered defence mechanism, present in about 40% of 
sequenced bacterial genomes, which confer acquired phage resistance to bacteria (Kunin et 
at-, 2007; Sorek et ai., 2008). The SzH70 CRISPR array is composed of 19 direct 
palindromic repeats, each 32 bp in size, separated by similarly-sized non-repetitive spacers 
(18 in total). Following transcription into RNA, these repeats are hypothesised to form 
RNA stem-loop structures (Sorek et ai., 2008). RNAfold software was used to predict the 
secondary structure of the 2 variants of these direct repeats that contain a 7 bp palindrome 
and differ by 3 nucleotides outside of the complementary palindromic region (Figure 2.8). 
The structural features of the RNA molecule and a conserved 3' terminus have been 
suggested to act as binding sites for one or more of the CRISPR-associated proteins. In 
this instance the 3' terminus motif is GAAAU, although the consensus varies slightly 
depending on which phylogenetic cluster the CRISPR repeat belongs to (Kunin et ai., 
2007). Small RNA species derived following transcription of the spacer region (and repeat 
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region) are thought to base pair with foreign nucleic acids, as directed by the sequence of 
the spacer region, leading to their degradation (by the activity of CRISPR-associated 
protein(s» (Sorek et al., 2008). All 18 SzH70 spacers are unique and BLASTN analysis 
revealed full length (or near full length) matches to prophage sequences in 7 of the 18 
spacers (Table 2.4). 2 share> 94% identity with prophage sequences present in the 
published genomes of S. pyogenes, 4 spacers have identical matches with prophage 
sequences found in the Se4047 genome (#6 with SEQ0163 of q>Seql, #7 with SEQ1743 of 
q>Seq3, #8 with SEQ1745 of q>Seq3 and #15 with SEQ1727 (seeM q>Seq3) and one spacer 
(#18) has a near identical match with the Se4047 prophage CDSs SEQ0190 (q>Seql) and 
SEQI729 (q>Seq3), differing only at the first nucleotide (C to T). 
The CRISPR-associated genes of the SzH70 CRISPR locus are present in the CRISPR 1 
locus of SzMGCS 10565 and the leader sequences that separate the CRISPR-associated 
genes from the CRISPR array in both genomes differ by only 8 bp. A single type 2 SzH70 
repeat and 9 type 1 SzH70 repeats are also present in CRISPR 1 of SzMGCS 10565 but 8 of 
the 9 interspersed spacers have unique sequences in comparison to the SzH70 CRISPR. 
However, spacer 9 of SzMGCS10565 CRISPR 1 has an exact match with spacer 18 of 
SzH70 (Beres et al., 2008). Another 2 CRISPR arrays with distinct repeats and spacer 
sequences were identified in SzMGCSI0565 (Beres et al., 2008) in regions of the genome 
that are absent from SzH70 and Se4047. 
The CRISPR region of SzH70 was present in 93% of S. zooepidemicus isolates examined 
by PCR, but was absent from all strains of S. equi tested (Figure 2.6). 
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Table 2.4 BLASTN analysis of SzH70 spacer regions in the clustered, regularly 
interspaced short palindromic repeat (CRISPR) locus 
Spacer BLASTN alignment Or..s.anism CDS 
#l Query 13 TTTTTTGACCGTCAATCAT 31 Cyanothece chaperone 
(33 1111111111111111111 sp . DnaJ domain 
nt) Sbjct 1768789 TTTTTTGACCGTCAATCAT 1768771 (CPOO129l) protein 
100% I d entity 
#2 Quer y 1 TTTGATGTAATCTGCGATA 19 Aspergillus 
(33 1111111111111111111 niger 
nt) Sbjct 97504 TTTGATGTAATCTGCGATA 97486 (AM270371) 
100% I d entity 
#3 Query 1 TTTGTTAAGGTGCTTGCTCTATTGCAAGATATC 33 S . pyogenes* <pMan .2 
(33 11111 11111 111 11111 11111111111111 Manfredo putative 
nt) Sbjct 678830 TTTGTCAAGGTGCTTGCTCTATTGCAAGATATC 678862 (AM295007) phage tail 
96% Identity protein 
#4 Query 11 TGCAAATTACAAGATTGATATTG 33 Plasmodi um BIR protein 
(33 11111111111111111111111 berghei 
nt) Sbjct 195 TGCAAATTACAAGATTGATATTG 217 (XM_ 669 489) 
100% I d entity 
#5 Query 11 TTCTCTTAGTTGGTTTACT 29 Microcystis hypothetical 
(36 1111111111111111111 aerugi nosa p rotein 
nt) Sbjct 21 51305 TTCTCTTAGTTGGTTTACT 2151287 (AP009552 ) 
100% Identity 
#6 Query : 34 ATGTTGGTTGGACTGTTCGTCAATGTTTGATTTG 1 Se4047 <pSeql 
(34 1111111111111111111111111111111111 SEQOl63 
nt) Sbjct : 155982 ATGTTGGTTGGACTGTTCGTCAATGTTTGATTTG 156015 phage DNA 
100 % Identity methylase 
#7 Query : 1 GTGTTCCGTTTGAAAAGCGAGTTTAGCTGCTTT 33 Se4047 <pSeq3 
(33 111111111111111111111111111111111 SEQl743 
nt) Sbjct : 1757760 GTGTTCCGTTTGAAAAGCGAGTTTAGCTGCTTT 1757792 phage major 
100 % Identity tail protein 
#8 Query : 1 TTTAGCCCTGTCGTTCCAACTACTTTTAAAGATA 34 Se4047 <pSeq3 
(34 1111111111111111111111111111111111 SEQl745 
nt) Sbjct : 1758654 TTTAGCCCTGTCGTTCCAACTACTTTTAAAGATA 1758687 hypothetical 
100 % Identity phage protein 
#9 Query 1 TCTGTTGGTAGGGTACAAACCCCAAC 26 S . e rythro 
(35 11111111111 11111111 11111 pneumoniae mycin 
nt) Sbjct 20707 TCTGTTGGTAGAGTACAAACACCAAC 20732 AP200 resistance 
92% I d entity (EF469826) transposon Tn1806 
#10 Query 9 CATTACCACCAAACTCAAACA 29 Vibrio heat-stable 
(33 111111111111111111111 chol era e nterotoxin 
nt) Sb jct 167 CATTACCACCAAACTCAAACA 187 (L 03220 ) (sto ) 
100% Identity caa caactgtaac caccgcggct 
#11 Query 1 GTGGGGTACTTGAATGAGCAATCTAGTATTATCG 3 4 S . pyogenes* 370.3 
(34 1111111 1111111111111111111 111111 Hl hypothetical 
nt) Sbjct 790586 GTGGGGTGCTTGAATGAGCAATCTAGTTTTATCG 790619 (AE004092) phage 
94% Identity 
protein 
#12 Query 10 TGGATACCTTTATCCAAG 27 Pse udomonas TPR repea t 
(3 4 111111111111111111 putida containing 
Sb jct 3410572 TGGATACCTTTATCCAAG 3410555 (CPOO0926 ) protein nt) 
100% Identity 
#13 Query 7 GGTGGAAAAACGGCTTGC 24 Bacteroides e rythro 
(35 111111111111111111 un iformis mycin 
Sbjct 72868 GGTGGAAAAACGGCTTGC 72851 (AY3 45595 ) resistance nt) 
100% I d entity trans poson CTnBST 
#1 4 Query 17 AGAATTACTTCGAGGATGG 35 Leishmania 
(37 1111111111111111111 braziliensis 
Sbjct 1282296 AGAATTACTTCGAGGATGG 1282278 (AM4 9 4970 ) nt) 
100% I d entity 
#15 Query : 34 GAGACCACCATTGATTGAATGTATTTGATCTTTT 1 Se4047 <pSeq3 
(34 1111111111111111111111111111111111 SEQl727 seeM 
Sbjct : 1742700 GAGACCACCATTGATTGAATGTATTTGATCTTTT 1742733 nt) 
100 % Identity 
#16 Query 2 GATGAAGCTGCTACAAAGC 20 Danio rerio 
(35 1111111111111111111 (zebrafish 
Sbjct 3830 GATGAAGCTGCTACAAAGC 3812 XM_ 689207 ) nt) 
100% Identity 
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Table 2.4 continued 
Spacer BLASTN a lignment Organ ism CDS 
#17 Query 1 TTTGGCATGCCTCACATCAGACTCATGTCTAGCAT 35 S . pyogenes putative 
(35 111111111 111111111111111111 111111 MGAS10270 cell 
nt) Sbjct 1336645 TTTGGCATGTCTCACATCAGACTCATGTTTAGCAT 1336679 (CPOO0260) surface 
94\ Identity protein 
#18 Query : 2 CGACACTGCGAACTAATCATTTGTGACTCCTTTC 35 Se4047 cpSeq3 
(35 1111111111111111111111111111111111 SEQl729 
nt) Sbjct : 1745050 CGACACTGCGAACTAATCATTTGTGACTCCTTTC 1745083 putative 
100 % Identity phage 
amidase; 
cpSeql 
Query : 35 GAAAGGAGTCACAAATGATTAGTTCGCAGTGTCG 2 SEQ0190 
1111111111111111111111111111111111 putative 
Sbjct : 177618 GAAAGGAGTCACAAATGATTAGTTCGCAGTGTCG 177651 phage cell 
wall 
100 % Identity hydrolase 
*Matches occur to phage proteins in additional S. pyogenes strains. Highlighted rows 
indicate full length (or near full length) spacer matches to CDSs in S. pyogenes (blue) and 
Se4047 (red). 
2.4.1.6 Nutritional capabilities 
2.4.1.6.1 Carbohydrate metabolism 
Comparison of the genome sequences identified a 5 kb deletion in the Se4047 genome that 
partially deleted lacD and lacG and deleted lacE, lacF and lacT, which encode the sugar 
phosphotransferase system (PTS) proteins and associated enzymes for lactose utilisation 
(Appendix Table A.2). Se4047 also contains a deletion that removes sorD and alters the 
N-terminus of srlM (SEQ0286) in the sorbitol operon (Appendix Table A.2). sorD 
encodes sorbitol-6-phosphate 2-dehydrogenase required to convert D-sorbitol-6-phosphate 
to ~-D-fructose-6-phosphate, whilst SrlM is a transcription antiterminator. The region 
between SEQ0536 and SEQ0537 that spans the operon required for ribose fermentation 
(rbsRKDACB) is also missing from Se4047 (Appendix Table A.2). All 26 S. equi strains 
examined lacked lacE, sorD and rbsD and the capacity to ferment lactose, sorbitol or 
ribose. However, only 15 (ST-7, ST-39, ST-57, ST-97 and ST-I06) and one (ST-39) of 
140 S. zooepidemicus isolates tested did not ferment ribose or sorbitol, respectively (Figure 
2.6). With the exception of 2 isolates of ST -7, all other S. zooepidemicus isolates unable to 
ferment ribose also lacked the rbsD gene. sorD was present in the S. zooepidemicus 
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isolate that was unable to utilise sorbitol (ST -39), which points to different mutation in the 
fermentation pathway in comparison to Se4047. Complete lactose, sorbitol and ribose 
operons were present in SzMGCS10565. 
An 11 bp deletion in SEQI613 (Se4047), which encodes a cellobiose-specific IIC PTS 
component, has introducted a frameshift after codon 313 and an early stop codon 18 
residues later. The Se4047 genome also has a nonsense mutation (TAC to TAA after 
codon 139) that has inactivated a sorbose superfamily PTS permease gene (SEQ0871) and 
an ISSeq3 element has disrupted a putative ~-galactosidase gene (SEQ0866) in the same 
operon. The sorbose Ell superfamily includes sorbose-specific transporters and the broad 
range permeases capable of transporting mannose, fructose and N-acetylgalactosamine. 
Bga, the characterised ~-galactosidase of Xanthomonas manihotis with most homology to 
SEQ0866 (40% amino acid sequence identity), specifically cleaves ~1-3- and ~1-4- linked 
galactose and resembles the acid ~-galactosidases of eukaryotes capable of cleaving ~ 1-3-
and ~1-4- linked galactose from glycoproteins and glycolipids (Taron et al., 1995). These 
CDSs are intact in SzH70 and SzMGCSI0565. 
2.4.1.6.2 Branched-chain amino acid uptake 
The SzH70 and SzMGCS10565 genomes encode a 50 kDa membrane protein 
(SZOI4690/Sez_0528) with similarity to the low-affinity, branched-chain amino acid 
carrier of Lactobacillus delbruckii subsp. lactis BmQ (37% amino acid sequence identity). 
SZOl4690 (and Sez_0528), like BmQ, contains 12 predicted transmembrane helices 
(TMHs). ISSeq3-mediated deletion has removed this gene from the Se4047 genome. 
SZ014690 was absent from all 26 S. equi isolates (Figure 2.6) but was a consistent feature 
of all 140 S. zooepidemicus isolates tested. 
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2.4.1.7 Hyaluronate lyase 
The SzH70 genome contains a single CDS encoding a putative secreted HA lyase 
(SZ006680). SEQ1479, the Se4047 orthologue, contains a 4 bp deletion (TCTC) leading 
to a frameshift at codon 199. An early stop codon would truncate the produced protein at 
amino acid 217 (including 18 aberrant residues at the C-terminus). <pSeq3, a prophage of 
Se4047 encodes a different HA lyase (SEQ2045) with a primary role most likely to be 
involved in phage penetration through the bacterial capsule. This phage enzyme lacks a 
signal sequence and is therefore only likely to reach the extracellular environment 
following bacterial cell lysis. PCR was performed using a forward primer that covered the 
4 bp of SZ006680 deleted in strain Se4047 to test for the presence of these 4 bp in other 
strains of S. equi and S. zooepidemicus. All 26 isolates of S. equi tested and one strain of S. 
zooepidemicus JKS115 (ST-57) were negative by PCR, whereas all other S. zooepidemicus 
isolates were positive (Figure 2.6). Sequencing revealed an IS element 905 bp from the 
translational start of this gene in the S. zooepidemicus JKS115 isolate that was negative by 
PCR (Holden, 2009). 
2.4.1.8 ESAT-6 secretion system 
A cluster of 9 genes with similarity to the 8 genes of the ESA T -6 secretion system (Ess) of 
S. aureus is present in the SzH70 genome (Burts et ai., 2005; Burts et al., 2008; 
Sundaramoorthy et ai., 2008) (Figure 2.9). 
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5 . aureus 
\>- ~ 9>0 ~ 
esxA esaA # $'8> esse ~~ QI FtsK-SpoIlIE 
44% 24% 24% 24% 42% 10% 
5.zH70 24% 15% q ~ ~ FtsK-SpoIIiE ~ SZ014680 - SZ014610 
100% 96% 95% 99% 100% 99% 
521'v1GCS 10565 98% 99% q ~ ~ FtsK-SpoIlIE ~ Sez_053J - Sez_0537 
99% 100% 99% 
594047 ~~ FtsK-SpoIllE ~o SEOO576 - SEQ0582 
Figure 2.9 Schematic drawing of the ess cluster in S. aureus, SzH70, SzMGCS 10565 and 
Se4047 
Colouring indicates function according the the characterisation of the S. aureus Ess system 
(Burts et ai., 2005; Burts et al. , 2008; Sundaramoorthy et ai., 2008) and the prediction of 
TMHs in putative membrane proteins; light grey: ESAT -6 like secreted WXG 100 proteins; 
dark grey: non-WXG100 secreted protein (less well conserved CDS of the ess clusters in 
Gram-positive bacteria); green: predicted membrane proteins; blue: cytoplasmic post-
transcriptional regulator; brown: partial or pseudogene; yellow: possible hypothetical 
protein. 2 FtsK-SpoIIIE domains, a characteristic of A TPases, are present in esse and the 
S. equi subspecies homologues. 
The extra CDS (SZ014650) in SzH70 is a possible hypothetical protein of 44 amino acids. 
SzMGCS10565 has a near identical gene cluster, whilst ISSeq3 elements have mediated 
the deletion of the first 2 genes in the homologous locus of Se4047. In addition, SEQ0576 
is missing an N-terminal portion and SEQ0578 has a frameshift after codon 13 (and an 
early stop 13 codons later). PCR analysis showed that none of the 26 isolates of S. equi, 
but 138 of 140 S. zooepidemicus isolates examined contained the esaA gene (Figure 2.6). 
EsxA and EsxB are referred to as leaderless WXG100 secretion proteins due to their lack 
of an N-terminal signal sequence, their approximate size of 100 amino acids and the 
presence of a centrally located WXG-motif. These features are also conserved in the 
homologous proteins of the S. equi subspecies (where present). The role of the WXG-
motif is unknown at present but may be involved in the formation of the EsxA-EsxB 
complex. EssA, EssB and EssC are predicted membrane proteins required for the 
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synthesis of EsxA and EsxB and possibly their secretion across the staphylococcal 
envelope. EssA, EssB and EssC contain predicted TMHs (1:1:2 respectively) and the 
homologues in the S. equi subspecies also contain predicted TMHs (2:1:1 respectively). 
EssC and its homologues in Se4047 , SzH70 and SzMGCS 10565 contain 2 FtsK/SpoIIIE 
domains that are often associated with ATPase activity. These proteins may therefore 
function as an ATPase to provide energy for the active export of secreted factors. The 
exact function of EsaA is unknown; although this protein has 6 predicted THMs like the 
homologous proteins in S. zooepidemicus. EsaB is a cytoplasmic protein involved in the 
post-transcriptional negative regulation of EsaC, and EsaC is another secretion substrate of 
the Ess pathway (Burts et al., 2008). Genes located immediately downstream of esxB in S. 
aureus and the S. equi subspecies are not depicted in Figure 2.9. However, their 
conservation in other related clusters from low G + C organisms suggest that they may also 
be associated functionally with the Ess cluster. Se4047 has only one downstream gene 
(SEQ0583) before another IS mediated deletion event has removed a large region of DNA 
that includes the previously described CRISPR locus. 
2.4.1.9 Factor H binding protein 
Se18.9 (SEQ0235) binds to the complement regulator factor H, decreases C3b deposition 
and reduces the bactericidal activity of equine neutrophils towards S. equi (Tiwari et al., 
2007). This 18.7 kDa protein is encoded with 4 other genes (including 2 pseudogenes) in a 
region of the genome that is novel to Se4047 in comparison to SzH70 and SzMGCS 10565. 
A low GC content suggests that this locus has been acquired through lateral gene transfer. 
Single CDSs with similar N-terminal signal sequences are present in the 2 S. 
zooepidemicus genomes but these only share 24 to 28% aa sequency identity with 
SEQ0235 overall. PCR analysis showed that all 26 isolates of S. equi, but only one out of 
140 S. zooepidemicus isolates examined contained the SEQ0235 gene (Figure 2.6). 
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2.4.1.10 Surface proteins 
2.4.1.10.1 Gene loss 
Like other Gram-positive bacteria, Se4047 and SzH70 display an array of cell wall-
anchored proteins; however the genome of Se4047 has undergone notable gene decay in 
this subset of proteins in comparison to SzH70 and SzMGCS 10565 (Table 2.5). SzH70 
encodes 34 intact cell wall-anchored proteins and 5 predicted pilus subunits that are likely 
to contribute to the formation of 2 mature pilus structures. 3 of these pilus subunits, 
encompassing one of the mature pilus structures, are absent from the Se4047 genome due 
to an IS-mediated deletion event (see below). The Se4047 genome contains homologues to 
the other 2 putative pilus subunits and to 33 of the 34 SzH70 cell wall-anchored protein 
CDSs, although 8 are pseudogenes or partial genes. 2 of these Se4047 pseudogenes 
encoding Fne (fibronectin- and collagen-binding protein) and FneD (collagen-binding 
protein) were previously described (Lannergard, 2006; Lindmark et al., 2001). The 
introduction of early stop codons has truncated Fne and FneD resulting in their likely 
secretion without a cell wall anchor and without 300 to 131 C-terminal amino acid 
residues, respectively. For Fne, this truncation results in the loss of a 2nd fibronectin-
binding site (Lindmark et at., 2001). Frameshift mutations have introduced similar early 
stops after codon 9 in a SeM-like surface protein (SEQ0232), after codon 182 in a SzPSe-
like surface protein (SEQ0566) and after codon 58 in a putative cell wall-anchored C5A 
peptidase (SEQI077). Further gene degeneration has left 3 partial genes in Se4047; for 2 
of these (SEQ1226 and SEQ1307a) only small gene fragments remain, whilst one lacks an 
N-terminal signal sequence required to direct its extracellular secretion (SEQ0556). 
SEQ1226 is part of a bacteriocin gene cluster that has likely degraded following its 
disruption by insertion of an ISSeq3 element and a subsequent intra-replichore 
recombination event. SZ009950, the SzH70 homologue of SEQ1226 contains a putative 
Pfam thioredoxin domain and may be involved in bacteriocin modification. Further 
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characterisation of SZ008560, the intact version of SEQ1307a in SzH70 is presented 
below. 
Conversely, Se4047 SEQ2190 encodes a surface anchored protein that has only a partial 
gene homologue in SzH70 (SZOI8970) and an unconfirmed pseudogene homologue in 
SzMGCS10565 (Sez_1908-191O) suggesting that gene degradation has occurred in SzH70 
and SzMGCS 10565 subsequent to their divergence from the ancestral S. zooepidemicus 
strain from which S. equi evolved. Interestingly, all diverse strains of S. zooepidemicus 
tested for the presence of an N-terminal region of SEQ2190 were negative by PCR (Figure 
2.6), which implies a lack of SEQ2190 homologues (at least with the same nucleotide 
sequence in the primer binding site(s)) in the general S. zooepidemicus population. 
SEQ2190 shares amino acid sequence identity (30%) with the C-terminal half of a GAS 
M3 protein that binds multiple ligands including fibrinogen, fibronectin and serum albumin 
(Reichardt et at., 1995), but has a unique N terminal region in comparison with other 
proteins in the public databases. 
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Table 2.5 Sortase-processed surface proteins of Se4047, SzH70 and SzMGCS10565 
CDS " JJ) " JJ) " JJ) " JJ) Pr"dul'l I putati, C Sdlclllalil' "I' prnll'ill h"IIIf1I"l!ucs 
" " 
, " , " ,,,rtasc Ill"tif) Iscc Ill'llI\\ I'"r kl'~ ) 
SEQ SZO SEQ SZO 
NP putative collagen-
like surface-
anchored protein 
SZOO0830 - - (LPATG) 
'-T I . 500 AGO 30 Nearly identical GXY . l07 
except for 
Sez_OO99 - 85.2 - 100 variation in the • L I . 428 AGO 23 
number of GXY, SeIZ.l 83 
SEQOO90 putati ve collagen- II II 397 GKPGEA • , AGO =, KGD = 2 like surface- SclG 74 
anchored protein 
SZOOO840 52.6 15.6 SclG (LP A TG) I I I . 436 GPP. , KGD=30 
85 
Sez_Ol OO 51.1 79.4 13.9 65.6 I I I 1 383 GPP =, KGD = 23 
SclZ.2 67 
NP putati ve collagen-
like surface-
anchored protein 
NP - - (LPATG) 
SecO l 62 - - - - I I II 335 KGD · 9 
SeIZ.3 56 
SEQ0232t SeM-like cell I 9 
surface-anchored Early stq> codon 
protein (LPSTG) 
SZOO l430 - - 411 
Sez_O I64 - 64.7 - - 392 
SEQ0256 putati ve cell 1 608 
surface-anchored 
protein (LPATA) 
SZOOl 590 74.3 - • 570 
Sez_01 85 85.4 79.0 - - . 608 
SEQ0260 putati ve collagen- I I I I 414 KGD 10 like cell surface- SeIH 65 
anchored protein 
SZOO l630 82.2 96.2 SclH (LP A TG) I I I I 423 GKPGEA = 1 KGD = 8 
71 
Sez_O I90 83.3 88.5 96.2 100 I I I 1 462 GKPGER 1 KGD = 10 SeIZ.4 80 
putati ve collagen-SEQ0280 II II 276 KGD = 7 like cell surface- SeIO 42 
anchored protein 
SZO I7540 85.2 100 SclD (LPATG) II II 324 KGD=12 100% ideiltical 58 
except for 
Sez_0213 82. 1 96.4 100 100 variation in the II II 336 KGD·. 13 
numberofGXY, SeIZ.5 61 
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Table 2.5 continued 
CI>S I, IJ) I, IJ) I, IJ) I, II> I'rndlll'llplltathr 
" 
\s \' \ S \ \s snrtasl' IIlntit') 
SEQ szo SEQ SZO 
SEQ0375t fibronectin and I Fni CL-bind ' 298 
collagen binding ' I~~ protein Fne/Fnz aa lD 
SZOl 6630 - 43.6 (LPQTN/S) II Fnf Cl 564 
Flu 100'/. i' )1 N 
aa lD "" iD 
Sez_0313 
- 65.8 43.6 100 II Fnl r i 576 GPP 1 
Fnz ~lPOT 
rqJCats (x5) 
SEQ0402 putati ve cell • _ 1 373 suriace-anchored 
protein (LPSTG) 
PKPE rich SZOl6370 61.6 41.4 
• _ 1 411 PX repeats 
Sez_0338 52.2 53.2 40.3 47.5 I 11 3al 
MlpZ 22 
SEQ0555 collagen and • II- I 411 fibronectin- FneE 5 
binding cell 
SZOl4890 39.0 45.7 suriace-anchored I I - I 731 KGD 6 protein FneE 92 
(LPRTN) 
Sez_0499 63.7 42.9 62.6 46.0 • 
._ .482 GPP 1 
FbpZ.2 6 
SEQ0556t putati ve collagen- I I I I 431 KGD 3 
I ike surface- Part ial 41 15 
anchored protein protein 
NP 
- - (LPKTN) 
Sez_0500 
- - - - I I I I 522 KGD 1 
SeIZ.6 51 10 
SEQ0563 chemokine .. .. :: : .. . .. , . . HI 
protease ScpC SciOC~ ~ l 1634 (LPSTG) 
SZO l4810 97.8 - •• - ' I:.: I. ... , .. 
SciOC~ ~ I 1634 
Sez_0511 98.6 98 .2 - - IQ~1t¥t ,f·j.j"H,w'1jj.j"j,jj,w:£iel.l"i:ij" J II 
SciOC I PP: pre-pro dam"n 1634 
SEQ0566t SzP/SzPSe-like r=:J 182 
cell suriace- Early Slcp codon 
anchored protein 
I PKPE rich SZO l4790 - 27 .1 (LPSTG) &'" PX repeats 80% aa lD Sez_05 13 
- 67.0 31.2 43.4 394 
SEQ0633 putati ve collagen- I ' ' I 3t2 RGD 1 KGD 2 
like surface- SeIE 52 
anchored protein 
SZOl3850 75 .0 45. 1 ScLE (LPATG) I I • 351 RGD 2 KGD ~ 2 
66 
Sez_0608 61.8 78.5 45.4 98.0 I ' ' I 441 RGD 2 KGD 1 
SeIZ.7 96 
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Table 2.5 continued 
CDS " JI) " JI) c, JI) " JI) Prfllllll'l (plllaliH 
SEQ0646 
SZOl3730 
SEQ072 I 
SZO I3070 
SEQ0855 
SZOJ2230 
SEQ0904 
SZOl1 790 
SEQ0933 
SZO l1 530 
SEQ0935 
SZO l1 510 
SEQ0936 
SZO J 1500 
\S \'s \ ' \S \ \S slIrlasc Illl1tit') 
SEC) SZO SEC) SZO 
95.5 
93.4 92.8 
99.5 
95.4 95.4 
77.0 59.6 
77.2 90.2 50.0 52.0 
97.4 
95.0 95 .9 
79.3 54.5 
78.2 90.6 53 .2 80.4 
88.9 88.2 
87. 1 94.2 86.5 91.2 
98 .3 
96.7 95.0 
putati ve cell 
surface-anchored 
protein (LPLTG) 
[g, a,M and 
albumin bin cling 
protein EaglZag 
(LPTTG) 
putati ve collagen-
like cell surface-
anchored protein 
SclF (LPSTG) 
endonucleasel 
exonucleasel 
phosphatase (exo 
en do phos) family 
su rface anchored 
protein (LPKTG) 
SzPSe: 
fibrinogen-binding 
cell sUlface-
anchored protein; 
SZP: adhesin and 
hypervariable 
protective antigen 
(LPSTG) 
collagen binding, 
putati ve ancillary 
pilus subunit Cne 
(LPDTG) 
putati ve backbone 
pilus subunit (T6-
antigen-like) 
(LPSTG) 
93 
290 KGD 1 
290 KGD 1 
290 KGD 1 
429 
Eag IgG 
429 
Zag IgG 
433 
Zag tgG 
II I I 364 SelF 70 
II I I 347 
64 
I I I I 343 SeIZ.8 62 
KGD = 1.RGD = 1 
KGD = 1.RGD = 1 
KGD = 1.RGD 2 1 
374 
383 
3n 
Szp 
I CLtird I I 
Cna 
I CLljrd I • 
I CLljrd I • FszA 
* * 
* * 
* * 
q,·macrO(joaJin ( a,M), 
Serum Altumln (A) ard 
IgG IJrdr>;) r.gons i'lgr;ighlAd 
KGD 8 
KGD 12 
KGD c 10 
926 
axoendophos domain 
926 
axo endo phos domain 
926 
axo endo phos domain 
Szp hypcrvarlable 
region 
• PEPK ri ch PX repeals 
• • 657 
. 654 
• • 654 
480 KGD = 2 
480 KGD = 2 
478 KGD 2 
Table 2.5 continued 
CDS (; JI) (; JI) (; JI) (; JI) Prudllcl (plltath c 
SEQ0939 
SZOl1470 
SEQ0944 
SZO l1 4 10 
Sec 0820 
SEQ I077 t 
SZOl0150 
SEQ 11 16 
SZOO8940 
SEQI 226T 
SZOO9950 
Sec0970 
SEQ 127& 
SZOO8800 
SEQI 307at 
SZOO&560 
\S \S , \S , \S surtasl' lIIutii') 
SEQ SZO SEQ SZO 
66.7 57.9 
73 .9 76.6 38.0 48.5 
9&.2 
97.9 99.0 
97 .6 
93.2 84.2 
94.5 94.4 87.2 88.& 
100 
99.4 
99 .1 99.1 
90.4 
putative cell 
surface-anchored 
protein (LPSTG) 
putative cell 
surface-
anchored 
pullulanase 
(LPKTG) 
putati ve cell 
surface-anchored 
C5A peptidase 
(LPKTS) 
putati ve adhesin 
(LPKTG) 
(uTG-like, 
S. agaiacliae) 
putative cell 
surface-anchored 
thioredoxin 
(FPKTG) 
(located into 
bacteriocin cluster) 
putati ve cell 
surface-anchored 
5'-nucleotidase 
(LPATG) 
Listeria-
Bacteroides repeat 
domain containing 
cell surfaced-
anchored protein 
(LPKTG) 
94 
• 1 417 KGO 1 
421 KGO 1 
• _ 1 400 KGO 1 
KGD .2 1238 
PUOPUO c ": AMH:l.~1 
KGD .2 1238 
PUA 
KGD . 2 PUO :pulanase-associated domain 1238 
C: carbohydrate bind ng mOCUe ~8 
58 
Early step codon 
I) H 
AM : amylasecalalylic domain 
OUF: domai n associated 
with p.lpndases 
-" , , ... 
ScpZ H RGO 1 11 18 
1000 
KGO = 2 1000 
_ I 111111 _ 11111 IlL: ~ ~._::t.~ ~ 
KGO = 2 n 1003 U Leuclre rich repeat (LRR) 
• 11 0 Partial protein 
• • • 283 
_ _ 283 
T: putative tlieredoxln domain 
MP S'Nuc 668 
MP S'Nuc 668 
MP S'Nuc 668 
MP: Metal lo·phosphoestcrase domai n 
SNuc: 5' nucleotidase C terminal domain 
Partial protein 
11 2 
I "" =..,_:;:1 I , 1 . 1 
KGO = 2, RGO = 2 11 60 
I ." 1'1 '1 . 1 
KGO = 2, RGO = 2 11 61 o Usterla-bi£tCfoldos repeat domain 
Table 2.5 continued 
CI>S ' , II> " II> " II) " II) I'rUlIllcl (plltath~ 
\S \S \' \S \' \S sflrtas~ mfltif) 
SEQ SZO SEQ SZO 
SEQ 1606 collagen-b inding I CL-bnd? I I iii 62B GKPGEA I 
collagen-like cell FneC 86 10 AGO = I KGO 3 
surface-anchored 
SZOO5380 56-4 385 protein FneC I SEI fSTI GKPGEA . I AGO I KGO 2 (LPKTN) 101 14 
NP 
SEQI607t collagen-binding I CL-brdl 214 
surface-anchored FnoO 
protein FneD 
SZOO5350 39-4 (LPKTN) 528 GP? 1 
46_6 33.6 50.2 I 1 1 498 AGO 2 KGO 2 
ScIZ.9 41 16 
collagen-binding I CL-bnd? III 516 AGO I KGD 3 
collagen-like FneF 5: 12 
SEQ 1649 
sU lface-anchored 
59.7 88.8 protein FneF I CL-tJnd? I e 750 ~~6~E: 4 
(LPKTN) 124 16 
SZOO49 10 
53. 1 67 .7 53 _9 54.7 I CL-bnd? 1 . 666 GKPGEA 2 AGO I KGO 3 ScIZ.l0 97 16 
pULati ve collagen- I I I I 491 RGO _2 KGD = 3 
like surface- ScI 105 
SEQ I817 
anchored protein 
74.2 19.7 Scll (LP ATG) I I I 480 GPP = 2 RGD = 2 KGD. 13 SZOO3720 
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16.7 35-4 £J 117 
ScIZ.11 , early stop 
codon (unconfirmed) 
SEQI959 
- - ,._ I 515 
SZOO2400 515 
Sez_ 1737 • ••••• :::1 515 
SEQI999 
SZOO2080 
SEQ2017 anti phagocytic = Repeat ragon 
cell surface- 19G-tJrdng region 
anchored 
SZOO 1900 65.8 fibrinogen- and 5IlO 
[gG Fc-binding 
protein SeM 
Sez_ I778 36.6 33.1 (LPSTG) 
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Table 2.5 continued 
CI>S l; II> C; II> l; II> l; II> I'rudllct (plltathc 
SEQ2100 
SZOl8100 
SEQ2101 
SZOl8110 
Secl803 
NP 
SZOl8330 
NP 
NP 
SZO l 8320 
NP 
NP 
SZOl8310 
NP 
NP 
NP 
NP 
NP 
" \S , " , \S surtaSl' lIIutif') 
SEQ SZO SEQ SZO 
98.7 97.9 
99.3 98.4 98.6 97.9 
58.8 16.9 
83.3 65.9 100 16.9 
putati ve cell 
surface-anchored 
protein (LPATG) 
putati ve collagen-
like surface-
anchored protein 
SclC (LPATG) 
putati ve minor 
pilus subunit 
(FPMTG) 
putative major 
pilus subunit 
(RrgB-like) 
(IPQTG) 
putative minor 
pilus subunit 
(RrgC- like) 
(VPYTG) 
putative major 
pilus subunit (T6-
antigen-like) 
(IPNTG) 
putative minor 
pilus subunit 
(IPYTG) 
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__ ~~ ___ ... 448 
448 
__ ---L*~ ___ .... 448 
CspZ.1 
• I I Iij 302 GAPGER SeIC 41 
• I I I 333 KGD 54 4 
* HXXHHH 
HHXXHXHHH 
motifs 
1 KGD ~ 8 
I I I 1 359 KGD 2 8 
SeIZ.12 60 
• II · 
KGO= 1 t LatcHng cleft base 
••• * ••••• CJI 713 
__ 1-..1. 290 
* 
616 
FszF 
___ "--__ 316 
FszE 
1409 
Table 2.5 continued 
(,DS ',ID ',ID ',ID ',ID Pr"rlllct (p"tath c 
\S \S \' \s , \ S s"rt"sc 1II"lif) 
SEQ SZO SEQ SZO 
NP putati ve minor 
pilus subunit 
(LPATG) 
NP - -
KGO = 1 
* 
Sez_1825 - - - - . 832 
FtpZ 
NP putati ve minor 
pilus subunit 
(LPSSG) 
NP - -
KGO = 1 
. 
Sez_1822 - - - - lit! 967 
FszO 
NP putati ve major 
pilus subunit (T6-
antigen-like) 
NP - - (LPSTG) 
RGO = 1 
Sez_1821 - - - -
_ 549 
FszC 
SEQ2 180 putati ve cell 
• I 626 surface-anchored 
99% aa 10 I 91% aa 10 protein (LPATG) 
SZO l 8890 94.3 98.3 (C-terminal region • 629 homology to GAS 46% aa 10 J 89% aa 10 
MlMrp proteins) 
Sez_190l 67.9 70.4 35 .8 37.9 • • 626 CspZ.2 
SEQ2 190 putati ve cell • • 673 surface-anchored I 82% aa 10 protein (LPATG) 
SZOl8970t - - (C-terminal region Partial prrnel n • 372 homology to GAS 
M proteins) 
Sez_ 1908- l910t - - - • IEarly S10p 271 i"4 POSSltjC: 1rlmc:;IlM 
Needleman-Wunsch global alignment was used to calculate % amino acid identity of intact CDS 
and V regions relative to the homologues in Se4047 (SEQ) and SzH70 (SZO) respectively. NP Not 
present. t Pseudogene or gene remnant. Integrin binding motifs shown (GXPGER, KGD, RGD, 
GPP). 
Key: -
• Secretion signal peptide 
o Variable region 
o Collagen-like region (no. of GXY-motifs shown in red) 
• PX repeats (no. of repeats shown in black) 
o Proline-rich cell wall spanning region 
• Cell wall anchor 
o Pfam Cna_ B domain (PF05738) 
• SdrG IgG-like domain 
* Pilin motif 
* E box 
Fn bind: fibronectin binding region 
CL bind : collagen binding region 
Fg bind: fibrinogen binding region 
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2.4. I . / o. / .J A lIle(·hanism .fbI" phase varia /ioll 
The SzH70 and SzMGCS 10565 genomes encode a 131 kDa putative surface protein 
containing 1,160 amino acids with an LPXTG motif (SZ008560 and Sez_1114). 
However, the Se4047 genome encodes only the final 112 amino acids of this protein 
(SEQ1307a) and lacks an adjacent gene predicted to encode a recombinase (SZ008550 
and Sez_1116) (Table 2.5). SZ008560 and Sez_1114 share sequence similarity with 
hypothetical proteins of S. suis strain 05ZYH33 (SSU05_0473) and S. agalactiae strain 
COHI (SAN_1519) and contain 4 Listeria-Bacteroides repeat Pfam domains (PF09479). 
These -70 amino acid residue repeats occur in a range of Gram-positive surface proteins 
including families of internalins of Listeria species (Figure 2.10). 
Flg_new consensus 
InlA Rl 
I nlA R2 
InlA R3 
SZ008560 Rl 
SZ008560 R2 
SZ008560 R3 
S2008560 R4 
Sez_1l14 Rl 
Sez_11l4 R2 
Sez_11l4 R3 
Sez_11l4 R4 
SSU05_0473 Rl 
SSU05_0473 R2 
SSU05_0473 R3 
SAN_1519 Rl 
SAN_15 1 9 R2 
Figure 2.10 Alignment of domains in SZ008560 and similar proteins to the Pfam hidden 
Markov model (HMM) for the Listeria-Bacteroides repeat domain (FI!Lnew) 
FIg_new repeats are a feature of some Bacteroides forsythus proteins and families of 
internalins of Listeria species. Matches to the highly conserved and less well conserved 
FIg_new residues are shown in dark and light grey respectively. 2 to 4 FI!Lnew repeats 
(Rl to R4) are shown in InIA, (Listeria monocytogenes, AB032414), SZ008560 (SzH70), 
Sez_I114 (SzMGCS 10565), SSU05_0473 (Streptococcus suis strain 05ZYH33, A4VTKO) 
and SAN_1519 (Streptococcus agalactiae strain COHl , Q3D8T2). 
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Examination of the SzH70 genome sequencing data revealed five sequence reads that 
positioned the promoter region of SZ008560 (-170 bp to -55 bp) in the reverse orientation 
(Matt Holden, Sanger Institute). This sequence is bordered by GTAGACTTTA and 
T AAAGTCTAC inverted repeats; inversion of this sequence may switch transcription of 
SZ008560 on or off, thereby modulating the production of this surface protein (Figure 
2.11). 
Recombinase Surface protein containing Listeria-Bacteroides 
repeat domains 
gtagacttta I---~L...---=-_-l '-_ __ -=s .=ZO.=..0.::.;8;,.:5..=6.=..0 ____ --, 
~ 
Invertible promoter 
ISZ0085~ g1agac;:l"""'-----t1 taaagtctac HL... ___ S_ZO_O..;,.8.;,..56..;,.O ____ 1 
Figure 2.11 Diagram of the SZ008560 invertible promoter in SzH70 
The promoter region of SZ008560 (-170 bp to -55 bp), bordered by GTAGACTTT A and 
T AAAGTCT AC inverted repeats, inverts to switch transcription from the forward to 
reverse orientation. 
Reverse transcription QPCR performed by Karen Steward (AHT) using RNA extracted 
from log-phase cultures of SzH70 and normalised for expression of the housekeeping gene 
gyrA demonstrated that the SZ008560 promoter of SzH70 transcribed 44-fold more RNA 
in the forward direction than the reverse. None of the 26 isolates of S. equi, but 101 of 140 
S. zooepidemicus isolates tested positive for SZ008560 by PCR (Figure 2.6), which 
represents a significant difference in the prevalence of this gene between the 2 subspecies 
(P < 0.0001 , Fischer' s exact test). In addition, a higher proportion of 5.. zooepidemicus 
respiratory isolates (including those from LN abscesses) and S. zooepidemicus isolates 
collected from cases of abortion or uterine infection had the SZ008560 gene (77%, n = 
99 
118) compared to other S. zooepidemicus isolates (66%, n = 20, P = 0.002, Fischer's exact 
test). Of the S. zooepidemicus respiratory isolates, a significantly higher percentage of 
those collected from the lower respiratory tract of horses and dogs (including isolates from 
cases of pneumonia) had the SZ008560 gene (100%, n = 14) than those collected from the 
upper respiratory tract (including from LN abscesses, 71 %, n = 59) (P = 0.03, Fischer's 
exact test). SzMGCS 10565 contains an IS element between the inverted repeats bordering 
the Sez_1114 promoter and the recombinase (Sez_1116). 
2.4.1.10.1.2 Pili 
2 putative sortase CDSs are present in the Se4047 genome: srtA (SEQl171) and srtC.l 
(SEQ0937), whereas the SzH70 genome contains 5: srtA (SZ009440), srtC.l (SZOI1490), 
srtC.2 (SZOI8290), srtC.3 (SZOI8280) and srtC.4 (SZOI8270). These putative sortase 
CDSs all contain a conserved TLXTC signature sequence, catalytic site residues 
corresponding to C184, H120 and R197 of SrtA in S. au reus and a predicted N-terminal signal 
sequence (Dramsi et at., 2005). Those belonging to the SrtC-family (labelled srtC.1-4) 
contain features characteristic of this sortase class including a C-terminal hydrophobic 
domain and a conserved proline residue located after the catalytic site TLXTC (Dramsi et 
ai., 2005). As SrtC enzymes are often clustered in the genome with their cognate pilin 
substrates, these srt CDSs are predicted to be involved in pilus expression (Dramsi et ai., 
2005). 
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A 
Ss4047 
SzH 70 
SzMGCS10S65 
B 
801 04 7 
SzH70 
SzMGCS10S65 
(2 distinct pilus 
gene clusters) 
Se51 .9 S. equi 
CF32 (C-lerminai 
fragment 
99%), 
Coliagen·birdirg puta1ive pilus 
Te1R protein Cne S. equi sLborit protein 
-like 1866 99% S. SuiS4ffi=V~~ 
Putative Pilin Motif 
~ ---=.!.'*! c= c . -
88% LPDTG 98% LPSTG 99% 
Putative E box 
Latchirg cleft base 
" "" ~ C:Sl~O~I:'~510~=-=j •• 1!I - Coliagen-birdirg region 
94% LPDTG 95% LPsr G 99% - SdrG IgG-like ci>main 
~==-.=.- = Cna p-otein B-typeci>main 
AraC-like 
( 
94% 
99% 
LPST G 
ISS0q3 
MGAS10750 
Spy181328% Spy0119 71% 
SrtC 51 % 
Putative Fn-birdirg protein 
M GASI 0750 Spy0115 68% MGAS10750 MGAS10750 
Fn-birdingprotein PrtF226% penial Spy01 1676%, Spy011 7 58%, 
Fg·birding protein SdrG 23% penial RrgB35% RrgC 28% 
~~ ____ S'~OI~~======~~I"""lOc~~I~~ 111I1I1I1I18iili 
IPOlG VPYTG SrtC Z SrtC.3" SrtC.4 
"."',PNTG ~g.IIIIi •• '----"=-:"---_-= J b Fimlll-
MGAS10394 
SpyOI6052% 
LPAT G 
MGAS10394 
SpyOI59 55';' SOC.2) 
C=~Soz~II1112~==~".I~. Fim ll 
LPSSG LPSTG 
Figure 2.12 A schematic of 2 pilus loci (A and B) in Se4047, SzH70 and SzMGCS 10565 
Diagram shows CDSs for putative backbone/major subunits (red), putative ancillary/minor 
subunits (orange), C-family sortases (green) and regulatory proteins (blue). Novel CDSs 
encode a putative exported protein (dark grey) and a hypothetical protein (light grey). 
Truncated regulatory pseudogenes (brown) are present in Se4047 in locus I (A) and locus 
II (B) resulting from a single point mutation (TAC to TAA) or insertion of an IS element 
respectively. Recombination between ISSeq3 elements has removed the 2nd pilus locus 
from Se4047, with the exception of the truncated remnant of SEQ2119. BLASTP matches 
are shown above with the percentage amino acid sequence identity indicated. Needleman-
Wunsch global alignments were used to conduct pairwise comparisons of CDSs in the 3 S. 
equi subspecies (percentage amino acid sequence identity shown). MGAS 10750 SpyOll5-
Spy0120 are CDSs of a predicted pilus locus in S. pyogenes M4 (Beres et at. , 2006), SdrG 
is a fibriongen-binding protein of Staphylococcus epidermidis (Ponnuraj et ai., 2003), 
PrtF2 is a fibronectin-binding protein of S. pyogenes (Ramachandran et ai., 2004), 
Spyl813 encodes a hypothetical phage protein of S. pyogenes MGAS6180 (Green et ai. , 
2005), whilst RrgB, RrgC, SrtB, SrtC and SrtD are variants of the RlrA pilin proteins and 
associated sortases of S. pneumoniae (Moschioni et ai., 2008). MGASI0270 SpyOl09-
SpyOllO (Beres et al. , 2006) and MGASI0394 Spy0160-Spy0159 (Banks et ai., 2004) are 
predicted fimbrial structural subunits in S. pyogenes M2 and M6 respectiv'ely. In addition, 
Sez_1821 and Sez_1829 have homology to GAS T-antigens (major fimbrial subunit) 
(Beres et aI. , 2008). Note the 2nd pilus locus is in the same genome location as the FCT 
locus of S. pyogenes, flanked by conserved CDSs encoding a heat shock protein 33 
homologue and a putative toxic anion resistance protein in all 3 S. equi SUbspecies (Bessen 
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& Kalia, 2002). * These encoded SrtC-family proteins share 36% to 50% amino acid 
sequence identity. 
The SzH70 genome contains 2 loci that contain genes required putatively for pilus 
expression (Figure 2.12). The fIrst of these (SZOI1520-SZ011490) encodes a regulator, 2 
putative pilin subunits and a putative sortase (SrtC.l). Orthologous loci are present in 
Se4047 (SEQ0934-SEQ0937) and SzMGCS10565 (FimI: Sez_081O-Sez_0813), and share 
88-99% and 94-99% amino acid sequence identity respectively with the SzH70 locus. 
However, the TetR-like regulator SEQ0934 of Se4047 contains a nonsense mutation at 
codon 43. The predicted major pilin subunit (SZ011500/SEQ0935/Sez_0812) has the 
conserved E box found in pilins of Corynebacterium diphtheria, Actinomyces naeslundii 
and some streptococci (Scott & Zahner, 2006; Telford et at., 2006) (Table 2.6). The highly 
conserved glutamate residue of the E box plays a role in the attachment of minor pilins to 
the shaft protein through an unknown mechanism (Ton-That et at., 2004). A possible pilin 
motif in SZ011500/SEQ0935/Sez_0812 contains only the conserved proline and lysine 
residues; the latter is thought to form a peptide bond with the threonine at the C-terminus 
of the next subunit (LPXTG motif) allowing the oligomerization of the backbone pilin 
(Kang et at., 2007; Scott & Zahner, 2006; Ton-That & Schneewind, 2003) (Table 2.6). 
The second pilus subunit (SZ01151O/SEQ0935/Sez_0811) lacks an E box or pilin motif 
and has been previously characterised as a collagen-binding adhesin Cne of S. equi 
(Lannergard et at., 2003), similar to Cna of S. aureus (Patti et at., 1992). Cne is therefore 
likely to be an accessory pilin subunit. 
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Table 2.6 Conserved motifs in putative and proven pilin subunits 
Strain(s) Pilus locus Name Pilin lUotif' Ebox CWSS 
(subunit) 
SzH70/Se4047/SzM 1 (major) SZO 11500/SBQ0936/Sez_0812 vvkntsfkPK YkLsETtAPgGY LPsTG 
GCSI0565 
SzH70/Se4047/SzM 1 (minor) SZOl1510/SBQ0935/Sez_0811 - - LPdTG 
GCSI0565 
SzH70 2 (minor) SZ0l8310 dadvtkqYPK YyLkEvkAPxGY vPyTG 
SzH70 2 (major) SZOl8320 stikelVYPK YyLeEltAPiGf iPqTG 
SzH70 2 (minor) SZ0l8330 - YaikEekAPdGY fPmTG 
SzMGCSI0565 21 (major) Sez_1829 tvedannsPK YyLkEvkAPaGY iPnTG 
SzMGCSI0565 21 (minor) Sez_1828 qkepllVYPK - iPyTG 
SzMGCSI0565 2 (minor) Sez_1825 - YeLwEikAPnGY LPaTG 
SzMGCSI0565 211 (minor) Sez_1822 
-
YyLyETkAraGY LPsSG 
SzMGCSI0565 211 (major) Sez_1821 - - LPsTG 
S.pyogeMs (major) T6 - - LPsTG 
MASI0394 
S. pyogeMs SF370 (major) SpyOl28 
- -
evpTG 
C. diptheria (major) SpaA WLQDVHVYPK FCLVETATASGY LPITG 
NCTCl3129 
C. diptherill (major) SpaD WNYNVVAYPK FCLKETKAPAGY LPmTG 
NCTCl3129 
S. agalactille (major) GBS80 LSBDKVIYPK YVLKEIBTQSGY iPkTG 
COHI 
S. pneumonia (major) RrgB DVVDAHVYPK YYLBETKQPAGY iPqTG 
TIGR4 
A. naeslundi T14V, (major) FimP WNYNVHVYPK YCLVETKAPBGY LPITG 
type I 
Consensus+ WxxxVxVYPK YxLxETxAPxGY LPxTG 
Table adapted from (Scott & Zahner, 2006). * CWSS, cell wall sorting signal motif 
preceding the hydrophobic stretch and charged tail. t Consensus sequence. 
The second SzH70 pilus cluster consists of CDSs encoding 3 putative surface proteins 
(SZ01831O-SZ018330), one putative exported protein (SZ018300), 3 putative sortase 
enzymes, SrtC.2, SrtC.3 and SrtC.4 (SZ018290-SZ018270), and an AraC-like 
transcriptional regulator (SZ018340). A similar locus that shares 58% to 76% amino acid 
sequence identity to these SzH70 CDSs is present in S. pyogenes MGAS10750 (SpyOl15-
Spy0120) (Beres et aI., 2006), although a homologue of SZ018300 is absent and the GAS 
locus appears to be under the control of a different RofA-like regulator (SpyOl13). The 
GAS locus also encodes an additional putative fibronectin binding protein (SpyOl14). The 
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genome of strain Se4047 lacks this putative pilus locus through ISSeq3-mediated deletion. 
None of the 26 isolates of S. equi, but 81 of 140 S. zooepidemicus isolates tested positive 
for srtC.3 or srtC.4 by PCR. This difference in prevalence between the 2 subspecies was 
statistically significant using Fischer's exact test (P < 0.0001). The genome of 
SzMGCS 10565 does not contain a homologue of this SzH70 pilus locus, but instead 
contains two other consecutive pilus loci Fim II and Fim III at the same genome location 
(Beres et al., 2008). Fim III is flanked by an AraC-like regulator (Sez_1830), which is 
orthologous to SZ018340 of SzH70. 
Further analysis was performed in order to probe the binding activity of this SzH70-
specific pilus. SZ018330 had most overall homology to SpyOl15 (putative fibronectin 
binding protein) (Beres et al., 2006) and partial homology with SdrG (Ponnuraj et ai., 
2003) and PrtF2 (Ramachandran et al., 2004) (23 - 26% amino acid sequence identity), 
which bind fibrinogen (Staphylococcus epidermidis) and fibronectin (S. pyogenes) , 
respectively. The homologous regions in SdrG include tandem IgG-like domains that 
allow folding of the protein to create a docking groove for fibrinogen binding between 
these domains (Ponnuraj et al., 2003). In addition, a conserved sequence motif 
TYTFTDYVD of SdrG is also present in one of the IgG-like folded domains of SZ018330 
(IYTFTDYVE), and represents the base of a potential latching cleft into which a latching 
strand could insert to stabilize an adhesin-ligand complex. This motif and IgG-like folds 
are a feature of Cna and a large family of structurally related putative Gram-positive 
MSCRAMMs (microbial surface components recognizing adhesive matrix molecules) that 
are likely to use a similar 'dock, lock and latch' model to bind short linear peptide ligands 
(Ponnuraj et al., 2003). Residues that interact with the fibrinogen peptide in SdrG are not 
conserved in SZ018330 suggesting that a different linear peptide is accommodated by this 
encoded protein in SzH70. Cna protein B-type domains are also a feature of SZ018330, 
SdrG and other related putative adhesins. In Cna, these are thought to form a stalk to 
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present the ligand binding domain away from the bacterial cell surface. PrtF2 has similar 
IgG-like folds and Cna protein B-type domains that align to SZ018330 but the 4 Pfam 
fibronectin binding repeat domains of PrtF2 that utilise a tandom ~-zipper mechanism for 
fibronectin binding (Rakonjac et aI., 1995; Schwarz-Linek et al., 2003) are not present in 
SZ018330. SZ018330 is a predicted ancillary pilin subunit and doesn't contain a pilin 
motif, although an E box is present suggesting that this isn't just a feature of backbone 
pilin subunits. 
SZ018320 and SZ018310 share 35% and 28% amino acid sequence identity with RrgB 
and RrgC, the major and ancillary pilins respectively encoded from the rlrA genetic islet of 
S. pneumoniae (Moschioni et aI., 2008) (Figure 2.12). The shaft protein of this putative 
pilus in SzH70 is therefore predicted to be encoded by SZ018320, whilst SZ018310 is 
likely to encode a minor subunit of the pilus, although surprisingly a putative pilin motif 
and E box is present in both proteins (Table 2.6). E box-like motifs have been identified in 
the accessory subunits of some GBS pilins (Rosini et aI., 2006) and the S. pneumoniae 
RlrA pilus, which in the latter are able to form heterodimers (Falker et al., 2008; LeMieux 
et al., 2008). SrtC.2, SrtC.3 and SrtCA also have homology to the 3 sortases of the rlrA 
cluster SrtB, SrtC and SrtD (55%, 51% and 31% amino acid sequence identity 
respectively) (Moschioni et al., 2008), which have recently been renamed SrtC.1, SrtC.2 
and SrtC.3 (LeMieux et al., 2008). Interestingly, the SzH70 SrtCA is more divergent in 
sequence from the other 2 Srt enzymes and like SrtD (SrtC.3) of the RIrA locus might be 
hypothesised to playa similar role in the non-homogenous focal presentation of the pilus 
on the bacterial cell surface (Falker et aI., 2008). 
All 3 subunit proteins have divergent CWSS motifs with a variant amino acid 
(phenylalanine, isoleucine or valine) replacing the canonical leucine in position one (Table 
2.6, Figure 2.12). Such variation in the CWSS has been shown at least in part to contribute 
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to sortase specificity, in particular for the recognition and incorporation of individual 
accessory subunits into the mature fimbrial structure (Barnett et aI., 2004; Gaspar & Ton-
That, 2006; LeMieux et al., 2008). 
2.4.1.10.2 Genetic diversification in surface proteins 
Substantial amino acid sequence variation is evident in many of the Se4047 surface 
proteins when compared to their homologues in SzH70 (and SzMGCS 10565) (Table 2.5). 
13 Se4047 CDSs share only 40 to 79% amino acid sequence identity with their SzH70 
homologues and, with the exception of FneF, display even greater variation in their N-
terminal regions (16 to 60% amino acid sequence identity). 8 of these encode collagen-
like proteins and are discussed in more detail below. The other 5 include 2 surface 
proteins of unknown function containing C-terminal proline-rich repeats (SEQ0402 and 
SEQ0939), a fibrinogen-binding protein SzPSe (Timoney et al., 1997b), the antiphagocytic 
fibrinogen and IgG-binding protein SeM (Meehan et aI., 2002; Timoney et aI., 1997b) and 
a fibronectin-binding protein FneB (Lannergard et aI., 2005). Generally, the function of 
equivalent proteins in SzH70 has not been determined, although Szp, the SzPSe-
homologue, exhibits hypervariability amongst S. zooepidemicus isolates and functions as 
an adhesin in the ATCC 35246 strain of S. zooepidemicus (Fan et aI., 2008) (86% amino 
acid sequence identity to Szp SzH70). Fnz2 (S. zooepidemicus strain VTU211), like its 
homologue FneB (Se4047) binds fibronectin via a C-terminal repeat region (Hong, 2005; 
Lannergard, 2006). Fnz2, but not FneB, is also able to bind collagen which may be 
explained through the differences that occur in the N-terminal domain of these proteins. A 
near identical homologue of Fnz2 (strain VTU211) is present in SzH70 and 
SzMGCG 10565. 
In addition, the 3 Se4047 pseudo genes likely to encode secreted proteins lacking a cell wall 
anchor, Fne, SEQ0566 (SzPSe-like) and FneD, share only 27 to 44% amino acid sequence 
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identity with the N-tenninal regions of their SzH70 homologues. The protein homologues 
often differ in size, which in many cases is influenced by the length of proline-rich C-
tenninal regions and the number of proline-rich repeats. Such domains may aid in the 
presentation of the ligand-binding site away from the bacterial cell surface. 
2.4.1.10.2.1 Collagell-like sUf:f{.u.:e proteins 
Like other cell wall-anchored proteins, Sc1s contain an N-tenninal signal sequence, 
followed by a unique non-repetitive region (V region), a proline-rich putative wall 
spanning region (W) preceding an LPXTG-motif and a hydrophobic transmembrane region 
(cell wall anchor). These proteins also contain contiguous tracks of Glycine-Xxx-Yyy 
(GXY) repeat motifs between the V and W domains, which confer an alfa-helix secondary 
structure (with the glycine acting as a backbone) similar to that of mammalian collagen 
(Han et al., 2006b; Xu et al., 2002). 11 scls are encoded in the genome of SzH70 (Table 
2.5). In comparison, Se4047 has 9 corresponding ScI genes but lacks a homologue of the 
SZ000830 encoded ScI or a collagen-like region in FneE (Table 2.5). FneE, a collagen-
and fibronectin-binding surface protein of S. equi (Lannergard, 2006), contains a string of 
2 + 3 GXY -motifs interrupted by 4 amino acids, which is a possible remnant of a collagen-
like domain. Similar interrupted GXY-motifs are present in Sez_0499, the FneE 
homologue in SzMGCSI0565, whereas the counterpart in SzH70 (SZOI4890) has a long 
collagen-like domain containing 92 GXY sequences. SZ005350, a putative collagen-
binding surface protein of SzH70, also contains possible traces of an ancestral collagen-like 
domain. GXY-motifs are present in SclZ.9 (n = 41) but not FneD, the respective 
SZ005350 homologues in SzMGCS 10565 and Se4047. The genome of SzMGCS 10565 
contains 11 scls (and an unconfirmed ScI pseudogene), with a novel CDS (sclZ3) relative 
to Se4047/SzH70 downstream of the transcription antitennination protein nusG gene. 
Another ScI gene sclZ6 is unique to this epidemic nephritis strain of S. zooepidemicus in 
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comparison to SzH70 although a partial gene homologue, lacking a secretion signal 
sequence is present in Se4047 (SEQ0556). 
FneE and 7 Sel CDSs in Se4047 (SelG, FneE, FneC, SelC, SclE, SelF, Scll, FneF) show 
considerable sequence divergence when compared to their Sel homologues in SzH70 
(Table 2.5). In 5 (SelG, FneE, FneC, SelC, SclE), the variation occurs in both the V and 
collagen-like regions with the level of amino acid sequence identity shared between the 
Se4047 and SzH70 homologues ranging from 16% to 46% in the V region and 4% to 63% 
in the collagen-like region. SelF and Scll show some variation in their collagen-like 
regions compared to their SzH70 counterparts (70 to 82% amino acid sequence identity) 
but are most variable in the V domain (19 to 60% aa sequence identity). FneF, SelH and 
SelD (Se4047) have diverse collagen-like regions (32 to 74% amino acid sequence 
identity) but more conserved V regions (89 to 100% aa sequence identity) compared to 
their SzH70 homologues. SclD (Se4047) differs from SZ017540 (SzH70) only in the 
number of GXY-motifs but in all other cases the collagen-like regions vary in both primary 
sequence and the number of GXY-motifs. 8 out of the 10 Se4047 CDSs (9 Sels and FneE) 
have 6 to 87 fewer GXY -motifs relative to their SzH70 homologues, whilst 2 (SelF and 
Scll) have an extra 6 to 9 GXYs (on average the Se4047 CDSs have 22 fewer GXY-motifs) 
(Table 2.5). 
A number of the SzH70 Sels have a much eloser homologue in SzMGCS 10565 than in 
Se4047, which may indicate subspecies-specific adaptations in these proteins. For 
example, SclG and SelE (Se4047) are more divergent from their homologues in SzH70 and 
SzMGCS10565 (Table 2.5). In addition, SZ000830 and SelZ.1 have no homologous CDS 
at the same genome location in Se4047, and only a truncated Se4047 collagen binding 
protein FneD (which has no cell wall anchor) is present in what appears to be a highly 
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variable region of the S. equi subspecies genomes encoding polymorphic putative cell 
wall-anchored proteins in SzH70 (SZ005350) and SzMGCS 10565 (SclZ.9) (Table 2.5). 
Potential integrin binding sequences within the collagen-like regions of the Scls have been 
highlighted in Table 2.5. Variation within the amino acid residues of these collagen-like 
domains has led to changes in the number and type of putative integrin binding motifs. For 
example, SclG (Se4047) contains one RGD, 2 KGD and one GKPGER whilst its 
homologues in SzH70 and SzMGCS 10565 have one GPP and 23 to 30 KGD motifs. 
2.5 Discussion 
Available evidence suggests that S. equi evolved from an ancestral S. zooepidemicus strain, 
a near commensal bacterium largely associated with subclinical inflammatory airway 
disease (lAD) in young horses (Wood et al., 2005a) but also able to cause opportunistic 
disease in a range of hosts. Given the close genetic similarity between these 2 
streptococci, comparative genomics was used to identify differences between the 
subspecies with a view to distinguishing key determinants of their differing pathogenic 
properties. This analysis has revealed the forces of gene gain, gene loss and gene change 
that have all contributed to the evolution of S. equi into a highly specialised host-restricted 
bacterial pathogen. 
2.5.1 Pathogenic specialization and gene gain 
The increased size of the Se4047 genome compared to the genome of SzH70 is due to the 
acquisition of a large number of MGEs. The gain of these regions by a progenitor may 
have opened up new pathogenic niches, and been critical in the emer~ence of S. equi. 
Unlike SzH70, Se4047 is polylysogenic, containing 4 prophage. The transductional 
acquisition of prophage plays an important role in the evolution of many pathogenic 
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bacteria (Brussow et ai., 2004). Cargo genes carried by prophage can increase the survival 
fitness or enhance niche adaptation of the lysogen (Beres & Musser, 2007; Brussow et ai., 
2004). q>Seq2 has introduced into the Se4047 genome a CDS that shares 98% amino acid 
sequence identity with the secreted phospholipase A2, SlaA, of S. pyogenes M3 MGAS315 
(Brussow et ai., 2004). SlaA is related to a potent toxin (textilotoxin) made by the 
Australian brown snake and has enzymatic activity against several phospholipid groups 
(Nagiec et ai., 2004). For example, SlaA cleaves and releases arachidonic acid, a powerful 
mediator of the inflammatory cascade. SlaA is known to contribute to streptococcal 
virulence and its recent acquisition by S. pyogenes M3 (in approximately 1987) was 
associated with increased morbidity and mortality (Brussow et ai., 2004). Deletion of slaA 
reduced the virulence of S. pyogenes in a mouse intraperitoneal infection model and 
severely compromised its ability to colonise the upper respiratory tract of a macaque model 
of pharyngitis (Sitkiewicz et aI., 2006). An impaired ability to adhere to and kill 
pharyngeal epithelial cells was also demonstrated by the L1s1aA mutant strain in comparison 
to the wild-type strain (Sitkiewicz et ai., 2006). slaA was present in all strains of S. equi 
and was widely distributed amongst S. zooepidemicus STs (31% of isolates examined) 
suggesting that phage lysogeny is also a feature of a subset of the S. zooepidemicus 
popUlation (Figure 2.6). Interestingly, 7 S. zooepidemicus ST groups included isolates that 
had slaA as well as isolates that were negative for this gene. This observation raises the 
possibility of recent horizontal gain of slaA by some members of these ST groups. Of 
particular note was the observation that S. equi CF32, which was isolated from a horse 
with strangles during 1981, contained slaA. This isolate predates all slaA positive isolates 
of S. pyogenes (Beres et al., 2002), and it is possible that slaA in the S. pyogenes gene pool 
gene may have arisen via phage-mediated horizontal transfer from a slaA-containing strain 
of S. zooepidemicus or S. equi, although the precise evolutionary origins remain unclear. 
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In support of the important role that these phospholipase toxins may play in colonisation 
and virulence of S. equi and S. zooepidemicus, a gene encoding a second putative 
phospholipase A2 toxin, SlaB, sharing 70% amino acid sequence identity with SlaA of S. 
pyogenes in the genomes of Se4047 and SzH70 was identified. slaB, a feature of all strains 
of S. equi and S. zooepidemicus (Figure 2.6), is likely to have been gained some time ago 
in the evolutionary history of these 2 subspecies. slaB was probably introduced via phage 
transduction as a hypothetical prophage gene (SEQ2154/SZ018660) is still present 
adjacent to slaB in both genomes. This additional gene may increase the dosage of 
phospholipase A2 produced by S. equi and some strains of S. zooepidemicus and increase 
host cell cytotoxicity. Overcoming the epithelial cell barrier may be important during the 
rapid invasion of S. equi in the early stages of infection. Certainly, SlaA is secreted very 
early in the interaction of GAS with host material (Banks et al., 2003; Nagiec et al., 2004; 
Shelburne et al., 2005). A continued host inflammatory response has been observed in the 
GPs of horses with prolonged carriage of S. equi. The activity of phospholipases and/or 
other proinflammatory mediators may contribute to this pathology and cell damage may, 
for example, release nutrients that contribute to the prolonged survival of S. equi in this 
site. Increased phospholipase A2 activity may also expand the population size of S. 
zooepidemicus isolates colonising the equine respiratory tract thereby promoting their 
persistence and transmission. 
q>Seq3 carries CDSs encoding the superantigens SeeL and SeeM, which share 97% and 
96% amino acid sequence identity with SpeL and SpeM of S. pyogenes MGAS8232, 
respectively (Alber et aI., 2005; Proft et al., 2003). These mitogenic proteins belong to an 
increasing family of related superantigenic exotoxins produced mostly by S. pyogenes and 
S. aureus. By simultaneously interacting with MHC class II molecules of antigen 
presenting cells and with T cells at specific motifs of the T cell receptor, these exotoxins 
simulate T lymphocyte proliferation causing a massive systemic release of pro-
111 
inflammatory cytokines (Fraser & Proft, 2(08). Streptococcal exotoxins are implicated in 
severe group A streptococcal infections of man including scarlet fever and streptococcal 
toxic shock syndrome (Fraser & Proft, 2008). The speL gene has been recently acquired 
by M3ff3 S. pyogenes isolates in Japan (sometime between 1973 and 1992) that have 
caused more than 10% of streptococcal toxic shock-like syndrome cases reported from 
1992 to 2002 (lkebe et al., 2002). In addition, the presence of the speL gene is highly 
associated with S. pyogenes M89, a serotype linked to outbreaks of rheumatic fever in New 
Zealand (Proft et al., 2003). Such extreme outcomes of superantigen function are unlikely 
to benefit the bacterium but an advantage is almost certainly gained during the early stages 
of infection when the superantigen induces a localized anesthesia of the innate immune 
responses that are essential for a rapid clearance of the invading bacterium. A similar 
function may be particularly important to S. equi during its brisk invasion of the equine 
respiratory tract. 
It is particularly striking that S. equi appears unaffected by high numbers of neutrophils in 
abscessing LNs, which would normally be able to rapidly kill invading bacteria. This 
suggests that S. equi may be able to misdirect the equine immune response and actually 
harness its power to enhance abscess formation. The genes encoding SeeL and SeeM were 
present in all strains of S. equi but only 4 of 140 isolates of S. zooepidemicus tested (Figure 
2.6). Interestingly, these S. zooepidemicus isolates represented 3 unrelated STs (ST-106, 
ST -118 and ST -120) recovered from the same outbreak of equine respiratory disease in 
1996. In addition, seeL and seeM were absent from other representatives of ST-106 and 
ST-118. S. equi CF32 also contained these superantigen genes, and predates SpeL- and 
SpeM-producing strains of S. pyogenes (lkebe et al., 2002), providing further evidence that 
S. equi and S. zooepidemicus act as reservoirs of virulence genes that may be transferred by 
lateral gene transfer events. 
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cpSeq4 contains cargo CDSs encoding the previously described superantigens SeeH and 
SeeI, which share 98% and 99% amino acid sequence identity with SpeH and SpeI, 
respectively (Artiushin et aI., 2002). Interestingly, cpSeq4, is very closely related to cpMan3 
of S. pyogenes Manfredo (Figure 2.7, Matt Holden) (Holden, 2009). seeH and see! were 
present in all strains of S. equi but have not yet been detected in any strains of S. 
zooepidemicus examined. Re-circularised cpSeq4 has been detected by PCR of phage 
particles purified from culture of Se4047 (Holden, 2009). These data suggest that the 
acquisition of cpSeq4 by S. equi, possibly originating from a strain of S. pyogenes, may 
have been a very recent event that could have influenced the emergence of S. equi. 
Recombinant SeeI, but not SeeH, was recently shown to induce a strong dose dependent 
proliferative response in equine CD4+ T lymphocytes and synthesis of interferon-'Y 
(Romain Paillot, unpublished data). In agreement with this result, deletion of see!, but not 
seeH, by allelic replacement in Se4047 , resulted in a reduction in mitogenic activity 
elicited by culture supernatant (Romain Paillot, unpublished data). In contrast, earlier 
work showed strong mitogenic responses by horse PBMCs to both SeeI and SeeH, 
although only the former was pyrogenic in horses (Artiushin et ai., 2002). Since only 
femtomolar quantities of SeeI elicit a mitogenic response from PBMCs, it is possible that 
cross-contamination confounded these earlier results. Alternatively, PBMCs from 
individual horses may respond differently. Although not pyrogenic in horses, SeeH was 
able to induce pyrexia in rabbits (Artiushin et ai., 2002) and SpeH, like SpeI, was 
mitogenic for human PBMCs (Brouillard et al.,. 2007; Proft et ai., 1999). Overall, these 
data suggest that the recently acquired SeeH superantigen is non-functional at least in some 
horses and therefore not adapted to the equine host. 
Phage can also improve the competitive fitness of the host strain through spontaneous 
induction to the lytic phase in a small number of host cells, resulting in the destruction of 
rival bacteria (Bossi et ai., 2003). The effect is exerted at the popUlation level since the 
113 
individual bacteria that suffer induction are presumably killed in the process; a form of 
altruistic suicide. Phage repressor and superinfection exclusion functions in the lysogens 
provide immunity against such lytic infection (Bossi et aI., 2003). From this perspective, 
s. equi has a formidable arsenal of weapons. Both q>Seq 1 and q>Seq4 were recently shown 
to revert to the lytic cycle following mitomycin C treatment and although phage particles 
were not detected from q>Seq2 and q>Seq3, these prophage appear intact and may be 
induced by alternative stimuli (Holden, 2009). Salmonella enterica serovar Typhimurium 
lysogens are able to out-compete non-lysogenic strains through the release of low titers of 
phage and this effect is even more dramatic when the lysogenic strains release more than 
one phage type (Bossi et al., 2003). Release of phage from S. equi may result in killing of 
susceptible bacteria, such as S. zooepidemicus, which may compete to colonise the 
epithelium of the equine nasopharynx, thereby resulting in more efficient attachment of S. 
equi and its invasion of the lymphatic system. The persistence of S. equi in the OP of 
horses, particularly in the abscence of chondroids, may be aided by such competitive 
measures; S. zooepidemicus isolates are occasionally cultured from this site in horses. 
Such a symbiotic phenomenon may have little cost to the lysogenic host strain and benefits 
the phage by enabling the spread of viral DNA. Opportunities for reassortment among 
different bacteriophage are also likely to arise and virulence cassettes could be further 
mobilised by this process. The diversity of prophage sequences identified in the genomes 
of streptococci and other pathogens is considerable and similarly, the prophage found in 
Se4047 showed only limited mosaic similarity with each other (Holden, 2009). 
Interestingly, the prophages of S. equi showed most extensive similarity with prophage 
from S. pyogenes suggesting commonality in the phage pool of these pathogens (Holden, 
2009). This agrees with the likely horizontal transfer of slaA, seeL, seeM, seeH and see! 
between the group C and group A streptococci. The 25 strains of S. zooepidemicus that 
demonstrated mitogenic activity but lacked S. equi superantigen genes probably contain 
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genes encoding other S. pyogenes superantigens or novel genes that represent an additional 
reservoir of as yet uncharacterised exotoxins. Interestingly, a significantly higher 
proportion of respiratory isolates of S. zooepidemicus had mitogenic activity (30%, n = 73) 
compared to other S. zooepidemicus isolates (9%, n = 65, P = 0.0027, Fischer's exact test), 
which suggests that superantigens contribute to the ability of these strains to colonise the 
respiratory tract. 
The absence of prophage in the SzH70 (and SzMGCS10565) genome, and low frequency 
of phage associated superantigens in the screening of S. zooepidemicus strains, is in stark 
contrast to S. equi. One explanation for the lack of prophage in S. zooepidemicus is that 
systems exist in naturally transformable streptococci that provide resistance to uptake and 
incorporation of foreign DNA and may co-incidentally prevent stable prophage integration 
(Beres et al., 2008). Prophage are not present in any of the 7 sequenced genomes of the 
naturally transformable streptococci, including S. pneumoniae, S. gordonii, S. sanguinis, or 
S. mutans (Ajdic et aI., 2002; Hoskins et al., 2001; Lanie et al., 2007; Tettelin et aI., 2001; 
Vickerman et al., 2007; Xu et al., 2007). Natural transformation by S. zooepidemicus has 
not yet been assessed but the presence of bacteriocin/competence gene homologues in the 
genome of SzMGCS 10565 points to the possibility that at least some strains of this 
subspecies might be naturally competent (Beres et al., 2008). Recombination is also a 
predominant feature of the highly diverse S. zooepidemicus population (Webb et al., 2008) 
and other bacterial species that are naturally c~mpetent (AIm et aI., 1999; Nassif et aI., 
1993; Read et aI., 2000). Se4047 lacks 9 intact putative competence genes (Appendix 
Table A.2) that are present in SzH70 and SzMGCS 10565, which could provide an 
explanation for the polylysogenic nature of Se4047. 2 of these putative competence genes 
were also absent from a strain of S. zooepidemicus (SzI775), which is more closely related 
to Se4047 than SzH70 (Andrew Waller, unpublished observations). Se4047 may therefore 
have evolved from a strain of S. zooepidemicus already deficient in competence formation 
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and functional redundancy in the remaining competence genes may have led to their 
subsequent loss. Integration of <pSeq3 into a putative late competence protein (SEQI725: 
ATP-binding DNA helicase/translocase) could have contributed to a redundancy in 
competence genes. 
An alternative explanation of the proliferation of prophage in S. equi can be found in the 
genome comparison between SzH70 and Se4047. In the SzH70 genome a locus containing 
a CRISPR array and CRISPR-associated genes was identified (Figure 2.8), which has been 
deleted from the Se4047 genome due to recombination between ISSeq11 elements. 
CRISPR arrays are composed of direct repeats that are separated by similarly-sized non-
repetitive spacers. These arrays, together with a group of associated proteins, confer 
resistance to phage directed by sequence similarity between the spacer regions and the 
phage in question, possibly via an RNA-interference-like mechanism (Barrangou et a!., 
2007; Sorek et a!., 2008). In response to phage infection, bacteria integrate new spacers 
that are derived from phage genomic sequences, which results in CRISPR-mediated phage 
resistance (Barrangou et ai., 2007). Because new spacer units are added at the leader-
proximal end of the array, a historical record of phage attack is revealed upon examination 
of the spacer sequences. SzH70 appears to have resisted infection by prophage containing 
CDSs similar to those present in <pSeql and <pSeq3 of Se4047 as well as other prophage of 
S. pyogenes (<pMan.2 and 370.3). Particularly interesting, is a region in the SeeM 
superantigen CDS that has been stored in the SzH70 CRISPR array (spacer 15). Without 
such a defence mechanism in place, this superantigen could have been gained by SzH70, 
which may have altered its pathogenic profile. A similar CRISPR system is present in 
SzMGCS10565, however, with the exception of one spacer sequence, the number and 
sequence of spacers differs in this S. zooepidemicus strain refecting likely differences in 
phage exposure in the respective environments of these 2 S. zooepidemicus strains. 
Additional, distinct CRISPR arrays are also present in SzMGCSI0565 (Beres et ai., 2008) 
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but absent from SzH70 and Se4047. The CRISPR loci of SzH70 and SzMGCS10565 may 
assist the development of resistance to circulating phage and maintain genome integrity. A 
CDS in the CRISPR region of SzH70 (SZ014370) was present in 93% of S. zooepidemicus 
isolates examined by PCR, but was absent from all strains of S. equi tested (Figure 2.6). 
Deletion of the CRISPR locus from the ancestor of Se4047 is likely to have resulted in 
increased genome instability and illustrates that in some circumstances gene loss may in 
tum influence the subsequent rate of gene gain. As mentioned above, Szl775, which is 
more closely related to Se4047 than SzH70, has lost 2 putative competence associated 
genes; however, this strain of S. zooepidemicus does have a CRISPR locus and no 
prophage in its genome (Andrew Waller, unpublished data). 
Both the SzH70 and Se4047 genomes contain different ICE regions. This type of MGE has 
been shown to be widely distributed (Burrus et at., 2002a), and associated with the transfer 
of a diverse range of functions. The 4 ICEs in the Se4047 and SzH70 genomes all carry 
distinct cargo, although 3 of these elements have related conjugation modules that are 
similar to those encoded in an ICE that confers erythromycin resistance in S. pyogenes 
strain MGAS10750 (Beres & Musser, 2007) and in 2 conjugative transposons of C. 
difficile strain 630 (Sebaihia et al., 2006). These group A and group C streptococci may 
therefore share a common ICE pool and may also acquire these MGEs from more distantly 
related bacteria. ICE MGAS10750-RD.2 was not present in other sequenced S. pyogenes 
strains (Beres & Musser, 2007) but the erythromycin resistance gene, ennA (or enn(TR», 
carried by this ICE is a common determinant of macrolide resistance in S. pyogenes 
(Robinson et al., 2006) and has been identified in other Streptococcus species such as S. 
agalactiae (Marimon et al., 2005) and group G streptococci (Woo et al., 2003). In 
addition, conjugal transfer of enn(TR) has been demonstrated between strains of S. 
pyogenes and other species such Enterococcus jaecalis, Listeria innocua and 
Peptostreptococcus magnus (Giovanetti et ai., 2002; Reig et ai., 2001). Akin to the 
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exchange of toxins between distinct prophage, it seems likely that virulence determinants 
may also be transferred between different ICEs. enn(TR) was recently discovered in S. 
pneumoniae AP200, encoded on a transposonJprophage remnant chimera Tn1806, which 
has partial similarity to ICE MGAS 10750-RD.2 (Camilli et al., 2008). 
One of the ICEs in the Se4047 genome, ICESe2, contained CDSs (SEQI233-SEQI246) 
with similarity to the NRPS systems of Clostridium kluyveri and Yersinia sp. that produce 
an unnamed siderophore (Seedorf et aI., 2008) and the ferric iron-binding siderophore 
yersiniabactin (Bobrov et al., 2002), respectively. Work described in Chapter 3 
demonstrates that the S. equi NRPS operon is required for the production of an undefined 
secreted molecule, provisionally named equibactin, which enhances the ability of S. equi to 
acquire iron. Siderophore biosynthesis has not previously been identified in any 
streptococci (Eichenbaum et al., 1996). However, homologues of SEQ1246 and SEQ1243 
(present as a pseudogene) are in the genome of S. agalactiae NEM316 serotype Ill, 
suggesting that a locus with similarity to the S. equi NRPS operon may have been 
important to this organism at some time. 
The ICESe2 locus was present in all of the S. equi isolates, but in none of the diverse 
collection of S. zooepidemicus isolates examined (Figure 2.6). Given the importance of 
iron acquisition to other streptococcal pathogens (Brown & Holden, 2002), the acquisition 
of ICESe2 may have contributed significantly to the increased pathogenesis of this 
Streptococcus. For example, the more efficient acquisition of iron could enhance the ability 
of S. equi to generate LN abscessation, which is critical to the establishment of long term 
carriage and vital to the success of this bacterium. It is intriguing to note that the 
production of yersiniabactin by Y. pestis is essential to its virulence (Bearden et al., 1997). 
It will be important to determine the contribution of ICESe2 to the formation of abscesses 
in the LN s of horses. 
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A facet of the Se4047 genome suggestive of recent niche adaptation is the large increase in 
the number of IS elements relative to SzH70 (SzH70 contains 30 whereas Se4047 contains 
73; Table 2.3, Matt Holden). In particular, there appears to have been an expansion of the 
IS3-family IS element, ISSeq3: the Se4047 genome contains 40 copies of ISSeq3 whereas 
SzH70 contains 4 (ISSz03). An expansion of IS elements has been observed in several 
host-restricted pathogens, which have recently evolved from generalist ancestors (Nierman 
et ai., 2004; Parkhill et ai., 2003). An evolutionary consequence of niche transit is 
hypothesised to be that many genes become dispensable, allowing increased inactivation. 
Niche change is also associated with significant evolutionary bottlenecks, which will be 
enhanced by repeated acquisition of MGEs. This leads to small effective population sizes, 
resulting in lower efficiency of selection, which in turn allows gene mutation and 
expansion of IS elements through accelerated genetic drift. A corollary of the IS 
proliferation has been the loss of genes by deletion (Nierman et ai., 2004): several 
examples of gene loss (discussed below) probably occurred through insertion and 
recombination between IS elements (Appendix Table A.2). 
2.5.2 Functional loss 
Se4047 has 58 partially deleted genes and 78 pseudogenes, compared with 62 and 29 
respectively in SzH70 (Figure 2.2B, Matt Holden and Appendix Table A.2). In particular, 
Se4047 is enriched for mutations associated with catabolic metabolism, transport, and the 
cell envelope. Such gene loss is typical of other host-restricted bacteria that have evolved 
from versatile ancestors (Nierman et ai., 2004; Parkhill et ai., 2003). The loss of ancestral 
functions appears to have played a seminal role in the evolution of S. equi, resulting in a 
refinement of its nutritional capabilities, and its host-cell interactions. 
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Genome-wide signature tagged mutagenesis and/or expression microarray analysis has 
linked the virulence of streptococcal pathogens to carbohydrate metabolism, including 
genes involved in lactose metabolism (Shelburne et aI., 2008a). Interestingly, 
carbohydrate catabolism in streptococci plays an important role in colonisation of mucosal 
surfaces (Shelburne et aI., 2008a; Shelburne et aI., 2008b). Comparison of the SzH70 and 
Se4047 genome sequences revealed deletion of genes necessary for lactose, sorbitol and 
ribose fermentation in the latter. This is the first time that the molecular basis for the 
diagnostic differentiation of S. equi from S. zooepidemicus (Bannister et al., 1985) based 
on carbohydrate fermentation has been revealed. An inability to ferment these 3 sugars is a 
consistent feature of S. equi strains; whilst all strains of S. zooepidemicus were able to 
utilise lactose and all but one used sorbitol during growth. 15 out of 140 S. zooepidemicus 
isolates failed to ferment ribose and 13 concomitantly lacked the rbsD gene (Figure 2.6). 
These data highlight lactose as the most reliable biochemical indicator for discrimination 
of the 2 SUbspecies. Specialization of S. equi has probably rendered these pathways 
redundant, resulting in their loss. Carbohydrate usage may enhance the colonising 
potential of S. zooepidemicus and an ability of this subspecies to inhabit broader host 
environments where alternative carbohydrate sources are available. For example, lactose 
utilisation would be a useful attribute in strains of S. zooepidemicus associated with 
mastitis and zoonotic outbreaks linked to contaminated dairy products. 
In addition, SzH70 (and SzMGCS 10565) encode a putative ~-galactosidase, a sorbose 
superfamily and cellobiose sugar PTS, all of which are disrupted in Se4047 (SEQ0866, 
SEQ0871, SEQI613, Appendix Table A.2). A branched chain amino acid transporter 
SZ014690 present in all S. zooepidemicus isolates but absent from S. equi isolates (Figure 
2.6) might contribute similarly to the more versatile nature of S. zooepidemicus. S. equi, 
having acquired many pro-inflammatory factors, might rely more heavily on host cell 
breakdown in order to acquire its energy sources. When environmental glucose levels are 
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low, GAS increase their production of virulence factors, such as SpeB, a streptococcal 
pyrogenic exotoxin with cysteine protease activity that could contribute to host damage 
and release nutrients in that way (Shelburne et ai., 2008b). 
HA lyases are secreted enzymes that degrade hyaluronic acid and chondroitins potentially 
facilitating invasion by bacteria and their toxins (Hynes & Walton, 2000). A HA lyase, 
present in all isolates of S. zooepidemicus examined, has been inactivated in all S. equi 
strains and S. zooepidemicus ST -57 (Figure 2.6). Se4047 has acquired a different HA lyase 
encoded on a prophage, which, like other examples of this type of phage-encoded enzyme 
is likely to have much lower activity and a reduced substrate range (Baker et ai., 2002; 
Lindsay et ai., 2009) than orthologues of the SzH70 HA lyase (SZQ06680) (Pritchard et 
ai., 1994) and may provide an explanation for why S. equi infection rarely progresses 
beyond the lymphatic system. 
Reduced HA lyase activity provides a possible explanation as to why S. equi maintains 
high levels of HA capsule and in agreement with this, the ST -57 isolate of S. 
zooepidemicus that tested peR negative also maintained high levels of capsule. HA lyase 
production contributes to capsule breakdown during periods of reduced capsule synthesis 
in GAS (Starr & Engleberg, 2006). The mucoid colony phenotype of Se4047, SzH70 and 
the ST -57 isolate was shown to be due to hyper-encapsulation as these all had a non-
mucoid phenotype when grown on plates containing hyaluronidase (Holden, 2009). 
Increased levels of capsule enhances resistance to phagocytosis (Anzai et ai., 1999b; 
Wessels et ai., 1991; Wibawan et ai., 1999) (unpublished data), an important feature of S. 
equi, which is demonstrated by the accumulation of long chains of extracellular 
streptococci surrounded by large numbers of degenerating neutrophils in the LN abscesses. 
More capsule could also reduce adhesion to the mucosal surface (J Slater, unpublished 
data) (Bartelt & Duncan, 1978; Srivastava & Barnum, 1983). As HA is a major constituent 
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of the ECM, S. zooepidemicus may use HA lyase to aid nutrient release (Starr & 
Engleberg, 2(06) and even use its own capsule as an energy source during periods of 
starvation. 
The ability of S. equi to survive despite considerable neutrophil recruitment may have 
lessened the need of this bacterium to maintain an active C5a peptidase. The C5a 
peptidase enzymes of group A (ScpA) and B (ScpB) streptococci specifically cleave and 
inactivate the complement system chemotaxin C5a, thereby reducing the trafficking of 
neutrophils to the site of infection (Chmouryguina et ai., 1996; Cleary et aI., 1992; Hill et 
aI., 1988; Ji et aI., 1996; Wexler et ai., 1985). The C5a peptidase homologue encoded by 
Se4047 (SEQlO77), which shares 35 to 37% amino acid sequence identity with 
ScpNScpB, has a frameshift mutation after codon 58 and an early stop at codon 94 that 
truncates this protein (Table 2.5, Appendix Table A.2D). Orthologues in SzH70 
(SZ010150) and SzMGCS10565 (Sez_0946) remain intact. A novel factor H binding 
protein Se18.9 (SEQ0235) (Tiwari et ai., 2(07) that is produced by all S. equi strains 
(Figure 2.6) may have allowed some redundancy in bacterial mechanisms aimed at 
subverting the complement system. In addition to this, another chemokine protease 
(SEQ0563), which shares 61% shared amino acid· sequence identity with the GAS 
interleukin-8 ScpC (Edwards et aI., 2005; Zinkemagel et ai., 2008) is present and intact in 
Se4047. It is also possible that SEQlO77 gene decay has resulted from positive selection 
and a drive to enhance abscess formation, augmented by the production of superantigens. 
Ess specialised secretion systems have been identified in M. tuberculosis and S. aureus and 
shown to trigger cell-mediated immune responses, including interferon-'Y production, that 
play an important role in virulence (Burts et ai., 2005). The SzH70 genome contains a 
cluster of 8 genes with similarity to the ess of SzMGCS10565 (Beres et aI., 2008) and S. 
aureus (Figure 2.9) (Burts et aI., 2005; Burts et aI., 2008; Sundaramoorthy et al., 2008). 
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The Se4047 genome lacks esxA, esaA and part of essA most likely as a result of 
recombination between ISSeq3 elements, one of which is still present at this site 
(SEQ0575-SEQ0574). esaB is also a pseudogene in Se4047. PCR analysis showed that 
none of the 26 isolates of S. equi, but 138 of 140 S. zooepidemicus isolates examined 
contained the esaA gene (Figure 2.6). This type VII secretion system is unlikely to be 
functional in S. equi since EssA and EsaB are required for the production of the secreted 
factors EsxA, EsxB (Burts et al., 2005) and EsaC (Burts et al., 2008) respectively in S. 
aureus. EssA is a predicted membrane protein that is presumed to form part of the 
secretion apparatus, whilst EsaB acts as a post-transcriptional negative regulator of EsaC 
production. Given that components of the S. aureus Ess promote persistent abscesses 
during animal infection, the finding that this system is partially deleted in S. equi is 
surprising. However, a type VII secretion system was not required for L. monocytogenes 
virulence in mice (Way & Wilson, 2005) and similar systems are also present in non-
pathogenic Gram-positive and mycobacterial species (DiGiuseppe Champion & Cox, 
2007). These systems may therefore have functions that are shared by pathogenic and non-
pathogenic bacteria such as cell-to-cell communication (DiGiuseppe Champion & Cox, 
2007). The EsaC protein is more divergent among Gram-positive species and may confer 
different functions in other systems. Differences in the pathogenic strategies employed by 
S. equi and S. zooepidemicus may also reflect the differing contributions of these 
alternative secretion systems to virulence. For example, S. equi may rely more heavily on 
superantigens to disrupt the host immune respon~e. 
Gram-positive bacteria classically display an array of cell wall-anchored proteins on their 
surface, which are attached covalently through a process mediated by sortase enzymes 
(Marraffini et al., 2006). In many cases, these cell wall-anchored proteins have been 
shown to play a role in modulating host-cell interactions. The genome of Se4047 has 
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undergone noteable gene decay in its collection of surface proteins in comparison to SzH70 
and SzMGCS 10565 (Table 2.5). 
S. equi strains typically bind significantly lower quantities of fibronectin than those of S. 
zooepidemicus (Lindmark et al., 2001). One possible explanation for this is a one-base 
deletion within SEQ0375 (foe) that was conserved in all strains of S. equi examined 
(Lindmark et al., 2001). The base deletion infne results in the loss of an LPXTG surface 
anchor and leads to the production of a secreted product, Fne, which binds both fibronectin 
and collagen (Lindmark et al., 2001). Interactions with fibronectin have been shown to 
attenuate the virulence of S. pyogenes in mice (Nyberg et ai., 2004). Similarly, reduction 
in the fibronectin-binding properties of S. au reus increases virulence in a rat pneumonia 
model (McElroy et al., 2002) and truncation of fne has been proposed to increase the 
virulence of S. equi (Lindmark et al., 2001). This study identifies other examples of 
mutation and gene loss that are likely to contribute to decreased fibronectin binding in S. 
equi. The surface protein Shr of S. pyogenes binds heme and transfers it to the 
streptococcal heme-binding protein Shp for import by the HtsABC heme transporter (Zhu 
et al., 2008). Shr also binds fibronectin and contributes to attachment of S. pyogenes to 
epithelial cells (Fisher et al., 2008). SEQ0443 encoding Shr in S. equi contains a 
frameshift mutation after codon 442 that truncates this protein. ScpB, the streptococcal 
C5a peptidase of S. agalactiae was recently also shown to bind fibronectin (Tamura et al., 
2006). SEQ1077 (scpB) is a pseudogene in S~4047 and encodes a truncated 93 residue 
protein. CDSs for another 4 cell-wall anchored proteins that potentially function as 
adhesins by binding host receptors or components of the ECM are also inactivated in 
Se4047. These include a SeM-like protein (SEQ0232), a collagen-like protein (SEQ0556), 
a Listeria-Bacteroides repeat containing protein (SEQ1307a) and a SzPSe-like protein 
(SEQ0566). Mostly, these are unlikely to produce functional proteins due to the 
introduction of a very early stop codon (SEQ0232), the lack of a signal sequence 
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(SEQ0566 and SEQ1307a) and/or near complete degradation (SEQ1307a). However, 
SEQ0566 is likely to secrete a 182 amino acid truncated product that may still retain ligand 
binding activity. In addition, FneD, which has collagen-binding activity, but also lacks C-
terminal residues, is likely to be secreted into the extracellular milieu (Lannergard, 2006). 
S. equi has therefore evolved to secrete a number of potential and proven host ligand 
binding proteins through a process of gene decay. Such changes are likely to have reduced 
the surface bound adhesive capacity of S. equi and may also reduce the number of host 
targets available for binding, either by S. equi or by competing bacteria. Sfs, a secreted 
fibronectin binding protein of S. equi, absent from 15% of S. zooepidemicus strains, may 
act in a similar fashion (Lindmark & Guss, 1999). These secreted proteins may confer 
other functions as demonstrated by Fne, which is able to re-shape host cells through an 
interaction with host integrins and ECM components. This interaction has been proprosed 
to offer a novel mechanism to protect S. equi from the innate immune response (Liden et 
al., 2008) but may also contribute to S. equi virulence in yet unknown ways. 
One of the SzH70 cell-wall anchored proteins deleted in Se4047 contains Listeria-
Bacteroides repeat domains that are common to families of intemalins of Listeria species 
(Figure 2.10). InIA, the intemalin of L. monocytogenes (Orsi et al., 2007) interacts with E-
cadherin to promote invasion of L. monocytogenes into particular host cells (Ireton, 2007). 
The production of this surface protein is likely to be switched on and off through the action 
of a putative site-specific recombinase (SZ008550) in a manner akin to phase variation in 
E. coli or B. fragilis (Figure 2.11) (Abraham et al., 1985; van der Woude & Baumler, 
2004). This is the first potential example of recombinase regulation of surface protein 
production in streptococci. Such phase variation would result in a heterogeneous S. 
zooepidemicus population, in which some bacteria have a greater potential to maybe 
adhere to or invade certain host cells. Phase variation may also help the bacteria to evade 
the host immune system. Whilst this regulated surface protein was absent from all isolates 
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of S. equi (n = 26), its presence was detected in a significantly higher proportion (72%, n = 
140) of S. zooepidemicus isolates (P < 0.0001, Fischer's exact test). SZ008550 was more 
prevalent in S. zooepidemicus isolates collected from the respiratory tract (including LN 
abscesses) or cases of abortion/uterine infection (77%, n = 118) compared to other S. 
zooepidemicus isolates (66%, n = 20, P = 0.002, Fischer's exact test). SZ008560 was also 
more prevalent in lower respiratory tract S. zooepidemicus isolates (including those 
isolated from cases of pneumonia, 100%, n = 14) than in upper respiratory tract isolates of 
S. zooepidemicus (including those associated with LN abscessation) (71 %, n = 59) (P = 
0.03, Fischer's exact test) and all other S. zooepidemicus isolates (69%, n = 124, P = 0.011, 
Fischer's exact test). These data suggest that the expression of SZ008560 may contribute 
an adaptation to particular sites of infection and in some cases increased pathogenicity. 
SzMGCS10565 has the same locus but contains an IS element between the inverted repeats 
bordering the Sez_1114 (surface protein) promotor and the recombinase (Sez_1116); the 
consequences of this on transcription of Sez_1114 are not yet known. It was also noted 
that S. zooepidemicus isolates lacking this surface protein had a significantly higher 
prevalence of the pilus locus (82%, n = 39) that had been deleted from Se4047 
(srtC2/srtC3, discussed below) than S. zooepidemicus isolates with SZ008550 (49%, n = 
101, P = 0.0003, Fischer's exact test) and only rarely did S. zooepidemicus strains lack 
both (5%, n = 140, Figure 2.6). Interestingly, 5 of the 8 S. zooepidemicus isolates that did 
not contain either of these loci grouped with S. equi by MLST (ST-6, ST-133, ST-137 and 
ST-149). The remaining isolates (ST-112 and ST-122) group together by MLST, but were 
isolated from the equine respiratory tract and may possess an alternative mechanism(s) for 
host interaction. 
The genome comparison has revealed clear differences between Se4047 and SzH70 in their 
potential for pilus assembly. Mutation of the putative TetR-like regulator of Se4047 may 
lead to de-regulation and over-expression of CDSs from the associated putative pilus 
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cluster in S. equi. Expression of rrgB, which encodes the shaft subunit of the RlrA pilus in 
S. pneumoniae, is necessary in order to detect the associated accessory adhesin RrgA in the 
presence of capsule (Falker et at., 2008). Over-expression of major pilin subunits can also 
result in the formation of extremely long pili (Lauer et ai., 2005; Scott & Zahner, 2006). 
Inactivation of the TetR-like regulator may therefore lead to constitutive pilus production, 
longer pili that could more effectively protrude through the larger capsule of S. equi and 
increase collagen binding by the adhesin Cne (Lannergard et at., 2003). This putative pilus 
in Se4047 may be important during the initial stages of infection enabling the piliated 
bacterium to rapidly secure (Manetti et al., 2007) onto pharyngeal/tonsillar epithelial cells 
through distant contacts. Minor pilins have been repeatedly shown to play important roles 
in adherence of streptococci and other Gram-positive bacteria to host tissues (Abbot et ai., 
2007; Dramsi et at., 2006; Krishnan et at., 2007; Maisey et ai., 2007; Mandlik et ai., 2007; 
Nelson et al., 2007). Interestingly, a pilus backbone of GBS contributes to the paracellular 
translocation of these bacteria through epithelial cells with pili observed in the intercellular 
space ahead of the translocating bacteria (Pezzicoli et al., 2008). The route taken by S. 
equi as it moves so rapidly across the epithelial barrier is unknown, however an 
upregulated pilus cluster offers an exciting proposition for a process similar to the one 
described in GBS. Moreover, the presence of pili also stimulates the host inflammatory 
response (Barocchi et ai., 2006), which might damage the mucosal barrier and facilitate 
invasion of S. equi. 
IS-mediated gene loss has removed the 2nd pilus from Se4047 , an event that may have 
contributed to a reduced colonisation potential and/or the restricted host and tissue tropism 
of S. equi. The associated srtC2/srtC3 genes were also missing from all other strains of S. 
equi tested (Figure 2.6). S. pyogenes pili promote bacterial aggregation, adhesion and 
biofilm formation (Manetti et al., 2007), features that may prove important for the 
persistence of S. zooepidemicus at the mucosal surface. Pili of S. pyogenes also display 
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adhesive specificity for clinically relevant human tonsil and skin cells but not Hep-2 or 
A549 cells (Abbot et al., 2007). In addition, tissue tropism of C. diptheriae for pharyngeal 
cells is governed by the specific minor pilins associated with one of 3 distinct pilus 
structures (Mandlik et aI., 2007). 
Pilus loci in streptococci are often clustered at the same genetic locus (flanked by highly 
conserved genes), have a lateral mode of transmission and common ancestry but display 
considerable variability with some evidence of recombination facilitating the generation of 
variant proteins with different adhesive specificities (Bessen & Kalia, 2002; Telford et al., 
2006). Host immune selection may also drive change as pili are among the most 
immunogenic and broadly recognized GAS antigens (Manetti et aI., 2007). S. 
zooepidemicus shows diversity in its complement of pili, highlighted by the presence of 2 
distinct pilus clusters in the same genome location in SzMGCS 10565 compared to SzH70. 
Other unique clusters may account for some (or all) of the 42% of diverse S. 
zooepidemicus strains that were negative by PCR for srtC.3 and/or srtC.4 (Figure 2.6). 
Such diversification of pilus loci could play an important role in the ability of S. 
zooepidemicus strains to infect different hosts and tissues. 
2.5.3 Adaptation through gene change 
Adaptation to a new niche is a continuous process. Newly acquired virulence traits, along 
with pre-existing core genes, continue to undergo selection. SeM, the major 
antiphagocytic surface protein of S. equi was previously shown to have a unique N-
terminal domain relative to its allelic variant SzM in SzH70 (Kelly et aI., 2006). As this N-
terminal region is necessary for the binding of SeM to fibrinogen and IgG, the replacement 
or modification of this region was proposed to represent an important evolutionary 
adaptation by S. equi that may have contributed to its increased virulence over S. 
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zooepidemicus (Kelly et al., 2006). In fact similar diversification is apparent in many of 
the shared surface proteins of these two subspecies (Table 2.5) as well as in other proteins 
throughout the genomes (Appendix Table A.2C). The high level of polymorphism in 
surface proteins correlates with their likely role in host-pathogen interactions (host/tissue 
adaptation and immune evasion) and includes fibrinogen, collagen and fibronectin binding 
proteins as well as many others with as yet unknown function. 
Collagen-like surface proteins make up a significant proportion of these diversifying cell-
wall anchored proteins. A large family of Scls is a peculiar feature of S. zooepidemicus 
and S. equi that has presumably contributed significantly to their ability to attach, colonise 
and possibly invade host cells. 9 ScIs (ScIC-SclI, FneC, FneF) were previously identified 
in S. equi (Karlstrom et al., 2004; Karlstrom et al., 2006; Lannergard, 2006) and 12 
putative Scls (including one unconfmned pseudogene) were identified in the genome 
sequence of SzMGCS 10565 (Beres et al., 2008). This study has identified 11 ScI CDSs in 
SzH70. Collagen-like proteins are quite rare in prokaryotic genomes (Rasmussen et al., 
2003) and few bacterial genomes have multiple genes encoding collagen-like proteins. 2 
collagen-like surface proteins have been identified in S. pyogenes (Scll or ScIA and Scl2 
or SclB), one in S. pneumoniae (PclA) (Paterson et al., 2008) and 2 in Bacillus anthracis 
(BclA and BclB) (Steichen et al., 2003; Sylvestre et al., 2002; Thompson & Stewart, 2008; 
Waller et al., 2005). Scll and PclA both contribute to bacterial binding and internalization 
into host cells (Caswell et al., 2007; Lukom~ki et al., 2000; Paterson et al., 2008). 
Genetically diverse GAS strains display a highly polymorphic Scll protein (Lukomski et 
al., 2000). 37 distinct Scll variants were identified in 21 M types, with most variation 
occurring in the N-terminal V regions and in the number and type of GXY repeats in the 
central collagen-like regions (Lukomski et al., 2000). Comparison of ScI homologues in 
Se4047 , SzH70 and SzMGCS10565 revealed similar genetic variation in a number of ScI 
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CDSs suggesting the importance of both these V and collagen-like domains in host 
interaction (Table 2.5). 
N-terminal V regions are predicted to be involved in ligand binding. Recent studies have 
located low density lipoprotein- and factor H-binding activities in the V region of different 
GAS serotype Scll proteins (Caswell et ai., 2008b; Han et ai., 2006a). 3 of the Se4047 
Scls FneC, FneE and FneF bind collagen and/or fibronectin (Lannergard, 2006). Variants 
of Scll and Scl2 demonstrate clear differences in their ligand-binding potential (Pahlman 
et ai., 2007) and the same may apply to those Scl types specific to Se4047 , SzH70 or 
SzMGCS 10565. 
By mimicking the structure of mammalian collagen, collagen-like regions of Scls may also 
be recognised by eukaryotic integrins that normally bind to collagen. Sequences within 
vertebrate collagens that are targetted by collagen receptors include GxOGER- and GPO-
motifs, whilst cryptic RGD and KGD motifs unveiled following denaturation of the triple 
helix (maybe via proteolytic degradation) are recognised by fibronectin/vitronectin 
receptors (Heino, 2007). Prokaryotes are unable to produce hydroxyproline (0) and so 
equivalent motifs in Scls might utilise proline (P) instead of O. Indeed, the GLPGER 
sequence in the collagenous domain of Scll acts as a functional integrin binding motif and 
mediates direct binding to the a.2~1 and a.11~1 integrins (Caswell et ai., 2008 a). Such 
interactions trigger intracellular phosphorylation. signalling cascades like those induced by 
integrin-binding of ECM components (Caswell et ai., 2007; Humtsoe et ai., 2005). 
Interestingly, Scll mediates GAS internalization by human pharyngeal epithelial cells 
upon binding to the a.2~1 integrin (Caswell et ai., 2007). All of the Scls in Se4047 and 
SzH70 have multiple putative integrin-binding motifs so it is possible that.interactions with 
host integrins via these motifs could provide a mechanism used by S. zooepidemicus and S. 
equi to abuse the host cell cytoskeleton dynamics and facilitate colonisation and/or 
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invasion. Multiple cell types appear to recognize and bind Scll via their collagen 
receptors, although their relative responses may be dependent on the dominance of certain 
integrins and their binding affinity for the GLPGER motif (Caswell et aI., 2008a). The 
differences observed in the number, type and order of potential integrin binding motifs in 
Se4047, SzH70 and SzMGCS10565 ScI homologues (Table 2.5) could therefore influence 
the different tissue types targeted by the S. equi and S. zooepidemicus subspecies, as well 
as their colonisation and invasion potential. 
Diversification in the collagenous region of ScIs may serve another purpose. Structural 
studies demonstrated that several ScI1 and ScI2 variants share a common 'lollipop-like' 
domain organization with stalks made of the collagen-like region and the globular head 
formed by the V region (Han et al., 2006b; Xu et al., 2002). The triple-helix structure may 
help to present the presumed ligand binding region (V domain) away from the bacterial 
surface. Differences in the number of GXY -motifs between homologues of ScIs in 
Se4047, SzH70 and SzMGCS10565 may therefore contribute to this stalk function and the 
accessibility of protein domains to the host cells. Interestingly, the adhesive contribution 
of PcIA in S. pneumoniae was only apparent in the presence of a capsule and may be 
related to its large size and protrusion beyond the capsule (Paterson et aI., 2008). Contrary 
to this, Se4047 is hyper-encapsulated in vitro but mostly has ScI proteins with shorter 
collagen-like regions in comparison to SzH70 (and SzMGCS10565). Interestingly, 
differences in the length of proline-rich C-termi~al regions (and the number of proline-rich 
repeats) demark many of the Se4047 and SzH70 cell-wall anchored proteins, particularly 
those without collagen-like domains (Table 2.5). These changes are also likely to alter the 
presentation of the ligand-binding site away from the bacterial cell surface. 
Since SzH70 (ST-1) and SzMGCS10565 (ST-72) are only distantly related to S. equi in 
comparison to other S. zooepidemicus subtypes, their differences in amino acid sequence of 
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cell-wall anchored proteins may correspond to variation that exists amongst the S. 
zooepidemicus population rather than differences that delineate the 2 subspecies. For 
example, 3 Fnz variants have now been identified in 4 S. zooepidemicus strains (SzH70, 
SzMGCS10565NTU211 and Z5) (Hong, 2005; Lindmark et ai., 1996; Lindmark et al., 
2001) and one of these encoded by S. zooepidemicus strain Z5 is nearly identical to Fne in 
S. equi. These Fnz alleles are well conserved in their C-terminal fibronectin-binding 
regions but differ significantly in their N-terminal regions (34 to 47% amino acid sequence 
identity). Fibronectin-binding activity has been demonstrated in the N-terminal regions of 
Fnz (VTU211) and Fnz (Z5) that share 47% amino acid sequence identity (Hong, 2005; 
Lindmark et ai., 1996; Lindmark et ai., 2001); the latter was also shown to bind collagen. 
Further analysis of surface proteins in strains of S. zooepidemicus that are more closely 
related to S. equi may shed more light on changes that contribute to the increased 
pathogenicity of S. equi. 
Chromosomal rearrangements have also contributed to gene change between the Se4047 
and SzH70 genomes. 2 inversions around the origin of replication differentiate the global 
gene order of Se4047 from SzH70. Such reciprocal inversions around the origin and 
terminus are the most common form of chromosomal rearrangement between related 
bacteria (Eisen et al., 2000; Tillier & Collins, 2000) and have been hypothesised to be 
caused by either direct recombination between replication forks (Tillier & Collins, 2000) 
or the fact that only those regions of DNA close to the replication forks are unpackaged 
and available for recombination (Deng et al., 2002). Neither inversion appears to have 
separated any flanking genes or operonic structures that had not been previously 
interrupted by insertion events, although a 2nd hasC paralogue has been translocated to the 
opposite replichore in SzH70 so that it is no longer 10 CDSs downstream of the gene 
cluster associated with capsule synthesis. hasC encodes uridyltransferase, an enzyme 
required for HA capsule production (Blank et at., 2008). 
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Intra-replichore inversions are less common possibly because genes are transcribed in the 
opposite direction to the movement of the replication fork and collisions may occur 
between the replication and transcription machineries (Fraser, 2004). Also, genes moved 
closer to the origin of replication may be present in more copies per cell than genes moved 
closer to the terminus, as chromomal replication occurs in advance of cell division. Such a 
gene dosage effect will likely influence specific expression levels in the cell (Fraser, 2004). 
However, a 14 kb intra-replichore inversion has occurred in Se4047 between the 2 hasC 
paralogues that has rearranged the genes associated with capsule production (Blank et aI., 
2008) (Figure 2.13) and may explain why S. equi produces such high levels of HA capsule. 
This intra-operon inversion has replaced the original hasC operon gene (SEQ0289) with 
the duplicated paralogue (SEQ0271), which has a novel 12 amino acid C-terminus and has 
also relocated the genes gluM and pgi into a separate operon (Blank et aI., 2008). gluM 
and pgi encode phosphoglucoisomerase and uridyltransferase respectively, which are 
involved in the pathway of UDP N-acetyl glucosamine synthesis, a precursor of HA (and 
peptidoglycan) (Blank et ai. , 2008). 
1.74Mb 
SzH70 
Se4047 
13.4Kb 
SzMGCS1 0565 
Figure 2.13 Organisation of the has operon 
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2.6 Conclusions 
The comparison of the genomes of Se4047 and SzH70 provides strong evidence that S. 
equi has passed through a genetic bottleneck during its evolution from an ancestral S. 
zooepidemicus strain. Many examples of gene loss have been identified that serve to 
reduce the ancestral capabilities of S. equi and increase the opportunity for genetic change. 
Different processes of gene change have accompanied the adaptation of S. equi to its new 
niche and the acquisition of new MGEs has been critical to its evolution. However, 
surveillance of the S. zooepidemicus population has identified examples of strains that did 
not cause strangles, but contain genes encoding phospholipase A2 toxins and 
superantigens. Therefore, the key speciation event in the evolution of S. equi is proposed 
to have been the acquisition of ICESe2, containing a novel NRPS involved in the 
acquisition of iron, which is the first of its kind to be identified in streptococci. 
This study provides strong evidence for genetic exchange between S. equi, S. 
zooepidemicus and S. pyogenes, which continues to influence the pathogenicity of these 
important bacteria. The genetic diversity of the S. zooepidemicus population as measured 
by MLST (Webb et al., 2008) suggests that further investigation of this species will be 
likely to identify many more genes of importance to both veterinary and human disease. 
Finally, the availability of the completed genomes of Se4047 and SzH70 has revolutionized 
our ability to develop new diagnostic tests and vaccines. A new strangles blood test, 
developed following comparison of these genomes and based on the S. equi specific 
surface antigen SEQ2190 (Figure 2.6), is available commercially and has already enhanced 
our ability to identify persistently infected horses. The S. equi-specific eqbE gene of 
ICESe2 has formed the basis of an improved commercial quantitative PCR test for 
strangles (Chapter 5). Biochemical diagnostic assays used at the AHT for the 
discrimination of S. equi and S. zooepidemicus have been modified to include lactose 
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fermentation in order to reduce the occurrence of false positive S. equi results. The 
identification of new S. zooepidemicus-specific DNA targets (lacE, SZ014690) has also 
improved our potential to differentiate S. zooepidemicus from S. equi using peR. 
Improved knowledge of potential S. equi virulence factors and access to reliable infection 
models in the natural host, coupled with the low genetic diversity of S. equi revealed by 
MLST, should enable significant progress to be made towards the development of safe and 
effective vaccines and the eradication of strangles. 
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Chapter 3 A novel streptococcal integrative conjugative element 
involved in iron acquisition 
3.1 Introduction 
3.1.1 Integrative and conjugative elements 
Horizontal gene transfer has facilitated greatly microbial evolution and rapid adaptation to 
new niches. The term ICE was adopted to describe all self-transmissible MGEs with 
predicted or demonstrated integrative and conjugative properties (Burrus et ai., 2002a; 
Burrus et ai., 2002b). ICEs excise from the donor chromosome to form a non-replicative 
circular molecule, then promote self-transfer to a new host by conjugation and 
subsequently insert into a new target site. This transfer can occur between genetically 
unrelated bacteria. 
Tn916, identified in Enterococcus faecalis, was the first ICE to be completely sequenced 
(Flannagan et ai., 1994). Recently, the number of sequenced ICEs has risen considerably, 
particularly with the advent of genome sequencing (Burrus et ai., 2002a; Burrus et aI., 
2002b; Sebaihia et ai., 2006). Comparisons between ICEs of low G + C Gram-positive 
bacteria have revealed that these elements are widespread and possess a modular 
organisation (Burrus et aI., 2002a; Garnier et ai., 2000; Roberts et aI., 2001). Each of 
these modules includes all of the CDSs required for a specific biological function, namely 
site-specific recombination, conjugation and regulation. This is not dissimilar to the 
combination of functional modules seen in other bacterial mobile elements such as phages 
and plasmids (Toussaint & Merlin, 2002) and allows these structures, even when unrelated 
or distantly related, to evolve by exchange of modules (Burrus et aI., 2002a). 
Consequently, a diverse set of mosaic ICEs are emerging; most encode a tyrosine 
recombinase (like the majority of integrated prophage) but a small number have been 
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identified that utilise a serine recombinase to mediate site-specific recombination (Burrus 
et al., 2oo2b; Wang et ai., 2000). 
ICEs have played an important role in the distribution of antibiotic resistance loci. Other 
functions encoded by ICEs include toxic aromatic compound degradation pathways, 
sucrose utilisation, bacteriocin biosynthesis, heavy metal resistance, type-III and type-IV 
secretion systems, capsule antigen and a metalloprotease virulence factor (Burrus & 
Waldor, 2004; Franco, 2004). A novel ICE in the ECOR31 strain of E. coli carries the 
high pathogenicity island (HPJ) encoding the yersiniabactin siderophore system, which is 
critical to the virulence of Yersinia sp. and is widely distributed among E. coli strains and 
other Enterobacteriaceae that cause extraintestinal infections (Schubert et ai., 2004). 
3.1.2 Non-ribosomal peptide biosynthesis 
Bacteria and fungi use large multifunctional enzymes, the so-called NRPSs, to produce 
peptides of broad structural and biological activity. Non-ribosomal peptides include 
siderophores (yersiniabactin, pyochelin, enterobactin), potent antibiotics (penicillin, 
vancomycin), surfactants (surfactin), antitumor (bleomycin), immunosuppressive 
(cyclosporin) or cytostatic agents (epothilone) (Du et al., 2000; Rofle, 2009; Kleinkauf & 
von Dohren, 1990; Marahiel et al., 1997; von Dohren et al., 1997; Weber et al., 1994). 
The biosynthetic process occurs without the usual ribosomal and post-translational 
machinery. NRPSs are modular assembly lines .that direct product formation on a protein 
template; reaction intermediates are covalently bounds as thioesters on phosphopantetheine 
prosthetic groups (Challis & Naismith, 2004; Konz & Marahiel, 1999). Genes coding for 
NRPSs are organized in operons or clusters and NRPSs are composed of modules, with 
each module responsible for the incorporation of a specific monomer. ·The number and 
order of modules corresponds to the number and order of specific incorporated monomers 
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and is often termed the colinearity rule. There are however several exceptions to the 
colinearity rule, particularly for NRPSs that assemble siderophores' (including 
yersiniabactin) (Gehring et ai., 1998c; Miller et ai., 2002; Yu et ai., 1998). Modules are 
further subdivided into domains, each domain catalysing a specific reaction in the 
incorporation of a monomer. The adenylation (A) domain selects and activates the 
monomer transforming it into adenyl ate form. A thiolation or peptidyl carrier protein 
(PCP) domain covalently binds the activated monomer to the synthetase. The 
condensation (C) domain catalyses the peptide bond formation between the residues linked 
onto 2 adjacent modules. Finally, the thioesterase (TE) domain, present in the final 
module, releases the peptide from the synthetase. The product can either be released as a 
linear compound or be transformed into a cyclic peptide through an intramolecular-' 
reaction. In NRPSs of iterative type, the TE domain can allow the enzyme to iterate the 
collinear biosynthesis several times to produce a larger than anticipated product (e.g. 
enterobactin biosynthesis by E. coli (Shaw-Reid et ai., 1999». Heterocyclisation (Cy) 
domains substitute for C-domains in several NRPSs, particularly those involved in 
siderophore biosynthesis (e.g. yersiniabactin) (Crosa & Walsh, 2002). The Cy-domain has 
a gain of function in that, after condensation, it can cyclise cysteine, serine or threonine 
residues to make the corresponding thiazoline or oxazaline ring (Duerfahrt et ai., 2004; 
Konz & Marahiel, 1999; Lautru & Challis, 2004). In addition, secondary domains that 
allow residue modi cations are present in many NRPSs. Examples include epimerization, 
methylation, oxidation and reduction domains (~onz & Marahiel, 1999). 
NRPSs use amino acids (including nonproteogenic amino acids) or hydroxyl acids as 
building blocks, catalysing the formation of amide or ester bonds (Donadio et ai., 2007). 
The resolution of 2 A-domain crystal structures: the phenylalanine-actiyating A-domain 
(Aphe) of the gramicidin S-synthetase A (GrsA, Bacillus brevis) (Conti et ai., 1997) and the 
2, 3-dihydroxybenzoate (DHB)-activating A-domain DhbE of Bacillus subtilis (May et ai., 
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2002) allowed the identification of critical amino acid residues involved in the 
coordination of the substrate activated. This led to the introduction of the non-ribosomal 
code, which allows the prediction of A-domain selectivity on the basis of its primary 
sequence (Challis et aI., 2000; Stachelhaus et al., 1999). 
A recent study analysed sequenced bacterial genomes for the presence of NRPS systems 
(and polyketide synthases (PKSs» and found these to be present in 50% of 223 genomes 
but not uniformly distributed within the bacterial world (Donadio et aI., 2007). 
Interestingly, these biosynthetic enzymes were rare in bacteria with genomes ~ 3 Mb. For 
bacteria with genomes > 5 Mh, there was a correlation between genome size and the 
number of NRPS/PKS clusters, suggesting that these are luxury items added after a basic" 
self-sustaining metabolic capacity has been met (Donadio et al., 2007; Sattely et al., 2008). 
The genera Streptomyces, Bacillus and Pseudomonas were among those that contained a 
high percentage of NRPSIPKS genes. Streptococci, on the other hand, display just 2 
NRPS/PKS clusters. One in S. mutans, the main cause of tooth decay, encodes a hybrid 
PKS-NRPS system consisting of 7 modules in total, 5 of which are NRPS modules 
(Donadio et al., 2007). The identity of the corresponding metabolite has not been reported 
although expression from the locus is downregulated when the organism is grown in mixed 
species cultures (Huang, 2008). The only other Streptococcus strain displaying an NRPS 
is S. thermophilus (a lactic acid bacterium often used as a starter culture in yogurt and 
cheese), which encodes a single monomodular ~RPS (Donadio et al., 2007). The study 
also found that relatively similar NRPS clusters were found in unrelated bacteria and in 
most instances, these clusters directed the synthesis of siderophores, compounds that are 
clearly important for growth in iron-limiting environments (Donadio et al., 2007). Thus 
horizontal transfer has likely played a strong role in spreading these biosynthetic genes. 
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3.1.3 Iron acquisition 
Most organisms require iron as an essential element in a variety of metabolic and 
informational cellular pathways. More than 100 enzymes acting in primarY and secondary 
metabolism possess iron-containing cofactors such as iron-sulfur clusters or heme groups 
(Miethke & Marahiel, 2(07). The acquisition of iron is therefore an essential process for 
all pathogenic bacteria. In mammalian hosts tissue iron is sequestered by ferritin 
(intracellular iron storage), transferrin (plasma), lactoferrin (various bodily fluids) or in red 
blood cells (Wooldridge & Williams, 1993). Bacterial pathogens access this limited iron 
supply through the production of cell surface receptors for ferritin, transferrin and 
lactoferrin, utilising heme-containing compounds, iron transporters, or by the synthesis and 
secretion of iron-sequestering siderophores (Miethke & Marahiel, 2007; Wandersman & 
Delepelaire, 2004). Y. pestis, the etiologic agent of bubonic plague (defined by the swollen 
LNs or buboes characteristic of the disease), has 8 inorganic iron and 2 hemelhemoprotein 
transport systems. In addition to this, Y. pestis produces the siderophore yersiniabactin, 
which is derived from a mixed PKSINRPS system encoded on the high pathogenicity 
island (HPI) (Crosa & Walsh, 2002). Interestingly, mutant Y. pestis strains deficient in 
yersiniabactin production or lacking its cognate receptor (Psn) exhibit a dramatic loss of 
virulence in mice infected subcutaneously (Bearden et ai., 1997). S. pneumoniae encodes 
multiple iron transporters that are important for virulence (Brown et aI., 2002) and a cell-
surface lactoferrin receptor (Hakansson et aI., 2(01). S. pyogenes utilises hemoprotein 
binding and transport proteins (Lei et aI., 2002b) and a multi-metal transport system 
(Janu1czyk et ai., 2003). S. mutans transports ferrous iron and produces a MnlFe uptake 
system that is important in vivo (Evans et ai., 1986). Recently, a siderophore-iron (III) 
transport gene was identified in S. pyogenes, S. agaiactiae and S. pneumoniae (Clancy et 
ai., 2006; Hanks et al., 2005; Pramanik & Braun, 2006), but siderophore. biosynthesis has 
not been previously identified in any streptococci (Eichenbaum et al., 1996). 
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3.1.4 Siderophores 
Siderophores are mostly small non-ribosomal peptide molecules, which contain side chains 
and functional groups that can provide a high-affinity set of ligands for the coordination of 
ferric ions (Crosa & Walsh, 2002). There are 3 main types of iron-coordinating functional 
groups in siderophores (Crosa & Walsh, 2002). Anguibactin, produced by the bacterial 
fish pathogen Vibrio anguillarum, has N-hydroxy amino acid side chains, with the oxygen 
atom as one of the ligands for Fe3+. Adjacent hydroxyls of catechol rings, almost always 
derived from DHB, are represented in anguibactin and enterobactin (E. coli). Enterobactin, 
which is the strongest iron chelator ever found, has 3 catecholic side chains that can 
provide a full hexadentate ligation set to ferric ion (Miethke & Marahiel, 2007). A variant 
on this theme uses salicylate instead of DHB, leading to phenolic moieties as iron ligands. 
Yersiniabactin and pyochelin (Pseudomonas aeruginosa) feature this class of coordinating 
group and also the 3rd type, namely the nitrogen atoms of 5-membered thiazoline and 
oxazoline rings (e.g. vibriobactin, Vibrio cholerae). Provided that the siderophore contains 
6 donor atoms, a 1:1 complex with Fe3+ is formed. If there are less than 6 donor atoms 
provided by the ligand, the vacancies may be occupied by alternative oxygen donors such 
as water molecules. Alternatively, siderophore complexes with higher stoichiometry may 
be built up. pyochelin, for example, can form both 1: 1 and 2: 1 siderophore: Fe3+ 
complexes (Tseng et al., 2006), whilst cepabactin forms 3:1 complexes (Klumpp et ai., 
2005; Miethke & Marahie1, 2007). 
Siderophores are produced by bacteria during periods of iron starvation and secreted into 
the extracellular environment to scavenge iron. Very few systems for siderophore 
secretion have been elucidated. However, since passive diffusion of siderophore 
molecules is unlikely to occur, dedicated exporters or transporters involv~d in the efflux of 
multiple substrates are likely to secrete the siderophore into the extracellular milieu. 
Siderophore exporters described so far belong to the major facilitator superfamily (MFS) 
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(Allard et aI., 2006; Brickman & Armstrong, 2005; Furrer et aI., 2002; Page et al., 2003; 
Tanabe et al., 2006) and the ATP-binding cassette (ABC) family (Zhu et al., 1998). A 
resistance, nodulation and cell division (RND) superfamily is involved in antibiotic efflux 
and has been suggested but not yet proven to be involved in pyoverdine efflux (P. 
aeruginosa) (Li et al., 1995; Miethke & Marahiel, 2007). Upon secretion, extracellular 
iron-complexes are formed with stabilities ranging over about 30 orders of magnitude for 
different siderophores. Next, either the iron charged siderophore is taken up by a specific 
ABC transporter (Chenault & Earhart, 1991; Fetherston et al., 1999; Hanks et ai., 2005; 
Koster & Braun, 1990; Sebulsky & Heinrichs, 2001; Shea & McIntosh, 1991; Wyckoff et 
aI., 1999) or siderophore-bound Fe3+ undergoes reduction to Fe2+ and is taken up as a 
single ion through an Fe2+ -specific transporter (Miethke & Marahiel, 2007). Systems for 
extracytosolic reduction utilise free extracellular or membrane-bound reductases but are 
not common in prokaryotes (Barchini & Cowart, 1996; Miethke & Marahiel, 2007; 
Schroder et ai., 2003; Vartivarian & Cowart, 1999). ABC importers generally require an 
extracytoplasmic substrate binding protein (periplasmic binding protein or lipoprotein) to 
scavenge the ferric-siderophore and deliver it to the membrane channel of the ABC 
transporter (Miethke & Marahiel, 2007). For Gram-negative bacteria, outer membrane 
receptors are also required to transport the ferric-siderophore across this first barrier 
(Buchanan et ai., 1999; Cobessi et ai., 2005; Locher et ai., 1998). Bacteria often encode 
mUltiple Fe-siderophore importers to allow the use of exogenously derived siderophores as 
iron sources (Miethke & Marahiel, 2007). 
If not already released extracytoplasmatically, the iron has to be removed from the ferric-
siderophore complex in the cytosol; a process mediated by intracellular ferric-siderophore 
reductases or hydrolases (Miethke & Marahiel, 2007). Most Fe-sideroph9res are supposed 
to be discharged through the indirect activity of established reductases that are not specific 
for ferrisiderophore substrates (Halle & Meyer, 1992; Miethke & Marahiel, 2007). Soluble 
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flavin reductases catalyse the reduction of flavin-based substrates such as flavin 
mononucleotide (FMN), FAD and riboflavin by using NAD(P)H as an .electron donor 
(Pierre et aI., 2002). The reduced flavins are released into solution to serve as reducing 
agents for a variety of compounds including Fe(III)-chelates. Reduction of Fe3+ to Fe2+ is 
followed by spontaneous release or competitive sequestration of the reduced species and 
may allow recycling of the siderophore. Hydrolytic release is less common and because of 
damage to the siderophore molecule is likely to be more cost-intensive (Miethke & 
Marahiel, 2007). The ferric enterobactin esterase (Fes) of E. coli does however prevent the 
potentially toxic effects of intracellular enterobactin accumulation (Furrer et aI., 2002). 
Siderophore production is tightly regulated to protect against the toxic effects of too much ',~ 
iron. In bacteria, gene regulation of siderophore utilisation and iron homeostasis is 
generally mediated at the transcriptional level by the ferric uptake repressor Fur (Gram-
negative bacteria) or the diphtheria toxin regulator DtxR (Gram-positive bacteria) (Hantke, 
2001). DtxR-like proteins also regulate manganese transport in bacteria that regulate iron 
homeostasis by Fur (Miethke & Marahiel, 2007). Various activators can also contribute to 
the regulation of siderophore utilisation through the direct or indirect sensing of extra- or 
intracellularly present ferric-siderophores. These include alternative sigma factors, 2 
component sensory transduction systems and AraC-type regulators (Miethke & Marahiel, 
2007). 
3.2 Aims 
Genome sequencing and comparative analysis of S. equi and its close ancestral relative S. 
zooepidemicus has enabled the identification of possible virulence determinants in the 
former that could contribute to its increased pathogenicity (Chapter 2). ICESe2 was 
identified by this process and detected in all strains of S. equi examined. The acquisition 
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of ICESe2 by S. equi was hypothesised to have been an important ,event in the speciation of 
this subspecies owing to its apparent absence from the S. zooepidemicus population. 
The overall aims of the work presented in this chapter were to determine the function of 
the NRPS encoded by ICESe2 in S. equi and to establish the contribution of individually 
encoded proteins to the biosynthesis, transport, regulation and virulence (in mice) of the 
NRPS product. These aims were achieved using the following specific objectives:-
1. PCR and Southern blot analysis to establish the prevalence and genome location of 
ICESe2 across a diverse selection of S. equi and S. zooepidemicus strains. 
2. Bioinformatic analysis to assess the similarity of the ICESe2 NRPS to other 
characterised NRPS systems. 
3. Structure-based bioinformatic analysis and biochemical analysis to determine the 
structure of the ICESe2 NRPS product. 
4. Allelic-replacement mutagenesis coupled with in vitro growth analyses to 
determine the role of the ICESe2 NRPS in S. equi cation (and more specifically 
Fe3+) incorporation. 
5. Allelic-replacement mutagenesis coupled with in vitro growth in chemically 
defined media to determine the biochemical requirements of the ICESe2 NRPS. 
6. Allelic-replacement mutagenesis coupled with in vitro growth analyses to identify 
the mechanisms for transport of the ICESe2 NRPS product. 
7. Allelic-replacement mutagenesis coupled with quantitative reverse transcription-
PCR to determine the transcriptional regulation of the ICESe2 NRPS eqbE gene by 
the proposed EqbA repressor. 
8. Electrophoretic mobility shift assays (EMSAs) to assess the ability of recombinant 
EqbA to bind to the promoter region of the eqbB gene (the 1st gene of the proposed 
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NRPS operon) and to determine the influence of some divalent cations (and Fe3+) 
on such binding activity. 
9. Allelic-replacement mutagenesis to establish the contribution of the eqbE putative 
NRPS gene to the virulence of S. equi in mice. 
3.3 Methods 
3.3.1 Bacterial strains, media and growth conditions 
Se4047 was isolated in 1990 from the submandibular abscess of a New Forest pony. 
Strains were cultured in THB (Sigma) or on Todd Hewitt agar (THA) (Sigma) at 37°C with 
5% CO2 unless otherwise stated. Chemically defined media (COM) for Group A 
Streptococci (SAFC Biosciences, Appendix Table A.3) was used to produce conditioned 
supernatant for siderophore assays and to identify the additional biochemical requirements 
of eqb NRPS product production on supplementation with 10 11M salicylate (Sigma) 
(CDMs). To measure the influence of free cation concentration on the growth of wild-type 
and mutant S. equi strains, THA was supplemented with 2 mM nitrilotriacetic acid (NT A, 
Sigma). 
3.3.2 Identification of Streptococcus equi restricted genes 
ACT (Carver et at., 2005) was used to view TBLASTX alignments of the publicly 
available sequence data from the S. equi and S. zooepidemicus genome sequencing projects 
(www.sanger.ac.uk accessed 10.03.09). Comparisons of predicted CDSs with Uniprot 
were performed using BLASTP and FASTA. Southern blot and PCR analyses were used 
to determine the genome location, circularisation and prevalence of ICESe2 across 18 
strains of S. equi and 73 strains of S. zooepidemicus (Table 3.1, App~ndix Table A.4). 
Diverse strains were selected based on their SeM allele (Kelly et aI., 2006) and RNA 
intergenic spacer/M protein sub-type (Newton et al., 2008), respectively (Appendix Table 
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A.4). Taq DNA polymerase (Sigma) was used for PCR according to manufacturer's 
instructions. 
Table 3.1 Oligonucleotide primers used for PCR to screen diverse S. equi and S. 
zooepidemicus strains for the presence of eqbE, to amplify across flanking regions of 
ICESe2, to generate DNA probes for Southern blot analysis and electrophoretic mobility 
shift assays, to clone plasmid constructs for gene expression or the production of allelic 
replacement S. equi deletion mutants and to perform quantitative RT-PCR analysis of 
eqbE/gyrA gene expression 
Primer Sequence (5'-3') Purpose 
ZM236 TTTTTTCTTCTTCCCACTGGC Left flank ofiCESe2 (498 bp) and 
circular form of ICESe2 (-537 bp) 
ZM343 TTGGGATGACCATGGGATAC Left flank ofiCESe2 (498 bp) 
ZM235 ATTGGGAACACCTTGCAAGG Right flank of ICESe2 (1590 bp) and 
circular form ofiCESe2 (-537 bp) 
ZM344 TGTTGGTGTTCCTGGGATTC Right flank of ICESe2 (1590 bp) 
ZM233 CGTGATTTGAGAGTAGGGAC eqbN probe for Southern blots (317 
ZM234 TGTAACGAAGTCGCTACTGC bp) 
EqbEf AAGATATAGCAGCATCGTATCG Sense primer QRT -PCR of eqbE 
(130 bp) 
EqbEr TCTAAATCTCTATTAAATAGCGGTATATTG Anti-sense primer 
GyrAf AAGGCGGGATTCCTAAAATC Sense primer QRT -PCR of gyrA 
(143 bp) 
GyrAr GATAAGTAAGCCCTCTAAAATGTG Anti-sense primer 
2f GGGTTGCCATGCATATCTTG eqbE screen (548 bp) 
2r TCCGGCTGTTTCCTTAATGG 
ZM94 GAGQTCGACGTCACAACAAGACTCTTCCC eqbE deletion (amino acids 4 to 
ZM95 GACGATATCATTATAGAAGGGAGTTTATGATG 2017) 
ZM96 GACQATAT~AAGTTCCATTCCAAAATCCTCC 
ZM97 GACQAATTCTCGGAATCGCTGAAGGATTG 
ZM123 GACQAATTCACTTTTACAACCGGACAGTTC eqbA deletion (amino acids 2 to 124) 
ZM124 GACQATAT~ATAAACTCATCTAACTTATCCCTTC 
ZM125 GACQATAT~CAAGATATAAGAGAAAGAACATGC 
ZM126 GACGTCGACCCATTCGGATTTGGTAACCC 
ZM199 GACGCGGAGGAATTCTTGCTGTAG eqbHIJ deletion (amino acids 3-
ZM198 GACGACGATATCGCTCATTATTATTCTCCTCTGT eqbH to 419-eqbJ) 
C -
ZM178 GACGACQATAT~GAAGGTATGCTTGCAGTGTC 
ZM179 GACGACGTCGACAACATCGCAAGAGCCATCTC 
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Table 3.1 continued 
Primer Sequence (5' -3') Purpose 
ZM162 GACGAATTCGGGTCTTAGAACTTTAGAGG eqbKL deletion (amino acids 3-eqbK 
ZM163 GACGATATCGCTCATGTAACTTCTCCACC to 572-eqbL) 
ZMl64 GACGATATCAGGGGTAAAACAGAGGACTG 
ZM165 GGGGTCGACCTGGCATACAAATAACGTCTCC 
ZM180 GACGACGAATTCTTACCTCAGCTGCAAGAAGC ftsB deletion (amino acids 23 to 304) 
ZM181 GACGACQATATCACTTGAGCAGGCGACTAATG 
ZM182 GACGACGATATCATCCTCTCAACTGGTGCAAG 
ZM183 GACGACGTCGACAGCCTCATTTGAGTGTAGCC 
ZM1l9 GACQAATT~CATGCTAAGGAGGGTTTTCC fur deletion (amino acids 3 to 155) 
ZM120 GACGATATCTCCAAGCTTACAACCTCCTC 
ZM121 GACGATATCCACAGACTATTGAGAGCTGG 
ZM122 GACGTCGACTGCCAGTTCAGATGTTGACC 
ZM329 GACGACQQATCCTTATGAATAAAATATATCATA Construction of pGEX -eqbA ' ....... 
AGG 
ZM330 GACGACQAATTCCATGTTCTTTCTCTTATATCTT 
G 
BIOZM AAGATATAAGAGAAAGAACATGC Amplification of 5' biotin end-
360 labelled target DNA for EMSA 
ZM36 I TCCATCTGATTATTAATATACTAC Used with BIOZM360 to amplify 
227 bp Peqb target DNA A for EMSA 
ZM362 TTAATCCTTCTAACATAAAAAGTC Used with BIOZM360 to amplify 
165 bp target DNA B for EMSA 
ZM452 CTAAAAGGCTTGAAGAAACTAAG Used with BIOZM360 to amplify 
103 bp target DNA C for EMSA 
ZM446 GACGACGAATTCGTAGTATAACAATAATAAGAA pAeqbA for cloning pGpAeqbA 
TGTTG 
ZM447 GACGACGACGTCGACTCTTTCTCTTATATCTTGT 
CTTC 
ZM442 GACGACGACCCCQQQCAAGATATAAGAGAAAG pB for recombinant PCR 
AACATGC 
ZM443 CTTTCTTTTATATTGTTAAGTTCCATCAAAACAC 
CTTCCATCTGATTATTAATATAC 
ZM444 GTATATTAATAATCAGATGGAAGGTGTTTTGAT eqbE-Nterm for recombinant PCR 
GGAACTTAACAATATAAAAGAAAG 
ZM445 GTTCTAAGCATGGGATGTCTG . 
Restriction sites are underlined. 
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For Southern blot analysis 2 to 4 ~g genomic DNA was digested with NdeI (NEB) 
overnight. NdeI restriction sites flank: an 8.2 kb DNA fragment containing part of the 
eqbN gene, the eqbM gene, the C-terminal and downstream regions of ICESe2. Digested 
DNA was separated by gel electrophoresis and transferred to a positively charged nylon 
membrane (Roche Applied Science) by capillary action following depurination (0.25 M 
HCI, 20 min), denaturation (0.5 M NaOH, 1.5 M NaCl, 2 x 15 min) and neutralisation (1 
M Tris-HCI pH 7.4, 1.5 M NaCI, 2 x 15 min) treatments. The capillary transfer was 
performed overnight using standard apparatus and 20 x SSC buffer (3 M NaCl, 0.3 M 
sodium citrate, pH 7.0). Transferred DNA was fixed to the nylon membrane by UV 
transillumination (3 min). The membrane was then pre-equilibrated with Dig Easy Hyb 
(Roche Applied Science) (30 min, 40°C) and probed with DIG (digoxigenin)-labelled eqbN ..... 
probe (denatured at 95°C for 5 min), diluted 1/500 in Dig Easy Hyb (40°C overnight). 
DIG-labelled eqbN probe was prepared using the PCR DIG Probe Synthesis Kit (Roche 
Applied Science) according to the manufacturer's instructions. Unbound probe was 
washed from the membrane with 2 x SSC, 0.1% SDS (2 x 5 min, RT) followed by 0.5 x 
sse, 0.1% SDS (2 x 15 min, 42°C). Bound probe was detected using the DIG 
Luminescent Kit for Nucleic Acids (Roche Applied Science) using anti-DIG-AP (alkaline 
phosphatase) conjugate and chemiluminescent detection according to the manufacturer's 
instructions. 
3.3.3 Allelic replacement 
Internal gene deletions were introduced into Se4047 through an allelic replacement 
strategy previously described for the production of a !iprtM mutant (Hamilton et al., 2006). 
First, a copy of the Se4047 gene (with flanking regions) containing a deletion was 
introduced into the pGhost9 plasmid by 3-way ligation. Phusion DNA polymerase (NEB) 
was used to generate DNA fragments by PCR, which were purified with Qiagen spin 
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columns. Table 3.1 shows the primers used and details internal deletions in the 
construction of plasmids pGeqbA~, pGeqbE~, pGeqbHIJ~, pGeqbKL~ and pGftsB~. 
Cloning was performed in E. coli TGlrepA+ cells, plasmids were purified using the 
QIAprep Spin Miniprep Kit (Qiagen) and sequencing with an ABI3100 DNA sequencer 
was performed to check for errors (BigDye® Terminator v3.1 Cycle Sequencing Kit, 
Applied Biosystems). In all cases, kits were used according to the manufacturer's 
instructions. Plasmid constructs (1 - 5 J..lg) were transformed into Se4047 by 
electroporation (Bio-Rad Gene Pulser electroporater with pulse settings of 2.5 kV cm-I, 
200 Q, and 25 J..lF) following growth of cells (10 ml) to early log phase in THB 
supplemented with hyaluronidase (30 J..lg ml-1), washing (3 x 1 ml) and resuspension in ice-
cold 0.5 M sucrose solution (100 J..lI). Transformants were selected by growth at 28°C (for ---
2 to 3 days) on THA supplemented with 0.5 J..lgml-1 erythromycin following a 2 to 3 h 
recovery time. pGhost9 is able to replicate at 28°C, but can only be maintained at 37°C by 
integrating into the bacterial chromosome. 2 rounds of homologous recombination were 
used to replace the wild-type gene with its respective deletion allele. The first 
recombination event, leading to integration of the plasmid construct, was achieved 
following growth at 37°C and the second recombination event, leading to the excision of 
the plasmid construct was performed at 28°C. PCR was used to identify successful 
integration events and to screen erythromycin sensitive colonies for the presence of a gene 
deletion. Sequencing was also used to confirm that a deletion had occurred and that no 
sequence errors were present in flanking regions: 
The ~eqbAE double deletion mutant was generated by transformation of S. equi strain 
~eqbE with the pGeqbA~ plasmid followed by recombination and selection as described 
previously. Similarly, for other mUltiple deletion strains, eqbA was always the last gene to 
be deleted. 
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3.3.4 RNA isolation 
Total RNA was extracted from bacteria using RNAprotect, RNeasy and DNase Kits 
according to the manufacturer's instructions (Qiagen). Bacteria grown to mid-log phase 
were pelleted by centrifugation for 10 min at 5000 g. The pellet was resuspended in 200 /ll 
of TE buffer (10 mM Tris-CI, 1 mM EDTA; pH 8.0) containing 3 mg lysozyme (Sigma) 
and 500 U mutanolysin (Sigma). After incubation at room temperature for 45 min with 
repeated vortexing, 700 /ll of RLT buffer containing ~-mercaptoethanol was added, and the 
tube was vortexed. The mixture was transferred to a 2 m1 reaction tube containing 0.05 g 
of 100 /lm-diameter acid-washed glass beads (Sigma) and vortexed for 5 min. The mixture 
was then centrifuged and total RNA was extracted from the supernatant using an RNeasy 
Midi Kit. 5 /lg of recovered RNA was treated with DNase to remove any contaminating 
DNA followed by clean up on an RNeasy mini column. The quantity and purity of RNA 
was determined by optical density measurements at 260 and 280 nm using a NanoDropR 
ND1000 spectrophotometer (NanoDrop Technologies). 
3.3.5 Reverse transcription and quantitative real-time peR 
Transcriptional regulation of the NRPS gene, eqbE by the putative repressor, EqbA was 
determined by quantification of eqbE transcript levels in the !!..eqbA and parent Se4047 
strains grown to mid-log phase in THB. A quantitative two-step reverse transcription PCR 
procedure was used to calculate levels of eqbE gene transcription relative to the 
housekeeping gene gyrA. Reverse transcription (RT) was performed using the Verso 
cDNA kit (Abgene). The RT reaction mixture (20 Ill) contained 96 ng total RNA, 2 /lM 
gene-specific anti-sense primer (Table 3.1), 500 /lM dNTP mix, 16 U RNase inhibitor 
(RNASIN, Promega), Ix cDNA synthesis buffer, 1 /ll RT enhancer and 1 /ll Verso enzyme 
mix. RT was performed at 50°C for 30 min and terminated by heating to 95°C for 2 min. 
QPCR was performed with a Techne Quantica instrument and data analysed using 
Quansoft software (Techne). For the QPCR, 6 /ll RT reaction mixture diluted 1/1000 was 
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mixed with 0.3 11M forward and reverse primers (Table 3.1), Ix ABsolute QPCR SYBR 
green mix (Abgene) and 40 nM ROX in a total volume of 20 III and subjected to 
thermocycling at 95°C for 15 min, followed by 40 cycles of 95°C for 15 sec and 60°C for 1 
min. Dissociation curves were analysed, following a final ramp step from 60°C to 90°C 
with reads at 0.5°C increments, to rule out non-specific amplification. No-template 
negative controls were included and reverse transcriptase negative controls to confirm the 
absence of contaminating DNA from RNA samples. Standard curves (Cp vs log gene copy 
number) with an efficiency of 1.9 (R2 = 0.999) were generated from gDNA for each target 
gene and used to calculate gene copy number in cDNA samples generated from 3 
independent RNA extractions. eqbE gene copy number was normalised to gyrA reference 
gene copy number to correct for differences in the amount of starting material. Data was 
expressed as fold increase in normalised eqbE transcript level in the LJeqbA mutant strain 
relative to the wild-type Se4047 strain. 
3.3.6 Streptonigrin sensitivity 
The minimum inhibitory concentration (MIC) of streptonigrin and erythromycin was 
determined following overnight incubation of bacterial strains in a standard 96-well 
microtiter plate assay. 100 III of re-suspended colony material corresponding to 104 colony 
forming units (CFU) ml-l in THB, CDMs or conditioned THB/CDMs was added to 100 III 
THB supplemented with streptonigrin (concentration ranging from 2 11M to 0.5 nM 
through two-fold serial dilutions) in duplicate wells of a microtiter plate. Sensitivity to 
erythromycin was determined using the same procedure (0.5 Ilg ml-l to 0.5 ng mrl 
erythromycin). Data is presented as the mode of at least 3 independent experiments. 2-
sample Wilcoxon rank-sum (Mann-Whitney) tests were used to measure the significance 
of differences in streptonigrin sensitivity between strains or conditioned media samples 
(performed by Richard Newton, ART, using Stata 9.2 software (StataCorp LP». 
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3.3.7 55FeCl3 accumulation 
Wild-type and mutant S. equi strains were depleted of iron by growth overnight on THA 
supplemented with 4 mM NT A. Colony material from these plates was re-suspended in 
PBS with the volume adjusted to give an optical density at 600 nm of 1.0. 0.5 ml of this 
bacterial suspension was added to 0.5 ml THB supplemented with 2.0 J1Ci ml-1 55PeCh 
(Perkin Elmer) and incubated at 37°C with 5% C02. After 3 hr, cell growth was monitored 
through measurement of optical density and a volume of cells equivalent to 6 x 107 CPU 
(optical density of 0.3 == 2 x 108 CPU ml-1) was collected in triplicate wells of a 96-well 
UniPilterR GP/CR (Perkin Elmer) with a Packard PilterMatelM Harvester. Cells were 
washed on the filter with 10 mM NTA and then methanol. The filter was dried for 1 hr at 
room temperature prior to the addition of 20 J11 Microscint 20 (Packard). Bacterial iron 
accumulation was measured by liquid scintillation counting on a TopCount NXTlM 
microplate counter (Packard). 2-sample Wilcoxon rank-sum (Mann-Whitney) tests were 
used to measure the significance of differences in mean 55PeCh accumulation between the 
/:::.eqbA strain and /:::.eqbAE, /:::.eqbHIJA and wild-type strains (performed by Richard 
Newton, AHT, using Stata 9.2 software (StataCorp LP». 
A modification of this method was used to analyse the accumulation of 55PeCh in the S. 
equi mutant strain iJ.eqbAE when cross-fed with filter sterilised culture supernatant from 
wild-type, /:::.eqbAE or /:::.eqbA strains grown to stationary phase overnight. Bacteria were 
resuspended in 1 ml 2X THB supplemented with 2.0 J1Ci ml-1 55PeCh to an optical density 
at 600 nm of 0.2 and mixed with an equal volume of filter sterilised culture supernatant. 
Cells were incubated at 37°C with 5% C02 until they reached an optical density at 600 nm 
of 0.5 and then a volume of cells equivalent to 1 x 108 CPU was coll~cted in triplicate 
wells of a 96-well UniPilterR GP/CR and processed as described above. 
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3.3.8 LC-MS analyses of culture supernatants 
Comparative metabolic profiling of the l1eqbA, l1eqbAE and l1eqbHIJA strains was 
performed using LC-MS (liquid chromatography-mass spectrometry) by Lijiang Song 
under the supervision of Greg Challis (Warwick University). Culture supernatants (50 ml) 
were extracted with ethyl acetate (3 x 50 ml) and both the combined organic extract and 
the residual culture supernatant were concentrated to dryness and re-dissolved in 20% 
acetonitrile I 0.1 % formic acid in water (1 ml). Each sample was split into two equal 
portions and ferric chloride was added to one portion of each sample to a final 
concentration of 5 mM. 50 III of each sample were analysed on an Agilent Zorbax C-18 
reverse phase column (150 x 4.6 mm) connected to an Agilent 1100 high performance 
liquid chromatography (HPLC) instrument. The outflow was transferred via a splitter 
(90% to waste, 10% to mass spectrometer) to a Bruker HCT+ mass spectrometer, equipped 
with an electrospray source, operating in positive ion mode. The column was eluted as 
follows (mobile phase A: water with 0.1 % formic acid, mobile phase B: acetonitrile with 
0.1 % formic acid). 100% mobile phase A for 5 min; a gradient from 100% mobile phase A 
to 100% mobile phase B over 25 min; 100% mobile phase B for 5 min; a gradient from 
100% mobile phase B to 100% mobile phase A over 5 min; 100% mobile phase A for 5 
min. 
3.3.9 Chrome azurol S assay 
Iron-chelating activity in supernatant samples was monitored by the chrome azurol S 
(CAS) assay and CAS shuttle assay (Schwyn & Neilands, 1987). Bacteria were grown 
overnight in 10 ml CDMs to stationary phase and then filter sterilised through a 0.22 11m 
filter (Millipore) to recover supernatant. 0.5 ml supernatant was mixed with an equal 
volume of CAS assay solution (or CAS shuttle assay solution) and change in absorbance at 
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630 nm was measured over time. Desferoxamine was included as a standard. CAS assay 
solution (made up to 100 m1 in H20) contained 6 m110 mM hexadecyltrimethylammonium 
(HDTMA), 1.5 m1 iron solution (1 mM FeCb, 10 mM HCI), 7.5 m1 2 mM CAS solution 
(0.06 g in 50 m1 H20), 4.3 g anhydrous piperazine dissolved in H20, 6.25 m1 12 M HCl. 
CAS shuttle assay solution also contained 4mM 5-sulfosalicylic acid. This reagent is 
intended to act as a shuttle to aid the removal of iron from the CAS-HDTMA-iron complex 
by low affinity iron chelators. All reagents were from Sigma unless otherwise indicated. 
Iron-chelating activity was also assessed using CAS agar overlayed with bacteria 
resuspended in THA in 15 m1 polystyrene tubes. 100 m1 of CAS agar contained 1.2 g agar, 
5 m1 CAS solution (0.06 g CAS in 50 m1 H20), 1 rn1 iron (III) solution (1 mM FeCh in 10 
mM HCI) and 4 m1 HDTMA (0.07 g in 40 m1 H20). Samples were cultured at 37°C with 
5% C02 for 5 days. S. au reus was included as a positive control. 
3.3.10 Overexpression and purification of EqbA 
The S. equi eqbA gene was amplified by PCR from Se4047 chromosomal DNA with 
Phusion polymerase (NEB), primer ZM329 and primer ZM330 (Table 3.1, Figure 3.1). 
The PCR product was cloned into the BarnHI/EcoRI sites of the pGEX-3X vector (GE 
Healthcare). The resulting construct, pGEX-eqbA, contains an N-terminal fusion of eqbA 
to a glutathione S-transferase (GST) tag driven by a tac promoter. Subsequent expression 
and purification of EqbA (126 amino acids) was performed by Carl Robinson (AHT). 
DHlOB E. coli cells harbouring the plasmid pGEX-eqbA were grown at 37°C with shaking 
(220 rpm) in 2 x YT containing 50 flg/ml ampicillin. Once the cells reached an optical 
density at 600 nm of 0.6, 1 mM isopropyl-~-D-thiogalactopyranoside (IPTG) was added to 
the medium and the culture was incubated for 4 h at 28°C with shaking· (220 rpm). Cells 
were then harvested and lysed by sonication, and the GST-EqbA fusion was purified over 
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glutathione sepharose 4B beads according to the supplier's protocol (GE Healthcare). 
Recombinant EqbA was cleaved from the beads by Factor Xa protease cleavage in 50 mM 
Tris-HCI (pH 7.5), 150 mm NaCl, and 1 mM CaCh according to the supplier's protocol 
(GE Healthcare). The purified EqbA protein appeared homogenous by SDS-
polyacrylarrude gel electrophoresis and coomassie blue staining. 
Figure 3.1 Diagram showing primer binding sites used for the amplification of eqbA and 
electrophoretic mobility shift assay DNA fragments by PCR 
Palindromic promoter region 
ZM329 BIOZM360 1 
-
-
ZM330 ZM361 
.. 
--ZM362 
103 bp 
.. 
--ZM452 
The eqbA gene was amplified using primers ZM329 and ZM330 for cloning and 
expression using pGEX-3X. 3 DNA fragments (A, B and C) upstream of the eqbB gene 
were amplified by PCR using the primers indicated in order to assess their binding to 
recombinant EqbA using electrophoretic mobility shift assays (EMSAs). Only fragment A 
contained the palindrorruc promoter region highlighted in red. 
3.3.11 Electrophoretic mobility shift assay 
5' biotin end-labelled DNA fragments A, B and C containing the upstream region of the 
eqb operon were amplified from the Se4047 chromosome using the primers indicated in 
Table 3.1 and Figure 3.1. Fragment A contains the -237 to -11 bp region upstream of the 
eqb operon (P eqb), whilst fragments B and C contain regions -237 to -73 bp and -237 to -
135 bp, respectively and lack the DNA palindrome of Peqb (-73 to -38 bp). The PCR 
products were purified from a 1.5% agarose gel using a gel extraction kit (Qiagen) . 
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Binding reactions (20 ~l) were carried out at room temperature for 20 min in 22.5 mM 
Tris-HCI (pH 7.5), 67.5 mM KCI, 5 mM MgCh, 1.45 mM dithiothreiotol (DIT) , 5% 
glycerol and 1 ~g dIdC. 20 finol biotin-labelled target-DNA were mixed with 300 pmol 
EqbA with or without the addition of 125 ~M freshly prepared FeS04, ZnS04, MnCh, 
CUS04 or FeC6Hs07. To assess the specificity of rEqbA binding to Peqb, 3.8 pmol 
unlabelled Peqb was added 5 min prior to the addition of biotin-labelled Peqb. To remove 
divalent metal-ion from the purified EqbA, the protein was incubated with 2 mM EDTA 
for 2.5 h with mixing at room temperature and then buffer exchanged against 20 mM Tris-
HCI (pH 7.5),50 mM KCI, 1 mM DTT using a vivaspin500 column (Sartorius). Samples 
were analysed by electrophoresis at 200 V on a 5.5% non-denaturing polyacrylamide gel 
containing 2.5% glycerol in 0.5 X Tris-borate-EDTA buffer. Transfer to a positively ,,~ 
charged nylon membrane (Roche Applied Science) and the subsequent detection of biotin-
labelled DNA by chemiluminescence were performed using the LightShiftR 
Chemiluminescent EMSA Kit (Pierce) according to the manufacturer's instructions. Kit 
controls were used to analyse the binding of the Peqb fragment and EqbA to an alternative 
protein extract and target DNA respectively. 
3.3.12 Experimental infection of mice 
2 repeat experiments were performed to assess the virulence of the !:l.eqbE mutant in 
comparison to the wild-type strain of S. equi in mice. Mice were challenged intranasally as 
previously described with some modifications (Chanter et al., 1995; Flock et al., 2004). 
To infect mice, bacteria were inoculated into THB supplemented with 10% foetal calf 
serum (Sigma) (THBfcs) and grown overnight. The culture was then diluted 20 times into 
THBfcs and grown to an optical density of 0.3 at 600nm. 20 7 to 8 week old female BalbC 
mice were challenged by intranasal administration of 1x104 CFU in a 1O~1 volume with 
either the parent Se4047 or !:l.eqbE S. equi strain. In order to assist complete delivery of the 
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innoculum into the nasal cavity and therefore improve infectivity rate, challenge was 
performed under sedation with Ketaset™ (Genus) administered intra-muscularly at 100 
mgkt l bodyweight. Mice were examined daily and clinical signs of ' disease such as 
weight loss and general demeanour were compared with a group of 5 unchallenged 
controls over a period of 7 days. An overall clinical observation score was assigned based 
on the sum of scores allocated for 9 categories: normal (0), slight piloerection (1), 
piloerection (3), marked sneezing (3), quietness (3), hunching (5), rapid breathing (5), ear 
imbalance (10) and immobility (10). Nasal shedding was also determined daily by gently 
touching the nostrils to 5% blood agar plates (bioMerieux). A sterile spreader was used to 
distribute the inoculum across the plate and bacterial growth following overnight 
incubation was scored (experiment one) or the number of CFU were counted (experiment ....... 
2). Bacterial growth was scored on a 5-point scale from 0 to 4, where 0 means no growth, 
1 means 1 to 10 CFU, 2 means 11 to 100 CFU, 3 means> 100 CFU and 4 means confluent 
growth. Any mice losing> 15% of their body weight or showing signs of suffering were 
considered to have reached the clinical end point and were euthanased, whilst all other 
mice were euthanased at the end of the 7 day period. All mice were examined post-
mortem for evidence of pneumonia or submandibular LN abscessation and heart swabs 
were taken to check for septicaemia (experiment 2 only). 2-sample Wilcoxon rank-sum 
(Mann-Whitney) tests were used to measure the significance of differences in mean 
cumulative weight loss per day and mean cumulative gain in nasal score per day between 
the tJ.eqbE and wild-type infected groups (per:ormed by Richard Newton, AHT, using 
Stata 9.2 software (StataCorp LP». Debs Flack, Beverley Walladge, Lyndsey Owen, 
Andrew Waller and Carl Robinson (ART) helped with the daily care, health checks and 
around the clock monitoring of the mice. 
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3.4 Results 
3.4.1 Identification and prevalence of a novel ICE encoding a siderophore-like NRPS in 
Streptococcus equi 
Comparison of the Se4047 genome and SzH70 genomes using ACT (Carver et ai., 2005) 
led to the identification of a large 63 kb locus in Se4047 that was absent from the S. 
zooepidemicus H70 genome, had a significant decrease in G+C content (31 % compared to 
42% across the whole Se4047 genome) and was bordered by 108 bp perfect inverted repeat 
elements. 
BLASTP and FASTA analysis against UniProt determined that the locus contained coding 
regions with similarity and conserved gene order with CDSs contained within the 
conjugative transposons CDTn2 and CDTn5 in the genome of C. difficile strain 630 
(Sebaihia et al., 2006) and the plasmid borne Tn1549 in Enterococcus spp. (Garnier et al., 
2000) (Figure 3.2). ICESe2 also shares some homology with an ICE in S. pyogenes 
MGAS10750 (ICE MGAS10750-RD.2, Figure 3.3) (Beres & Musser, 2007). 
Consequently I have named this S. equi integrative conjugative element, ICESe2, 
according to the suggested nomenclature (Burrus et al., 2002b). Like Tn916, these 
elements appear modular, with CDSs likely to be associated with conjugation and site-
specific recombination located in the left and right extremities respectively. The 
recombination module of ICESe2 encodes a single serine recombinase (284 amino acids) 
and has homology (64%-43% amino acid sequence identity) to the N terminal regions (first 
277-303 amino acids) of similar proteins in ICE MGAS 10750-RD.2, CDTn2 and CDTn5, 
and also TndX (533 amino acids, 43% amino acid sequence identity), which is responsible 
for the integration and excision of the conjugative transposon Tn5397 (Wang et ai., 2000). 
The sequence and annotation of ICESe2 has been submitted to GenBanklEMBL with the 
accession number AM909652. 
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Figure 3.2 Comparison of ICESe2 with the conjugative transposons CDTn2 and CDTn5 
of C. difficile Strain 630 (Sebaihia et ai., 2006) and Tn1549 from E. faecalis (Garnier et 
ai. , 2000) 
Figure reproduced with kind permission from Matt Holden (displayed using ACT (Carver 
et ai. , 2005)). Grey bars represent the forward and reverse strands of DNA. The red lines 
between the elements represent protein similarity (TBLASTX). CDSs involved in similar 
function are given the same colour: pink, conjugal transfer and integration and excision; 
blue, regulation; white, secondary metabolism; green, transport; red, accessory function. 
The gene names of Tn1549 are shown on top. The genes encoding the equibactin NRPS 
are shown in white and those encoding the ABC transporters associated with the equibactin 
locus are shown in green. 
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Figure 3.3 Comparison of ICESe2 with the MGAS10750-RD.2 ICE of S. pyogenes 
MGAS10750 
Alignment displayed using ACT. The Se4047 genome region encoding ICESe2 is shown 
on the bottom and the S. pyogenes genome region encoding MGAS10750-RD.2 ICE 
(Beres & Musser, 2007) is shown on the top. Grey bars represent the forward and reverse 
strands of DNA with numbering in between to indicate genome location. The blue (and 
red) lines between the elements represent protein similarity (TBLASTX, cut-off score of 
75). CDSs involved in similar function are given the same colour: pink, conjugal transfer 
and integration and excision (* putative serine recombinase); blue, regulation; white, 
secondary metabolism; green, transport; red, accessory function; majenta, erythromycin 
and putative spectinomycin resistance; grey, hypothetical and unclassified; brown, pseudo-
or partial gene. The MGAS10750-RD.2 ICE carries genes encoding erythromycin 
resistance, putative tetronasin resistance and putative spectinomycin resistance. ICESe2 
encodes equibactin NRPS biosynthetic genes and associated transporters. 
The 'cargo' region between the conjugation and recombination modules that encodes 
vancomycin and erythromycin resistance in Tn1549 and ICE MGAS10750-RD.2, 
respectively, carries transport genes of unknown function in CDTn2/5 and CDSs in 
ICESe2 with most overall similarity to the NRPS cluster 1 of Clostridium kluyveri, which 
is proposed to biosynthesise a putative siderophore (Seedorf et aI., 2008) (Figure 3.4). 
Several of the encoded proteins were also similar to the NRPS complex of Yersinia sp. that 
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produces the ferric iron-binding siderophore yersiniabactin. Therefore, I hypothesised that 
the ICESe2 cargo region which contains the 'eqb' gene cluster is responsible for the 
biosynthesis of a novel thiazoline-containing non-ribosomal peptide that I have tentatively 
named 'equibactin' although it is possible that the product from this NRPS could be 
identical to previously identified molecules. The eqb cluster contains 14 coding sequences 
(eqbA-N), the putative functions of which include a DtxR-like repressor (eqbA), non-
ribosomal peptide biosynthetic proteins (eqbB-G, eqbMN), a ferric-siderophore-like 
importer (eqbH-J) and ABC transporters (eqbKL) (Figure 3.SA). 
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Figure 3.4 Comparison of the ICESe2 NRPS cluster with NRPS cluster 1 in C. kluyveri 
strain DSM555 
Alignment displayed using ACT. The C. kluyveri NRPS cluster 1 (Seedorf et ai., 2008) is 
shown on top and includes 9 CDSs putatively involved in non-ribosomal peptide 
biosynthesis (CKL_1503 to CKL_151l) and 5 downsteam putative ABC transporter CDSs 
(CKL_1512 to CKL_1517). The putative functions of 10 CDS immediately downstream 
of CKL_1517 (not shown) include a multi-antimicrobial extrusion (MATE) family 
drug/sodium anti porter (CKL_1518), a hypothetical protein (CKL_1519), a 
glycosyltransferase (CKL_1520), an ATPase (CKL_1521) and a membrane protein 
containing 12 predicted TMHs (CKL_1522), followed by a PKS gene cluster (CKL_1523 
to CKL_1527, cluster 2 (Seedorf et ai., 2008». The ICESe2 NRPS cluster is shown on the 
bottom and includes an upstream regulator (eqbA, SEQ1246), 8 CDS involved in non-
ribosomal peptide biosynthesis [eqbB (SEQ1247) to eqbG (SEQ1240), eqbM (SEQ1234) 
to eqbN (SEQ1233)] and 5 downstream ABC transporter CDSs [eqbH (SEQ1239) to eqbL 
(SEQ1235)]. Grey bars represent the forward and reverse strands of DNA with numbering 
in between to indicate genome location. The blue lines between the elements represent 
protein similarity (TBLASTX, cut-off score of 75). CDSs involved in similar function are 
given the same colour: blue, regulation; white, non-ribosomal peptide biosynthesis; green, 
transport; grey, hypothetical or unclassified. Putative functions of CDS are indicated. 
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Figure 3.5 The equibactin locus and predicted functions of the eqb gene products 
(A) Predicted functions of CDSs in the ICESe2 eqb cluster (IdeR, iron dependent regulator; 
Te, type-II thioesterase; ppt, 4' -phosphopantetheinyl transferase; A, salicylate-AMP ligase; 
NRPS, non-ribosomal peptide synthetase; Red, thiazoline reductase; P, permease 
(component of ABC transporter); ATP, ATPase (component of ABC transporter); ABC, 
ABC transporter; Re, putative oxidoreductase; alB, putative alB hydrolase). See Table 3.2 
for homology to other NRPS systems and transporters. (B) Organisation of modules and 
domains in the Eqb NRPS (ArCP, aryl acid carrier protein; Cy, heterocyclisation; A, 
adenylation; E, epimerization; PCP, peptidyl carrier protein; MT, methyl transferase; Te, 
type-I thioesterase. (C) Proposed intermediates in equibactin biosynthesis. 
The prevalence of the equibactin locus in diverse S. equi and S. zooepidemicus populations 
was determined by Southern blot with a probe specific to the eqbN gene and PCR of the 
eqbE gene using primers listed in Table 3.1. The eqbN and eqbE genes were detected in 
18 of 18 S. equi isolates but 0 of 73 S. zooepidemicus isolates. In addition, the location of 
the ICESe2 as determined by Southern blot (Figure 3.6) and PCR across flanking regions 
was identical in all 18 S. equi strains. Chapter 2 also describes the use of PCR to screen 12 
more S. equi isolates (all positive) and another 102 S. zooepidemicus isolates (all negative) 
for the presence of the eqbE gene. 
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Figure 3.6 Southern blot showing the prevalence of the eqbN gene in diverse S. equi and 
S. zooepidemicus isolates 
DNA was probed with a DIG-labelled 317 bp eqbN-specific DNA probe generated by 
PCR. M: DIG-labelled DNA molecular weight marker II (Roche Applied Science). See 
Appendix Table A.4 for details of strains tested. 
3.4.2 Functions of the equibactin gene cluster as predicted by genetic analysis 
Dissection of the modular structure revealed a remarkable similarity between the C. 
kluyveri, yersiniabactin and equibactin NRPS systems (Table 3.2). Yersiniabactin, a 
siderophore produced by Yersinia sp., is composed of one salicylate and 3 thiazoli( di)ne 
heterocycles derived from cysteine. A PKS module links the 2nd and 3rd heterocycles with 
a methylated malonyl-CoA derived linker (Miller et al., 2002). The NRPS system of C. 
kluyveri is predicted to synthesise a similar aryl-capped siderophore containing salicylate 
and 4 thiazoli(di)ne rings derived from cysteine (Seedorf et al., 2008). Siderophore 
activity has been demonstrated in the supernatant of C. kluyveri, but the biosynthetic 
cluster(s) responsible for siderophore production has not yet been established (Seedorf et 
al., 2008). In Se4047, the first of the two peptide synthetases, EqbE, shares 45% and 30% 
aa sequence identity with CKL_1505 and HMWP2, respectively, while EqbG shares 25% 
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aa sequence identity with CKL_1511 and HMWP1 (Table 3.2). Analogous to the 
characterised HMWP1 and HMWP2, EqbG and EqbE are comprised of 4 carrier domains, 
3 cyclisation domains, an epimerisation domain, a single adenylation domain, a 
methyltransferase domain and a type-I thioesterase domain (Figure 3.5B). The EqbG 
protein has 1272 amino acids, but lacks the N-terminal 1895 amino acids of HMWP1 
involved in polyketide synthesis (Miller et aI., 2002). EqbC shares 23% amino acid 
identity with CKL_1523 (Table 3.2). Although lacking sequence homology, eqbC like 
ybtD, which is located outside of the Y. pestis HPI (Bobrov et aI., 2002) encodes a putative 
4'-phosphopantetheinyl transferase. EqbM shares 31 % amino acid identity with 
CKL_1509 of C. kluyveri (Seedorf et al., 2008) and aligned to the Pfam Saccharopine 
dehydrogenase family, a member of the FAD/NAD(P)-binding Rossmann fold superfamily -'-
of redox enzymes. EqbN, a putative membrane protein has a predicted N-terminal 
transmembrane helix and shares 31 % amino acid identity with a hypothetical protein 
Csac 2163 of Caldiceliulosiruptor saccharolyticus. EqbN and Csac_2163 aligned to the 
Pfam aJ~ hydrolase family of enzymes that contain a catalytic triad associated with diverse 
catalytic activity (Table 3.2). 
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Table 3.2 BLASTPIFASTA analysis of the eqb cluster 
Match by FASTAIBLASTP analysis 
S. CDS Amino Function Organism Accession Reference 
equi acid no. 
CDS sequence 
identity 
% 
EqbA gbs1749 42 Putative repressor S. agaiactiae Q8E3K9 (Glaser et 
serotype III al.,2oo2) 
CKL_1082 40 Putative repressor C.kiuyveri ASN743 (Seedorf et 
ai., 2008) 
MntR 33 Manganese- B. subtilis P54512 (Que & 
dependant repressor HeImann, 
2000) 
DtxR 28 Iron-dependant C. diphtheriae P33120 (Qiu et al., 
reEressor 1996~ 
EqbB CKL_1503 52 Thioesterase C. kiuyveri ASN8B4 (Seedorf et 
al.,2008) 
PchC 34 Thioesterase P. aeruginosa P72176 (Serino et 
(pyochelin al.,1997) 
biosythesis) 
ybtT 31 Thioesterase Y. pestis Q56949 (Bearden et 
(yersiniabactin ai., 1997) ',,-
biosl::nthesis) 
EqbC GSP 27 4'-phospho- Bacillus miguianus P40683 (Lambalot 
pantetheinyl- etai., 
transferase 1996) 
Sfp 25 4'-phospho- B. subtilis P39135 (Quadri et 
pantethein yI- al., 1998) 
transferase 
CKL_1523 23 Putative 4'-phospho- C. kiuyveri A5N8D4 (Seedorf et 
pantetheinyI- ai., 2008) 
transferase (S!E) 
EqbD CKL_1504 55 Putative salicyI- C. kiuyveri ASN8B5 (Seedorf et 
AMP ligase al.,2oo8) 
YbtE 42 Salicyl-AMP ligase Y. pestis Q56950 (Gehring et (yersiniabactin ai., 1998a) 
biosynthesis) 
DhbE 41 2,3-dihydroxy- B. subtilis P40871 (Mayetai., 
benzoate-AMP 2002) 
ligase (bacillibactin 
bios~nthesis) 
EqbE CKL_1505 45 NRPS (putative C. kiuyveri ASN8B6 (Seedorf et 
siderophore ai., 2008) 
biosynthesis) 
HMWP2 30 NRPS Y. pestis Q9Z399 (Gehring et (yersiniabactin ai., 1998b) 
biosynthesis) 
Irp2 30 NRPS (siderophore Photobacterium Q2HQW9 (Osorio et 
biosynthesis) damseiae subspecies al.,2oo6) 
e,iscicida 
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Table 3.2 continued 
Match by FASTAIBLASTP analysis 
Accession S. CDS Amino Function Organism Reference 
equi acid no. 
CDS sequence 
identity 
% 
EqbF YbtU 32 Thiazoline reductase Y. pestis Q9Z3C6 (Gehring et 
(partial) al.,1998a) 
CKL_1506 32 Putative NRPS C. kluyveri ASN8B7 (Seedorf et 
(partial) reductase al.,2008) 
CKL_151O 31 Putative NRPS C. kluyveri ASN8Cl (Seedorf et 
(partial) reductase al., 2008) 
Irp3 26 Putative P. piscicida Q2HQW7 (Osorio et 
(partial) oxidoreductase al., 2006) 
(siderophore 
biosynthesis) 
PchG 25 NADPH-dependent P. aeruginosa Q9HWG5 (Reimmann 
(partial) thiazoline reductase etal., 
(pyochelin 2001) 
biosxnthesis 2 
EqbG CKL_151I 25 NRPS (putative Clostridium kluyveri ASN8C2 (Seedorf et 
(partial) siderophore al., 2008) '-, 
biosynthesis) 
HMWPI 25 NRPSIPKS Y. enterocolitica 054511 (Pelludat et 
(partial) (yersiniabactin al., 1998) 
biosynthesis) 
PchF 29 NRPS (enantio- Pseudomonas A8U045 (Youard et 
(partial) pyochelin fluorescens al., 2007) 
bios x:nthesis) 
EqbH Cbei_3098 54 Putative membrane Clostridium A6LY05 
Erotein be ije rinckii 
EqbI Cbei_3097 34 Putative cobalt C. beijerinckii A6LY04 
transport membrane 
protein 
CKL_1516 24 Putative transporter C. kluyveri ASN8C7 (Seedorf et 
(membrane Erotein) al., 2008) 
EqbJ Cbei_3096 48 putative ABC C. beijerinckii A6LY03 
transporter ATPase 
CKL_1517 45 Putative ABC C. kluyveri ASN8C8 (Seedorf et 
transE0rter ATPase al., 20082 
EqbK SAS2320 55 putative ABC S. aureus Q6G6P2 (Holden et 
transporter (ATPase al.,2004) 
and permease) 
Cbei_3094 48 Putative ABC C. beijerinckii A6LYOI 
transporter (ATPase 
and permease) 
CKL_1512 42 Putative ABC C. kluyveri ASN8C3 (Seedorf et 
transporter (ATPase al., 2008) 
and permease) 
YbtP 29 (no Yersiniabactin Y. pestis Q9ZGOI (Fetherston 
match in importer etal., 
Nterm69 1999) 
aa) 
Y. pestis Q9Z375 (Fetherston YbtQ 29 (no Yersiniabactin 
match in importer et al., 
Nterm 1999) 
109 aa) 
167 
Table 3.2 continued 
Match by FASTAIBLASTP analysis 
S. CDS Amino Function Organism Accession Reference 
equi acid no. 
CDS sequence 
identity 
% 
EqbL SAS2319 57 Putative ABC S. aureus Q6G6P3 (Holden et 
transporter aI.,2oo4) 
Cbei_3093 46 Putative ABC C. beijerinckii A6LYOO 
transporter (ATPase 
and permease) 
CKL_1513 40 Putative ABC C. kluyveri ASN8C4 (Seedorf et 
transporter (ATPase aI.,2oo8) 
and permease) 
YbtP 28 (no Yersiniabactin Y. pestis Q9ZGOI (Fetherston 
match in importer etat., 
Nterm 1999) 
109 aa) 
YbtQ 30 (no Yersiniabactin Y. pestis Q9Z375 (Fetherston 
match in importer etat., 
Nterm 1999) 
125 aa) 
EqbM CKL_1509 31 unknown C. kluyveri A5N8CO (Seedorf et 
(Eartial) ai., 2oo82 
EqbN Csac_2163 31 unknown C. saccharolyticus A4XLGO 
~artiaQ 
The 3 predicted ABC transporters encoded by eqbHIJ, eqbK and eqbL are homologous 
(34-54% aa sequence identity) to the unknown ABC transporters in Clostridium 
beijerinckii (Cbei_3098, Cbei_3097, Cbei_3096, Cbei_3094 and Cbei_3093, respectively) 
(Table 3.2) and in C. difficile encoded on CDTn2 (Figure 3.2, CD0429, CD0430, CD0431, 
CD0432, CD0433, 26-38 % amino acid sequence identity). In addition, EqbI, EqbJ, EqbK 
and EqbL share 24% to 45% amino acid identity with the putative C. kluyveri proteins 
CKL 1516 CKL 1517 CKL_1512 and CKL_1513, respectively (Seedorf et al., 2008) 
- , - , 
(Table 3.2). Closer homologues to EqbK and EqbL include SAS2320 and SAS2319 in S. 
au reus (Holden et al., 2004) (55 to 57% amino acid sequence identity) (Table 3.2). 
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Figure 3.7 Organisation of membrane spanning and ATP-binding domains in the eqb 
ABC transporters 
Predicted TMHs are shown in white (a possible TMH is bordered by dashed lines); ATP-
binding domains are shown in green. 
Like ABC-type importers, the putative EqbHIJ transporter has transmembrane and ABC 
subunits as distinct polypeptide chains (Miethke & Marahiel, 2007) (Figures 3.SA, 3.7). 
eqbH and eqbJ encode 2 permease domains containing 6 and 3 to 4 putative TMHs, 
respectively, whilst 2 ATP-binding components are encoded by eqbJ (Figure 3.7). 
However, no extracytoplasmic substrate binding protein CDS is apparent in the eqb cluster. 
Gram-positive bacteria tend to use a lipoprotein to scavenge the appropriate substrate and 
deliver it to the membrane channel of the associated ABC transporter. EqbI has a 
hydrophilic region located between the 3rd and 4th TMHs (Figure 3.7) that could potentially 
function as an extracellular substrate binding domain, although this region shows no 
homology to known ligand binding subunits. The cobalt uptake system of S. typhimurium 
represents a novel class of ATP-binding transporters that use extracytoplasmic regions 
within small integral membrane proteins (CbiN in S. typhimurium) to capture specific 
substrates (Rodionov et al., 2006; Rodionov et ai., 2009). Other chimeric glycine betaine 
and glutamate/glutamine ABC transporters, which are widespread among Gram-positive 
bacteria, have fused substrate binding domains at the N or C terminus of translocator 
moieties (van der Heide & Poolman, 2002). Alternatively, the hydrophilic C-terminal 
region of EqbI may form a cytoplasmic loop and possible contact site for ATP-binding 
proteins (Davidson & Chen, 2004; Rodionov et ai., 2006). Most of the EqbI protein aligns 
poorly to the Pfam HMM of CbiQ and various other cobalt transport proteins (PF02361, 
score 0.00031). Although EqbI generally shares poor amino acid sequence identity with 
the Pfam members containing this domain, including CbiQ (12% identity), the domain 
organisation is similar. CbiQ is an unessential transmembrane component of the cobalt 
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uptake transport system in S. typhimurium, which also contains a possible cytoplasmic loop 
between the 4th and 5th predicted TMHs (Davidson & Chen, 2004; Rodionov et al., 2006). 
EqbK and EqbL, on the other hand, have a fused N-terminal permease and C-terminal 
ATPase, which would normally suggest involvement in efflux of extracellular toxins 
(Figure 3.7) (Chang & Roth, 2001; Chang, 2003; Dawson & Locher, 2006; Saurin et al., 
1999). Generally efflux ABC transporters possess 6 TMHs in each permease domain 
(Miethke & Marahiel, 2007); EqbK and EqbL contain 5 and 6 predicted TMHs, 
respectively (Figure 3.7). EqbK and EqbL may form the 2 chains of a single ABC 
transporter (heterodimer), or alternatively form 2 homodimeric ABC transporters. EqbK 
and EqbL are similar to the ABC transporters of Y. pestis (YbtP and YbtQ) and M. 
tuberculosis (IrtA and IrtB), which also have fused N-terminal permease and C-terminal 
ATPase domains typical of efflux systems. However, YbtP, YbtQ and IrtB function as 
ferric-siderophore importers (yersiniabactin and carboxymycobactin) rather than exporters 
and are therefore structurally unique among the subfamily of ABC transporters associated 
with iron transport (Farhan a et al., 2008; Fetherston et al., 1999; Rodriguez & Smith, 
2006). YbtP/YbtQ, and IrtA/IrtB were presumed to forms heterodimers (Fetherston et al., 
1999; Rodriguez & Smith, 2006) but IrtA and IrtB have recently been shown to form 
separate homodimers, with IrtA functioning as an exporter of apo-carboxymycobactin, not 
an importer of ferric-siderophore as previously thought (Farhana et al., 2008). EqbK 
shares 29 to 27% amino acid sequence identity with YbtP and IrtA (not including the N-
terminal 262 amino acids), respectively; EqbL shares 29 to 25% amino acid sequence 
identity with YbtQ and IrtB, respectively. EqbK and EqbL share 29% amino acid 
sequence identity with each other. These ABC transporters all show most homology in 
their C-terminal halves that encode the ATP-binding domain and contain.the characteristic 
walker A, walker B and ABC transporter signature motifs. The N-terminal membrane 
components are more diverse, even when compared to each other (e.g. EqbK vs EqbL). 
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YbtP, YbtQ, IrtB, EqbK and EqbL are all similar in size (approximately 600 amino acids) 
but IrtA, which is larger, encodes an additional substrate binding domain in its N-terminal 
region (-260 amino acids). A siderophore interaction domain fused to the ABC transporter 
is an unusual feature. This particular domain is likely to be exposed on the intracellular 
surface and involved in scavenging the apo-carboxymycobactin to deliver it for export 
(Farhana et al., 2008). No periplasmic/extracellular siderophore binding proteins are 
encoded in the irt/ybt clusters but IrtB is predicted to use Rv2985c, encoded elsewhere in 
the M. tuberculosis genome to bind ferric-carboxymycobactin (Farhana et al., 2008; 
Fetherston et al., 1999). 
3.4.3 Substrate predictions 
An important characteristic of the equibactin and yersiniabactin biosynthetic clusters is the 
presence of a single A-domain in HMWP2IEqbE that is probably responsible for the 
aminoacylation of all 3 different PCP domains (2 in HMWP2IEqbE and one in 
HMWPIIEqbG), 2 of which are not linked physically to the A-domain. By comparison to 
the GrsA APhe prototype, critical residues lining the substrate-binding pocket of the EqbE 
A-domain active site were identified (Challis et aI., 2000; Stachelhaus et al., 1999) and 
found to match those mediating cysteine recognition with the exception of a change from 
asparagine to aspartate at residue 278 (Table 3.3). The C. kluyveri NRPS cluster has 2 
putative cysteine-activating A-domains (Table 3.3) likely to aminoacylate 4 PCP domains, 
2 of which are not linked physically to an A-domain. 
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Table 3.3 Prediction of EqbD and EqbE A-domain substrate specificity 
Residue (according to APhe numbering) 
A-domaina Substrate 235 236 239'" 278 299 301 322 330'" Accession 
number 
HMWP2 Cys D L Y N M S M I Q9Z399 
BacA Cys D L Y N L S L I 068006 
AngR Cys D L Y N M S M I P19828 
PchE Cys D L .F N L S L I Q9RFM8 
PchF Cys D L Y N L S L I Q9RFM7 
CtaC Cys D L Y N M S L V Q5MD35 
MtaC Cys D L Y N M S L I Q9RFK9 
BlmIV Cys D L Y N L S L I Q9FB18 
CKL_1505 Cys? D L Y N L S M I A5N8B6 
CKL_1511 Cys? D L Y N L S L I A5N8C2 
EgbE Cy"s? D . L y . .D .M .. S M I 
DhbE DHB N Y S A Q G V V P40871 
EntE DHB N Y S A Q G V V P10378 
MxcE DHB N F S A Q G V V Q9F638 
VibE DHB N F S A Q G V V 007899 
AngE DHB N F S A Q G V V Q5DK17 
YbtE Sal N F C A Q G V L Q56950 
PchD Sal N F C A Q G V I Q9RFM9 
CKL_1504 Sal? K F C A Q G L I A5N8B5 
EgbD Sal? N F C G Q G I I 
SnbA 3-hydroxy- N F C S Q G V L P95819 
picolinic 
acid 
The predicted amino acid sequence between core A4 and A5 sequence motifs of the EqbE 
A-domain and EqbD were aligned, using CLUSTALW, to A-domains or aryl-amp ligase 
homologues with> 30 % sequence identity to EqbE or EqbD, respectively (Stachelhaus et 
aI., 1999). Based on the structural data of DhbE and GrsA, residues conferring substrate 
specificity were identified (May et aI., 2002; Stachelhaus et aI., 1999). * Amino acids at 
positions 239, 330 discriminate salicylate from DHB (May et al., 2002). S. equi residues 
defined in bold differ from the consensus code of characterised substrate activating 
proteins. a Protein name; HMWP2, yersiniabactin-NRPS, Y. pestis (Gehring et al., 1998b); 
BacA, bacitracin NRPS, Bacillus licheniformis (Konz et ai., 1997); AngR, anguibactin 
NRPS, V. anguillarum (Tolmasky et al., 1993); PchE and PchF pyochelin NRPSs, P. 
aeruginosa (Quadri et ai., 1999); CtaC, cystothiazole A NRPS, Cystobacter fuscus (Feng 
et aI., 2005); MtaC, myxothiazol NRPS, Stigmatella aurantiaca (Silakowski et al., 1999); 
BlmIV, bleomycin NRPS, Streptomyces verticillus (Du et ai., 2000); CKL_1505 and 
CKL_1511, C. kluyveri (Seedorf et ai., 2008); DhbE, bacillibactin DHB-AMP-ligase, B. 
subtilis (May et al., 2002); EntE, enterochelin synthase, E. coli (Gehring et al., 1997); 
MxcE, myxochelin DHB-AMP-ligase, S. aurantiaca (Silakowski et al., 2000); VibE, 
vibriobactin DHB-AMP-ligase, V. cholerae (Wyckoff et al., 1997); AngE, anguibactin 
DHB-AMP-ligase, V. anguillarum (Alice et al., 2005); YbtE, yersiniabactin salicyl-AMP-
ligase, Y. pestis (Gehring et al., 1998b); PchD, pyochelin salicyl-AMP-ligase, P. 
aeruginosa (Quadri et ai., 1999); CKL_1504, C. kluyveri (Seedorf et al., 2008); SnbA, 
pristinamycin I 3-hydroxy-picolinic acid-AMP-ligase, Streptomyces pristinaespiralis (de 
Crecy-Lagard et ai., 1997). 
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EqbD shares 42% amino acid identity to the YbtE salicylate-AMP ligase (Gehring et al., 
1998a), 41 % sequence identity with DHB AMP ligase, DhbE (May et al., 2002) and 55% 
amino acid identity with the uncharacterised CKL_1504 of C. kluyveri (Seedorf et aI., 
2008). The adapted specificity conferring code for aryl acid activating domains 
discriminates between DHB and salicylate activating enzymes (May et al., 2002). EqbD 
and CKL_1504 are predicted to activate salicylate since they both have a cysteine at 
position 239, which would impede access of the 3' -OH group of DHB and a more 
sterically demanding isoleucine at position 330 that replaces the conserved valine in DHB-
activating enzymes (Table 3.3). However, a small change in EqbD from alanine to glycine 
was identified relative to residue 278 according to GrsA Aphe-numbering, which differs 
from other NRPS systems that utilise salicylate. CKL_1504 has a lysine residue in place 
of the usual asparagine at position 235, which forms bivalent hydrogen bonds to the 2'-
and 3' -OH groups of DHB in DhbE (May et aI., 2002). 
3.4.4 Proposed mechanism of equibactin biosynthesis 
3 condensation (C) domains identified in the 2 peptide synthetases, EqbE and EqbG are 
strongly modified, diverging from classical C domains involved in peptide bond formation. 
Instead, C-domains shared highest homology (29 to 32% amino acid sequence identity) 
with cyclisation (Cy) domains that catalyse thiazoline ring formation in yersiniabactin and 
bacitracin biosynthesis (Bobrov et aI., 2002; De Crecy-Lagard et aI., 1995; Konz et ai., 
1997) or are predicted to catalyse similar heterocyclisation reactions in the uncharacterised 
NRPS system of C. kiuyveri (24 to 57% amino acid sequence identity). 7 signature regions 
identified in Cy domains of Y. enterocolitica (yersiniabactin), B. licheniformis (bacitracin) 
and V. anguilla rum (anguibactin) by (Konz et ai., 1997), were also mostly conserved in the 
3 putative Cy domains of EqbE and EqbG (Figure 3.8) and the 4 putative Cy domains of 
the C. kiuyveri NRPS system (data not shown). Some differences in these sequence 
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alignments were apparent although the contribution of residues in these regions to catalytic 
activity is not yet known. However, the highly conserved Cy motif DXtDX2S that 
corresponds in location to the highly conserved condensation domain catalytic core, 
HHX3DGXS (Keating et al., 2000; Konz et al., 1997) is present in all 3 putative Cy 
domains of S. equi (Figure 3.8) and the 4 putative Cy domains of the C. kluyveri NRPS 
system (data not shown). This suggests an involvement of these putative Cy domains in 
heterocyc1isation activity since the two asparate residues of this Cy core are essential to 
both amide bond formation and heterocyc1isation by Cy1 of HMWP2 in Y. pestis (Keating 
et al., 2000). 
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HMWP2_ 2 
HMWP1 1 
HMWP2_ 1 
EqbE_ 1 
EqbE_2 
EqbG 1 
GrsA 
HMWP2_ 2 
HMWP1 1 
HMWP2 1 
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EqbE_ 2 
EgbG 1 
GrsA 
HMWP2_ 2 
HMWP1 1 
HMWP2_ 1 
EqbE_ 1 
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HMWP2_ 2 
HMWP1_1 
HMWP2_ 1 
EqbE_ 1 
EqbE_ 2 
EgbG 1 
GrsA 
HMWP2_ 2 
HMWP1_ 1 
HMWP2_ 1 
EqbE_ 1 
EqbE_ 2 
EqbG 1 
GrsA 
HMWP2_2 
HMWP1 1 
HMWP2 1 
EqbE_ 1 
EqbE_ 2 
EqbG 1 
GrsA 
Cy1 Cy2 
fpLt . . Qxa . 1.gr ...... ggv ... .. . EF 1 . . rHp . 1 
FALTDVQQAY LVGRQPGFALGGVGSHFFVEFEI--ADLDLTRLETVWNRL IARHDMLRAI 58 
FP LTPIQHAYWLGRTH LIGYGGVACHVLFEWDKRHDEFDLAILEKAWNQL IARHDMLRMV 60 
FPLTPVQHAY LTGRMPGQTLGGVGCH LYQEFEGH--CLTASQLEQAITTLLQRHPMLHIA 58 
,'DL' DVQY '" YI GREDDQ LGGVGCHAYLE DGE--N IDEDKLKEAWNK LQYRHPMLRTK 58 
,'DL TDVQHAYYVGRNKDMI LGGVSTHCYFE.IESS--DIDVNKLEKAWNY L IKIHPMLRAI 58 
LPLTE.QSAYLLGRRNHFELGGVASHVYMEVILP--LLDIDRAEKVWND I:LKHDALHSI 58 
IGLTPIQHWFFEQQFTNMHHWNQSYMLYRPNGFD-----KEILLRVFNKIVEHHDALRMI 55 
VGYVDGMPARLWLCL JN L 1 I,DGLSMQILLAELE----HGYRYPQQLLPPLPVTFRDYLQQ 165 
VSEIDDCHYRLHMNLDI LQrDVQS FKVMMDDLA----QVWRG--ETLAPLAITFRDYVMA 172 
LTLLPDNRHRLHVNI DLI IMDASSFTLFFDELN----ALLAGESLPAIDTRYDFRSYLLH 172 
LAKFSDEKSRIFFDVDLLVSDVMSMSIMIKELA----ELYSG-VELDNLNEYTFKDYMQN 171 
I SKREDKADIIHISFDN LDGWSMFFILEQWS----NIYKYGKYEEAINEISFREYVNY 162 
VSQLDD- NSLLHLSFDFLILDWAS IWILLKEFE----ECYFDGKTIMDN- SYDLKEIRTS 165 
LFHTQNG-DHLFMAI ' I VVDG SWRILFEDLATAYEQAMHQQTIALPEKTDSFKDWSIE 173 
Cy3 
P . . p.LP . ... p 
PSLQ---SPNPDSLAWWQAQLDDI PP- APA LPLRC LPQEVETPRFARLNGALDSTRWHRL 221 
EQARRQTSAWHDAWDYWQEKLPQLP L-APELPVVETP--PETPHFTTFKSTIGKTEWQAV 229 
QQKIN-QPLRDDARAYWLAKAST LPP- APV LP LACEPATLREVRNTRRRMIVPATRWHAF 230 
---GIGESINDADKEFWEQKINSFEIERPNLPLRKQPEQIKETKFTRRKRIIKKSEWETI 228 
INKLKSTPKYFTDKEYWINRIEGFLK-APIISDYYPKTTSKQIKFSRREAYIEPLRWKSL 221 
QLKLKHSSKYLSDKDFWERRIPFLPD- APLLP--- IK NKIVKNGFERIQLRIDENTWSKI 221 
LEKYANSELFLEEAEYWHHLNYYTENVQIKKDYVTMNNKQKNIRYVGMELTIEETEK-LL 232 
Cy4 Cy5 
TP ... L .. . . .. vL .. W gd FT .. 
KKRAADAHL TPSAV LLSVWSTVLSAWSAQPEFTLNLTLFDRRPLHP--QINQILGDFTS L 279 
KQRWQQQGVTPSAALLTLFAAT LERWSRTTTFTLNLTFFNRQPIHP--Q INQLIGDFTSV 287 
SNRAGEYGVTPTMALAT FSAV LARloJGGLTRLLLNITLFDRQPLHP--AVGAMLADFT NI 288 
KDIAASYRS TPSMVL l TAYALVLERWCNQDKFFINIPLFNRDLENE--NLKEMVADFTNI 286 
KNIASKNNL'~"'SLl GAYAEA REVSLNENFTINVTRFNRPQING--KTNSTLGDFTNL 279 
KSNI SE IGV,'QTSFLVT I LALVLNRWSSNSEFTIN LTTMNRPKEYI - - KS - DVVNDFTST 278 
KNVNKAYRTEINDILLTALGFALKEWADIDKIVINLEGHGREEILEQMNIARTVGWFTSQ 292 
Cy6 
.L1 P.vFtS 
MLLSWHPGE--SWLHSAQSLQQRLSQNLN HRDVSAIRVMRQLAQRQNVPAVP- MPVVFTS 336 
TLVDFNFSAPVTLQEQMQQTQQRLWQNMAHSEMNGVEVIRELGRLRGSQRQPLMPVVFTS 3 47 
LLLDTACDG- DTVSNLARKNQLTFTEDWEHRHWSGVELLRELKRQQR- - YPHGAPVVFTS 3 45 
LLVEHEAVDDSNFLDNLKRINKTFLENVSHSEYNGVQVQRDISKKQG- TSVYIAPVVFAC 3 45 
LLl EI NNSKHEKILDRFREIQGQLIEDLSHELFSGIEMQKELRKIEK-DNLVLMP IVFTS 338 
C:LLEFRMESLQPFYVLLKHIQQQMIEDLQHETFTGVEVTREVRKNVE- RRDAIFPFVFTS 337 
YPVVLDMQKSDDLSYQIK LMKENLRRIPNKGIGYEIFKY LTTEYLRPV LPFTLKPEINFN 352 
Cy7 
. L w .. • q .. qv . . d ... . e . . g .. . .. WD 
ALGFEQD----NFLARRNL----- --- -LKPVWGISQTPQVWL DHQIYESEGE LRF NW DF 383 
MLGMTLEGMTIDQAMSHLF------ - --GEPCYVFTQTPQVWLDHQVMESDGELMFSWYC 398 
NLGRSLY----SSRAESPL----- ----GEPEWGISQTPQVW IDHLAt'EHHGEVW LQWDS 392 
N DYPLE----TEFSRKNL--------- GKVSYM SQ"PGVWLDFQTY IVDGDLI LCWD S 392 
GJ GINSWD------ DDERL---- - ---- GKIVYGLSQTPQVFLDNQVFVYNDGLKIYWDS 383 
AI GIKAS-------EYKYI-- -------SLQKEGLSETPQVLMDCQVMEVNHELIINFDL 381 
YLGQFDTDVKTELFTRSPYSMGNSLGPDGKNNLSPEGESYFVLNINGFIEEGKLHITFSY 412 
Figure 3.8 Bioinformatic prediction of eqb NRPS substrates 
CLUSTALW alignment of amino acid sequences of the putative Cy domains of EqbE, 
EqbG S. equi, HMWP1 , HMWP2 Y. pestis and the classical condensation domain of GrsA 
B. brevis (below line). Highlighted areas (red: S. equi, blue: Y. pestis) represent the 7 
conserved signature sequences (C1-C7) with the consensus shown above (Konz et ai., 
1997). The DNDX2S catalytic core containing the 2 aspartate residues critical to amide 
bond fonnation and heterocylization (Keating et ai. , 20(0) is shown in green. The 
lllIX3DGXS catalytic core of classic condensation domains is shown in purple for GrsA 
(Konz et ai. , 1997) . 
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The presence of a putative thiazoline reductase (EqbF) with 32% amino acid identity with 
YbtU (Gehring et al., 1998a) and 32% and 31 % amino acid identity with CKL_1S06 and 
CKL_1S1O of C. kluyveri, respectively (Seedorf et aI., 2008), supports a prediction of 
thiazoline rings in the chemical structure of equibactin (Table 3.2). Thiazoline rings of 
yersiniabactin and pyochelin are reduced to thiazolidine by the activity of these thiazoline 
reductase enzymes (Miller et al., 2002; Patel & Walsh, 2001). These enzymes also have a 
methyl transferase module, which although apparently non-functional in yersiniabactin 
biosynthesis, introduce a methyl group to the N-atom of the thiazolidine residue in 
pyochelin (Miller et aI., 2002; Patel & Walsh, 2001). A prediction of the NRPS 
intermediates is presented in Figure 3.SC. 
Non-ribosomal peptides are usually released from the last carrier domain in the assembly 
line through the activity of a terminal thioesterase (type-I) (Challis & Naismith, 2004). 
The C-terminal domain of EqbG has similarity with type-I thioesterases. However, 
sequence alignment ofthis domain to thioesterases in Pfam showed a S 1092 to A mutation 
in the critical serine residue (GXSXG-motif) of the predicted serine, histidine, aspartate 
catalytic triad essential for function (Bobrov et al., 2002; Reimmann et aI., 2004). The 
terminal thioesterase of CKL_lS11 (c. kluyveri) has an unusual GYSFSG motif, but the 
critical serine residue is conserved. Alignment of the type-II thioesterase encoded by eqbB 
showed an intact catalytic triad. 
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3.4.5 Regulation of the eqb NRPS 
Upstream of the eqb operon is a CDS predicted to encode a putative metal ion dependent 
repressor,EqbA Close homologues of eqbA and eqbD gene products are present in the 
genome of S. agaiactiae serotype III NEM316, although the latter gene appears to be a 
pseudogene in this GBS. EqbA is predicted to have the characteristic N-terminal DNA 
binding, central metal ion binding and dimerisation domains of the MntR and IdeR family 
of manganese and iron-dependent repressors to which it has 33% and 28% sequence 
identity, respectively (Que & HeImann, 2000; Schmitt & Holmes, 1991). DtxR, a member 
of the growing family of IdeR global iron-dependent regulators in Gram-positive bacteria 
is activated on binding of divalent iron. Subsequent binding of the homodimeric form to a 
21 bp DNA duplex blocks the transcription of downstream genes (Pohl et ai., 1999a; 
Schmitt & Holmes, 1991). A unique 36 bp incomplete palindrome (underlined) was 
identified in the promoter region of eqbB and represents a potential operator sequence for 
EqbA:-
5'-
AACTATTATTGTTAGATGIATCTAACAATAATAGTTCTAGTAGTATATTAATAATCAGATGGAAGGTGTTT 
TGATG-3' (-35, -10 promotor sites and the ATG translational start are highlighted in bold). 
To determine the role of EqbA on the regulation of the eqb NRPS, I generated a series of 
allelic replacement mutants in Se4047. Deletion of eqbE had no effect on the growth rate 
of S. equi on THA (Figure 3.9) or in THB (Figure 3.1OB). However, deletion of eqbA 
produced very small colonies (Figure 3.9) as a result of a much reduced growth rate 
(Figure 3.10A). I hypothesised that this phenotype resulted from iron toxicity resulting 
from over-production of the product(s) of the eqb cluster. Over-expression of eqbE was 
confirmed since deletion of eqbA resulted in a 13-fold increase in eqbE transcript levels 
(Figure 3.l1A). The generation of an AeqbA, AeqbE double deletion strain (AeqbAE) , 
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which had a large colony phenotype on THA, established that the slow growth of the 
!:1eqbA strain was as a direct consequence of the function of the eqbE gene product (Figure 
3.9). Transformation of the !:1eqbA or !:1eqbAE strains with the pGhost9 plasmid containing 
a 2nd copy of eqbA under the control of the eqbA promoter or a 2nd copy of eqbE under the 
control of the eqbB promoter complemented the !:1eqbA and !:1eqbE and induced a large or 
small colony phenotype, respectively (Heather et aI., 2008). The lack of an effect on the 
growth phenotype of S. equi grown in vitro following deletion of eqbE (Figures 3.9, 3.10) 
may be due to continued import of cations through the activity of several alternative cation 
transport systems, which include an HtsABC heme-binding system (SEQ0445 to 
SEQ0448) (Nygaard et aI., 2006), a putative MtsABC Mn2+ and Fe3+ metal transport 
system (SEQ1658 to SEQ1660) with 80 to 91 % amino acid sequence identity to that of S. 
pyogenes (Janulczyk et al., 1999) and a putative FtsABCD Fe3+ ferrichrome transport 
system (SEQ1836 to SEQ1839) with 59 to 77% amino acid sequence identity to that of S. 
pyogenes (Hanks et al., 2005). 
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Wild-type lleqbA lleqbAE lleqbHIJA lleqbKLA lleqbAMtsB 
TH 
TH .. 2mMNTA 
lleqbE llflsB lleqbHIJ lleqbKL 
TH 
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Figure 3.9 Influence of deletions in the eqb gene cluster on colony size 
Photographs show colonies of wild-type, tleqbA, tleqbAE, tleqbHIJA, tleqbKLA, 
tleqbAftsB, tleqbE, tlftsB, tleqbHIJ and tleqbKL, S. equi strains grown overnight on THA 
and the increase in colony size of the tleqbA, tleqbKLA and tleqbAftsB strains grown on 
THA supplemented with 2 mM NT A. 
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Figure 3.10 Effects of deletions in the eqb gene cluster on growth in THB 
Graphs show the change in mean optical density at 600 nm over time (± SEM, n = 3). (A) 
Graph shows the slow growth of l1eqbKLA, l1eqbA and l1eqbAftsB S. equi strains 
compared to the wild-type S. equi strain (using resuspended colony material as a starter 
culture). (B) Graph shows the similar growth rates of wild-type, l1eqbA, l1eqbAE, 
l1eqbHIJA, l1eqbKLA, l1eqbAftsB, l1eqbE, I1ftsB, l1eqbHIJ and l1eqbKL S. equi strains 
(using overnight THB culture as a starter culture). The growth rate was slightly reduced in 
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the lieqbAE and lieqbHIJA strains compared to wild-type, with mean doubling times (± 
SEM) of 73.5 min ± 2.1,79.5 ± 3.3 and 61.4 ± 0.7, respectively. 
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Figure 3.11 Phenotypic effects of deletions in the eqb gene cluster 
(A) Fold increase in eqbE transcript level in the lieqbA strain relative to the wild-type 
Se4047 strain, which has been normalised to one (mean ± SEM, n = 3). (B) Quantification 
of 55Fe accumulation by different S. equi strains (mean ± SEM, n = 3). The difference in 
55Fe accumulation between the lieqbA strain and the Ii eqbAE, lieqbHIJA and wild-type 
strains was found to be statistically significant using two-sample Wilcoxon rank-sum 
(Mann-Whitney) tests (P = 0.05, n = 3). (c) Quantification of 55Fe accumulation by S. 
equi strain lieqbAE cross-fed with filter-sterilised culture supernatant from different S. equi 
strains grown to stationary phase. 
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Further studies supported the hypothesis that the eqbA deletion phenotype resulted from 
increased iron uptake. Supplementation of THA with 2 mM NT A, a known chelator of 
iron, restored near normal colony size in the !:J.eqbA strain (Figure 3.9). Susceptibility to 
streptonigrin was used as an indirect measure of intracellular iron concentration (Brown et 
aI., 2002). Growth of wild-type S. equi was prevented by a minimal inhibitory 
concentration of 0.06 11M streptonigrin in THB. The !:J.eqbA mutant was 16 times more 
sensitive to streptonigrin, whilst strains predicted to be unable to produce the NRPS 
product(s) through deletion of the biosynthetic gene eqbE (!:J.eqbE and !:J.eqbAE) were 2 
times more resistant to the antibiotic (Table 3.4A). Interestingly, the SzH70 strain was also 
twice as resistant to streptonigrin compared to wild-type S. equi, which is consistent with 
the lack of an eqb cluster in this subspecies (Table 3.4A). There was no difference in 
susceptibility of these strains to the antibiotic erythromycin. Therefore, increased 
sensitivity of the !:J.eqbA mutant to streptonigrin compared to wild-type, !:J.eqbE or !:J.eqbAE 
strains suggests a greater intracellular iron pool in the former most likely as a result of de-
repression of eqb non-ribosomal peptide synthesis. Similar differences in streptonigrin 
sensitivity were conferred when the !:J.eqbAE mutant was cross-fed with filter-sterilised 
stationary-phase culture supernatant from the wild-type and various mutant strains (Table 
3.4B), consistent with an accumulation of iron being mediated by an excreted, soluble 
factor. 
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Table 3.4 Production of the eqb NRPS product(s) by allelic replacement mutants of 
Se4047 and SzH70 
A 
Strain Streptonigrin MIC (!lM) Erythromycin MIC (Jlg mrl) 
Wild-type 0.06 0.016 
tJ.eqbA 0.004 0.016 
tJ.eqbE 0.125 0.016 
tJ.eqbHIJ 0.06 0.016 
tJ.eqbKL 0.06 0.016 
tJ.ftsB 0.06 0.016 
tJ.eqbAE 0.125 0.016 
MqbHIJA 0.03 0.016 
tJ.eqbKLA 0.004 0.016 
tJ.eqbAtJ.ftsB 0.004 0.016 
SzH70 0.125 0.016 
B 
Conditioned THB from strain Streptonigrin MIC of strain Erythromycin MIC of strain 
MqbAE(!lM) tJ.eqbAE (Jlg mrl) 
Wild-type 0.03 0.016 
tJ.eqbA 0.004 0.016 
tJ.eqbE 0.125 0.016 
tJ.eqbAE 0.125 0.016 
tJ.eqbHIJ 0.016 0.016 
tJ.eqbKL 0.06 0.016 
MtsB 0.03 0.016 
tJ.eqbHIJA 0.002 0.016 
MqbKLA 0.016 0.016 
tJ.eqbAAftsB 0.004 0.016 
C 
Conditioned Supplementation Streptonigrin MIC of strain Erythromycin 
CDM from strain tJ.eqbAE (llM) MIC of strain tJ.eqbAE (Jlg mr 
1) 
tJ.eqbAE 0.125 0.03 
tJ.eqbHIJA 0.125 0.03 
tJ.eqbAE 10 J.lM salicylate 0.125 0.03 
tJ.eqbHIJA 10 J.lM salicylate 0.0005 0.03 
(A) Sensitivity of wild-type and allelic replacement strains of S. equi to streptonigrin and 
erythromycin. MIC refers to the minimum inhibitory concentration of antibiotic required 
to prevent growth. The 2-fold difference in the streptonigrin MIC of wild-type versus 
!J.eqbE was found to be statistically significant using a 2-sample Wilcoxon rank-sum 
(Mann-Whitney) test (P = 0.008, n = 4). (B) Streptonigrin and erythromycin sensitivity in 
the !J.eqbAE strain cross-fed with filter-sterilised culture supernatant from wild-type and 
allelic replacement strains grown to stationary phase in THB. The 2-fold difference in 
!J.eqbAE streptonigrin MIC conferred by cross-feeding with !J.eqbA conditioned CDM 
relative to !J.eqbHIJA conditioned CDM was found to be statistically significant using a 2-
sample Wilcoxon rank-sum (Mann-Whitney) test (P = 0.008, n = 4). (C) Streptonigrin and 
erythromycin sensitivity in the !J.eqbAE strain cross-fed with filter-sterilised culture 
supernatant from !J.eqbAE and !J.eqbHIJA allelic replacement strains grown to stationary 
phase in CDM ± 10 liM salicylate. 
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The increased production of the eqb NRPS product(s) in the lleqbA mutant was further 
supported by 55FeCh incorporation assays, which showed an almost 2-fold increase in 
intracellular iron in the repressor deletion strain, compared to wild-type or the lleqbAE 
mutant (Figure 3.11B). lleqbAE cross-fed with filter-sterilised stationary-phase culture 
supernatant from the lleqbA strain but not the lleqbAE strain had a similar increase in 
55FeCh accumulation (Figure 3.11 C). 
A slight reduction in the growth rate of the lleqbAE mutant (mean doubling time 73.5 min 
± 2.1 standard error mean (SEM)) compared to the lleqbE (63.2 ± 1.2) and wild-type (61.4 
± 0.7) S. equi strains (Figure 3.lOB) suggests that the EqbA regulator has further impacts 
on growth independent of iron uptake, particularly since both lleqbAE and lleqbE mutants 
have similar intracellular iron pools as indicated by streptonigrin sensitivity. 
As the global ferric uptake repressor Fur is an important regulator of siderophore 
utilisation and iron homeostasis in Gram-negative bacteria (Hantke, 2001), a Fur 
homologue (SEQ0255) was also deleted in S. equi to assess the influence of this protein on 
eqb non-ribosomal peptide biosynthesis. Deletion of the fur gene to generate a llfur 
mutant strain failed to alter the large colony wild-type phenotype suggesting that this Fur 
homologue in S. equi has no role in the repression of the eqb NRPS (data not shown). 
3.4.6 The mechanisms for transport of the NRPS product(s) 
The small colony phenotype of the lleqbA mutant was exploited to identify other CDSs 
likely to be involved in eqb product function. Deletion of the putative ABC transporters 
encoded by eqbK and eqbL or the ftsB gene, which lies outside the eqb locus and encodes a 
putative ferric-siderophore receptor (Clancy et ai., 2006; Hanks et ai., 2005), did not 
prevent the generation of the small colony phenotype on subsequent deletion of eqbA 
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(Figure 3.9). However, deletion of the eqbH, eqbJ and eqbJ genes, followed by deletion of 
eqbA (!1eqbHIJA) did prevent the generation of the small colony phenotype (Figure 3.9). 
Reduced levels of 55Fe in the tleqbHIJA strain also suggested that the eqbH, eqbJ and/or 
eqbJ gene products are essential for the majority of eqb product dependent iron 
accumulation (Figure 3.llB). 
To determine if eqbH, eqbJ and eqbJ were important to the export or import of the NRPS 
product(s), filter sterilised culture supernatant from mutant strains was added to the 
tleqbAE strain and its susceptibility to streptonigrin was quantified. Media from the 
!1eqbHIJA strain increased the sensitivity of the tleqbAE strain by 64-fold compared with a 
32-fold increased sensitivity conferred by media from the tleqbA strain (P = 0.008, Table 
3.4B). Similarly, media from the tleqbHIJ mutant conferred 2-fold greater streptonigrin 
sensitivity to the tleqbAE strain compared with media cross-fed from the wild-type strain. 
These data suggest that the tleqbHIJA and tleqbHIJ strains secrete, but are unable to 
import the NRPS product(s) resulting in a build-up of this product in the culture media. In 
addition, tleqbAE cross-fed with filter-sterilised culture supernatant from the !1eqbHIJA 
strain had an increase in 55FeCh accumulation slightly greater, although not significantly 
so, than that observed when tleqbAE was cross-fed with supernatant from the !1eqbA strain 
(Figure 3.llC). However, the tleqbHJJA strain grows slower than wild-type S. equi 
(Figures 3.9, 3.lOB, mean doubling time 79.5 ± 3.3 vs 61.4 ± 0.7, respectively) and is 
slightly more sensitive to streptonigrin (2-fold compared to wild-type, Table 3.4A), which 
infers that this mutant still suffers some effects of iron toxicity and that other mechanisms 
may also contribute to import of the eqb product(s). 
The tleqbA and tleqbAtlftsB mutants were equally sensitive to streptonigrin and 
conditioned media from these strains conferred the same streptonigrin sensitivity to the 
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cross-fed lleqbAE strain (Tables 3.4A and 3.4B). In contrast, lleqbAE cross-fed with 
supernatant from the lleqbKLA strain had a 4-fold lower sensitivity to streptonigrin 
suggesting that lleqbKLA is partially defective in the secretion of the NRPS product(s) 
(Table 3.4B). Conditioned media from the lleqbKL strain, but not the IlftsB mutant also 
conferred a 2-fold lower sensitivity to streptonigrin in the cross-fed lleqbAE strain relative 
to the lleqbAE strain cross-fed with wild-type supernatant (Table 3.4B). These data are 
consistent with a reduced secretion of the NRPS product(s) by the lleqbKL and lleqbKLA 
strains and suggest that one or both of the EqbKL ABC transporters contribute to the 
export of the non-ribosomal peptide(s). The lleqbKLA strain does however exhibit the 
same sensitivity to streptonigrin as the lleqbA strain, suggesting that these strains have 
similar levels of intracellular iron, despite reduced secretion of the NRPS product(s) in the 
former strain. It is possible that intracellular accumulation of the NRPS product(s) occurs 
in the lleqbKLA mutant, which removes iron from iron-dependent regulators and 
upregulates alternative iron import mechanisms. 
3.4.7 The biochemical requirements for the eqb NRPS 
A homologue of the salicylate synthases encoded by ybtS in Yersinia sp. (Miller et aI., 
2002) or pchA and pchB of Pseudomonas sp. (Serino et al., 1995) were not identified in 
Se4047. S. equi cultured in Todd-Hewitt media prepared from bovine heart infusion and a 
tryptic digest of animal tissue required no supplementation for equibactin production. 
However, production of the eqb product by the lleqbHIJA strain in chemically defined 
media (CDM) required salicylate supplementation consistent with salicylate being a 
substrate for the equibactin NRPS (Table 3.4C). The CDM contains 0.2 mM L-cystine. 
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3.4.8 Electrophoretic mobility shift assay 
Electrophoretic mobility shift assays were used to analyse recombinant EqbA (rEqbA) 
binding to a 227 bp DNA fragment (A) containing the upstream region of the eqb operon 
(Peqb) (-237 to -11 bp) (Figures 3.1, 3.12). Unbound DNA ran as 2 distinct bands on non-
denaturing polyacrylamide gel, which may be an artifact of the PCR method employed to 
generate the DNA probe, resulting in resolution of an additional single-stranded probe 
band that runs above the double-stranded band of interest (Varhimo et al., 2007). 
Unbound DNA was unaffected by the presence of different cations (125 11M) (Lanes 1,3, 
5, 7, 9, 11, 13, 19 and 25). Binding of rEqbA caused a shift in the mobility of the lower 
band (Lane 2). Pre-treatment of rEqbA with EDTA resulted in a partial shift in the 
mobility of the lower band (Lane 4), which could be enhanced in the presence of additional 
125 11M Fe2+ or 125 11M Zn2+ (Lanes 6 and 12) and to a lesser degree by 125 11M Mn2+ 
(Lane 8), but not by 125 11M Fe3+ or 125 11M Cu2+ (Lanes 10 and 14). The presence of the 
-73 bp to -38 bp DNA palindrome was essential for rEqbA binding as no shift was 
observed using DNA fragments containing the -237 to -73 bp (B) (Lanes 15 and 16) or -
237 to -135 bp (C) (Lanes 17 and 18) upstream regions of the eqb operon. Incubation of a 
control DNA fragment (Pierce LightShiftR Chemiluminescent EMSA Kit) with rEqbA did 
not result in a shift in mobility (Lanes 22-24) and a control crude extract (Pierce 
LightShiftR Chemiluminescent EMSA Kit) did not bind to Peqb (Lanes 19-21), suggesting 
that rEqbA binds specifically to Peqb. In addition, pre-incubation with 3.8 pmol unlabelled 
Peqb (190-fold excess) reduced the amount of Peqb lower band shifted by rEqbA (Lanes 25-
27). 
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Figure 3.12 Electrophoretic mobility shift assay. 
(A) Biotin end-labelled DNA fragments containing upstream regions of eqbB, A (227 bp 
P
eqb , -237 to -11 bp), B (165 bp, -237 to -73 bp) or C (103 bp, -237 to -135 bp) were 
incubated in the presence of 125 11M Fe2+, 125 11M Mn2+, 125 11M Fe3+, 125 11M Zn2+, 125 
IlM Cu2+ or control (-) as indicated with (+) or without (-) rEqbA and with (+) or without (-
) prior treatment of rEqbA with EDTA. DNA fragments B and C lack the palindromic 
promoter region (-73 to -38 bp) immediately upstream of eqbB. Experimental conditions 
are described in the Methods. (B) DNA fragment A (Peqb) or control DNA (Pierce 
LightShiftR Cherrlilurrlinescent EMSA Kit) were incubated in the presence of Fe2+ with (+) 
or without (-) rEqbA or control extract (Pierce LightShiftR Chemilurrlinescent EMSA Kit) . 
* 3.8 pmol unlabelled DNA fragment A (Peqb) was added 5 min prior to the addition of 
biotin-labelled Peqb (lane 27). 
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3.4.9 Iron-chelating activity 
The universal siderophore assay (Schwyn & Neilands, 1987) was used to compare the iron-
chelating activity of various S. equi strains including lleqbHIJA, lleqbA and lleqbAE. 
Surprisingly, using a CAS agar overlay method, no differences were detected in the ability 
of these strains to decolourize the CAS-HDTMA-Fe3+ complex despite their disparities in 
non-ribosomal peptide biosynthesis and intracellular iron accumulation (Figure 3.13A). 
Growth of S. equi, like many other Gram-positive bacteria (Schwyn & Neilands, 1987), is 
inhibited by the detergent in the CAS-HDTMA-Fe3+ complex. As a result the S. equi 
strains were unable to grow in contact with the CAS agar. Growth of the control bacterium 
S. au reus was less effected by CAS-HDTMA-Fe3+ inhibition. Small but consistent 
differences were detected using the CAS supernatant assay on supernatant samples 
collected from lleqbHIJA and lleqbAE strains grown in CDM supplemented with salicylate 
(CDMs) (Figure 3.l3B). Compared to supernatant from the lleqbAE strain, supernatant 
from the lleqbHIJA sample caused a reduction in absorbance (A630nm) following incubation 
with the CAS assay solution. This reduction in A630nm was equivalent to approximately 5 
11M desferoxamine dissolved in lleqbAE conditioned media. However, when iron was 
omitted from the CDMs, these differences between lleqbHI1A and lleqbAE were no longer 
evident (even using the CAS shuttle assay) and no reduction in A630nm occurred. 
Desferoxamine at a concentration of ~ 2 11M dissolved in lleqbAE conditioned media (with 
iron omitted) did reduce A630nm (data not shown). This finding suggests that the NRPS 
product(s) in lleqbHI1A conditioned medium was not able to remove iron from the CAS-
iron complex directly. but may be able to bind free iron. 
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Figure 3.13 CAS siderophore assay 
1.4 l 
1.2 
a I 
~ 0.8 
(2 0.6 J 
< 0.4 
0.2 
o -;----'-----.-
t.eqbIDJA t.eqbAE 
Conditioned media (with iron) 
(A) Photograph shows an inability of S. equi mutant strains cultured as a suspension in 
THA (upper yellow layer) to remove iron from the CAS-iron complex (lower blue layer). 
S. au reus was included as a positive control. (B) Graph shows a reduction in absorbance at 
630 run in the CAS supernatant assay using conditioned media from the !1eqbHI1A strain 
vs conditioned media from the !1eqbAE strain. This difference between the !1eqbHI1A and 
!1eqbAE strains only occurred if iron was included in the chemically defined media 
supplemented with salicylate (CDMs). 
3.4.10 Virulence of the AeqbE mutant strain in mice 
In experiment one, the eqbE gene was shown to be essential for the full virulence of S. equi 
in mice (Figure 3.14). !1eqbE-challenged mice had a significantly reduced weight loss 
(Figures 3.14A: P < 0.0001, B) and improved survival rate compared to wild-type-
challenged mice (Figure 3.14F). 30% had gained weight 7 days post-challenge compared 
to just 5% of wild-type-challenged mice and 65 % were still alive at day 7 post-challenge 
compared to only 45% of wild type-challenged mice. Significantly lower levels of S. equi 
were re-isolated from the nares of !1eqbE-challenged mice (P < 0.0001) suggesting a 
reduced ability of this strain to colonise the respiratory tract (Figure 3:14E). However, 
although the onset of disease was delayed in the !1eqbE-challenged mice, it was associated 
with deterioration in health as seen in the wild-type challenged group (Figures 3.14B, C 
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and D). Low levels of intracellular iron may have slowed down the early invasion of S. 
equi but could also have up-:regulated other virulence factors able to aid directly or 
indirectly (via tissue damage and release of intracellular iron) in improved iron uptake 
through compensatory mechanisms. 
Another experiment was performed to see if this delayed onset of disease was a repeatable 
phenomenon. Surprisingly, the lJ.eqbE and wild-type strains behaved in a more 
comparable fashion in the 2nd trial and no significant differences were identified in their 
ability to cause disease (Figure 3.15). Wild-type challenged mice were euthanased (due to 
severe disease or > 15 % weight loss) slightly more rapidly than ~eqbE-challenged mice, 
but by day 7 the number of surviving mice differed by just one between the 2 groups 
(Figure 3.15F). Pneumonia was detected in 4 extra mice in the ~eqbE-challenged group 
compared to the wild-type-challenged group, but 2 of these 4 mice suffered from severe 
pneumonia compared to 4 in the wild-type-challenged group (Figure 3.15G). The 
occurrence of septicaemia was also similar for both groups (wild-type = 3, ~eqbE = 2, 
Figure 3.15G). The prevalence of pneumonia and septicaemia has not been reported for 
experiment one because septicaemia was not measured in all cases and the accurate 
detection of pneumonia was complicated by euthanasia-induced changes in the lungs. 
However, pathological changes in the LNs were detected in one mouse from the ~eqbE­
challenged group in experiment one, which had a single LN abscess. In experiment 2, one 
wild-type-challenged mouse developed a LN abscess and 5 had enlarged LNs, whilst 3 
mice had swollen LNs in the ~eqbE-challenged group but no LN abscesses were detected. 
Overall, the pathological signs of disease were not significantly different between the 2 
challenge groups. 
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Figure 3.14 Virulence of the /':.eqbE mutant compared to wild-type S. equi 10 ffilce 
(experiment one) 
(A) Graph shows a significantly reduced mean cumulative percentage weight loss per day 
in the /':. eqbE-chalIenged mice compared to those challenged with wild-type S. equi (P < 
0.0001). The measurement of cumulative weight loss per day takes into account the 
number of days survived in the post-challenge period and the influence of early euthanasia 
on mean values. (B) Graph shows a 2-3 day delay in the onset of weight loss in the 
eqbE-challenged mice compared to wild-type-challenged mice. (C) . Graph shows no 
significant difference in the mean cumulative gain in observation score between the 2 
challenge groups (cumulative gain was calculated over the post-challenge survival period 
for each mouse). (D) Graph highlights the delayed increase in clinical observation score in 
the /':. eqbE-chaUenged mice compared to wild-type-challenged mice. (E) Graph shows that 
the mean cumulative nasal growth was significantly lower in the /':. eqbE-challenged mice 
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compared to wild-type-challenged mice (P < 0.0001). (F) Graph shows that l1eqbE-
challenged mice had a slightly better survival rate compared to wild-type-challenged mice. 
For graphs A to E, values represent the mean ± 95 % confidence interval. 20 mice were 
challenged with the l1eqbE strain and 20 mice challenged with wild-type S. equi. 5 mice 
were present in the unchallenged control group. 
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Figure 3.15 Virulence of the /1.eqbE mutant compared to wild-type S. equi in mice 
(experiment 2) 
Graphs show no significant differences between /1.eqbE-challenged mice and wild-type-
challenged mice in mean weight loss (A and B), mean clinical observation score (C and 
D), survival rate (F) or in pathological changes resulting from S. equi infection (G). Graph 
E shows a trend for decreased numbers of S. equi CFUs recovered from the nares of eqbE-
challenged mice compared to wild-type-challenged mice. However, the levels of isolated 
S. equi were similar for both groups on all days except day 5 (data not shown) when 
confluent growth of S. equi in a few mice contributed to a large but statistically 
insignificant increase in mean value. For graphs A to E, values represent the mean ± 95 % 
confidence interval. 20 mice were challenged with the /1.eqbE strain and 20 mice 
challenged with wild-type S. equi. 5 mice were present in the unchallenged control group. 
3.5 Discussion 
Available evidence suggests that S. equi evolved from an ancestral S. zooepidemicus strain 
(Jorm et aI., 1994; Webb et aI., 2008), an opportunistic zoonotic pathogen largely 
associated with sub-clinical inflammatory airway disease (lAD) in young horses (Wood et 
aI., 2005 a). Given the close genetic similarity between these two streptococci, I used 
comparative genomics to identify differences between the species with a view to 
distinguishing key determinants of their differing pathogenic properties. The full results of 
this genome comparison are reported in Chapter 2. However, in addition to previously 
described genetic differences (Alber et al., 2005; Artiushin et al., 2002; Galan & Timoney, 
1987; Lindmark et al., 1999; Proft et al., 2003; Timoney et aI., 1997b), I report here the 
identification of a streptococcal ICE, ICESe2 and the function of the siderophore-like 
NRPS system encoded by this element. This element was previously noted in a broad 
screen for ICEs in sequenced bacterial genomes, but no putative function was assigned 
(Burrus et aI., 2oo2a). 
ICESe2 was present in all strains of S. equi, but absent from all strains of S. zooepidemicus 
examined. These strains were selected to be a diverse population based on their SeM allele 
(Kelly et al., 2006; Waller & Jolley, 2007) or 16S-23S RNA gene intergenic spacerlSzP 
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PCR sub-type (Newton et ai., 2008) and were highly diverse based on their MLST 
sequence type (Webb et aI., 2008). My results also indicated that ICESe2 was located at 
the same genome position in all 18 S. equi strains, suggesting that its integration was an 
early and stable event in the evolution of S. equi. 
The similarity of ICESe2 CDSs predicted to be involved in conjugation and site-specific 
recombination to those from C. difficile CDTn2 and CDTn5 is extremely interesting and 
raises the possibility of acquisition of the equibactin NRPS locus via a conjugative-like 
mechanism from a genetically unrelated bacterium. ICESe2 is also related to other ICEs in 
Se4047 (ICESel), SzH70 (ICESzl) (Ch~pter 2) and S. pyogenes (ICE MGAS 107S0-RD.2) 
(Beres & Musser, 2007), athough these elements all carry distinct genetic cargo. These 
group A and group C streptococci may therefore share a common ICE reservoir. 
Although I predict integrative and conjugative genes are present in ICESe2, to date I have 
failed to detect a circular intermediate by PCR through repeated experiments suggesting 
that this element may no longer retain the ability to recircularise and transfer to other> 
bacteria. Similarly, circular forms of 4 out of 7 ICEs, including CDTn2, were not detected 
in C. difficile (Sebaihia et al., 2006). 
ICESe2, CDTn2 and CDTn5 have putative conjugation modules that are closely related to 
the conjugation module of Tn1549 in Enterococcus spp. (Gamier et ai., 2000) suggesting 
that they have inherited their similar structure from a common module ancestor. However, 
the serine recombinase encoded at the right flank of these elements differs from the Int 
(tyrosine recombinase) and Xis of Tn1549, which taken together with the differences in 
accessory functions highlights the importance of module exchange in the evolution of 
novel mosaic ICE structures. Serine recombinases are less common and genetically 
unrelated to the tyrosine recombinases and use a different mechanism for the site specific 
recombination of mobile elements (Grindley et al., 2006). However, this family is rather 
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heterogeneous and ranges in size from 180 to nearly 800 amino acid residues. ICESe2 
encodes a small recombinase (SEQI229) with homology to the N-terminal half of the large 
TndX resolvase, which mediates excision and insertion of Tn5397 by introducing 2 bp 
staggered cuts at the 3' ends of GA dinucleotides at the ends of the element (excision) or in 
the target site (integration) (Wang et aI., 2000). Consequently, direct GA dinucleotide 
repeats delineate the ends of Tn5397 and one copy is also present at the joint of the circular 
form. CDTn5 also has 5 bp direct repeats at these corresponding sites, whereas no direct 
repeats were identified in the flanks of ICESe2. However, particularly large 108 bp perfect 
inverted repeats were present at the flanks of the element in S. equi, which like the much 
smaller imperfect inverted repeats (19-20 bp) in Tn5397 and other ICEs may represent 
DNA binding sequences for the recombinase during the formation of the synaptic complex. 
The sequence of a NRPS has been used previously to predict the structure of the peptide 
produced (Challis & Ravel, 2000; Lautru et al., 2005). The similarity in type and 
organisation of functional modules in the equibactin NRPS and the yersiniabactin . 
biosynthetic system (Miller et aI., 2002) leads me to suggest a tentative model for 
equibactin biosynthesis (Figure 3.5). Initially, I propose activation of the aryl acid carrier 
protein (ArCP) domain of EqbE and the peptide carrier domains (PCP) of EqbE and EqbG 
by the putative 4'-phosphopantetheinyl transferase encoded by eqbC. EqbD is proposed to 
activate salicylate, which is then transferred to the phosphopantotheine thiol of the ArCP-
domain of EqbE. My observation that addition of salicylate is required for production of 
the eqb NRPS product(s) in chemically defined medium provides evidence in support of 
the proposed involvement of salicylate. Salicylate was also required for optimum 
production of the NRPS product(s) in E. coli containing the reconstituted NRPS (Chapter 
4), but was not required for production of the NRPS product(s) by S. equi in Todd Hewitt 
media. This medium is prepared from bovine heart infusion and a tryptic digest of animal 
tissue and I propose that an appropriate NRPS substrate is released from host tissue during 
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infection with S. equi. The single adenylation (A)-domain of EqbE is predicted to activate 
cysteine, which is then transferred to the phosphopantotheine thiol of each of the 3 PCP-
domains of the NRPS (2 in EqbE and one in EqbG). I predict that the cysteinyl thioesters 
attached to each PCP domain will be condensed and cyc1ised as the growing chain 
translocates to each of the 3 PCP domains. The presence of a putative thiazoline reductase 
(EqbF) suggests that as in yersiniabactin biosynthesis, the 2nd thiazoline ring of equibactin 
is likely to be reduced to a thiazolidine to prevent the auto-oxidation of the 1st ring to a 
thiazole. However, the available data do not rule out the possibility that the 1st or 3rd 
thiazoline ring could be reduced to a thiazolidine instead or as well. 
Yersiniabactin is released from the last PCP-domain by a C-terminal thioesterase domain. 
However, the C-terminal thioesterase domain of EqbG has the critical serine residue 
(S 1092) of the predicted serine, histidine, aspartate catalytic triad essential for function 
(GXSXG-motif) mutated to alanine. The type-II thioesterase encoded by eqbB has an 
intact catalytic triad, but to date these type-II TEs have only a presumed editing role in· 
maintaining the efficiency of non-ribosomal peptide synthesis via removal of inappropriate 
substrates (Bobrov et ai., 2002; Butler et ai., 1999; Marahiel et ai., 1997; Reimmann et ai., 
2004; Schneider & Marahiel, 1998). Interestingly, the tetrapeptide coelichelin is 
synthesised by a trimodular NRPS lacking a TE domain and is proposed to be released 
through the action of a separately encoded hydrolase (Lautru et ai., 2005). EqbN encodes 
a putative aJ~ hydrolase which could provide another potential mechanism for hydrolytic 
chain release similar to coelichelin. The eqbN gene was required for optimal production of 
the eqb NRPS product(s) by E. coli and induction of increased streptonigrin sensitivity in 
cross-feeding assays (Chapter 4). However, absence of eqbN did not abolish production of 
the NRPS product(s) in this system suggesting that E. coli may produce an endogenous 
hydrolase that can complement the activity of EqbN or that direct hydrolysis with water 
without the formation of an acyl enzyme intermediate is also possible, either at a low 
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background level or through a base-catalysed attack of water rather than nucleophilic 
attack of an active site serine (Li & Bugg, 2007). 
Regulation of eqb non-ribosomal peptide synthesis is achieved through the action of the 
DtxRlIdeR-like transcriptional repressor EqbA. Deletion of eqbA led to increased 
transcription of the eqbE gene in the NRPS operon, over-production of the NRPS 
product(s) and increased import of iron causing toxicity and a small-colony phenotype. 
Deletions of ideR and other ideRifur homologues have been lethal in M. tuberculosis and 
several species of Pseudomonas, Vibrio and Neisseria (Berish et al., 1993; Tolmasky et al., 
1994; Venturi et al., 1995). In M. tuberculosis, a rare deletion of ideR was obtained when 
the lethal effects of ideR inactivation were alleviated by a 2nd -site suppressor mutation that 
restricted iron assimilation capacity (Rodriguez et al., 2002). I propose that like other IdeR 
family members, EqbA is activated on binding iron, leading to homodimerisation and 
binding to a 36 bp DNA palindrome located immediately upstream of the NRPS operon to 
block its transcription. EqbA has a number of novel features compared with other IdeR . 
family members. The suggested operator site is unlike other palindromic DNA iron boxes 
and this is reflected in the substitution of N-terminal Helix-Turn-Helix residues involved in 
DNA contact (Figure 3.16). Some of the conserved metal binding and dimerisation 
residues differ in EqbA. In addition, the SH3-like fold of DtxR and ldeR, which functions 
to stabilize the DNA binding conformation of these repressors (Oram et aI., 2005; Pohl et 
aI., 1999b) is lacking in EqbA. EqbA is therefore likely to represent a new sub-class of the 
IdeR family. Electrophoretic mobility shift assays confirmed that EqbA does indeed bind 
to the eqbB promoter in a Fe2+, Zn2+ and Mn2+ responsive manner. EqbA binding was not 
affected by Cu2+ or Fe3+ and was dependent on the presence of the eqbB promoter's DNA 
palindrome. The shift due to addition of Mn2+ was not complete and may reflect a reduced 
affinity of EqbA for Mn2+. These data are in broad agreement with the activation of IdeR 
by different cations rather than MntR, which is Mn2+ specific (Chou et aI., 2004; Guedon 
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& HeImann, 2003; Que & HeImann, 2000; Schmitt et ai., 1995). Further comparison of 
the putative residues involved in the coordination of the regulatory metal (Guedon & 
HeImann, 2003) revealed that EqbA shares a cysteine at amino acid position 104 with 
DtxR, which confers Fe2+ responsiveness rather than the Mn2+ responsive glutamate 
possessed by MntR and TroR at the homologous position (Figure 3.16). The Fe2+ 
responsive methionine of DtxR has been replaced by asparagine at amino acid position 13 
of EqbA, which is similar to the homologous residue in the Mn2+ responsive TroR. 
EqbA (S.equi) 
DtxR (C.dip) 
MntR (B. sub) 
TroR (T.pal) 
EqbA (S .equi) 
DtxR (C.dip) 
MntR (B. sub) 
TroR (T .pal) 
EqbA (S.equi) 
DtxR (C.dip) 
MntR (B. sub) 
TroR (T .pal) 
EqbA (S.equi) 
DtxR (C.dip) 
MntR (B. sub) 
TroR (T .pal) 
MNKIYHKEYVEQNYLEN IYTLYLE--RDEVRN IDIVDKLGVARATVTHMLRNLEKK GYIK 58 
---MKDLVDTTEMYLRTIYELEEE--GVTPLRARIAERLEQSGPTVSQTVARMERDGLVV 55 
-----MTTPSMEDYIEQIYMLIEE--KGYARVSDIAEALAVHPSSVTKMVQKLDKDEYLI 53 
--MSLVS DlAAENYLKTVVKALARSRRERVGTGELSRLLHVTPGT ISTMVKRLEKGG YVQ 58 
: *:. : * 
YGDDKIVRFTSKGRTLAVELYEKHIYLTQVFK-HIGVDEKIAEIEACQIEHIISKDTFN- 116 
VASDRSLQMTPTGRTLATAVMRKHRLAERLLTDIIGLDINKVHDEACRWEHVMSDEVERR 115 
YEKYRGLVLTSKGKKIGKRLVYRHELLDQFLR-IIGVDEEKIYNDVEGIEHHLSWNSIDR 112 
RTHRLGCTLTRKGAVFGSAVLRKHRLLESFLSQVLCLEAGVVHKEAEMLEHACSDELIDV 118 
: * . * : * ** *: 
--KIKKYFE-----------------DKI------------------------------- 126 
LVKVLKDVSRSPFGNPIPGLDELGVGNSDAAVPGTRVIDAATSMPRKVRIVQINEIFQVE 175 
IGDLVQYFE-----------------EDDARKKDLKSIQKKTEHHNQ------------- 142 
IDRYLQYPTRDPHG------------QPIPRKDTLLDLYVEDDVPGV------------- 153 
TDQFTQLLDADIRVGSEVEIVDRDGHITLSHNGKDVELIDDLAHTIRIEEL 226 
Figure 3.16 CLUSTAL W alignment of IdeRs 
Primary structure alignment of EqbA homologues known to be regulated by Fe2+ or Mn2+. 
Sequence alignment was generated using CLUSTALW. The putative residues involved in 
the coordination of the regulatory metal are shown in bold. The Helix-Turn-Helix motif is 
underlined. Sequences used are: DtxR, P33120 (Qiu et ai., 1996); MntR, P54512 (Que & 
HeImann, 2000); TroR, P96120 (Hardham et ai., 1997). 
No iron-chelating activity could be detected in the D..eqbHIJA or D..eqbA mutants of S. equi 
using the universal CAS assay for iron chelators (Schwyn & Neilands, 1987) (Figure 3.13). 
Biochemists at Warwick University were also unable to identify equibact~n by comparative 
metabolic profiling of the D..eqbA, D..eqbAE and D..eqbHIJA strains using LC-MS. 
Furthermore, examination of biologically active conditioned LB (Luria-Bertani) and MM 
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(minimal media) from E. coli containing the reconstituted equibactin NRPS by LC-MS 
also failed to identify equibactin (Chapter 4). These data suggest that the concentration of 
equibactin in culture supernatant is low or the product of the eqb cluster may have a low 
affinity for iron and a structure different to that proposed. Pyochelin, a siderophore that 
lacks the 3rd incorporated thiazoline and malonyl linker of yersiniabactin, but otherwise 
shares the salicyl-bis-thiazonyl core has a relatively low affinity for iron. A role for 
pyochelin in the uptake of other essential metals has been proposed (Visca et ai., 1992) and 
this may also represent an alternative function for the eqb NRPS product(s). The host 
catecholamine norepinephrine, although unable to remove iron from CAS complex, can 
increase the availability of free iron to bacteria through an interaction that interferes with 
host glycoprotein iron sequestration (Freestone et ai., 2000). 
These data are also consistent with a signaling role for the NRPS product(s) in the up-
regulation of iron transport system(s). A number of siderophores are able to function as 
signaling molecules, influencing the expression of their own biosynthetic genes and cell . 
surface receptors as well as other secreted virulence factors (Beare et aI., 2003; Crosa, 
1997; Michel et al., 2005; Michel et al., 2007; Miethke & Marahiel, 2007; Pelludat et al., 
1998). Ferric-pyochelin acts as an intracellular effector via a direct interaction with an 
AraC-type regulator (Michel et aI., 2(05). The AraC-type YbtA regulator also induces 
yersiniabactin operons involved in yersiniabactin biosynthesis, Fe,.yersiniabactin uptake 
and salicylate synthesis, and the Fe-yersiniabactin receptor. An interaction of the YbtA 
with its DNA promoter target and Fe-yersiniabactin is proposed to be a prerequisite for the 
recruitment of the RNA polymerase complex (Anisimov et aI., 2005a; Anisimov et aI., 
2005b; Fetherston et ai., 1996; Miethke & Marahiel, 2007; Perry et aI., 1999). 
Siderophore-mediated iron uptake operons, similar to the ferric hydroxamate uptake (jhu) 
systems of S. aureus and B. subtilis, have been identified in other streptococci (Clancy et 
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aI., 2006; Hanks et aI., 2005; Pramanik & Braun, 2006). FhuD, the associated lipoprotein 
receptor in S. agalactiae is able to bind a range of siderophores of both hydroxamate and 
catecholate classes. The homologous operon (42-55% amino acid sequence identity) is 
also present in the S. equi genome and I hypothesised that this could be involved in 
acquisition of the eqb NRPS product(s). However, deletion of the ftsB gene did not 
prevent iron toxicity due to overproduction of the NRPS product(s) on the further deletion 
of eqbA (Figure 3.9, Table 3.4). This indicates that FtsB is not absolutely required for 
import of the NRPS product(s) and further studies are necessary in order to determine if 
surface receptors playa role in import of the NRPS product(s). 
EqbK and EqbL are ABC transporters with characteristics of ABC-type efflux systems 
(including siderophore export) but also structurally unique siderophore importers of Y. 
pestis and M. tuberculosis (Farhana et ai., 2008; Fetherston et ai., 1999). Although the 
tl.eqbKLA strain had a slow growth phenotype similar to the tl.eqbA strain (Figures 3.9, 
3.lOA) and both strains had the same sensitivity to streptonigrin suggesting equivalent· 
intracellular iron stores (Table 3.4A), conditioned media from the tl.eqbKLA consistently 
conferred lower streptonigrin sensitivity to the cross-fed tl.eqbAE strain than media from 
tl.eqbA (Table 3.4B). Supernatant cross-feeding studies also demonstrated that strain 
tl.eqbKL conferred 2-fold decreased sensitivity to streptonigrin relative to wild-type (Table 
3.4B). These conflicting results suggest that one or both of the eqbKL encoded ABC 
transporters plays a partial role in export of the NRPS product(s) and that the resultant 
accumulation of NRPS product(s) in the cell somehow impacts on iron and streptonigrin 
toxicity. A severe growth defect was seen in a strain of B. bronchiseptica that accumulated 
intracellular alcaligin due to a null mutation in a major facilitator superfamily transporter 
responsible for exporting this siderophore (Brickman & Armstrong, 2005). The drastically 
reduced growth rate was only seen when the strain was grown in conditions of high iron 
concentration and was reversed in a double deletion mutant that was also unable to 
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synthesise alcaligin (Brickman & Armstrong, 2005). The mechanistic basis for such an 
iron effect in the B. bronchiseptica mutant or the l1eqbKLA strain of S. equi is unknown 
(Brickman & Armstrong, 2005). It is possible that intracellular accumulation of the eqb 
NRPS product(s) or alcaligin removes iron from iron-dependent regulators and upregulates 
alternative iron import mechanisms. Further work, including 55FeCh accumulation assays 
will determine whether or not the l1eqbKLA strain incorporates as much iron as the l1eqbA 
strain. eqbK and eqbL may encode 2 polypeptide chains of a single ABC transporter 
heterodimer or as suggested for IrtA and IrtB of M. tuberculosis, may form separate ABC 
transporter homodimers with potentially distinct export/import functions (Farhana et aI., 
2008). The generation of separate deletion mutants would help to clarify this. The ABC 
transporter encoded by the eqbH, eqb/ and eqbJ genes plays a major role in the eqb 
dependent incorporation of iron. 
Siderophore biosynthesis has not been identified in any streptococci examined to date 
(Eichenbaum et al., 1996). A hybrid PKS-NRPS system has been noted in the published 
genome sequence of the oral pathogen S. mutans. Unlike the eqb locus, this NRPS module 
appears to incorporate 5 diverse residues into a molecule of unknown identity that is 
predicted to have more of an antibiotic-like structure (gramicidinlbacitracin family); 
expression from this locus was downregulated when the organism was grown in mixed 
species cultures (Huang, 2008). The only other Streptococcus strain displaying an NRPS 
is S. thermophilus, which encodes a single monomodular NRPS (Donadio et aI., 2007). 
However, homologues of eqbA and eqbD (pseudogene) are present in the genome of S. 
agalactiae serotype III, suggesting that a locus with similarity to the eqb NRPS may have 
been important to this organism at some point in its history .. 
Surprisingly, the mutant S. equi l1eqbE strain that is unable to acquire iron· though 
equibactin NRPS function was not significantly attenuated for virulence in mice, despite an 
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early experiment showing delayed onset of disease in this mutant strain compared to the 
wild-type strain (Figures 3.14, 3.15). The reasons for the disparities in virulence between 
the 2 mouse studies are unclear but highlight the need for reproducibility and caution when 
interpreting the results of such experiments, particularly when disease models in unnatural 
hosts are used. The mouse model used in this study resulted in a high incidence of 
pneumonia (Figure 3.15G), which is not a general feature of strangles in horses and may 
have limited the reliability of this method for establishing the virulence of the strain tested. 
Even studies looking at the virulence of mutant S. equi strains in mice using a less 
pneumonic-type disease model have given variable results when later compared with their 
ability to cause strangles in horses (Hamilton et a!., 2006). Quantification of the in vivo 
effects of the equibactin NRPS in horses may be the only way to establish its pathological 
significance. 
3.6 Conclusions 
ICESe2 is a key feature in the evolved genome of S. equi. Whilst I have not yet identified 
the peptide made by the equibactin NRPS or shown direct iron binding, data consistent 
with its role in iron acquisition has been established. Given the importance of iron 
acquisition to other streptococcal pathogens (Brown & Holden, 2002), the acquisition of 
ICESe2 may have contributed to the increased pathogenesis of this important 
streptococcus. Although the ll.eqbE mutant strain was not significantly attenuated in mice, 
the contribution of the equibactin NRPS to disease in the horse has yet to be established. 
More efficient acquisition of iron may enhance retropharyngeal LN abscessation and/or 
persistence in the GP of horses, both of which are critical to the establishment of long term 
carriage and vital to the success of S. equi. 
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In addition, this study has identified EqbA, a new member of the IdeR family of iron-
dependent repressors. Transcriptional regulation of the equibactin NRPS is achieved by 
specific binding of EqbA to the eqb palindromic promoter sequence in an Fe2+, Zn2+ and 
Mn2+ responsive manner. Further investigation is now warranted to gain a detailed 
understanding of the structure and mechanics of EqbA function and to establish the 
contribution (if any) of EqbA to the regulatory control of other potential virulence 
determinants. 
Genes in the eqb cluster encode putative ABC transporters that contribute to the transport 
of the eqb NRPS product(s). EqbH, I andlor J have an essential role in eqb NRPS 
product(s) dependent iron import, whilst EqbK andlor EqbL may contribute to export of 
the secondary metabolite. Studies with further allelic replacement mutants containing 
deletions in individual and multiple transporter genes should shed more light on the precise 
function of each genetic component. Random mutagenesis may be a useful technique to 
establish any receptor requirements for the eqb ABC importer(s). 
Salicylate is a proven substrate of the eqb NRPS. However, a concerted effort is clearly 
required to unravel the identity of the non-ribosomal peptide(s) synthesised by S. equi. 
The work detailed in Chapter 4 brings this important objective one step closer. 
Purification and elucidation of the eqb NRPS product structure is warranted to better 
understand the role played by the NRPS product(s) in vivo. 
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Chapter 4 Heterologous biosynthesis of equibactin utilising Escherichia 
coli 
4.1 Introduction 
NRPS systems produce peptides that have a composition of unusual amino acids and 
modifications, which often have tremendous therapeutic value. Harnessing this medicinal 
potential, however, is frequently limited by the rudimentary knowledge of growth 
requirements or poor growth characteristics of the original microbial host. In fact, most 
clinically important natural products, including many antibacterials, antifungals, 
immunosuppressants and antitumor agents, are produced by complex, slow growmg 
microorganisms such as actinobacteria, myxobacteria and filamentous fungi (Challis, 
2006). Consequently, there has been a move towards the heterologous production of these 
NRPS (and PKS or mixed NRPS-PKS) metabolites in rapidly growing, genetically 
tractable hosts like E. coli. Not only does the ease of E. coli fermentation makes this 
organism particularly suitable for metabolite overproduction but also, the genetic 
tractability of E. coli enables the use of genetic modification to manipulate and further 
study the biochemical process of secondary metabolite production. The modular nature of 
NRPS (and PKS) systems makes them amenable to the construction of recombinant 
hybrids and opens potential avenues for the manufacture of novel peptides (Donadio & 
Sosio, 2003; Watanabe et ai., 2003). 
Examples of the de novo biosynthesis of NRPS or mixed PKS-NRPS products in E. coli 
include the production of diketopiperazine (an intermediate in the biosynthesis of the 
tyrocidine antibiotic produced by B. brevis) (Gruenewald et ai., 2004), the production of 
echinomycin (a quinoxaline antibiotic from Streptomyces iasaliensis) .(Watanabe et ai., 
2006) and the assembly of the thiazoline-containing siderophores pyochelin and 
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yersiniabactin from P. aeruginosa (Reimmann et al., 2001) and Y. pestis (Pfeifer et aI., 
2003), respectively. 
Because of the large size or number of genes expressed, in most cases several plasmids 
containing mutually compatable origins of replication are required to assemble the gene 
clusters in E. coli. Most studies use natural or synthetic polycistronic operons under the 
control of an inducible T7 promoter to express the biosynthetic genes. The heterologous 
production of echinomycin, however, used 3 mutually compatible plasmids with 16 
monocistronic gene cassettes, each with its own T7 promoter (Challis, 2006; Watanabe et 
aI., 2006); an approach that enabled the easy manipulation of gene clusters in order to 
examine the function of individual biosynthetic genes. 
E. coli can also be utilized as a host for the overproduction and purification of recombinant 
biosynthetic proteins so that NRPS products can be synthesised in a test tube. This 
approach has been used to successfully reconstitute the 3 siderophores enterobactin 
(Gehring et ai., 1998c), pyochelin (Quadri et al., 1999) and yersiniabactin (Miller et ai., 
2002). In vitro reconstitution by this method coupled with HPLC and MS allows a 
thorough dissection of the molecular organization, mechanisms and substrates used by 
NRPS (and PKS) catalysts. For example, the in vitro production of a product matching the 
authentic yersiniabactin produced in vivo required the proteins: YbtE (salicylate 
adenylation domain), HMWP2 (NRPS) , HMWP1 (PKSINRPS), YbtU (reductase), Sfp 
(phosphopantetheinyl transferase) and substrates: salicylate, cysteine, malonyl-CoA, SAM, 
NADPH and ATP. Intermediate biosynthetic products were assessed by omitting catalytic 
domains from the reaction. For example, the function of the YbtU thiazoline reductase 
was deduced from MS analysis of reactions with and without YbtU. Deuterated substrates 
were used to validate the number of specific substrate molecules present in the final 
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product (Miller et aI., 2002). Such techniques can be used to build a picture of the 
complete biosynthetic process (Miller et al., 2002). 
4.2 Aims 
S. equi is usually cultured in Todd Hewitt, a complex medium prepared from bovine heart 
infusion and a tryptic digest of animal tissue, supplemented with dextrose. A chemically 
defined medium (CDM) that supports the growth of S. equi was identified in this study 
(Chapter 3), but due to the metabolic requirements of streptococci, this CDM contained 
many components and remained complex in nature. Our biochemist collaborators at 
Warwick University were unable to identify a product from the ICESe2 NRPS and 
attributed this partly to the complex nature of the S. equi growth media. The work 
described in this chapter utilized E. coli for the production of the ICESe2 NRPS product(s) 
with the main aim of producing the NRPS product(s) in a less complex media in order to 
facilitate its identification by HPLC-MS analysis. By using different combinations of 
putative biosynthetic genes, I also intended to assess the contributions of individual 
proteins to the successful production of the secondary metabolite. The first objective was 
to clone all potential ICESe2 NRPS biosynthetic genes into compatible plasmids for their 
coordinated expression and the heterologous production of the NRPS product(s) in E. coli 
(cultured in LB broth or minimal media (MM». A second objective aimed to reconstitute 
the ICESe2 NRPS product(s) in vitro using purified recombinant forms of the NRPS 
biosynthetic proteins. 
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4.3 Methods 
4.3.1 Heterologous production of the ICESe2 NRPS product(s) in Escherichia coli 
Novagen expression plasmids with compatible replicons were used for the co-expression 
of eqbBCD, eqbMN, eqbF, eqbG (multicystronic) and eqbE from T7 promotors in E. coli 
strain BL21(DE3) (Figure 4.1). DNA fragments containing eqbBCD, eqbMN, eqbF, eqbG 
and eqbE genes were amplified by PCR from Se4047 chromosomal DNA with Phusion 
polymerase (NEB), using primer pairs indicated in Table 4.1. eqbBCD was cloned into the 
multiple cloning site (MCS)-l of pACYCDuet-1 using Ncol/BamBI to generate pACYC-
BCD. eqbMN was cloned into MCS-2 of pACYC-BCD using BglIII AatII to generate 
pACYC-BCD-MN (chloramphenicol resistant). eqbF was cloned into MCS-1 of 
pCDFDuet-1 using NcoIlBamBI to generate pCDF-F. eqbG was cloned into MCS-2 of 
pCDF-F using Fsell AatII to generate pCDF-F-G (spectinomycin resistant). eqbE was 
cloned into pET21 a using NheIlBamHI to generate pET21a-E (ampicillin resistant). 
Figure 4.1 Plasmid contructs for the coordinate expression of 8 eqb genes in E. coli 
17 I 
pCDF-F-G :i 
N pET21a-E 
( 
"96~ 
pACYC-BCD-MN • 
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Table 4.1 Oligonucleotide primers used for cloning eqb gene expression vectors 
Primer Sequence (5'-3') Purpose 
ZM248 TAGTATCATCCATGGAAGGTGTTTTGATGGG eqbBCD for cloning pACYC-BCD 
ZM249 CACGACGGATCCAGTTCCATTCCAAAATCCT 
CC 
ZM402 GACGACGACCCATGGCAATGAAAATATATAG eqbC fragment for cloning pACYC-
AATAGAAATTTC CD-MN (from pACYC-BCD-MN) 
ZM403 CGCAACTTCCGACTTATATGC 
ZM406 TGGTGTTAGTTACATCTAACAC eqbC fragment for cloning pACYC-
ZM407 CACGACGGATCCTCCTATATGCAAATTGCTC BC-MN (from pACYC-BCD-MN) 
C 
ZM250 GACGACGACAGATCTTATGTATAATATAGGA eqbMN for cloning pACYC-BCD-
GTTTTAGGTTG MN and pACYC-MN 
ZM251 GTAGGTAGCGACGTCCAGCCAATAAAACCCA 
CTAATG 
ZM311 GACGACGACAGATCTAATGGATATGAGTTAT eqbN for cloning pACYC-BCD-N 
TTGAATTTA (used with primer ZM251) 
ZM312 GTAGGTAGCGACGTCTTATAGATTAAGTGGT eqbM for cloning pACYC-BCD-M 
GATGTGC (used with primer ZM250) 
ZM252 GACGACGACCCATGGTTATGATGAAAAAAGT eqbF for cloning pCDF-F 
TATTATATGTGG 
ZM253 GACGGATCCCAAGACCTTTTCTGTACAACTC 
ZM254d GACGACGACGGCCGGCCTCATGAAAATAGA eqbG for cloning pCDF-F-G and 
GAATAAATTAATAGAG pCDF-G 
ZM255 CACTACGCCGACGTCTTATTGCTCATTATTAT 
TCTCCTC 
ZM240 GACGACGACGCTAGCATGGAACTTAACAATA eqbE for cloning pET21a-E 
TAAAAGAAAG 
ZM241 GACGACGGATCCTTTTTTCATCATAAACTCCC 
TTC 
ZM313 GACGACGGATCCCGATGGAAGGTGTTTTGAT eqbB for cloning pGEX-eqbB 
GGG 
ZM314 GACGACCCCGGGCTTGTGTTAGATGTAACTA 
ACACC 
ZM315 GACGACGGATCCCAATGAAAATATATAGAAT eqbC for cloning pGEX-eqbC 
AGAAATTTC 
ZM316 GACGACGAATTCCTCCTATATGCAAATTGCT 
CC 
ZM317 GACGACGGATCCCTATGAATATAGAATTGAA eqbD for cloning pGEX-eqbD 
AGAAAATTTAG 
210 
Table 4.1 continued 
Primer Sequence (5' ·3') Purpose 
ZM318 GACGACGAATTCAGTTCCATTCCAAAATCCT eqbD for cloning pGEX-eqbD 
CC 
ZM319 GACGACGGATCCCAATGGAACTTAACAATAT eqbE for cloning pGEX-eqbE 
AAAAGAAAG 
ZM320 GACGACCCCGGGCTTTTTTCATCATAAACTCC 
CTTC 
ZM321 GACGACGGATCCCTATGATGAAAAAAGTTAT eqbF for cloning pGEX -eqbF 
TATATGTGG 
ZM322 GACGACGAATTCCAAGACCTTTTCTGTACAA 
CTC 
ZM323 GACGACGGATCCCCATGAAAATAGAGAATA eqbG for cloning pGEX-eqbG 
AATTAATAGAG 
ZM324 GACGACCCCGGGTTATTGCTCATTATTATTCT 
CCTC 
ZM325 GACGACGGATCCCTATGTATAATATAGGAGT eqbM for cloning pGEX-eqbM 
TTTAGGTTG 
ZM326 GACGACGAATTCTTATAGATTAAGTGGTGAT 
GTGC 
ZM376 GACGACGGATCCTTAAGATATTTAACAAAAG eqbN for cloning pGEX-eqbN 
AATAGACTATG 
ZM328 GACGACGAATTCCAGCCAATAAAACCCACTA 
ATG 
Restriction sites are underlined. 
pACYC-BCD-MN. pCDF-F-G and pET21a-E were introduced to BL21(DE3) via 
electroporation. The resultant E. coli strain was grown in Luria-Bertani (LB) broth media 
or a ininimal media (MM) containing: 1.5 mg mrl KH2P04, 4.34 mg ml-l K2HP04, 0.4 mg 
mrl (N~hS04' 0.22 mg ml-I MgS04.7H20, 5 mg ml-I glucose, 24.5 mg ml-I FeC6Hs0 7, 
2.76 mg mrl ZnS04.7H20. 1 mg ml- I CaCho 2 mg ml- I Na2Mo04.2H20, 1.21 mg ml- I 
CUS04 and 0.5 mg ml- I H3B03. Media was supplemented with 50 f.1g mrl ampicillin, 50 
f.1g ml- I spectinomycin and 34 f.1g ml- I chloramphenicol. Cultures were inocul~ted 4% 
(vol/vol) with a starter culture and growth was carried out at 37°C on a rotary shaker (220 
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rpm) to an optical density at 600 nm between 0.6 and 0.8. 0.4 mM IPTG was added 
together with 1 mM salicylate and the culture was incubated for a further 20 h at 28°C with 
shaking (220 rpm). Samples were taken for SDS-PAGE analysis prior to IPTG induction 
and 4 h post IPTG induction. After 20 h, supernatant was collected and filter sterilised for 
LC-MS analysis (see Chapter 3 methods). Supernatants were also tested for their ability to 
decolourise CAS reagent (Schwyn & Neilands, 1987) (see Chapter 3 methods). In 
addition, CAS test agar (Schwyn & Neilands, 1987) containing 1.2% agar, CAS indicator 
and MM, supplemented with salicylate, antibiotics and IPTG (as described above) was 
prepared to see if halos of decolourization appeared around cultured E. coli strains 
expressing all 8 Eqb proteins. 10 m1 CAS indicator containing 5 m1 CAS solution (0.06 g 
CAS in 50 m1 H20), 1 m1 iron (III) solution (1 mM FeCh in lOmM HCI) and 4 m1 
HDTMA (0.07 gin 40 ml H20) was added per 100 m1 of CAS test agar. For a positive 
control, P. aeruginosa was cultured on CAS test agar. 
In order to test the influence of cross-fed filter sterilised supernatant from E. coli on the . 
streptonigrin sensitivity of S. equi strain /1eqbAE (see Chapter 3 methods), cells induced 
for 4 h with IPTG were harvested, washed 3 x and re-suspended in fresh media without 
antibiotics. Cells were incubated for another 16 h at 28°C with shaking (220 rpm) before 
the supernatant was collected, filter sterilised and analysed for its influence on 
streptonigrin sensitivity (/1eqbAE cross-feeding bioassay) and by LC-MS. 
Additional combinations of plasmids were constructed in order to assess the contribution 
of EqbB, EqbD, EqbE, EqbF, EqbG, EqbM and EqbN to the biosynthesis of the eqb NRPS 
product(s) in E. coli and also to provide appropriate negative controls for this system of 
production. An eqbC N-terminal DNA fragment was used to replace eqbB and part of 
eqbC in pACYC-BCD-MN following NcoI/NsiI digestion to generate pACYC-CD-MN 
(Table 4.1). An eqbC C-terminal DNA fragment was used to replace eqbD and part of 
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eqbC in pACYC-BCD-MN following NsiIlBamID digestion to generate pACYC-BC-MN 
(Table 4.1). eqbM and eqbN were cloned separately into the MCS-2 of pACYC-BCD 
using BgIlllAatII to generate pACYC-BCD-M and pACYC-BCD-N, respectively (Table 
4.1). 2 E. coli strains lacking EqbB and EqbD contained pACYC-CD-MN, pCDF-F-G, 
pET21a-E and pACYC-BC-MN, pCDF-F-G, pET21a-E, respectively. 2 further E. coli 
strains lacking EqbE and EqbF contained pACYC-BCD-MN, pCDF-F-G, pET21a and 
pACYC-BCD-MN, pCDF-G, pET21a-E, respectively. An E. coli strain lacking EqbG 
contained pACYC-BCD-MN, pCDF-F and pET21 a-E. Another 2 strains lacking EqbM or 
EqbN contained pACYC-BCD-N, pCDF-F-G, pET21a-E or pACYC-BCD-M, pCDF-F-G, 
pET21a-E, respectively. 
4.3.2 In vitro reconstitution of the ICESe2 NRPS product(s) 
The pGEX-3X expression system (GE Healthcare) was used for the production and 
purification of recombinant EqbB, EqbC, EqbD, EqbE, EqbF, EqbG, EqbM and EqbN 
proteins in E. coli DHlOB using the method described in Chapter 3 (for the overexpression 
and purification of EqbA). Carl Robinson (AHT) expressed and purified the Eqb proteins. 
DNA fragments containing eqbB, eqbC, eqbD, eqbE, eqbF, eqbG, eqbM and eqbN genes 
were amplified by PCR from Se4047 chromosomal DNA with Phusion polymerase (NEB), 
using primer pairs indicated in Table 4.1. eqbB, eqbE, eqbG were cloned into the MCS of 
pGEX-3X using BamHIISmaI digestion and eqbC, eqbD, eqbF, eqbM, eqbN were cloned 
into the MCS of pGEX-3X using BamHIISmaI digestion. The resulting constructs were 
named pGEX-eqbB to pGEX -eqbN (Table 4.1). 
The in vitro synthesis of the ICESe2 NRPS product was performed using the method used 
to reconstitute yersiniabactin (Miller et ai., 2002), with some modifications. A solution of 
0.2 11M EqbB, 0.2 11M EqbC, 0.2 11M EqbD, 0.2 11M EqbE, 0.2 11M EqbF, 0.2 11M EqbG, 
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0.2 11M EqbM, 0.2 11M EqbN, 100 mM Tris-CI (pH 7.6),0.1 M NaCl, 0.8 mM CaCh, 1 
mM TCEP, 1 mM CoASH, 2 mM L-cysteine, 0.75 mM SAM, 0.75 mM NADPH and 
2mM salicylate was incubated at 30°C for 1 hr to allow phosphopantetheinylation of the 
EqbE and EqbG. As a control, the same reaction mixture was prepared, but with EqbE and 
EqbG omitted. Then, 10 mM ATP was added, and the reaction mixtures were incubated 
for 14 hr at 30°C. All reagents were purchased from Sigma. Reaction mixtures were 
stored at -20°C until their analysis by LC-MS according to the methods described in 
Chapter 3. A small sample was diluted 1 in 4 (in water), filter sterilized and analysed for 
its influence on streptonigrin sensitivity using the AeqbAE cross-feeding bioassay (see 
Chapter 3 methods). The diluted sample was also tested for its ability to decolourise CAS 
reagent (see Chapter 3 methods). 
4.4 Results 
4.4.1 Heterologous production of the ICESe2 NRPS product(s) in Escherichia coli 
To determine if all of the genes necessary for the production of the ICESe2 NRPS 
product(s) were present in the eqb locus, and to produce this product in a less complex 
media, eqbB, eqbC, eqbD, eqbE, eqbF, eqbG, eqbM and eqbN were cloned into 3 
expression plasmids with compatible replicons (Figure 4.1). Production of all 8 Eqb 
proteins was induced by IPTG treatment of transformed E. coli strain BL21(DE3) cells 
grown to log phase in LB broth or a MM in the presence of 1 mM salicylate as described in 
Methods. SDS-PAGE analysis revealed protein bands corresponding to EqbD, EqbF and 
EqbE in induced samples (Figure 4.2); however protein bands representing the other 5 Eqb 
proteins were not obvious in the soluble fraction. 
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Figure 4.2 SDS-PAGE analysis of E. coli strains expressing Eqb proteins 
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SDS-PAGE gel pictures in panels A to D show soluble protein fractions collected from E. 
coli strains expressing different complements of Eqb proteins following culture in LB 
broth (panels A and C) or minimal media (MM) (panels B and D). Proteins were separated 
on 8% (panels A and B) and 15% resolving gels (panels C and D). M: protein marker; lane 
1: pre-induction sample from E. coli expressing EqbBCDEFGMN proteins; lanes 2-7: 4 h 
post-induction samples; lane 2: E. coli expressing EqbBCDEFGMN proteins; lane 3: E. 
coli expressing EqbBCD proteins; lane 4: E. coli expressing EqbMN proteins; lane 5: E. 
coli expressing EqbF protein; lane 6: E. coli expressing EqbG protein; lane 7: E. coli 
expressing EqbE protein. Red arrows highlight protein bands corresponding to EqbD (60 
kDa, lanes 2 and 3), EqbF (82 kDa, lanes 2 and 5), EqbE (235 kDa, lane 7). Bands 
corresponding to EqbB (29 kDa), EqbC (26 kDa), EqbM (41 kDa), EqbN (35 kDa) and 
EqbG (148 kDa) were not observed. 
Filter sterilised supernatant from E. coli containing all 8 eqb CDS and grown in LB 
increased the sensitivity of strain l1eqbAE to streptonigrin from 1 11M to 9.002 11M, but had 
no effect on the sensitivity to erythromycin in cross-feeding assays (Table 4.2). Exclusion 
of eqbB, eqbE, eqbF, eqbG, eqbM or eqbN prevented the associated increased streptonigrin 
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sensitivity suggesting that all 6 of these proteins are required for reconstitution of the 
equibactin NRPS in E. coli (Table 4.2). However, exclusion of EqbD, which is predicted 
to acetyl ate salicylate, did not prevent the increase in streptonigrin sensitivity unless 
salicylate was also left out of the culture media. An increased sensitivity to streptonigrin 
on cross-feeding strain !:J.eqbAE with filter sterilised MM following growth of E. coli 
containing all 8 eqb CDS from 0.06 to 0.002 was also observed (Table 4.2). 
Table 4.2 Streptonigrin and erythromycin sensitivity in the /).eqbAE strain cross-fed with 
filter-sterilised culture supernatant from E. coli strains expressing different complements of 
Eqb proteins 
Conditioned media from Media Streptonigrin MIC Erythromycin MIC of 
E. coli expressing Eqb of strain l1eqbAE (~) strain l1eqbAE (Ilg ml'!) 
proteins 
EqbBCDEFGMN LB 0.06 0.004 
EqbBCDEFGMN LB + 1 mM salicylate 0.002 0.004 
EqbCDEFGMN LB + 1 mM salicylate 1 0.004 
(no EqbB) 
EqbBCEFGMN LB + 1 mM salicylate 0.002 0.004 
(no EqbD) 
EqbBCEFGMN LB 1 0.004 
(no EqbD) 
EqbBCDFGMN + LB + 1 mM salicylate 1 0.004 
pET21a (no EqbE) 
EqbBCDEGMN LB + 1 mM salicylate 1 0.004 
(no EqbF) 
EqbBCDEFMN LB + 1 mM salicylate 1 0.004 
(no EqbG) 
EqbBCDEFGN LB + 1 mM salicylate 1 0.004 
(no EqbM) 
EqbBCDEFGM LB + 1 mM salicylate 0.5 0.004 
(no EqbN) 
EqbBCDEFGMN MM + 1 mM salicylate 0.002 0.016 
EqbBCDFGMN + MM + 1 mM salicylate 0.06 0.016 
pET21a (no EqbE) . 
Bacteria were grown to stationary phas.e i~. LB ± 1 mM ~alicylate ?~ ~M + .1 mM 
salicylate. MIC refers to the minimum mhlbltory concentratIOn of antibIOtiC reqUired to 
prevent growth. 
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However, despite these effects on the streptonigrin sensitivity of strain ~eqbAE in cross-
feeding assays, repeated LC-MS analysis of culture supernatants, including conditioned 
MM, failed to identify equibactin. In addition, no changes were observed in the CAS assay 
indicative of iron-chelating activity. 
4.4.2 In vitro reconstitution of equibactin 
Recombinant forms of the 8 Eqb proteins (expressed and purified by Carl Robinson, AHT) 
were mixed with substrates that were predicted to be required by the NRPS catalysts for 
the biosynthesis of equibactin. Equibactin is proposed to have the same substrates and 
mechanism of synthesis as yersiniabactin (with the exception of the polyketide component 
of yersiniabactin synthesis requiring the substrate malonyl-CoA) and reaction conditions 
accordingly were similar to those used for the in vitro reconstitution of yersiniabactin. 
However, limitations in the quantity and concentration of purified Eqb proteins meant that 
a lower concentration of biosynthetic proteins was used for the in vitro reconstitution of the 
eqb NRPS product(s) (0.2 J.lM compared to 5 J.lM used in yersiniabactin biosynthesis) and 
the experiment was performed only once. Unfortunately, LC-MS analysis (performed by 
Lijiang Song, Warwick University) failed to identify differences between the test and 
negative control samples. Neither was a colour change observed in the CAS assay, 
although reaction mixtures had to be diluted 1 in lOin order to perform this test without 
interference from components of the reaction mixture. However, an increased sensitivity 
to streptonigrin on cross-feeding strain ~eqbAE with filter sterilised reaction mixture 
(diluted 1 in 4) containing a118 Eqb proteins from 0.03 to 0.008 (4-fold) was observed. 
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4.5 Discussion 
Reconstitution of the equibactin NRPS in E. coli was successfully achieved using three 
compatable expression plasmids containing eqbB, eqbC, eqbD, eqbE, eqbF, eqbG, eqbM 
and eqbN. Production in E. coli was enhanced by supplementation of growth media with 1 
mM salicylate, was abolished in the absence of eqbB, eqbE, eqbF, eqbG and eqbM and 
was reduced in the absence of eqbN. Therefore, each of these genes plays a role in the 
biosynthesis of an active eqb NRPS product(s) and the equibactin locus contains all of the 
genes unique to S. equi that are required for the biosynthesis of the NRPS product(s). 
The predicted functions of these encoded proteins are discussed in detail in Chapter 3. 
Clearly, the absence of either of the 2 NRPS proteins (EqbE and EqbG), which contain 7" 
and 4 of the 17 assigned functional domains, would be expected to severely disrupt the 
biosynthetic process. In agreement with this result, the ll.eqbE S. equi mutant strain was 
also unable to generate the NRPS product(s) (Chapter 3). eqbF encodes a putative 
thiazoline reductase with some partial homology to YbtU, the thiazoline reductase in Y. 
pestis. In vitro reconstitution of yersiniabactin in the absence of YbtU resulted in the 
production of a molecule that, unlike yersiniabactin, had a thiazoline ring in position 2 (not 
reduced to thiazolidine) and a thiazole in position one (resulting from spontaneous 
oxidation) (Miller et at., 2002). The impact of these modifications on yersiniabactin 
function has not been reported. PchG, the homologous thiazoline reductase of P. 
aeruginosa, introduces a methyl group to the ~-atom of the thiazolidine ring in pyochelin 
(Patel & Walsh, 2001). A similar function catalysed by EqbF in S. equi could alter the 
stereochemistry of the final NRPS product(s) and influence its iron-binding activity as a 
result. 
Interestingly, EqbD, which is predicted to activate salicylate to the adenyl ate form and 
initiate the equibactin biosynthetic process, was not necessary for production of the NRPS 
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product(s) provided that salicylate was added to the growth medium. This result is 
somewhat surprising and suggests that E. coli BL21 (DE3) has an alternative mechanism to 
activate salicylate. The finding that EqbB was required for the biosynthesis of the NRPS 
product(s) suggests that this stand alone thioesterase may playa more significant role in 
the biosynthetic process than is generally observed in other NRPS systems. These type-II 
thioesterases were initially thought to cleave incorrectly loaded substrates from PCP 
domains, but more recent work suggests that their role is to hydrolytically remove 
inactivating acetyl groups from the 4' -phosphopantetheine thiols of PCP domains 
(originating from the utilization of acetyl-CoA instead of CoA in the post-translational 
modification of PCP domains) to regenerate active free thiol groups (Challis & Naismith, 
2004; Schwarzer et aI., 2002). The removal of type-II TEs generally decreases product 
titres but does not completely abolish product synthesis (Schneider & Marahiel, 1998). 
Finally, the role played by EqbM and EqbN in the biosynthesis of the NRPS product(s) is 
unknown. The process used to release the mature NRPS product from the last carrier 
domain of EqbG is unclear and EqbN, a putative aJ~ hydrolase may prove to be important 
here. 
In vitro reconstitution of the eqb NRPS product(s) appeared successful as evidenced by the 
4-fold increase in streptongrin sensitivity of the LleqbAE strain cross-fed with reaction 
mixture containing all 8 Eqb proteins. This suggests that further work using higher 
concentrations of recombinant proteins might yield useful information on the structure of 
the NRPS product(s) and its mechanism of biosynthesis. 
4.6 Conclusions 
E. coli has once again proven to be a suitable host for the heterologous production of a 
foreign non-ribosomal peptide. The ease of genetic manipulation in this host has enabled 
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a rapid identification of the biosynthetic eqb genes necessary for the production of the eqb 
NRPS product(s), at least in E. coli. Although these advances have not yet led to the 
identification of the NRPS product(s), the early success shown using in vitro reconstitution 
suggests that, with improvements, this goal is much closer to being met. 
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Chapter 5 Quantitative PCR for the detection of Streptococcus equi 
5.1 Introduction 
S. equi is a highly successful pathogen that has plagued the equine population for centuries 
and contributes to nearly 30% of all infectious diseases reported in horses worldwide 
(Chanter, 1997). A major facet to this success, as for many bacterial pathogens, is the 
ability to readily transmit to others and propagate in naive hosts. This is particularly 
important to S. equi, a bacterium that is unable to survive for long in the environment. 
Accordingly, measures that interfere with the transmission process contribute considerably 
to the containment of the disease. Diagnostic assays are clearly important for disease 
control. Identification of horses that are acutely infected with the pathogen, a process that 
may simply require confirmation of infection following a display of classical strangles 
signs, will usually initiate the implementation of movement restrictions and isolation 
procedures to contain the infection. Of equal importance, the ability of diagnostic tests to 
detect persistently infected healthy horses that harbor the pathogen can prevent the 
initiation of future outbreaks. Greater understanding of the contribution that persistently 
infected carriers have to the spread of strangles has highlighted the need to develop 
increasingly sensitive assays in order to identify these animals more easily. 
For many years, detection of S. equi relied solely on morphological and biochemical 
evaluation, a process that is still in use today. Culture on streptococcal selective blood 
agar allows the examination of colony chatacteristics such as size, colour, mucoid 
appearance and beta-haemolytic activity. The Lancefield capsule agglutination assay is 
used to distinguish different streptococcal groups. The catalase test is frequently used to 
differentiate streptococci from staphylococci. Finally, S. equi is differentiated from S. 
zooepidemicus, which shares many phenotypic characteristics and is often isolated from 
the respiratory tract of horses. Discrimination of these 2 subspecies relies on their ability 
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(or inability) to ferment ribose, sorbitol and lactose. An inability to ferment trehalose 
separates the S. equi and S. zooepidemicus from S. equisimilis. Culture testing has the 
advantage of detecting only viable bacteria so that veterinarians are aware of the definitive 
risk these infected individuals pose to others. Strains collected in this way can also be used 
for further research. However, this approach suffers a number of disadvantages. 
Notwithstanding the time consuming, labour and skills intensive nature of such analysis, 
this methodology also suffers drawbacks of S. equi growth inhibition (or masking) by 
competing bacteria, which ultimately reduces assay sensitivity. In addition, atypical S. 
equi that ferment one or both of lactose and trehalose have been described (Grant et ai., 
1993). 
The era of nucleic acid-based assays has revolutionized the diagnosis of infectious 
diseases, more recently built on the increasing number of published genome sequences 
from pathogenic bacteria. Today the major driving forces for developing new diagnostic 
techniques are reduced hands-on-time and time to diagnosis, as well as increased 
sensitivity and specificity. These goals are achieved by automating processes and refining 
detection methods. PCR can detect down to a single molecule of target DNA in a test 
sample by the amplification of millions of copies lying between oligonucleotide primers, 
used to direct repeated rounds of synthesis by a DNA polymerase. PCR also has the 
potential to detect a single target organism amongst millions of others. 
The earliest assessment of PCR-mediated S. equi identification focused on the 16S-23S 
rONA intergenic spacer region but was quickly ruled out due to the inability to design 
species-specific oligonucleotide primers able to differentiate S. equi from S. zooepidemicus 
(Chanter et ai., 1997). With this came a discouraging realisation that the identification of 
S. equi-specific target DNA absent from the very closely related but heterogeneous S. 
zooepidemicus population was not going to be an easy task. In 1997, as. equi PCR test 
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was developed based on the seM gene (Timoney & Artiushin, 1997). This test was 3 times 
more sensitive than culture for detection of S. equi in clinical samples· (Timoney & 
Artiushin, 1997) and has been used in the USA as a diagnostic assay for strangles 
(Holland,2008). Another version of this seM-based test was developed at the AHT using 
nested PCR (Newton et aI., 2000) and evaluated in a number of strangles outbreaks in the 
UK and Denmark (Gronbaek et al., 2006; Newton et aI., 2000). Using NP swab samples 
from established strangles carriers (n = 61), almost twice as many swabs were positive by 
PCR (56%) than by culture (30%) and 61 % were positive if both results were combined 
(Newton et aI., 2000). Of 12 GP lavage samples collected from established carriers, 76% 
were positive by PCR and 59% were positive by culture (Newton et al., 2000). The 
Danish group described a diagnostic sensitivity of 45% for PCR and 18% for culture from .~~ 
nasal swab samples and 80% vs 20% respectively from abscess material (Gronbaek et aI., 
2006). In addition, of 165 isolates of Lancefield group C identified to species level using 
standard biochemical tests, 45/45 S. equi isolates were positive by PCR, whilst 40 isolates 
of each species S. zooepidemicus, S. dysgalactiae and S. equisimilus were negative by 
PCR. This strain collection included epidemiologically independent Danish field isolates 
(Gronbaek et al., 2006). 
These findings were in agreement with previous work, which suggested that SeM is highly 
homogenous because of the cross-reactivity of sera from a horse convalescent from 
strangles with a number of different S. equi isolates and the lack of variation in HindIII 
restriction pattern between different S. equi isolates on Southern blot analysis using a seM 
gene probe (Galan & Timoney, 1988). However, subsequent work by 2 independent 
researchers demonstrated differences to the published sequence of the seM gene 
immediately after the region encoding the N-terminal signal sequence (Chanter et aI., 
2000; Meehan et aI., 1998). Even more recently, variation in the 5' region of the seM gene 
h d t · g method to differentiate members of the previously as been use as a ypm 
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indistinguishable S. equi population (Figure 5.1) (Anzai et aI., 2005 ; Kelly et aI. , 2006; 
Waller & Jolley, 2007). A publicly available online database at 
http://pubmlst.org/szooepidemicus/seM/ accessed 12.03.09 shows the identification of a 
total of 64 alleles of SeM. 
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Figure shows the functional regions of the S. equi SeM anti-phagocytic surface protein. 
Sequence variation occurs in the sub-typing region highlighted in grey between different 
strains of S. equi. A high ratio of non-synonymous to synonymous substitutions suggests 
that this sub-typing region is under strong diversifying selection. SzM, the homologous 
protein in SzH70 shares only 33% amino acid sequence identity in the divergent S. equi-
specific N terminal region shown in red. In-frame deletions have been identified in the N 
terminal portions of SeM in some S. equi strains isolated from strangles carriers. These 
fall within the 'deleted region' highlighted in the figure. 
The ratio of non-synonymous to synonymous substitutions in this target is extremely high 
suggesting that the SeM protein is under strong diversifying selection (Waller & Jolley, 
2007). This finding is not surprising since SeM is a cell-wall anchored surface protein 
(Table 2.5 , Chapter 2) that is accessible to the host immune system. SeM contributes an 
important protective antiphagocytic role to S. equi (Boschwitz & Timoney, 1994a; 
Boschwitz & Timoney, 1994b; Chanter, 1994; Meehan et aI., 2001; Timoney et aI., 
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1997b). In fact SeM is an immunodominant epitope of S. equi and a large proportion of 
antibody responses are directed to the N-terminus of this protein (Timoney, 1998). 
Mutation of seM over time has been observed during the course of strangles outbreaks 
(Katy Webb, unpublished data) and circumstantial evidence suggests that SeM sequence 
diversification aids the persistence of S. equi in the GP (Kelly et aI., 2006; Waller & Jolley, 
2007). Moreover, a small proportion of carriers harbor variants of S. equi with N-terminal 
in-frame regions deleted from the seM gene (Figure 5.1). In one study, 24% of carriers 
sampled from independent outbreaks carried truncated SeM alleles compared to < 1 % of 
horses still in the acute phase of strangles (Chanter et aI., 2000). The deletions were in 
slightly different positions between the signal sequence and the central repeat region of 
SeM, equivalent to approximately 20% of the mature expressed protein (Chanter et a!., 
2000). A recent, more extensive study identified 2 variants from 2 carriers in a single 
outbreak that had a 324 bp N-terminal deletion on a SeM-9 background (Katy Webb, 
unpublished data). A SeM-9 strain had previously been identified from one of these 
horses. This was out of 37 carrier isolates (5.4%) identified in the study of 259 S. equi· 
isolates (115 horses, 23 independent strangles outbreaks). Such deletions in the seM target 
DNA would lead to false negative results by PCR in this small population of horses. 
Variation in the primer binding sites might also lead to false negative PCR results. SzH70 
encodes a variant of SeM with a unique N-terminus (SzM, Figure 5.1). Therefore, S. equi-
specific seM primers must be designed to the N-terminal variable region of this S. equi 
protein in order to prevent cross-reaction with ~. zooepidemicus derived DNA. 
Overall, these data suggest that more appropriate targets should be investigated in order to 
reduce the potential risk of infective horses being missed during PCR screening. A 
multiplex PCR test, based on a S. equi subspecies-specific region of the superoxide 
dismutase gene sodA and the S. equi-specific mitogenic toxin gene see!, was developed to 
detect and differentiate S. equi and S. zooepidemicus subspecies (Alber et ai., 2004). A 
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number of S. equi and S. zooepidemicus isolates (17 and 26 respectively) were tested using 
this multiplex PCR. The sodA gene was amplified in all isolates; whilst the see! gene was 
only detected in the S. equi isolates (100%). Figure 2.6, Chapter 2 also shows that the see! 
gene was present in all diverse S. equi isolates but absent from the collection of varied S. 
zooepidemicus strains. However, SeeI is a secreted protein of S. equi and the authors did 
propose that a large number of isolates should be screened to ensure that sequence 
variation in primer binding sites was not occurring (Alber et aI., 2004). Allelic variation in 
the S. pyogenes mitogen, SmeZ, highlights the pressure on superantigens to avoid host 
immune defences (Arcus et al., 2000). 
More recently a Swedish group developed a real-time version of this multiplex PCR and 
correctly assigned the identity of 23/23 S. equi isolates and 24/24 S. zooepidemicus isolates 
from a strain collection of the National Veterinary Institute (Baverud et aI., 2007). The 
sensitivity of the real-time PCR test in terms of DNA copy number detected was not 
established but the test was shown to enhance the detection of S. equi by 13% (2115) 
compared to conventional biochemical analysis. PCR was performed on DNA extracted 
from mixed and pure colony material following culture of clinical samples on agar plates. 
The authors did amplify the see! target in a control strain of S. pyogenes, which in a mixed 
culture with S. zooepidemicus could result in a false positive S. equi result (Baverud et al., 
2007), although S. pyogenes is not likely to be detected in equine respiratory samples. The 
test was. not appropriate for the reliable detection of S. zooepidemicus since 3 S. 
zooepidemicus isolates with aberrant sodA gene sequences were negative by PCR (Baverud 
et aI., 2007). 
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5.2 Aims 
The genome comparison of Se4047 and SzH70, aided by gene prevalence screening across 
a diverse population of typed S. equi and S. zooepidemicus strains has given an 
unprecedented opportunity to identify novel diagnostic targets that delineate these 
subspecies. For the specific detection of S. equi, the eqbE gene was selected as an ideal 
DNA target for PCR. eqbE, present on ICESe2, was a constant genetic feature of all S. 
equi strains but was absent from the collection of S. zooepidemicus strains tested (Chapters 
2 and 3). In addition, no close homologues of eqbE were identified in any other organisms 
in the public databases. The work described in this Chapter set out to further assess the 
suitability of the eqbE target for the detection of S. equi by PCR. I also intended to make 
use of new technological advances and assess the suitability of the eqbE target for " 
quantitative real-time PCR. Since eqbE PCRs were developed for Chapters 2 and 3, the 
specific objectives for this Chapter were as follows:-
1. To sequence a diverse set of S. equi strains in order to examine sequence 
variability in the eqbE target. 
2. To develop a real-time quantitative eqbE-based PCR test and assess the sensitivity 
of this assay. 
5.3 Methods 
5.3.1 DNA extraction 
To extract a high yield and quality of genomic DNA from Se4047 to serve as a stock for 
the preparation of PCR standard controls, the following protocol was used. A 10 ml 
overnight starter culture of Se4047 in THB was subcultured into 2QO ml fresh THB 
supplemented with 30 ~gm1-1 hyaluronidase and grown overnight at 37°C with 5% C02. 
Cells were harvested (5,000 g, 10 min, room temperature) and resuspended in 20 ml 0.1 M 
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EDTA, 0.15 M NaCI, pH 8.5. Lysozyme (10 mg) and mutanolysin (5 kU) were added and 
the suspension was incubated without shaking at 37°C for 2 h for lysis to occur. 200 III 
RNase solution (R6148, Sigma) was added and the suspension was incubated for a further 
10 min at room temperature. 1 ml of 10% SDS was then added, followed by 4.2 ml 5 M 
sodium perchlorate and 50 ml chloroforrnloctanol (24:1 volume:volume), with thorough 
mixing between each addition. The mixture was then mixed thoroughly for 15 min at 
room temperature and centrifuged (15,000 g, 20 min, 4°C). Following centrifugation, the 
top aqueous layer was removed and added gently to a beaker containing 2.5 volumes of 
ethanol to create 2 phases. DNA was recovered by spooling on a glass hook, washed in 
70% ethanol (5 ml) and resuspended in 1 ml 10 mM Tris-HCI, pH 9.0,0.5 mM EDTA. 
The quantity and purity of DNA was determined by optical density measurements at 260 
and 280 nm using a NanoDropR NDlO00 spectrophotometer (NanoDrop Technologies). 
Agarose gel electrophoresis was also used to assess the quality of the DNA extracted. 
DNA template copy number was determined using the formula:-
Number of copies = amount of DNA (ng) x 6.022 x 1023 
length of DNA (bp) x 1 X 109 x 650 
This calculation assumes that the average weight of a bp is 650 Daltons. The length of the 
S. equi chromosome is 2,253,793 bp. 
All other DNA extractions were performed on colony material scraped from agar plates or 
collected by centrifugation (1 ml) from overnight cultures grown in THB at 37°C with 5% 
CO2• DNA was extracted using the GenElute Bacterial Genomic BNA kit (Sigma) 
according to manufacturer's instructions. 
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5.3.2 Real-time quantitative peR 
Table 5.1 Oligonucleotides used for eqbE endpoint-PCR, eqbE quantitative PCR and 
sequencing across the eqbE PCR target sites 
Primer/ probe Sequence (5' to 3') Purpose 
EqbEf AAGATATAGCAGCATCGTATCG QPCRand 
sequencing 
EqbEr TCTAAATCTCTATTAAATAGCGGTATATTG QPCR 
Equidetectin TCTaTGgTTcTTcT AACTGCCTATGC Dual labelled 
hybridization probe 
for QPCR 
2f GGGTTGCCATGCATATCTTG eqbE endpoint-PCR 
2r TCCGGCTGTTTCCTTAATGG 
ZM435 CCGAATTTGTCCAAGTGGTATG Sequencing 
ZM436 GCACTCCGTTATACTCACTG 
ZM437 TTTGCTAGTGCTACTCCTGC 
Locked nucleic acids (LNAs) are shown in undercase. 
Probe and primer sequences were designed by Sigma using Beacon Designer software 
(Table 5.1). The DNA probe was dual labelled with 5' 6-FAM and 3' BHQ-1 (Black Hole 
Quencher-1) and contained LNAs to improve probe thermostability. Suitable primer and 
probe concentrations for QPCR were established following optimization experiments. All 
reactions were performed in duplicate or triplicate. The optimized 20 Jll reaction contained 
test DNA sample (2 Jll) or standard Se4047 DNA of a known template copy number, 0.3 
JlM forward and reverse primers (Sigma), 150 nM DNA probe (Sigma) and Ix ABsolute 
Blue QPCR mix (Abgene). Thermocycling was performed at 95°C for 15 min, followed 
by 50 cycles of 95°C for 15 s, and 60°C for 30 s. Fluoresence was read during the 
annealing/extension step of each cycle. Positive, negative and no-template controls were 
included. QPCR was performed in Techne Thermofast 96 non-skirted low-profile plates 
sealed with clear seal diamond optically clear heat sealing film (Thermo Scientific) in a 
Techne Quantica instrument and data analysed using Quansoft software (Techne). 
Crossing point (Cp) was determined for each sample or standard using the default settings 
of the Quansoft programme. Fluorescence was plotted on a log scale against cycle number 
(Figure 5.2). A noise threshold was set 4 standard deviations (SD) above background 
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fluorescence, which was calculated as the average fluorescence between cycles 3 and 10. 
A crossing threshold was set 10 SD above background fluorescence. Cp was determined 
using 2 fit points on the curve above the crossing threshold to calculate by linear regression 
the best-fit gradient. The intersection of this line through the crossing threshold was 
defined as the Cp in terms of cycle number. Standard curves (Cp vs log gene copy 
number) were generated to assess PCR efficiency and calculate the number of template 
DNA copies in an unknown sample. 
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Figure 5.2 Calculation of crossing point (Cp) 
Relative fluorescence is plotted on a logarithmic scale against cycle number. Red lines 
represent signal from standard controls , the green line is an unknown sample and the blue 
line is a no-template control. Crossing threshold and noise threshold are marked at 10 SD 
and 4 SD above background fluorescence, respectively. 2 fit points are marked on each 
curve above the crossing threshold and a line of best fit to these points is marked. Cp is 
determined where this line intersects the crossing threshold. 
QPCR was also performed using the above conditions without probe and with the 
ABsolute QPCR SYBR Green mix (Abgene) instead of the ABsolute Blue QPCR mix 
(Abgene). Dissociation curves were analysed following a final ramp step from 60°C to 
90°C with reads at O.SoC increments. This SYBR Green QPCR was performed to check 
that the primers were not mispriming and generating non-specific amplification products . 
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5.3.3 Sequence analysis 
A 1,063 bp region of the eqbE gene that included both endpoint-PCR and QPCR target 
sites was sequenced in 26 strains of S. equi (including diverse SeM and MLST types, Table 
5.2) to check for sequence variability. PCR was performed using Phusion DNA 
polymerase (NEB) according to the manufacturer's instructions using the ZM435 and 
ZM436 primers (Table 5.1). The amplified product was purified using the QIAquick PCR 
purification kit (QIAGEN) according to the manufacturer's instructions. Sequencing was 
performed using BigDye® Terminator Cycle Sequencing (Applied Biosystems). A 15 III 
sequencing reaction contained 2 III BigDye reaction mix, 2 III dilution buffer (0.4 M Tris 
pH 9.0, 10 mM MgCh), 1.6 III 10 11M ZM435, ZM436, ZM437 or EqbE f primer (Table 
5.1) and 1 III purified PCR product. 25 thermocyc1es of 96°C for 30 s, 50°C for 15 sand __ 
60°C for 4 min were performed. DNA was precipitated by the addition of 21.t1 3 M sodium 
acetate, pH 4.6 and 50Jll95% ethanol (15 min, room temperature). Precipitated DNA was 
pelleted by centrifugation at 2,254 g for 30 min, the supernatant was discarded and 180 III 
of 70% ethanol was added. A 2nd centrifugation step (2,254 g for 10 min) was performed, 
the supernatant discarded and the pellet air dried at 37°C for approximately 30 min. The 
DNA was finally resuspended in 10 III HiDi formamide (Applied Biosystems), heated to 
95°C for 2 min and analysed with an ABI 3100 DNA sequencer. SeqMan 5.03 DNAstar 
software (Lasergene) was used to analyse sequence reads. 
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Table 5.2 Identity of S. equi isolates screened for sequence variability in the eqbE gene 
target 
SeM ST Source Isolate ID Diseasel Source Animal Year 
allele 
2 179 Ireland SA Strangles Horse 1999 
2 179 Canada 303 Strangles Horse 1999 
2 179 New York CF32 Strangles Horse 1981 
3 179 Hampshire Se4047 Strangles Horse 1990 
5 179 Leicestershire B237325 Strangles Horse 2003 
5 179 Leicestershire 7326 Strangles Horse 2003 
6 179 Hertfordshire 8229 Strangles Dog 2004 
6 179 Suffolk 7060 Strangles Horse 2003 
6 179 Kent 1351 Strangles Horse 2004 
6 179 Essex 1350 Strangles Horse 2003 
6 179 Norfolk JKS 044 Strangles carrier Horse 2006 
6 151 Gwent 7329 Strangles Horse 2006 
7 179 Suffolk 1931 Strangles Horse 2004 
9 179 Hampshire 7344 Strangles Horse 2003 
9 179 Essex JKS 559 Strangles Horse 2007 
10 179 Hampshire 7140 Strangles Horse 2003 
10 179 Shetland 7171 Strangles Horse 2003 
11 179 Suffolk 7364 Strangles Horse 2003 
12 179 Suffolk 3154 Strangles Horse 2004 
13 179 Suffolk 3155 Strangles Horse 2004 
14 179 Suffolk 3156 Strangles Horse 2004 
15 179 Australia 181063 Strangles Horse 1999 
16 179 Lincolnshire JKS 063 Strangles Horse 2006 
44 179 Lincolnshire JKS 225 Strangles Horse 2006 
47 179 Norfolk JKS 043 Strangles Horse 2006 
52 151 UK Mo Strangles brain abscess Horse 2008 
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5.4 Results 
5.4.1 A conserved region in Streptococcus equi strains 
No sequence variability occurred in the 1,063 bp region of the eqbE gene amplified by 
ZM435 and ZM436 primers in 26 S. equi isolates. Primer sets 2ff2r and EqbE ff EqbE r 
were used for the eqbE-based end-point PCR (Chapter 3) and QPCR, respectively. These 
primers hybridize within the DNA fragment amplified by ZM435 and ZM436 in a region 
of the eqbE NRPS gene that encodes a putative condensationlheterocylization domain. 
The diverse set of isolates examined was representative of different SeM-types found 
around the world (Table 5.2 and Figure 1.4, Chapter one) and included the 2 most 
prevalent variants SeM-9 and SeM-6 (Kelly et aI., 2006), (Katy Webb, unpublished data). 
S. equi strains are mostly MLST ST-179 but 2 is?lates have been identified with ST-151, 
which is a single locus variant of ST-179. These were included in the analysis; one of 
which was recovered from a brain abscess, which is an unusual manisfestation of S. equi 
infection. One isolate tested was recovered from the first documented case of canine 
strangles (Ladlow et aI., 2006) and another was isolated from a persistently infected 
strangles carrier (Table 5.2). 
5.4.2 Development of a real time quantitative peR test for the detection of Streptococcus equi 
A dual labelled-probe based QPCR method was developed for the detection of S. equi. 
Probe and primer sequences specific for the eqbE gene were designed for QPCR using 
Beacon Designer software by Sigma (Table 5.1). The DNA probe was labelled with 5' 6-
FAM and 3' BHQ-l (Black Hole Quencher-l) and contained LNAs. A LNA nucleotide 
has a modified ribose moiety with an extra bridge connecting the 2' and 4' carbons. LNAs 
were included to increase the strength of the interaction between th~ probe and target 
sequence in a region of DNA that was rich in A and T nucleotides. This aimed t() ensure 
probe hybridisation prior to primer annealing so that extension by DNA polymerase 
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resulted in efficient exonucleolytic cleavage of the bound probe, release of the 6-FAM dye 
and a resultant increase in fluorescence as the 6-FAM moves away from the quencher dye. 
A higher melt temperature also promotes the specificity and sensitivity of probe 
hybridization to the target DNA. 
Suitable primer and probe concentrations for the QPCR were established following 
optimization experiments. Primer titrations using 50 nM, 300 nM and 900 nM 
concentrations of each primer were assessed to establish the optimum primer 
concentrations for the amplification of a 130 bp eqbE DNA fragment from a Se4047 
genomic DNA sample. 300 nM of EqbE f and 300 nM EqbE r gave the lowest Cp reading 
without introducing non-specific amplication (Figure 5.3A). Primer concentrations of 
300/900, 900/300 and 900/900 gave lower Cp values but non-specific products were 
sometimes amplified late in these PCR reactions. Probe concentrations of 50 nM, 100 nM, 
150 nM, 200 nM, 250 nM and 300 nM were evaluated. 150 nM was the minimal 
concentration of probe required to give the lowest Cp value (Figure 5.3B). The highest 
PCR efficiency was also achieved using 150 nM probe compared to 50 nM, 100 nM and 
250 nM probe (Table 5.3). Optimum PCR conditions therefore had 300 nM of forward 
and reverse primer and 150 nM of DNA probe. Using these conditions a standard curve 
was generated from Se4047 genomic DNA template controls ranging in concentration from 
107 copies to 10 copies through lO-fold serial dilutions (Figure 5.4). These standards fell 
within the linear working range of the assay (R2 = 0.998), which had a PCR efficiency of 
93%. A good QPCR assay is usually expected to have efficiency within the range 90% -
110%. One copy of template DNA could be detected using this assay, but not in a 
consistent fashion (not shown). Generally no fluorescent signals were recorded from 
negative or no-template controls but occasionally a signal was observed very late in the 
PCR reaction at a cycle number equivalent to less than 10 copies of DNA, possibly as a 
result of cross contamination. A SYBR Green assay showed that only one product with a 
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melt temperature of 77.5°C was being amplified from the EqbE f and r primers at 300 nM 
concentrations (Figure 5.5). 
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Figure 5.3 Optimisation of primer and probe concentrations for QPCR 
(A) Primer concentrations of 300/900, 900/300 and 900/900 (nM/nM) gave the lowest Cp 
values but non-specific amplification products were sometimes amplified late in these PCR 
reactions. 300/300 (nM/nM) was therefore picked as an optimum concentration of forward 
and reverse primer. (B) 150 nM probe gave the lowest Cp value. 
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Table 5.3 Influence of probe concentration on QPCR efficiency 
Equidectin probe concentration (nM) QPCR efficiency (%) 
50 91.9 
100 92.6 
150 93.4 
250 91.4 
QPCR on 7 Se4047 genomic DNA standards ranging in concentration from 107 to 10 DNA 
copies through lO-fold serial dilutions was used to construct a standard curve and calculate 
QPCR efficiency for reactions using 300 nM forward and reverse primer and varying 
concentrations of probe. 
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Figure 5.4 eqbE QPCR standard curve 
(A) PCR cycle number plotted against relative fluorescence shows the increase in 
fluorescence as the PCR progresses. Red lines show Se4047 genomic DNA template 
standard controls ranging from 107 copies to 10 copies in 10-fold serial dilutions. Higher 
concentrations of template DNA are amplified earlier in the PCR reaction. The green line 
represents a sample of previously unknown S. equi DNA concentration. No-template 
controls are shown in blue. (B) Log template concentration is plotted against Cp (cycle 
number) to generate a standard curve. The equation of the line shown above the graph is 
used to calculate the quantity of S. equi DNA in unknown samples from their Cp value. 
The R2 value of 0.998 shows a good fit to the straight line (for a perfect fit R2 = 1) and the 
linear range covers 107 to 10 copies of template DNA. An E value of 1.867 demonstrates 
good PCR efficiency. An efficiency of 2 is achieved from an exact doubling of PCR 
product with each cycle. Similarly, a gradient of -3.32 represents 100% doubling 
efficiency. 
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Figure 5.5 Melt curve generated following QPCR 
A SYBR green assay shows one product being amplified with a dissociation temperature 
of 77.SoC from standard control Se4047 genomic DNA template samples. The negative 
first derivative (-dF/dT) peaks at a temperature at which the double stranded 130 bp 
fragment of eqbE PCR product melts and loses fluorescence due to loss of SYBR green 
intercalation. 
5.5 Discussion 
Improving technology provides new tools to identify better diagnostic targets and to detect 
those targets more effectively. Comparative genomic analysis revealed a novel genetic 
locus in S. equi, an NRPS system encoded on ICESe2, which may have contributed to the 
evolution of this important veterinary pathogen through increasing its ability to acquire 
iron (Chapters 2 and 3). This locus also offers an ideal target for PCR detection of S. equi. 
Although the product of this NRPS system is secreted, the eqbE-encoded enzyme involved 
in its biosynthesis has a predicted location in the intracellular compartment of the cell. 
Consequently, EqbE is not likely to be subjected to the high levels of diversifying selection 
suffered by other surface exposed antigens, such as SeM (Kelly et aI., 2006). The eqbE 
gene is also unlikely to vary in response to immune selection imposed on the secreted 
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peptide. Non-ribosomal peptides may be too small to elicit an immune response and, 
unlike ribosomally synthesised proteins, have little opportunity to vary in structure and still 
retain their activity. The diverse strains of S. equi examined here differed in their seM 
gene sequences, but had identical eqbE genes (in the target region examined). As mutation 
in primer binding sites generally leads to PCR failure, the variation in seM sequence has 
the potential to cause false negative results using tests that target this gene. 
In addition, a variant of SeM is encoded by SzH70 (SzM, Chapter 2) and other forms of 
SzM are likely to be spread throughout the heterogenous S. zooepidemicus population. 
Primers designed to the N-terminal region of seM were used to screen some of the diverse 
S. zooepidemicus strains detailed in Appendix Table A.4. Although this data has not been 
reported in this thesis, some isolates of S. zooepidemicus were positive by PCR suggesting 
that a small proportion of the S. zooepidemicus population encode a close SeM homologue. 
A risk of false positive reporting is therefore possible using seM-based PCR tests. 
Conversely, eqbE was not detected in any of the diverse S. zooepidemicus isolates by PCR 
(Chapters 2 and 3) and eqbN was absent from S. zooepidemicus isolates despite using low 
stringency conditions for detection by Southern blot (Chapter 2), suggesting that this locus 
is specific to S. equi. Moreover, the predicted amino acid sequence of EqbE had no close 
homologues in the public databases (Chapter 3). eqbE as a PCR target therefore offers 
advantages over the see] PCR target that can be detected in some strains of S. pyogenes 
(Alber et aI.~ 2004; Baverud et aI., 2007). ~RPS systems are rare in streptococci and 
potential siderophore biosynthetic systems have not yet been detected in streptococci 
(Donadio et aI., 2007) other than S. equi. 
An end-point PCR, developed in Chapter 3, that amplifies part of the eqbE gene was 
passed on to the AHT diagnostic team in 2006 for further validation and was subsequently 
commercialised for strangles testing. The eqbE-PCR had an approximate 5-fold improved 
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sensitivity compared to a seM-based PCR test being used at the time and also performed 
better on clinical isolates (Olivia Wahlan, unpublished data). 
The eqbE-PCR test was later redesigned to allow analysis by QPCR. A QPCR test with 
93% efficiency was developed, which could detect as few as 10 copies of S. equi genomic 
DNA (Figure 5.4). The QPCR was found to be more sensitive than the end-point PCR, 
which could detect 50 copies of template DNA. In addition, the probe hybridisation 
strategy used for detection of QPCR amplification confers an additional level of specificity 
to the test as the probe and both primers are required to anneal to the target sequence in 
order for the QPCR to work. The QPCR method was passed on to the AlIT diagnostic 
team for further validation and is now in operation as a commercial test. A patent" 
application has been submitted to permit licensing of this test to other diagnostic 
laboratories around the world. 
QPCR offers many advantages over the classical end-point PCR test. One important 
benefit is the quantification of the amount of S. equi DNA in the sample being tested. For 
example, a high level of S. equi detected in a clinical wash sample may leave a practitioner 
in less doubt that non-viable bacteria or cross-contamination of equipment during sampling 
could have contributed to a positive result. Customer confidence usually leads to greater 
usage, which has obvious advantages to the control and even eradication of strangles. 
Detection of iow levels of S. equi should not lead to the assumption that either of these 
scenarios has occurred. Intermittent NP shedding is a feature of S. equi infection and 
individuals carrying the pathogen in the GP may well shed fewer bacteria. Instead, these 
animals should be investigated further with repeat testing and/or GP endoscopy. 
Understanding how to use available diagnostic tools to their best advantage is an important 
aspect of disease control. Access to quantitative tools may also help to assess recovery 
from infection, including GP infections that often require lengthy antibiotic therapy. Other 
241 
advantages offered by the QPCR test include reduced, safer user handling with improved 
turnaround times and lower contamination risks. 
5.6 Conclusions 
Comparative genomic analysis has led to the identification of an excellent S. equi specific 
target for diagnostic PCR. The PCRs developed based on this DNA target offer improved 
sensitivity and potentially improved specificity with a reduced risk of false negative or 
positive results being reported. Already commercially available in the UK, the wider 
application of these tests may offer significant improvements to the diagnosis and control 
of strangles, particularly with the new quantitative aspect offered. In the future it may be 
possible with new technologies to translate this test onto a platform suitable for point of 
care diagnosis. 
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Chapter 6 Overall conclusions and future work 
The genome comparison between Se4047 and SzH70 has provided some explanations for 
the differences in host range and pathogenesis of these closely related organisms. In 
evolving from a versatile S. zooepidemicus ancestor to a highly specialised obligate equine 
pathogen, major adaptive features of the S. equi genome include the gain of MGEs, a loss 
of ancestral capabilities, and a change in the organisation or sequence of a number of genes 
(Holden, 2009). 
Gene prevalence screening by peR across diverse members of each subspecies helped to 
clarify genetic features that are unique to S. equi and identified members of the S. 
zooepidemicus population that share common features with S. equi with the potential to '" 
promote virulence. Quick, 'next-generation', sequencing technologies will allow many 
more S. equi and S. zooepidemicus genomes to be sequenced so that genetic changes that 
have contributed to the emergence of S. equi will be better defined and an order to these 
events described. This may highlight the importance of genetic factors identified in this 
study, but not yet analysed further. Future sequencing should also help to define the extent 
of heterogeneity in the largely clonal S. equi popUlation, which will be critical to future 
epidemiological analysis, vaccine development and the identification of changes that may 
occur as a result of host-pathogen interactions, for example, during persistence in the GP. 
Where vaccines are desired to prevent disease associated with S. zooepidemicus infection, 
more isolates can be sequenced to identify linked fitness genes that might prove suitable 
for vaccination. 
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6.1 The contribution of prophage exotoxins to pathogenicity or 
survival fitness of S. equi and strains of S. zooepidemicus 
In this study, S. equi was shown to have acquired 4 prophage, encoding a combination of 4 
superantigens and a phospholipase A2 toxin. A small number of S. zooepidemicus isolates 
also contained speL and speM, and further strains were predicted to encode novel 
superantigens. In addition, a significant proportion of the S. zooepidemicus population 
contained the phospholipase A2 gene, introduced into Se4047 by cpSeq2, but possibly 
acquired on a different prophage backbone in S. zooepidemicus. Superantigens and 
phospholipase A2 toxins are hypothesised to corrupt the equine immune response and 
facilitate the pathogenesis or survival fitness of S. equi and strains of S. zooepidemicus. 
The ability of these toxins to misdirect the equine immune system and thereby disrupt 
efficacious responses could be addressed using in vitro assays that quantify lymphocyte 
proliferation, cytokine responses, T cell anergy and antigen presentation. Early progress 
has already been made in this area, with See!, SeeL and SeeM shown to induce 
lymphocyte proliferation and the synthesis of interferon-y «Artiushin et aI., 2002), Romain 
Paillot, unpublished data). The contribution of exotoxins to pathogenicity could be 
established using in vivo models of disease and allelic replacement strains lacking specific 
toxin genes. 
Based on previous work carried out with GAS, superantigens and/or phospholipase A2 
enzymes are hypothesised to enhance specifically the adherence, colonisation, host cell 
cytotoxicity and/or dissemination exhibited by S. equi and certain strains of S. 
zooepidemicus. These characteristics could be assessed during in vivo infection and 
explored using in vitro assays. Human cell lines have been utilised to investigate the 
contribution of phospholipase A2 (SlaA) to GAS adherence and killing of epithelial cells, 
and similar systems could be established using equine celllines. Alternatively, an already 
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established air-interface model of the equine respiratory tract (Hamilton et al., 2(06) could 
be used to quantify these attributes at different time points following infection of organ 
cultures by wild-type and mutant strains of S. equi or S. zooepidemicus. This model may 
be more appropriate for studying S. zooepidemicus infection, as S. equi appears unadapted 
to colonise the upper respiratory tract for more than a few hours (Timoney & Kumar, 
2008). However, it may be possible to identify differences between different S. equi 
strains, particularly early adherence and invasive potential using electron microscopy and 
bacterial counting techniques. Host cell cytoxicity could be monitored potentially by 
quantifying levels of lactate dehydrogenase released by tissue (Sitkiewicz et ai., 2006), 
although this has not been attempted previously using the air interface model. Of course 
such in vitro models lack a humoral immune response, which may negate the role played 
by these exotoxins during the infection of organ cultures. Since Se4047 SlaA is nearly 
identical to the orthologous protein in GAS, this protein is hypothesised to have similar 
enzymatic activity against phospholipids (Nagiec et al., 2004), which could be confirmed 
using the same in vitro assay previously described (Nagiec et al., 2(04) and any 
differences in phospholipase A2 activity elicited by SlaA and SlaB could be established. 
6.1.1 Does host variation impact on superantigen-mediated pathogenicity in S. equi? 
Whilst superantigens are hypothesised to contribute to the increased pathogenicity of S. 
equi, their full contribution to virulence may be dependent on individual host factors. 
Polymorphisms in the genetic background of the host, for example in MHC class II 
molecules, have been shown to result in quantitative and qualitative differences in cytokine 
responses to certain GAS superantigens (Fraser & Profi, 2008). Individual horses may 
therefore respond differently to the various S. equi toxins and reflect this in the severity of 
disease shown (including disease complications) or their carrier status. Future 
experimentation should allow for potential differences in the specificities of some 
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superantigens to different MHC class II molecules and investigate a possible link to 
disease severity. Similarly, the production of neutralising anti-toxin antibodies and 
associations to severity of disease could be examined in individual horses, as an absence of 
neutralising antibodies has been highlighted as a significant risk factor for susceptibility to 
toxin shock syndrome associated with S. au reus or S. pyogenes infection in humans (Fraser 
& Proft, 2008). Early experiments have already detected specific responses to S. equi 
superantigens in convalescent sera from strangles cases (Nicola Butcher, unpublished data) 
and serum samples have been shown to neutralise See! mitogenic activity (Artiushin et al., 
2002), (Romain Paillot, unpublished data). However, these initial experiments detected an 
inconsistent production of neutralising antibodies against SeeL and SeeM (Romain Paillot, 
unpublished data) between individuals, which is a finding that deserves further 
investigation. 
6.1.2 Future vaccines based on prophage exotoxins 
Protection against S. equi infection is hypothesised to require the targeting of S. equi-
specific virulence factors, such as superantigens highlighted in this study, as horses that are 
regularly exposed to S. zooepidemicus antigens remain susceptible to strangles. 
Immunisation with regions of superantigen proteins have conferred protection against S. 
aureus disease in animal models (Ulrich et ai., 1998). Vaccination with partial regions of 
recombinant phospholipase A2 or superantigen toxin(s) or full length proteins that have 
been mutated to prevent their toxic effects could therefore be assessed for their ability to 
produce neutralising antibodies and to protect against S. equi (and in some cases S. 
zooepidemicus) infection using in vivo models. As superantigens are also hypothesised to 
interfere with the generation of specific immune responses, similar mutations could be 
introduced into the toxin genes of S. equi live attenuated vaccine strains in an attempt to 
246 
improve the induction of constructive immune responses, whilst still presenting epitopes 
for the generation of specific immunity to these toxin proteins. 
6.1.3 A common phage pool and novel superantigens in strains of S. zooepidemicus 
This research has highlighted a common phage pool shared relatively recently by both 
group A and group C streptococci, suggesting that the evolution of these important human 
and veterinary pathogens can not be considered in isolation. A number of S. 
zooepidemicus isolates had mitogenic activity (Holden, 2009), but this study showed that 
they were negative by PCR for superantigen genes found in S. equi. Future sequencing is 
therefore required to identify potentially novel superantigens encoded by these strains and 
any prophage that may contribute to their mobilisation. The ability of prophage to revert to 
lytic infection and the properties of new superantigens could then be assessed. 
6.2 Defence against phage infection 
Gene loss has been revealed during this study as a major feature of S. equi evolution, 
which in the case of the CRISPR locus and possible competence associated defence 
systems, may have contributed to the formation of polylysogeny in S. equi and the gain of 
multiple phage cargo. A CRISPR-associated gene was identified in most strains of S. 
zooepidemicus examined, including many of the isolates with superantigens, slaA or 
mitogenic activity. This suggests that CRISPRs generally help to maintain genome 
stability and prevent deleterious effects of phage infection, although situations are also 
likely to arise whereby phage transduction and the gain of an associated exotoxin confer a 
selective advantage that promotes strain survival. Prophage may be subsequently elimited 
from the chromosome as has presumably occurred with slaB. FurtheJ" sequencing of S. 
zooepidemicus genomes might highlight the contribution of CRISPR or competence loci to 
phage defence and could be studied in more detail using phage infection studies. 
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6.3 Gene loss in S. equi: genetic drift or positive selection? 
An accumulation of pseudogenes and the proliferation of IS elements suggests that S. equi 
passed through a population bottleneck during its transition into a new specialised niche. 
Gene loss, which is most evident in catabolic metabolism, transport and the cell envelope, 
may have arisen largely from genetic drift rather than a response to environmental 
pressures. In the case of sugar metabolism, the gene decay responsible for the biochemical 
differentiation of S. equi from S. zooepidemicus has been established for the first time and 
a requirement to include lactose fermentation in diagnostic S. equi detection has been 
highlighted and subsequently put into practise in the AHT diagnostic laboratory. However, 
some gene inactivations may have been positively selected for. The truncation of the 
fibronectin-binding protein, Fne, tallies with this pathogen's reduced fibronectin-binding ". 
capacity, which has previously been hypothesised to be an important factor behind the 
invasive nature of S. equi infection (Lannergard et al., 2005; Lindmark & Guss, 1999; 
Lindmark et al., 1999). This study has revealed a number of S. equi surface proteins that 
have been truncated or deleted and I hypothesise that further adhesion mechanisms have 
been lost in S. equi, which contribute to its decreased colonisation potential and may in 
some cases have increased its pathogenicity. Secreted adhesins that have lost their cell 
wall anchor may induce changes in the host cells through interactions with host integrins 
and ECM components, as observed with Fne (Liden et al., 2008). This small subset of 
decayed, secreted surface proteins with retained N-terminalligand binding moieties should 
probably not be ruled out as potential virulenc~ factors and could be investigated further. 
6.4 The contribution of surface proteins lost by S. equi to survival 
fitness or pathogenicity in strains of S. zooepidemicus 
Surface proteins lost during the evolution of S. equi, are likely to contribute to the ability of 
S. zooepidemicus strains to colonise different hosts or certain tissue types and in some 
248 
cases cause opportunistic disease. 2 loci in particular are hypothesised to promote 
properties such as bacterial aggregation, biofilm formation, host cell adhesion and/or 
invasion (Abbot et aI., 2007; Dramsi et al., 2006; Gaillard et aI., 1991; Krishnan et aI., 
2007; Maisey et al., 2007; Mandlik et al., 2007; Mandlik et aI., 2008; Manetti et aI., 2007; 
Nelson et al., 2007; Pezzicoli et aI., 2008). In most cases, the S. zooepidemicus isolates 
examined contained at least one of these genetic loci: a predicted cell wall-anchored 
protein (SZ008560) with conserved domains found in internalins of Listeria species and/or 
a putative pilus cluster with similarities to the rlrA locus in S. pneumoniae. Expression of 
the SZ008560 gene was hypothesised to be switched 'on' and 'off through a process of 
recombinase-mediated phase variation that has not yet been reported for a surface protein 
in streptococci. Switching between 2 phenotypes may aid the avoidance of adaptive '.~ 
immunity and is a hallmark of organisms persistently colonising mucosal surfaces. 
SZ008560 was significantly more prevalent in lower respiratory tract S. zooepidemicus 
isolates (including those isolated from cases of pneumonia, 100%, n = 14) than in upper 
respiratory tract isolates of S. zooepidemicus (including those associated with LN 
abscessation) (71 %, n = 59) (P = 0.03, Fischer's exact test) and all other S. zooepidemicus 
isolates (69%, n = 124, P = 0.011, Fischer's exact test). Since this study, my colleagues at 
the ART have examined more isolates of S. zooepidemicus and further demonstrated that a 
significantly higher proportion of isolates recovered from the lower respiratory tract or 
cases of pneumonia (93%, n = 41) had the SZ008560 gene compared to other S. 
zooepidemicus isolates (72%, n = 161, P = ~.004, Fischer's exact test, Andrew Waller, 
unpublished data). It is therefore proposed that a switch in phase is a virulence trait and 
the in vitro equine air-interface model described previously could be used to compare the 
ability of 'locked-on' and 'locked-off mutants, either independently or during co-culture, 
to colonise and/or invade respiratory tissue (particularly lung tissue). Organ culture plugs 
from the air-interface model are usually homogenised to allow numbers of viable bacteria 
to be measured, but pre-treatment of plugs with antibiotics that target extracellular bacteria 
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could also be assessed in an attempt to quantify the number of intracellular bacteria. Phase 
variants are probably not ideal vaccine targets unless the 'off phase coincides with 
reduced infection (Langermann & Ballou, 2001). 
The 2nd pilus locus may also prove to be important to S. zooepidemicus infection, as a 
similar pilus contributes to the virulence of S. pneumoniae in mice following intranasal 
inoculation (Hava & Camilli, 2002). Properties conferred by this putative pilus could also 
be examined in the in vitro equine air-interface culture system and electron microscopy, 
using gold-conjugated antibodies recognising the backbone and ancillary proteins to 
analyse the structure of the pilus and the contributions of the different sortase enzymes, 
pilus protein components and their structural motifs to pilus assembly. Pilus proteins have " 
shown promise as antigens for vaccine development (Buccato et ai., 2006; Gianfaldoni et 
al., 2007; Maione et al., 2005; Mora et al., 2005; Telford et al., 2006), although limited 
variation must exist in the target population if the vaccine is to provide broad coverage. 
6.5 Has gene loss altered pilus structure and production in S. equi? 
The same strategy could be employed to assay the 1 st pilus locus in the S. equi subspecies, 
as the introduction of a stop mutation into a tetR-like gene is hypothesised to lead to a 
production of longer pili in S. equi. Basic transcriptional analysis could be used to 
establish the regulatory control exhibited by the TetR-like protein and electron microscopy 
used to compare pilus structure in wild-type Se4047 , SzH70 and various allelic 
replacement mutants containing either a repaired tetR regulator or deleted pilus subunits (in 
the parental Se4047 background). If this hypothesis is proven, then this pilus may play an 
important role in S. equi pathogenesis and its contribution to, for example, the rapid 
intracellular or paracellular translocation of S. equi across epithelial cells or biofilm 
formation in the GP, where S. equi has been shown to persist even in the absence of 
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chondroids, could be assessed. A pilus vaccine in S. equi may stand more chance of 
success than a similar vaccine in S. zooepidemicus, as the pilus target in former may prove 
to be less variable. 
6.6 The influences of gene degradation and gene change on 
hyaluronate capsule production in S. equi 
This study has highlighted other examples of gene degradation in S. equi, including the 
inactivation of the HA lyase gene, which is hypothesised to reduce the degradation of its 
own HA capsule and limit the spread of S. equi beyond the lymphatic system. 
Experiments could be performed to disrupt the same gene in SzH70 and assess the impact 
this has on encapsulation and tissue spread using in vitro and in vivo assays. The HA gene 
in Se4047 and S. zooepidemicus ST -57 could also be repaired to see if these hyper-
encapsulated strains gain a small colony phenotype like SzH70 and reduced resistance to 
phagocytosis as a result. 
The other main force that has shaped the genome evolution of S. equi is gene change. An 
intra-replichore inversion event has reorganised the genes of the has operon involved in 
HA biosynthesis. This change is hypothesised to alter the expression levels of precursors 
in HA biosynthesis in Se4047, which could also contribute to the hyper-encapsulated 
phenotype of S. equi and the significant resistance shown by this pathogen to phagocytosis. 
Quantitative RT-PCR analysis would reveal quickly any differences in the expression 
levels of these precursors between Se4047 and SzH70. 
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6.7 Genetic variation in surface proteins: identification and 
characterisation of potential S. equi-specific vaccine targets 
Many surface proteins varied in sequence between Se4047 and SzH70lSzMGCS 10565, and 
were not screened by PCR in this study mostly because of the concern that variation in 
primer binding sites would mislead the interpretation of the results obtained. However, 
surface proteins are likely to be important in the interaction of these subspecies with their 
hosts and are good candidates for the development of subunit vaccines. Further 
sequencing of S. zooepidemicus strains is therefore required to assess the true extent of 
variation between S. equi and more closely-related strains of S. zooepidemicus. Antigens 
of S. equi that differ even when compared to their homologues in closely related S. 
zooepidemicus isolates may reflect the specific pathogenicity of S. equi and follow up work 
could aim to identify ligand binding activities and the contribution of individual antigens to 
adherence/invasion of host cells. It would be interesting to see if certain surface proteins 
contribute to colonisation in the GP, particularly as this site in the horse is so important to 
S. equi carriage and contains glycans that have not been reported in any sections of the 
equine respiratory tract (Parillo et aI., 2009). This study highlighted differences in 
potential integrin binding motifs in collagen-like surface proteins, which when mutated 
may reduce the ability of S. equi to bind and possibly invade certain cells. 
6.8 The gain ofiCESe2 by S. equi: a possible speciation event 
Chapters 3 to 4 describe the recently published work characterising the ICESe2 NRPS in 
detail (Heather et aI., 2008). The gain of ICESe2 was identified as possibly the genetic 
event that defines the speciation of S. equi. ICESe2 encodes a novel siderophore-like 
NRPS system, the first of its kind to be identified in streptococci. In fact, NRPSs in 
general are rare in streptococci and other bacteria with genomes ~3 Mb in size probably 
due to their large metabolic cost (Donadio et aI., 2007), which suggests that the S. equi 
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NRPS offers a critical function to this pathogen. As the secreted product of this NRPS 
system was shown to be involved in iron uptake, I hypothesise that iron acquisition by this 
process plays a vital role in S. equi pathogenesis. Although this was not demonstrated in a 
mouse infection model, its contribution to virulence would be best assessed in the natural 
host using an established strangles model (Hamilton et at., 2006). The air interface organ 
culture could also be used to examine the influence of the NRPS on S. equi replication in 
an environment that is iron limiting. 
The precise mechanism of ICESe2 NRPS product function is currently unclear as I have 
not yet identified direct iron-binding activity by this metabolite. Elucidating the structure 
of the NRPS product will be an important step towards understanding its activity. 
However, S. equi, during its persistence in LN abscesses and the GP, is likely to encounter 
lactoferrin, the iron-sequestering glycoprotein secreted by neutrophils. S. pyogenes, which 
is not able to produce its own siderophores, is also unable to use lactoferrin as an iron 
source (Eichenbaum et ai., 1996). It would therefore be interesting to see if the ICESe2· 
NRPS product allows S. equi to release iron from lactoferrin, particularly as the host 
catecholamine norepinephrine, although unable to remove iron from the CAS complex, can 
increase the availability of free iron to bacteria through an interaction that interferes with 
host glycoprotein iron sequestration (Freestone et at., 2000). Norepinephrine formed 
stable complexes with lactoferrin and transferrin, and incubation of either of these 
glycoproteins with norepinephrine resulted in their loss of bound iron as indicated by the 
appearance of monoferric and apo-isoforms upon electrophoresis in denaturing gels 
(Freestone et at., 2000). Similar experiments could be performed with the eqb NRPS 
product, using the purified peptide if this becomes available or conditioned media. 
Alternatively, the ability to incorporate 55Fe from 55 Fe-labelled lactoferrin or transferrin 
could be measured in the different S. equi stains (Freestone et ai., 2000). 
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Genes required for the biosynthesis of the NRPS product were identified following its 
heterologous expression in E. coli and the deletion of the eqbE gene in S. equi. I proposed 
a mechanism for the biosynthesis of the NRPS product following structure-based 
bioinformatic analysis and hypothesised that the final equibactin product would contain a 
single residue of salicylate and 3 thiazoli(di)ne rings formed from the heterocyclisation of 
cysteine. Salicylate was proven to be a substrate for this biosynthetic process, but further 
work is now required to establish the contribution of cysteine (and any other substrates) 
and determine the precise mechanisms of biosynthesis, so that the structure of the product 
can finally be elucidated. In vitro reconstitution (Chapter 4) is likely to provide the best 
opportunity to reveal the structure of the NRPS product by HPLC, MS and NMR (nuclear 
magnetic resonance), given that previous attempts to identify the product in conditioned 
media from S. equi mutant strains or E. coli expressing the biosynthetic proteins have 
failed. Other researchers were able to reveal the complete biosynthetic pathway for 
yersiniabactin production using in vitro reconstitution (Miller et aI., 2002). Individual 
catalytic domains were omitted in order to define their function and deuterated substrates· 
were used in order to validate the number of specific substrate molecules present in the 
final product. Similar analysis could be performed with the S. equi NRPS, in addition to 
ATP/C2p]pyrophosphate exchange assays to assess A domain substrate specificity (Otten 
et aI., 2007). A method for the large scale purification of the NRPS product may be easier 
to develop once. the molecular weight and/or structure of the molecule is defined. 
Biological assays could then be performed with purified NRPS product rather than 
conditioned media and X-ray crystallography could be used (with NMR data) to elucidate 
its precise metal binding chemistry. 
Thin layer chromatography (TLC) could be used as an alternative approach to identifying 
the eqb NRPS product. Mutant S. equi strains that either overproduce (lleqbHIJA) or fail 
to make the metabolite (lleqbAE) could be grown in CDM supplemented with 14C 
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salicylate, a known substrate of the NRPS. Following TLC and autoradiography, spots that 
are only present in the former strain could be scraped from the TLC plate, dissolved in a 
suitable solvent and assessed by MS. Rf values may need to be calculated and non-
radioactive samples run separately or alongside to avoid contamination of MS equipment 
with radioactive material. The identity of a yersiniabactin spot from a TLC plate was 
previously assessed using atmospheric pressure chemical ionization MS (Ferreras et al., 
2005) and MALDI-TOF (matrix-assisted laser desorption ionization time-of-flight) MS 
(Miller et aI., 2002). 
6.S.1 Mechanisms for transport of the eqb NRPS product(s) 
ABC transporter(s) EqbK and/or EqbL are hypothesised to export the eqb NRPS product 
and a failure to export the product is hypothesised to result in excessive iron accumulation 
through the upregulation of alternative iron import mechanisms. These hypotheses would 
be best examined using separatel:!..eqbK, l:!..eqbL, l:!..eqbKA, l:!..eqbLA deletion strains in 
growth, streptonigrin and 55Fe incorporation assays described in Chapter 3. This will 
establish whether or not eqbK and eqbL encode distinct homodimeric ABC transporters 
with distinct functions or a single heterodimeric ABC transporter with a single function. If 
a failure to export the NRPS product is proven to result in excessive 55Fe accumulation, 
then global gene expression analysis could be used to investigate upregulated iron import 
mechanisms. Gene arrays have not yet been developed for S. equi/S. zooepidemicus but 
could be custom-made relatively easily using information from the genome analysis. 
The ABC transporter (EqbH, I and/or J) was shown to be critical for the majority of NRPS 
product-mediated iron import and an as yet unidentified receptor is hypothesised to 
contribute to this process. eqbH, I and J are also hypothesised to form a single ABC 
transporter. The latter hypothesis can be assessed relatively easily using separate mutants 
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with deletions in these individual components as described above for eqbK and eqbL. 
However, examining the requirement for a separately encoded import receptor is likely to 
be more problematic. Pre- and post-infection sera collected from horses could be assessed 
for the ability of antibodies in the latter to neutralise import function. Blocking of NRPS 
product-mediated iron import would point to an extracellular import domain. A S. equi 
HIMAR1 transposon library (May et a!., 2004) generated in the tl.eqbAE mutant and grown 
on media supplemented with streptonigrin and D..eqbHIJA conditioned media (positive 
selection) could be used to identify a cell surface receptor for the NRPS product. 
The hypothesis could be disproven if an extracellular binding domain was shown to be 
encoded within eqbHIJ (for example in the C-terminal hydrophilic region of EqbI). A 
plasmid expressing eqbHIJ could be introduced into SzH70 and other 
streptococcall1actococcal bacterial species and their ability to acquire iron evaluated 
following cross-feeding with conditioned media from the S. equi tl.eqbHIJA strain 
(compared to media from the tl.eqbAE strain). If these recombinant strains all showed 
increased eqb NRPS product-mediated iron accumulation, then either they all share a 
suitable receptor or, more likely, an extracytoplasmic domain within EqbHIJ scavenges the 
NRPS product for import. Biochemical, immunological and genetic procedures could be 
used to determine whether or not the hydrophilic C-terminal region of EqbI is exposed at 
the extracellular surface. For example, the fusion of a protein tag or ~-lactamase into this 
region of EqbI could be used to screen for extracellular exposure using immunofluoresence 
or ampicillin resistance (Pearce et a!., 1992), respectively. Alternatively, import might 
occur without the involvement of a solute binding domain. However, no change in 
streptonigrin sensitivity or 55Fe incorporation in some or all of the cross-fed recombinant 
species expressing EqbHIJ would suggest that a receptor is required for import of the 
NRPS product and that this is encoded in a S. equi-specific genomic region relative to the 
recombinant strains showing no change in iron accumulation. 
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6.8.2 A novel IdeR-like iron dependent repressor 
The eqbE biosynthetic gene of the NRPS locus was repressed by the actions of a repressor 
(EqbA) shown to be responsive to Fe2+, Zn2+ and to a lesser extent Mn2+. This novel 
repressor is hypothesised to represent a new variant of the IdeR global iron-dependent 
repressor superfamily in Gram positive bacteria. Attempts could be made to crystallise 
EqbA and elucidate the structure of this novel S. equi IdeR-like iron-dependent repressor. 
This would require purification of recombinant EqbA in a suitable buffer to a scale and 
purity required to yield crystals that diffract X-rays to sufficient resolution to allow 
structure determination. Genetic analysis could then be performed to validate the 
contribution of specific residues to functions such as operator binding, dimerisation, other 
conformational changes and metal binding/selectivity. DNA footprinting could be used to 
define the exact region of the eqbB promoter bound by EqbA. 
eqbB-N is hypothesised to be transcribed as a single operon (polycistronic mRNA 
molecule) under the repression of EqbA in the presence of iron. Further quantitative RT-
peR experiments could be performed assess this hypothesis using NTA chelation to 
remove iron from growth media. The EqbA repressor is also hypothesised regulate gene(s) 
outside of the eqb cluster as slight differences in growth rate were seen between the 
l:leqbAE and l:leqbE S. equi strains, which appeared to be independent of intracellular iron 
concentrations (suggested by streptonigrin sensitivity). Any regulatory control exhibited 
by EqbA outside of the eqb NRPS could be investigated following culture in vitro and 
comparing global gene expression profiles in the l:leqbAE and l:leqbE S. equi strains. The 
general effects of eqb NRPS product production and disregulation of iron import 
mechanisms of S. equi could also be determined using gene arrays and various gene 
deletionlwildtype strains. 
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6.8.3 Is ICESe2 capable of mobilisation? 
S. equi is proposed to have gained the eqb NRPS though conjugation. Because circular 
intermediates of ICESe2 were not detected by PCR in this study, I hypothesise that this S. 
equi element no longer retains the ability to recircularise and transfer to other bacteria. 
Various stimuli including DNA-damaging treatments used for the activation of the phage 
lytic pathway and other ICEs could be assessed for their ability to induce conjugative 
transfer of ICESe2 and disprove this hypothesis (Auchtung et ai., 2007; Beaber et ai., 
2004; Bellanger et at., 2009; Bonheyo et at., 2001). Mating experiments could also be 
performed to see if ICESe2 and an antibiotic resistance cassette incorporated into this 
element can be transferred from Se4047 into S. zooepidemicus or other bacteria (Bellanger 
et ai., 2009). 
6.8.4 The development of S. equi diagnostic tools and vaccines specific to ICESe2 
Given its absence from the S. zooepidemicus population, the eqbE gene of the ICESe2 
NRPS was used as a target for the successful development of sensitive, specific PCR and 
QPCR tests for the detection of S. equi (Chapter 5). This QPCR is currently being used 
commercially and has received positive feedback, particularly in terms of turnaround time. 
In terms of vaccine development, either a receptor for the NRPS product (if identified) 
could be investigated for its efficacy as a subunit vaccine or deletions in eqb genes could 
be assessed for their contribution to live attenuated vaccine strains. The NRPS product 
itself is hypothesised to be too small to generate an antibody response; this could be tested 
by comparing the capacity of pre- and post-infection sera collected from horses to 
neutralise NRPS product function in streptonigrin and 55Fe accumulation assays. 
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6.9 Concluding remarks 
Overall, this study has significantly increased our understanding of S. equi evolution and 
the complex interplay of genetic forces that have shaped the transition of this pathogen 
from coloniser to invader. A wealth of information is now available that can be utilised to 
examine in detail the many potential virulence factors and aspects of S. equi pathogenicity. 
A number of possible vaccine targets have been identified that could be investigated 
further for their suitability to the development of live attenuated or subunit vaccines to 
provide broad spectrum, efficacious protection against strangles. Our understanding of S. 
zooepidemicus has also been widened to reveal many features that help to explain the 
versatile nature of this subspecies. The sheer diversity of the S. zooepidemicus population 
is likely to hinder the development of suitable vaccines against important diseases 
associated with this opportunistic pathogen. However, some avenues of research have 
already been opened and the further analysis of many more genomes may help to identify 
invariant targets that contribute to pathogenicity in subsets of the S. zooepidemicus 
popUlation. 
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Appendix 
Table A.I Identity, source and mitogenicity of S. equi and S. zooepidemicus isolates 
studied for the prevalence of selected differences between the Se4047 and SzH70 genomes 
Stimulation 
Species ST Strain ID Disease! Source Animal Year index 
Sz 19 B273726.1 Uterine infection/abortion Horse 2007 1.5 
Sz 101 3604 Uterine infection/abortion Horse 2006 1.2 
Sz 101 B242382 Uterine infection/abortion Horse 2004 1.6 
Sz 101 B244996 Uterine infection/abortion Horse 2004 1.7 
Sz 142 3727 Uterine infection/abortion Horse 2007 1.1 
Sz 56 B233322 Uterine infection/abortion Horse 2003 1.7 
Se 179 3154 Strangles Horse 2004 2.8 
Se 179 8229 Strangles Dog 2004 3.3 
Se 179 B237325 Strangles Horse 2003 2.5 
Se 179 4047 Strangles Horse 1990 4.2 
Se 179 SA Strangles Horse 1999 2.9 
Se 179 303 Strangles Horse 1999 4 
Se 179 7060 Strangles Horse 2003 2.9 
Se 179 1931 Strangles Horse 2004 4.3 
Se 179 1351 Strangles Horse 2004 3.1 
Se 179 1350 Strangles Horse 2003 3.3 
Se 179 7344 Strangles Horse 2003 2.8 
Se 179 7140 Strangles Horse 2003 2.8 
Se 179 7171 Strangles Horse 2003 3.5 
Se 179 7364 Strangles Horse 2003 3.1 
Se 179 7326 Strangles Horse 2003 2.3 
Se 179 3155 Strangles Horse 2004 3.6 
Se 179 3156 Strangles Horse 2004 3.2 
Se 179 181063 Strangles Horse 1999 3 
Se 179 JKS 044 Strangles carrier Horse 2006 2.6 
Se 179 JKS 043 Strangles Horse 2006 3.4 
Se 179 JKS 063 Strangles Horse 2006 3 
Se 179 JKS 225 Strangles Horse 2006 3.2 
Se 179 CF32 Strangles Horse 1981 2.6 
Se 179 JKS 559 Strangles Horse 2007 2.2 
Se 151 7329 Strangles Horse 2006 2.7 
Se 151 Mo Strangles brain abscess Horse 2008 2.7 
Sz 49 B254861.1 Wound infection Horse 2005 0.9 
Sz 49 B236378 Uterine infection/abortion Horse 2003 0.8 
Sz 49 B271175.2 Uterine infection/abortion Horse 2007 1.1 
Sz 49 B268276 Upper respiratory Horse 2006 1.3 
Sz 137 628 Uterine infectiOn/abortion Horse 2007 1.0 
Sz 149 6619 Uterine infectiOn/abortion Horse 2003 1.4 
Sz 6 S13 Skin swab Dog 2002 1.7 
Sz 133 2258 Foot swab Horse 2007 1.6 
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Table A.I continued 
Stimulation 
Species ST Strain ID Disease! Source Animal Year index 
Sz 10 BHS32 Lower respiratory Dog 2001 1.0 
Sz 10 BHS41 Lower respiratory Dog 2001 1 
Sz 10 B266443 Wound infection Horse 2006 1.3 
Sz 22 BHS53 Lower respiratory Dog 2001 1.1 
Sz 47 BHS 28 Lower respiratory Dog 2000 1.2 
Sz 55 B237163 Uterine infection/abortion Horse 2003 2.1 
Sz 15 B236907 Uterine infection/abortion Horse 2003 1.1 
Sz 15 B272806.2 Uterine infection/abortion Horse 2007 1.0 
Sz 91 BHS 37 Lower respiratory Dog 2001 1.1 
Sz 110 4847 Upper respiratory Horse 1996 1.5 
Sz 119 4904 Upper respiratory Horse 1996 1.1 
Sz 119 5382 Upper respiratory Horse 1996 1.0 
Sz 45 605851 Upper respiratory Horse 1996 1.2 
Sz 45 5845 Upper respiratory Horse 1996 1.5 
Sz 45 D56 Lower respiratory Horse 2000 0.7 
Sz 147 6875 Uterine infection/abortion Horse 2006 1.4 
Sz 51 B236074 Uterine infection/abortion Horse 2003 1.7 
Sz 143 3512 Uterine infection/abortion Horse 2007 1.3 
Sz 128 8718.2 Uterine infection/abortion Horse 2006 1.9 
Sz 111 5831 Upper respiratory Horse 1996 1.8 
Sz 126 5079 Uterine infection/abortion Horse 2006 2.4 
Sz 131 3543 Foot swab Horse 2006 0.9 
Sz 16 B247132 Upper respiratory Horse 2004 1.1 
Sz 140 B273530.1 Wound infection Horse 2007 1.3 
Sz 134 2567.1 Udder swab Horse 2007 1.4 
Sz 57 JKS 115 Upper respiratory Horse 2006 2.4 
Sz 1 H70 Upper respiratory Horse 2000 1.4 
Sz 1 B237271 Uterine infection/abortion Horse 2003 1.5 
Sz 1 B270479 Uterine infection/abortion Horse 2007 1.3 
Sz 71 605632 Upper respiratory Horse 1996 1.0 
Sz 71 605013 Upper respiratory Horse 1996 1.3 
Sz 104 8278 Upper respiratory Horse 2006 1.2 
Sz 104 8275 Upper respiratory Horse 2006 1.2 
Sz 108 5938 Upper respiratory Horse 1996 1.3 
Sz 108 4853 Upper respiratory Horse 1996 0.9 
Sz 123 BHS5 Lower respiratory Dog 1999 6.7 
Sz 127 6360 Wound infection Horse 2006 5.0 
Sz 141 482 Uterine infection/abortion Horse 2007 5.8 
Sz 7 B268900 Wound infection Horse 2006 5.5 
Sz 7 B271185 Uterine infection/abortion Horse 2007 3.5 
Sz 7 602333 Upper respiratory Horse 1996 4.9 
Sz 48 B254433 Lymph node abscess Horse 2005 3.3 
Sz 70 B268310 Upper respiratory Horse 2006 3.3 
Sz 70 B268277 Upper respiratory Horse 2006 2.6 
Sz 5 B247159 Lymph node abscess Horse 2004 5.4 
Sz 5 B247043 Lymph node abscess Horse 2004 2.9 
Sz 53 B247102.2 Lymph node abscess Horse 2004 7.1 
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Table A.I continued 
Stimulation 
Species ST Strain ID Disease! Source Animal Year index 
Sz 8 H8 Lower respiratory Horse 2000 9.6 
Sz 8 D40 Lower respiratory Horse 2000 5.3 
Sz 8 D2a Lower respiratory Horse 2000 5.1 
Sz 46 B250061 Lymph node abscess Horse 2005 3.6 
Sz 113 4885 Upper respiratory Horse 1996 6.5 
Sz 113 5617 Upper respiratory Horse 1996 5.3 
Sz 96 B254763 Lymph node abscess Horse 2005 1.0 
Sz 20 B254042.1 NA Horse 2005 1.7 
Sz 118 3050 Nasal fluid Horse 2007 1.5 
Sz 118 4901 Upper respiratory Horse 1996 1.4 
Sz 118 2329 Upper respiratory Horse 1996 2.0 
Sz 139 972395 Upper respiratory Horse 1997 0.8 
Sz 146 8250 Wound infection Horse 2006 1.1 
Sz 58 B26Tansey Nephritis Horse 2006 1.3 
Sz 61 B268269.1 Wound infection Horse 2006 1.0 
Sz 61 B260225 Uterine infection/abortion Horse 2006 1.1 
Sz 94 B236170 Uterine infection/abortion Horse 2003 1.7 
Sz 26 B272596 Uterine infection/abortion Horse 2007 1.3 
Sz 26 B266993 Uterine infection/abortion Horse 2006 1.6 
Sz 124 5808 Wound infection Horse 2003 0.7 
Sz 135 2265 Intra-abdomen pus Horse 2007 1.8 
Sz 39 B266334 Wound infection Horse 2006 1.0 
Sz 39 JKS 241 Upper respiratory Horse 2007 1.3 
Sz 106 605849 Upper respiratory Horse 1996 8.0 
Sz 106 5936 Upper respiratory Horse 1996 3.2 
Sz 106 8306 Upper respiratory Horse 2006 1.5 
Sz 107 8307 Upper respiratory Horse 2006 0.7 
Sz 9 H54 Upper respiratory Horse 2000 1.9 
Sz 120 4897 Upper respiratory Horse 1996 3.5 
Sz 63 B262253 Uterine infection/abortion Horse 2006 1.4 
Sz 63 B263540 Foot swab Horse 2006 1.2 
Sz 54 B247155 Upper respiratory Horse 2004 1.6 
Sz 130 7101 Wound infection Horse 2006 1.6 
Sz 50 B255405 Lymph node abscess Horse 2005 1.5 
Sz 138 917 Uterine infection/abortion Horse 2007 1.0 
Sz 82 B266458 Uterine infection/abortion Horse 2006 1.6 
Sz 178 2958 Uterine infection/abortion Horse 2003 1.6 
Sz 109 5820 Upper respiratory Horse 1996 1.3 
Sz 150 8311 Upper respiratory Horse 2006 1.0 
Sz 150 8308 Upper respiratory Horse 2006 1.8 
Sz 4 B274388 Uterine infection/abortion Horse 2007 1.3 
Sz 4 B244389 Uterine infection/abortion Horse 2004 1.4 
Sz 132 2853 Lymph node abscess Horse 2007 0.8 
Sz 132 1913 Uterine infection/abortion Horse 2007 1.0 
Sz 103 8300 Upper respiratory Horse 2006 1.0 
Sz 103 8297 Upper respiratory Horse 2006 1.2 
Sz 116 8293 Upper respiratory Horse 1996 1.1 
Sz 112 4866 Upper respiratory Horse 1996 1.0 
Sz 112 5951 Upper respiratory Horse 1996 1.2 
Sz 122 4871 Upper respiratory Horse 1996 1.4 
Sz 93 B237166 Uterine infection/abortion Horse 2003 1.0 
Sz 121 5185 Upper respiratory Horse 2006 1.9 
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Table A.I continued 
Stimulation 
Species ST Strain ID Diseasel Source Animal Year index 
Sz 3 D33 Lower respiratory Horse 2000 1.8 
Sz 92 B234314B NA Horse 2003 2.0 
Sz 125 7157 Upper respiratory Horse 2004 1.6 
Sz 136 3101 Uterine infection/abortion Horse 2007 0.8 
Sz 97 B265081.1 Uterine infection/abortion Horse 2006 1.0 
Sz 97 B268570 Uterine infection/abortion Horse 2006 1.2 
Sz 97 B268571 Uterine infection/abortion Horse 2006 1.6 
Sz 97 B272742.2 Uterine infection/abortion Horse 2007 1.1 
Sz 97 B277714 Lymph node abscess Horse 2007 1.5 
Sz 97 B270624.2 Uterine infection/abortion Horse 2007 1.1 
Sz 97 B270624.1 Uterine infection/abortion Horse 2007 1.6 
Sz 97 B268575 Uterine infection/abortion Horse 2006 1.4 
Sz 99 B270739 Uterine infection/abortion Horse 2007 1.4 
Sz 117 5623 Upper respiratory Horse 1996 1.8 
Sz 148 4875 Upper respiratory Horse 1996 1.3 
Sz 2 Dl4a Lower respiratory Horse 2000 2.4 
Sz 12 B250590 Wound infection Horse 2005 0.9 
Sz 13 B260863 Uterine infection/abortion Horse 2006 1.7 
Sz 18 1770 Fatal haemorrhagic pneumoniae Dog 2008 0.9 
Sz 18 1727 Fatal haemorrhagic pneumoniae Dog 2008 1.0 
Sz 95 B247156 Upper respiratory Horse 2004 1.1 
Sz 98 B268337 Keratitis Horse 2006 1.1 
Sz 98 B272247 Uterine infection/abortion Horse 2007 0.8 
Sz 100 B263593 Keratitis Horse 2006 1.5 
Sz 102 8299 Upper respiratory Horse 2006 1.8 
Sz 115 4893 Upper respiratory Horse 1996 2.0 
Sz 144 2410 Upper respiratory Horse 1997 3.0 
Data are ordered as in Figure 2.6. Horizontal line breaks separate phylogenetic clusters of S. 
zooepidemicus (Sz) and S. equi (Se) isolates identified by ClonaiFrame analysis of MLST alleles, 
with the exception of the last 12 isolates, which represent 10 unrelated sequence types (STs). NA 
Information not available. Details of all of these isolates are also available on the online MLST 
database: http://pubmlst.orglszooepidemicus/.Accessed23.02.09).Stimulation index data 
indicates the level of mitogenic activity towards equine PBMCs detected in supernatant samples 
following overnight culture of S. zooepidemicus or S. equi isolates (provided by Romain Paillot, 
AHT). 
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Table A.2A Novel Se4047 DNA loci 
No. Element Notes CDS! Function Total %GC 
region no. 
novel 
CDS 
1 putative SEQ0047* putative ABC transporter A TP-binding ! 4 29.12 genomic oermease protein 
island SEQOO48' ThiF family protein (pseudogene) 
SEQ0050' insulinase family metallopeptidase 
SEQ0051' putative regulatory protein 
2 SEQ0100 transposase (pseudogene) 2 30.11 
SEQ0101* putative exported protein 
3 Prophage insertion in SEQ0133 integrase 65 40.22 
<pSeq1 Se4047 SEQ0134 hypothetical phage protein 
SEQ0135 phage repressor protein 
SEQ0136 putative phage repressor 
SEQ0137 hypothetical phage protein 
SEQ0138 hypothetical phage protein 
SEQ0139 putative DNA-binding phage protein 
SEQ0140 hypothetical phage protein 
SEQ0141 hypothetical phage protein 
SEQ0142 putative DNA-binding phage protein 
SEQ0143 hypothetical phage protein 
SEQ0144 hypothetical phage protein 
SEQ0145 hypothetical phage protein 
SEQ0146 hypothetical phage protein 
SEQ0147 hypothetical phage protein 
SEQ0148 putative phage RecT family protein 
SEQ0149 hypothetical phage protein 
SEQ0150 hypothetical phage protein (pseudogene) 
SEQ0151 hypothetical phage protein 
SEQ0152 hypothetical phage protein 
SEQ0153 hypothetical phage protein 
SEQ0154 hypothetical phage protein 
SEQ0155 hypothetical phage protein 
SEQ0156 hypothetical phage protein 
SEQ0157 putative phage membrane protein 
SEQ0158 phage DNA methylase 
SEQ0159 hypothetical phage protein 
SEQ0160 hypothetical phage protein 
SEQ0161 hypothetical phage protein 
SEQ0162 putative autolysin regulatory protein 
SEQ0163 phage DNA methylase 
SEQ0164 hypothetical phage protein 
SEQ0165 phage terminase 
SEQ0166 putative minor capsid protein 
SEQ0167 putative minor capsid protein 
SEQ0168 hypothetical phage protein 
SEQ0169 hypothetical phage protein 
SEQ0170 hypothetical phage protein 
SEQ0171 putative phage major capsid protein 
SEQ0172 hypothetical phage protein 
SEQ0173 hypothetical phage protein 
SEQ0174 hypothetical phage protein 
SEQ0175 hypothetical phage protein 
SEQ0176 hypothetical phage protein 
SEQ01n hypothetical phage protein 
SEQ0178 hypothetical phage protein 
SEQ0179 putative phage Gp15 protein 
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SEQ0180 putative phage minor tail protein 
SEQ0181 hypothetical phage protein 
SEQ0182 hypothetical phage protein 
SEQ0183 collagen-like repeat phage protein 
SEQ0184 hypothetical phage protein 
SEQ0185 hypothetical phage protein 
SEQ0186 hypothetical phage protein 
SEQ0187 hypothetical phage protein 
SEQ0188 putative phage holin 
SEQ0189 putative phage membrane protein 
SEQ0190 phage-associated cell wall hydrolase 
SEQ0191 putative DNA-binding phage protein 
SEQ0192 hypothetical phage protein 
SEQ0193 hypothetical phage protein 
SEQ0194 phage membrane protein 
SEQ0195 putative DNA-binding phage protein 
SEQ0196 hypothetical phage protein 
SEQ0197 hypothetical phage protein 
4 SEQ0214 putative DNA-binding protein 7 35.62 (pseudoaenel 
SEQ0216* putative membrane protein 
SEQ0217* putative membrane protein 
SEQ0218* putative membrane protein 
SEQ0219* ABC transporter, ATP-binding protein 
SEQ0220* putative membrane protein 
SEQ0221* putative membrane protein 
5 SEQ0235 factor H-binding secreted protein Se18.9 5 33.15 
SEQ0236 putative exported protein (pseudogene) 
SEQ0237 putative membrane protein 
SEQ0238 putative membrane protein 
SEQ0239 ABC transporter, ATP-binding protein 
(oseudogene) 
6 SEQ0281 putative membrane protein 1 30.11 
7 SEQ0307 transposase (fragment) 1 35.69 
8 similar region SEQ0309 conserved hypothetical protein 4 36.73 
in SzH70 SEQ0309a putative membrane protein 
SEQ0310 hypothetical protein 
SEQ0311 hypothetical protein 
9 SEQ0343 hypothetical protein 
10 SEQ0466* fibronectin-binding protein SFS 1 47.31 
11 ICESe1 C- SEQ0753 putative group II intron reverse 8 34.83 
terminal transcriotase/maturase 
region SEQ0756 putative conjugative transposon regulatory 
protein 
SEQ0757 putative modification methylase 
SEQ0758 putative type II restriction enzyme 
SEQ0759 putative transposase 
SEQ0760 putative transposase 
SEQ0761 conserved hypothetical protein 
SEQ0762 conserved hypothetical protein 
12 Prophage insertion in SEQ0787 putative integrase 64 39.24 
<pSeq2 S64047 SEQ0788 phage membrane protein 
SEQ0789 putative hypothetical phage protein 
SEQ0790 putative phage repressor 
SEQ0791 putative transposase 
SEQ0792 putative transposase 
SEQ0793 hypothetical phage protein 
SEQ0794 putative DNA binding phage protein 
SEQ0795 hypothetical phage protein 
SEQ0796 hypothetical phage protein 
SEQ0797 hypothetical phage protein 
SEQ0798 hypothetical phage protein 
324 
SEQ0799 hypothetical phage protein 
SEQOSOO hypothetical phage protein 
SEQOS01 putative essential recombination function 
protein 
SEQOS02 putative Single-strand binding protein 
SEQOS03 hypothetical phage protein 
SEQOS04 putative hypothetical phage protein 
SEQOS05 hypothetical phage protein 
SEQOS06 phage membrane protein 
SEQOS07 putative DNA methylase 
SEQOSOS putative C-5 cytosine-specific DNA 
methvlase (pseudogene) 
SEQOS10 hypothetical phage protein 
SEQOS11 phage membrane protein 
SEQOS12 hypothetical phage protein 
SEQOS13 hypothetical phage protein 
SEQOS14 putative autolysin regulatory protein 
SEQOS15 hypothetical phage protein 
SEQOS16 hypothetical phage protein 
SEQOS17 hypothetical phage protein 
SEQOS1S putative phage HNH endonuclease 
SEQOS19 putative phage terminase, small subunit 
SEQOS20 putative phage terminase, large subunit 
SEQOS21 hypothetical phage protein 
SEQOS22 putative hypothetical phage protein 
SEQOS23 putative phage portal protein 
SEQOS24 putative phage ClpP protease 
SEQOS25 putative phage major capsid protein 
SEQOS26 hypothetical phage protein 
SEQOS27 hypothetical phage protein 
SEQOS2S hypothetical phage protein 
SEQOS29 hypothetical phage protein 
SEQOS30 hypothetical phage protein 
SEQOS31 major tail protein 
SEQOS32 hypothetical phage protein 
SEQOS33 hypothetical phage protein 
SEQOS34 putative phage tail protein 
SEQOS35 hypothetical phage protein 
SEQOS36 hypothetical phage protein 
SEQOS37 putative phage hyaluronidase 
SEQOS3S hypothetical phage protein 
SEQOS39 putative hypothetical phage protein 
SEQOS40 hypothetical phage protein 
SEQOS41 hypothetical phage protein 
SEQOS42 putative phage membrane protein 
SEQOS43 putative phage membrane protein 
SEQOS44 putative phage membrane protein 
SEQOS45 putative phage amidase protein 
SEQOS46 hypothetical phage protein 
SEQOS47 hypothetical phage membrane protein 
SEQOS48 hypothetical phage protein 
SEQOS49 phospholipase Az SlaA 
SEQOS50 phage membrane protein 
SEQOS51 hypothetical phage protein 
13 SEQ0902 hypothetical protein 
14 insertion in SEQ1101 hypothetical protein (fragment) 2 2S.1 S84047 SEQ1102 putative conjugative transposon site-
specific recombinase 
15 SEQ11S3 hypothetical protein 1 30.26 *diverse 
16 ICESe2 insertion in SEQ1229 putative conjugative transposon site- 42 30.6 S84047 specific recombinase 
SEQ1231 putative DNA-binding protein 
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SEQ1232 hypothetical protein 
SEQ1233 putative hydrolase EqbN 
SEQ1234 putative oxidoreductase, EqbM 
SEQ1235 ABC transporter, ATP-binding membrane 
orotein EqbL 
SEQ1236 ABC transporter, ATP-binding membrane 
protein EqbK 
SEQ1237 ABC transporter, ATP-binding component 
EabJ 
SEQ1238 ABC transporter permease component 
Eabl 
SEQ1239 ABC transporter permease component 
EqbH 
SEQ124Q equibactin nonribosomal peptide synthase 
protein EabG 
SEQ1241 putative thiazoline reductase EqbF 
SEQ1242 equibactin nonribosomal peptide synthase 
protein EabE 
SEQ1243 putative salicylate-AMP-ligase EqbD 
SEQ1244 putative 4'-phosphopantetheinyl 
transferase EabC 
SEQ1245 putative non-ribosomal peptide synthesis 
thioesterase type II EabB 
SEQ1246 iron-dependent repressor EqbA 
SEQ1247 putative conjugative transposon 
membrane orotein 
SEQ1249 putative conjugative transposon 
mobilization·orotein 
SEQ1250 putative conjugative transposon 
mobilization orotein 
SEQ1251 putative conjugative transposon 
membrane orotein 
SEQ1252 putative conjugative transposon single-
strand binding orotein 
SEQ1253 putative conjugative transposon DNA 
recombination -orotein 
SEQ1254 conjugative transposon hypothetical 
protein 
SEQ1255 conjugative transposon hypothetical 
protein 
SEQ1256 putative DNA topoisomerase 
SEQ1257 putative abortive infection protein 
SEQ1258 conjugative transposon hypothetical 
protein 
SEQ1259 putative membrane protein 
SEQ1260 conjugative transposon hypothetical 
orotein 
SEQ1261 putative conjugative transposon 
membrane orotein 
SEQ1262 modification DNA methylase 
SEQ1263 putative conjugal transfer protein 
SEQ1264 putative conjugative transposon 
membrane orotein 
SEQ1265 putative conjugative transposon 
membrane protein 
SEQ1266 putative conjugative transposon 
membrane orotein 
SEQ1267 putative conjugative transposon 
membrane oroteln 
SEQ1268 putative conjugative transposon exported 
protein 
SEQ1269 putative ABC transporter, ATP-binding 
orotein 
SEQ1270 putative membrane protein 
SEQ1271 putative bacteriocin 
SEQ1272 putative two-component sensor histidine 
kinase (fraamenti 
17 insertion in SEQ1273 conserved hypothetical protein (fragment) 3 34.47 564047 SEQ1274 ParB-like nuclease protein 
SEQ1275 sporulation initiation inhibitor Soj 
homologue 
18 deletion in SEQ1328 conserved hypothetical protein 1 28.19 
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SzH70 and (pseudogene) 
SzMGCS10565 
19 deletion in SEQ1517 conserved hypothetical protein 2 37.69 
SzH70 SEQ1518 hypothetical protein (fragment) 
20 SEQ1654 conserved hypothetical protein 1 30.86 
21 SEQ1677a conserved hypothetical protein (fragment) 1 38.31 
22 tRNA 1734575- tRNA-Gly 
1734638 
23 prophage insertion in SEQ1726 hypothetical phage protein 40 39.02 
<pSeq3 S64047 SEQ1727 exotoxin M precursor SeeM 
SEQ1728 exotoxin l precursor Seel 
SEQ1729 putative phage amidase protein 
SEQ1730 putative phage membrane protein 
SEQ1731 putative phage membrane protein 
SEQ1732 hypothetical phage protein 
SEQ1733 hypothetical phage protein 
SEQ1734 hypothetical phage protein 
SEQ1735 hypothetical phage protein 
SEQ1736 putative collagen-like repeat protein 
SEQ1737 hypothetical phage protein 
SEQ1738 putative phage tail protein 
SEQ1739 putative phage minor tail protein 
SEQ1740 hypothetical phage protein 
SEQ1741 hypothetical phage protein 
SEQ1742 phage major tail protein 
SEQ1743 phage major tail protein 
SEQ1744 hypothetical phage protein 
SEQ1745 hypothetical phage protein 
SEQ1746 hypothetical phage protein 
SEQ1747 hypothetical phage protein 
SEQ1748 hypothetical phage protein 
SEQ1749 putative phage capsid protein 
SEQ1750 hypothetical phage protein 
SEQ1751 hypothetical phage protein 
SEQ1752 hypothetical phage protein 
SEQ1753 hypothetical phage protein 
SEQ1754 hypothetical phage protein 
SEQ1755 hypothetical phage protein 
SEQ1756 hypothetical phage protein 
SEQ1757 phage Mu protein F like protein 
SEQ1758 putative phage portal protein 
SEQ1759 putative phage terminase, large subunit 
SEQ1760 putative transposase 
SEQ1761 putative transposase 
SEQ1762 putative phage repressor protein 
SEQ1763 hypothetical phage protein 
SEQ1764 hypothetical phage protein 
SEQ1765 putative phage integrase 
24 SEQ1853 putative exported protein 1 31.05 
25 SEQ1857 putative membrane protein 2 29.72 
SEQ1855a conserved hypothetical protein 
26 rRNAsl 1970594- 16S rRNA, tRNA-Ala, 23S rRNA, 5S 
tRNAs 1976601 rRNA, tRNA-Val, tRNA-Asp, tRNA-lys, 
tRNA-leu, tRNA-Thr, tRNA-Gly, tRNA-
leu, tRNA-Arg, tRNA-Pro 
27 Genomic SEQ1971 putative plasmid stabilisation system 14 37.18 
island protein 
SEQ1972 putative plasmid stabilisation system, 
antitoxin protein 
SEQ1973 conserved hypothetical protein 
SEQ1974 type I restriction-modification system R 
protein 
SEQ1975 anticodon nuclease 
SEQ1976 type I restriction-modification system S 
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protein 
SEQ19n type I restriction-modification system M 
protein 
SEQ1978 conserved hypothetical protein 
SEQ1979 conserved hypothetical protein 
SEQ1980 conserved hypothetical protein 
SEQ1981 conserved hypothetical protein 
SEQ1982 putative DNA-binding protein 
SEQ1983 putative DNA-binding protein 
SEQ1984 putative integrase 
28 SEQ2035* putative DNA-binding protein (fragment) 1 31.28 
29 Prophage insertion in SEQ2036 exotoxin H precursor SeeH 54 39.18 
<pSeq4 584047 SEQ2037 exotoxin I precursor Seel 
SEQ2038 putative phage lysin protein 
SEQ2039 putative phage membrane protein 
SEQ2040 putative phage holin 
SEQ2041 phage membrane protein 
SEQ2042 hypothetical phage protein 
SEQ2043 hypothetical phage protein 
SEQ2044 hypothetical phage protein 
SEQ2045 putative phage hyaluronidase 
SEQ2046 hypothetical phage protein 
SEQ2047 hypothetical phage protein 
SEQ2048 putative phage minor tail protein 
SEQ2049 hypothetical phage protein 
SEQ2050 hypothetical phage protein 
SEQ2051 putative phage major tail protein 
SEQ2052 hypothetical phage protein 
SEQ2053 hypothetical phage protein 
SEQ2054 hypothetical phage protein 
SEQ2055 hypothetical phage protein 
SEQ2056 hypothetical phage protein 
SEQ2057 hypothetical phage protein 
SEQ2058 hypothetical phage protein 
SEQ2059 putative phage membrane protein 
SEQ2060 putative phage minor head protein 
SEQ2061 putative phage portal protein 
SEQ2062 putative phage terminase, large subunit 
SEQ2063 putative phage terminase, small subunit 
SEQ2064 hypothetical phage protein 
SEQ2065 putative hypothetical phage protein 
SEQ2066 hypothetical phage protein 
SEQ2067 hypothetical phage protein 
SEQ2068 hypothetical phage protein 
SEQ2069 hypothetical phage protein 
SEQ2070 SNF2 family phage protein 
SEQ2071 hypothetical phage protein 
SEQ2072 putative phage DNA primase/helicase 
protein 
SEQ2073 putative phage DNA polymerase 
SEQ2074 hypothetical phage protein 
SEQ2075 hypothetical phage protein 
SEQ2076 hypothetical phage protein 
SEQ20n hypothetical phage protein 
SEQ2078 hypothetical phage protein (pseudogene) 
SEQ2079 hypothetical phage protein 
SEQ2080 hypothetical phage protein 
SEQ2081 hypothetical phage protein 
SEQ2082 hypothetical phage protein 
SEQ2083 putative phage DNA-binding protein 
SEQ2084 putative phage membrane protein 
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SEQ2085 putative hypothetical phage protein 
SEQ2086 putative phage DNA-binding protein 
SEQ2087 hypothetical phage protein 
SEQ2088 hypothetical phage protein 
SEQ2089 phage integrase 
30 SEQ2093 hypothetical protein (pseudogene) 3 26.06 
SEQ2094* major facilitator superfamily protein 
SEQ2095 putative exported prot-ein 
31 deletion in SEQ2170 ABC transporter membrane protein 4 
SzH70 and SEQ2171 ABC transporter, ATP-binding subunit SzMGCS10565 SEQ2172 two-component response regulator 
SEQ2173 putative two-component sensor kinase 
protein 
* Homologue present in SzMGCSI0565 
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Table A.2B Novel SzH70 DNA loci 
No. Element Notes CDS! region Function Total %GC 
no. 
novel 
CDS 
1 SZOO0830· putative collagen-like cell surface- 1 54.35 
anchored protein 
2 SZ001230 putative exported protein 1 34.02 
3 SZ001450 putative exported protein 1 28.65 
4 deletion in SZ001750· sorbitol-6-phosphate 2- 1 43.12 
5e4047 dehydrogenase SorD 
5 genomic SZ002230 integrase 8 32.52 
island SZ002240 DNA-binding protein 
SZ002250 conserved hypothetical protein 
SZ002260 putative membrane protein 
SZ002270 hypothetical protein 
SZ002280 conserved hypothetical protein 
SZ002290 hypothetical protein 
SZ002300 hypothetical protein 
6 SZ003350 putative exported protein 3 31.92 
.diverse 
SZ003360 putative exported protein 
SZ003370· putative exported protein 
7 tRNAs 486423 - 486623· tRNA-lIe, tRNA-Glu 
8 distinct SZ004240 putative type I restriction enzyme 6 38.39 
restriction- protein 
modification SZ004250 hypothetical protein 
system in SZ004260 type I restriction modification DNA 5zMGCS10565 specificity protein 
SZ004270 hypothetical protein 
SZ004280 putative type I restriction enzyme 
methylase protein 
SZ004281 hypothetical protein (fragment) 
9 SZ005080 transposase (fragment) 8 30.32 
SZ005081 conserved hypothetical protein 
SZ005090 putative permease 
SZ005100 ABC transporter protein 
SZ005110 putative lantibiotic synthetase protein 
SZ005120 prolyl oligopeptidase family protein 
SZ005130 ABC transporter protein 
SZ005131 conserved hypothetical protein 
(fragment) 
10 deletion in SZ005580 putative lantibiotic transport ATP- 12 32.45-
5e4047 mediated binding protein 43.24 
byiSSeq3 SZOO5590 putative lantibiotic transport protein 
elements SZ005600 putative lantibiotic transport protein 
SZ005610· ABC transporter protein 
SZOO5620· putative membrane protein 
SZ005630· putative membrane protein 
SZOO5640 dhaKLM operon coactivator DhaQ 
SZOO5650 dhaKLM operon transcriptional 
activator DhaS 
SZ005660 PTS-dependent dihydroxyacetone 
kinase, dihydroxyacetone-binding 
subunit DhaK 
SZ005670 PTS-dependent dihydroxyacetone 
kinase, ADP-binding subunit DhaL 
SZ005680 sugar phosphotransferase system 
(PTS), IIC component 
SZOO5690 glycerol uptake facilitator protein GlpF 
11 similar region in SZ005820·~verse putative exported protein 5 36.37 
5e4047 and SZ005830·~v.,.e putative exported protein 5zMGCS10565 SZOO5840 putative exported protein 
(pseudogene) 
SZ005850 putative exported protein 
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SZ005860,awerse conserved hypothetical protein 
12 deletion in SZ006070 phosphate transport system protein 1 40.51 
5e4047 and PhoU (pseudogene) 
5zMGCS10565 
13 deletion in 8Z006280 hypothetical protein 6 43.47 
8e4047 mediated SZ006290 ,u· .~ putative membrane protein 
by IS8eq3 SZ006300 conserved hypothetical protein elements 
.dlverse 
SZ006310 conserved hypothetical protein 
..diverse 
SZ006320 putative membrane protein 
.cJiverse 
SZ006330 conserved hypothetical protein 
14 genomic SZ007580 replication initiator protein (fragment) 12 31.26 
island SZ007581 conserved hypothetical protein 
(fragment) 
SZ007590 mobilisation protein 
8Z007600 putative relaxase (fragment) 
SZ007620 sensor histidine kinase 
SZ007630 response regulator protein 
SZ007640 putative membrane protein 
SZ007660 lantibiotic biosynthesis protein 
SZ007670 lantibiotic transport/processing ATP-
binding protein 
SZ007680 putative lantibiotic ABC transporter 
protein 
SZ007690 putative lantibiotic ABC transporter 
protein 
SZOO7700 putative lantibiotic ABC transporter 
protein 
15 similar region in SZ008010' putative membrane protein 2 34.11 
5e4047 and SZ008020' putative membrane protein 
5zMGCS10565 SZ008030' putative membrane protein 
SZ008040' putative membrane protein 
SZ008050 putative membrane protein 
16 deletion in SZ008550' putative recombinase 2 37.64 
5e4047 SZ008560' putative cell surface-anchored protein 
17 genomic 8Z009570 conserved hypothetical protein 9 30.25 
island 8Z009580 putative protein kinase 
SZ009590 hypothetical protein 
SZ009600 conserved hypothetical protein 
SZ009610 conserved hypothetical protein 
SZ009620 hypothetical protein 
SZ009630 type \I restriction enzyme-methylase 
SZ009640 type \I restriction enzyme and 
methylase 
SZ009650 hypothetical protein 
18 deletion in SZ009940' bacteriocin-associated membrane 6 35.92 
5e4047 mediated protein 
by ISSeq3 SZ009941, putative bacteriocin 
elements 8Z009950' putative thioredoxin 
8Z009951, putative bacteriocin 
SZ009952' putative bacteriocin 
SZ009960' putative membrane protein 
19 SZ010340' conserved hypothetical protein 11 32.24 
SZ010361 , conserved hypothetical protein 
(fragment) 
SZ010360' putative exported protein 
8Z010370' conserved hypothetical protein 
8Z010380' conserved hypothetical protein 
SZ010390 conserved hypothetical protein 
SZ010400 putative exported protein 
SZ01041 0 conserved hypothetical protein 
(fragment) 
SZ010420 putative exported protein 
SZ010430' conserved hypothetical protein 
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(pseudogene) 
8Z010440' putative membrane protein 
20 deletion in 8Z012330' putative ABC transporter, ATP- 8 33.77 
5e4047 mediated bindina/oermease orotein 
by recombination 8Z012340 putative membrane protein 
between 188eq3 8Z012350 ABC-2 type transporter protein 
andl88eq5 
8Z012360 ABC transporter protein elements 
8Z012370 hypothetical protein 
8Z012380 radical 8AM superfamily protein 
8Z012390 radical 8AM superfamily protein 
8Z012400 putative DNA-binding protein 
21 ICE5z1 C- 8Z012560 conserved hypothetical protein 17 34.57 
terminus 8Z012570 conserved hypothetical protein 
(fragment) 
8Z012580 conserved hypothetical protein 
(fragment) 
8Z012590 conserved hypothetical protein 
(fragment) 
8Z012600 putative DNA-binding protein 
8Z012660 DNA topoisomerase (fragment) 
SZ012670 putative replication initiation protein 
(fragment) . 
SZ012680 putative membrane protein 
SZ012690 conserved hypothetical protein 
SZ012700 site-specific recombinase 
8Z012710 conserved hypothetical protein 
8Z012720 radical 8AM superfamily protein 
SZ012730 conserved hypothetical protein 
SZ012740 conserved hypothetical protein 
SZ012750 putative DNA-binding protein 
SZ012760 conserved hypothetical protein 
SZ012770 relaxase/moblllsation protein 
22 ICE5z1 N- SZ012900 group II intron reverse transcriptase 2 34.23 
terminal maturase (pseudogene) 
region SZ012930 ABC transporter protein 
23 SZ013420 putative exported protein 1 34.68 
24 SZ014080' response regulatory protein 4 38.04 
SZ014090' sensor histidine kinase 
SZ0141 00' ABC-2 type transporter protein 
SZ014110' ABC transporter protein 
25 CRISPR deletion in 1604884-1606107 CRISPR repeats 24 40.56 
locus 5e4047 mediated *dlstinctrepeats 
by ISSeq11 SZ014370' CRISPR-associated protein Cas2 
elements SZQ14380' CRISPR-associated protein Cas1 
SZ014390' CRISPR-associated protein Cas4 
SZ014400' CRISPR-associated protein 
8Z014410' CRl8PR-associated protein 
SZ014420' CRl8PR-associated protein 
SZ014430' CRISPR-associated helicase 
SZ014440' hypothetical protein 
SZ014450' hypothetical protein 
SZ014460 hypothetical protein 
SZ014471' conserved hypothetical protein • 
(fragment) 
SZ014470' conserved hypothetical protein 
SZ014480 hypothetical protein 
8Z014490' conserved hypothetical protein 
8Z014500' hypothetical protein 
SZ014510' putative membrane protein 
SZ014520 conserved hypothetical protein 
SZ014530 conserved hypothetical protein 
SZ014540 hypothetical protein 
SZ014550' hypothetical protein 
SZ014560 putative membrane protein 
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8Z014570" hypothetical protein 
8Z014580" hypothetical protein 
8Z014590" putative membrane protein 
26 ESAT-6- deletion in 8Z014660" E8AT-6 secretion system protein 4 42.29 
like locus 594047 mediated EssA 
by 188eq3 8Z014670" E8AT-6 secretion system protein 
elements EsaA 
8Z014680" E8AT-6 secreted protein EsxA 
8Z014690' branched-chain amino acid transport 
system carrier protein 
27 8Z014721" conserved hypothetical protein 8 33.1 
(fragment) 
8Z014730' transport protein ComB 
8Z014740' transport/processing A TP-binding 
protein ComA 
8Z014744' putative competence stimulating 
peptide 
8Z014743" hypothetical protein 
8Z014742' putative competence stimulating 
peptide 
8Z014741" conserved hypothetical protein 
8Z014750' DNA-binding protein 
28 deletion in 8Z014870 putative exported protein 1 36.51 
594047 and 
5zMGC81 0565 
29 deletion in 8Z015030' ABC transporter, ATP-binding protein 4 41.1 
594047 8Z015040" putative membrane protein 
8Z015050' putative membrane protein 
8Z015060' conserved hypothetical protein 
30 deletion in 8Z015110' D-ribose-binding protein precursor 6 43.95 
594047 RbsD 
8Z015120' ribose transport system permease 
protein RbsC 
8Z015130" ribose import A TP-binding protein 
RbsA 
8Z015140" high affinity ribose transport protein 
RbsD 
8Z015150' ribokinase RbsK 
8Z015160' ribose operon repressor RbsR 
31 deletion in 8Z015220' 6-phospho-beta-galactosidase LacG 5 44.11 
594047 8Z015230' sugar phosphotransferase system 
(PT8), lactose-specific IICB 
component LacE 
8Z015240' sugar phosphotransferase system 
(PT8), lactose-specific 
phosphotransferase enzyme IIA 
component LacF 
8Z015250" transcription antiterminator LacT 
8Z015260' tagatose 1,6-diphosphate aldolase 
LacD 
32 similar region in 8Z017200 hypothetical protein 12 37.97 
594047 8Z017210 hypothetical protein 
8Z017220 hypothetical protein 
8Z017230 hypothetical protein 
8Z017240 hypothetical protein 
8Z017250 hypothetical protein 
8Z017260 conserved hypothetical protein 
8Z017270 hypothetical protein 
8Z017280 hypothetical protein 
8Z017290 conserved hypothetical protein 
(fraament) 
8Z017300' conserved hypothetical protein 
8Z017310 conserved hypothetical protein 
33 8Z017550 conserved hypothetical protein 2 29.63 
8Z017560 hypothetical protein 
34 ICE5z2 insertion in 8Z017561 relaxase (fragment) 41 38.64 
5zH70 8Z017570 group II intron-encoded protein 
(pseudogene) 
333 
SZ017580 putative relaxase (fragment) 
SZ017590 mobilisation protein 
SZ017600 conserved hypothetical protein 
SZ017610 DNA-binding protein 
SZ017620 conserved hypothetical protein 
SZ017630 conserved hypothetical protein 
SZ017640 conserved hypothetical protein 
SZ017650 conserved hypothetical protein 
SZ017660 conserved hypothetical protein 
(pseudooene) 
SZ017680 putative exported protein 
SZ017690 multi antimicrobial extrusion (MATE) 
family transporter 
SZ017700 conserved hypothetical protein 
SZ017710 radical SAM superfamily protein 
SZ017730 transcriptional regulator 
SZ01n40 putative membrane protein 
SZ017750 conserved hypothetical protein 
SZ017760 putative helicase 
SZ017nO putative group IIlntron reverse 
transcriptase/maturase 
SZ017790 conserved hypothetical protein 
SZ017800 putative glucan-binding protein 
SZ017810 hypothetical protein 
SZ017820 conserved hypothetical protein 
SZ017830 conserved hypothetical protein 
SZ017840 putative amidase (fragment) 
SZ017850 putative peptidase (fragment) 
SZ017860 conserved hypothetical protein 
(pseudooenei 
SZ017870 putative group II intron reverse 
transcriptase/maturase 
SZ017890 conserved hypothetical protein 
(pseudogenej 
SZ017900 putative membrane protein 
SZ017910 putative membrane protein 
SZ017920 TraG family protein (pseudogene) 
SZ017940 conserved hypothetical protein 
SZ017950 abortive infection protein 
SZ017960 conserved hypothetical protein 
SZ017970 conserved hypothetical protein 
(fragment) 
SZ017980 conserved hypothetical protein 
(fragment) 
SZ017990 C-5 cytosine-specific DNA methylase 
SZ018000 replication initiator A protein 
SZ018010 conserved hypothetical protein 
35 deletion in SZ018270 sortase SrtC.2 8 37.91 
S94047 mediated SZ018280 sortase SrtC.3 by ISSeq3, 2 SZ018290 sortase SrtC.4 distinct pilus 
clusters in SZ018300 putative exported protein 
SzMGCS10565 SZ018310 putative ancillary pilus subunit 
SZ018320 putative backbone pilus subunit 
SZ018330 putative pilus subunit 
SZ018340' AraC family regulatory protein 
36 genomic insertion in SZ019050' plasmid stabilization system protein 4 36.88 
island SzH70 and SZ019060' conserved hypothetical protein SzMGCS10565 SZ019061' phage hypothetical protein into the end of (pseudogene) rpsD SZ019062' phage hypothetical protein (fragment) 
37 similar region in SZ019300' putative membrane protein 1 34.61 
S94047 SZ019310' putative membrane protein 
SZ019320' putative membrane protein 
SZ019330 putative membrane protein 
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* Homologue present in SzMGCSI0565 
Table A.2C Diversified regions of the SzH70 and Se4047 genomes 
No. 564047 SzH70 % Similarity Function 
§ 
1 SEQ0084 SZOO0790 78.9. hypothetical protein 
2 SEQ0090 SZOO0840 66.7 putative collagen-like cell surface-anchored protein SclG 
3 SEQ0121 SZOO1080 77.0 putative membrane protein 
4 SEQ0202 SZOO1211t 77.8 putative exported protein 
SEQ0203 SZOO1220 88.8 putative exported protein 
5 SEQ0256 SZOO1590 81.2 putative cell surface-anchored protein 
SEQ0260 SZOO1630 84.7 putative collagen-like cell surface-anchored protein SclH 
6 SEQ0280 SZ017540 76.5 putative collagen-like cell surface-anchored protein SclD 
7 SEQ0308 SZ017320 71.6 membrane protein 
8 SEQ0367 SZ016670 76.2 MerR family regulatory protein 
9 SEQ0375 SZ016630 71.5 collagen- and fibronectin-binding protein Fne/Fnz 
t 
10 SEQ0402 SZ016370 71.9 putative cell surface-anchored protein 
11 SEQ0432 SZ016140 90.7 endoglycosidase EndoS 
12 SEQ0521 SZ015350 91.7 putative negative regulator of copper transport operon CopY 
13 SEQ0527 SZ015290 93.6 galactose-6-phosphate isomerase LacA subunit 
14 SEQ0555 SZ014890 45.1 putative collagen and fibronectin-binding cell surface-anchored 
protein FneE 
15 SEQ0566 SZ014790 59.3 Szp/SzPSe-like cell surface-anchored protein 
t 
16 SEQ0633 SZ013850 80.1 putative collagen-like surface-anchored protein SclE 
17 SEQ0855 SZ012230 83.3 putative collagen-like surface-anchored protein SclF 
18 SEQ0896 SZ011861 63.4 putative exported protein 
19 SEQ0933 SZ011530 84.2 fibrinogen-binding cell surface-anchored protein SzPSe; adhesin 
and hypervariable protective antigen Szp 
20 SEQ0938 SZ011480 81.3 Mac family IgG endopeptidase anti phagocytic and neutrophil-
binding protein IdeElldeZ 
SEQ0939 SZ011470 75.5 putative cell surface-anchored protein 
21 SEQ1051 SZ010440 51.0 putative membrane protein 
22 SEQ1510 SZ006420 82.2 conserved hypothetical protein 
SEQ1511 SZ006410t 88.5 hypothetical protein 
23 SEQ1543 SZ006080 85.2 putative exported protein 
24 SEQ1564 SZ005860 58.7 conserved hypothetical protein 
SEQ1565 SZ005820 73.5 putative membrane protein 
25 SEQ1606 SZ005380 67.3 putative collagen-binding collagen-like surface-anchored protein 
FneC 
26 SEQ1607 SZ005350 48.3 putative collagen-binding surface-anchored protein FneD 
t 
27 SEQ1649 SZ004910 63.1 putative collagen-like surface-anchored protein FneF 
28 SEQ1670 SZ004720 44.9 putative exported protein 
29 SEQ1817 SZ003720 79.3 collagen-like cell surface-anchored protein Scll 
30 SEQ1941 SZ002570 74.6 putative membrane protein 
31 SEQ1999 SZ002080 85.0 fibronectin and collagen-binding cell surface anchored protein 
FneB/Fnz2 
32 SEQ2017 SZOO1900 74.7 anti phagocytic cell surface-anchored fibrinogen- and IgG Fc-binding 
protein 
33 SEQ2101 SZ018110 69.1 putative collagen-like surface-anchored protein SclC 
§ Needleman-Wunsch global alignment of amino acid sequences. t Pseudogene or partial 
gene. Regions 1 to 33 are also diverse in SzMGCS10565 relative to Se4047 and/or SzH70 
(a homologous CDS is absent in SzMGCS 10565 in regions 7, 23 and 30). 
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Table A.2D Se4047 pseudogenes (includes partial genes) 
No. Se4047 SzH70 Intact in Function 
ortholoQ SzH70 
1 8EOO036t 8Z000360 no conserved hypothetical protein 
2 8EOO036a 8Z000370 no conserved hypothetical protein 
t 
3 8EOO038 8Z000390 yes putative DNA-binding protein 
4 8EOOO48 not present - ThiF family protein 
5 8EOO083 8Z000780 no transposase 
6 8EOO085 8Z000800 yes putative membrane protein 
7 8EOO100t not present - putative transposase 
8 8EOO115 not present - transposase 
9 8EOO150 not present - hypothetical phage protein 
(q>8ea1) 
10 8EOO214 not present - putative DNA-binding protein 
11 8EOO232t 8Z001430 yes putative cell wall anchored protein 8pa 
12 8EQ0236 not present - putative exported protein 
13 8EOO239 not present - ABC transporter, ATP-binding protein 
14 8EQ0273t 8Z017520 yes putative rhomboid family membrane protein 
15 8EQ0275 not present - transposase 
16 8EQ0275 not present - transposase 
17 8EOO307t not present - transposase 
18 8EOO309a not present - putative membrane protein 
t 
19 8EQ0313 8Z017180 yes hypothetical protein 
20 8EOO320 8Z017120 yes putative N-acetylmannosamine-6-phosphate 2-epimerase 
21 SEQ0328t SZ017040 yes putative acetyl xylan esterase (AXE1) family protein 
22 8EQ0370 8Z016650 yes response regulator 8aeR 
23 8EOO375 8Z016630 yes Fne collagen and fibronectin-binding protein 
24 8EOO380 8Z016601 yes putative DNA-binding protein 
25 8EOO405t 8Z016340 no putative hypothetical phage protein 
26 8EOO424 8Z016200 yes conserved hypothetical protein 
27 8EOO426 8Z016190 yes conserved hypothetical protein 
28 8EOO438 not present - transposase 
29 8EOO443 82016070 yes Shr heme binding cell surface protein 
30 8EOO495 8Z015570 yes putative haloacid dehalogenase-like hydrolase 
31 8EOO509a 8Z015450 no putative integrase 
t 
32 8EQ0509b 8Z015440 no putative transposase 
t 
33 8EQ0511t 8Z015430 no putative membrane protein 
34 8EQ0514t 8Z015420 no conserved hypothetical protein 
35 8EQ0530t 8Z015260 yes putative tagatose 1 ,6-diphosphate aldolase 
36 8EOO531t 8Z015220 yes 6-phospho-beta-galactosidase LacG 
37 8EOO541t SZ015030 yes ABC transporter, ATP-binding protein 
38 SEQ0556t not present - 8cl surface protein 
39 8EOO566 8Z014790 yes M-like surface-anchored protein 
40 8EOO573t not present - transposase 
41 8EOO576t 8Z014660 yes E8AT-6 secretion system protein EssA 
42 8EQ0578 8Z014651 yes E8AT-6 secretion system protein EsaB 
43 8EQ0583a 8Z014590 yes putative membrane protein 
t 
44 8EOO584t 8Z014360 yes transposase 
45 8EQ0585t 8Z014350 yes transposase 
46 8EOO663 8Z013550 yes transposase 
47 8EOO685 8Z013370 yes putative competence protein CoiA-like family protein 
48 8EOO738 SZ012890 yes putative membrane protein on ICE8e1 
49 8EOO733 8Z012940 no putative conjugal transfer protein 
50 8EOO746t 8Z012820 yes putative DNA topoisomerase on ICE8e1 
51 8EOO749t 8Z012660 yes putative DNA topoisomerase on ICE8e1 
52 8EQ0763t 8Z012770 yes putative relaxase/mobilization protein end of ICE8e1 but not end of 
ICEsz1 
53 8EOO774 8Z012430 yes putative oligopeptidase 
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54 SEOO780t SZ012330 yes putative ABC transporter, ATP-binding/permease protein 
55 SEOO808 not present - putative C-5 cytosine-specific DNA methylase 
(q>SeQ2) 
56 SEQ0866 SZ012130 yes putative beta-galactosidase precursor 
57 SEOO871 SZ012110 yes sugar phosphotransferase system (PTS), sorbose-specific family, IIC 
component 
58 SEOO899t SZ011830 no transposase 
59 SEOO909 SZ011740 yes putative 1,4-alpha-glucan branching enzyme 
60 SEOO934 SZ011520 yes TetR family regulatory protein 
61 SEOO943t SZ011420 no transposase 
62 SEOO986 not present - transposase 
63 SEQ1007 not present - transposase 
64 SEQ1064 SZ010210 yes putative ABC transporter permease protein 
65 SEQ1068 not present - transposase 
66 SEQ1077 SZ010150 yes putative cell surface-anchored C5A peptidase precursor 
67 SEQ1088 SZ010050 yes conserved hypothetical protein 
68 SEQ1098t SZ009960 yes putative membrane protein 
69 SEQ1101t not present - hypothetical protein 
70 SEQ1103t SZ008820 yes putative ABC transporter ATP-binding membrane protein 
71 SEQ1149 SZ009270 yes putative ABC-type glycine betaine transport system ATP-binding 
protein 
72 SEQ1151 SZ009280 yes putative glycine betaine ABC transporter permease and substrate 
binding protein 
73 SEQ1155 SZ009310 yes ApbE family protein 
74 SEQ1189 SZ009690 yes putative ABC transporter permease 
75 SEQ1209 SZ009840 yes putative ammonia monooxygenase 
76 SEQ1223 SZ009930 yes putative ABC transporter ATP-binding protein 
77 SEQ1225t SZ009940 yes bacteriocin-associated membrane protein 
78 SEQ1226t SZ009950 yes putative thioredoxln (bacteriocin cluster) 
79 SEQ1272t not present - putative two-component sensor histidine kinase (on start of ICESe2) 
80 SEQ1273t not present - hypothetical protein (upstream of ICESe2) 
81 SEQ1276t SZ008820 yes putative ABC transporter ATP-binding membrane protein 
82 SEQ1281 SZ008770 yes putative ABC transporter, ATP-binding/permease protein 
83 SEQ1284 SZ008750 yes putative ABC transporter ATP-binding protein 
84 SEQ1307a SZ008560 yes putative cell surface-anchored protein 
t 
85 SEQ1328 not present - conserved hypothetical protein 
86 SEQ1364t SZ007970 no putative uncharacterized protein 
87 SEQ1380t SZ007810 no putative membrane protein (bacteriocin associated) 
88 SEQ1383t SZOO7780 no putative bacteriocin transport/processing ATP-binding protein 
89 SEQ1385 SZOO7770 no putative bacteriocin secretion protein 
90 SEQ1387 SZOO7750 no putative transposase 
91 SEQ1467 SZ006800 yes aminopeptidase PepS 
92 SEQ1479 SZ006680 yes hyaluronate lyase precursor HysA 
93 SEQ1492 SZ006560 yes conserved hypothetical protein 
94 SEQ1494 SZ006550 yes conserved hypothetical protein 
95 SEQ1507 SZ006440 yes putative membrane (In operon with RNA polymerase sigma factor 
protein) 
96 SEQ1518t SZ006361 no hypothetical protein 
97 SEQ1523 SZ006260 yes major facilitator superfamily protein 
98 SEQ1528t SZ006220 no transposase 
99 SEQ1573 not present - putative transposase 
100 SEQ1585t SZ005580 yes putative lantibiotlc transport ATP-binding protein 
101 SEQ1588a SZ005541 no conserved hypothetical protein 
t 
102 SEQ1589t SZ005540 no putative transposase 
103 SEQ1590t SZ005530 no putative transposase 
104 SEQ1607 SZ005350 yes collagen-binding surface-anchored protein 
105 SEQ1613 SZ005300 yes sugar phosphotransferase system (PTS), IIC component 
106 SEQ1632t SZ005140 no conserved hypothetical protein 
107 SEQ1667 SZ004750 yes conserved hypothetical protein 
108 SEQ1671 SZ004710 yes putative exported protein 
109 SEQ1677t SZ004650 no conserved hypothetical protein 
110 SEQ1677a not present - conserved hypothetical protein 
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t 
111 SEQ1699 SZOO4441 no putative exported protein 
112 SEQ1720t SZ004200 no transposase 
113 SEQ1724 SZ004180 yes putative late competence protein ComFC 
114 SEQ1725 SZ004170 yes putative late competence protein ComFA 
115 SEQ1810 SZ003760 yes putative exported protein 
116 SEQ1824a SZ003651 no transposase 
t 
117 SEQ1854t SZ003390 yes conserved hypothetical protein 
118 SEQ1855a not present - conserved hypothetical protein 
t 
119 SEQ1873 not present - transposase 
120 SEQ1924 not present - transposase 
121 SEQ1942t SZ002560 no integrase 
122 SEQ1966t SZ002330 no transposase 
123 SEQ1968t SZ002310 no transposase 
124 SEQ2010 SZOO1970 yes conserved hypothetical protein 
125 SEQ2035t not present - putative DNA-binding protein 
126 SEQ2078 not present - hypothetical phage protein 
(q>Seq4) 
127 SEQ2093 not present - hypothetical protein 
128 SEQ2099 SZ018092 yes conserved hypothetical protein 
129 SEQ2117 not present - transposase 
130 SEQ2119t SZ018340 yes AraC family regulatory protein 
131 SEQ2122 SZ018370 yes deoxynucleoside kinase 
132 SEQ2138 SZ018520 yes putative membrane protein 
133 SEQ2184 SZ018940 yes conserved hypothetical protein 
134 SEQ2192 SZ018990 yes putative MutT/NUDIX hydrolase family protein 
135 SEQ2225 not present - transposase 
136 SEQ2227 SZ019320 yes putative membrane protein 
t indicates partial gene 
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Table A.2E SzH70 pseudogenes (includes partial genes) 
No. SzH70 Se4047 ortholog Intact in Function 
Se4047 
1 SZOO0360t SEQ0036 no conserved hypothetical protein 
2 SZOO0370t SEQ0036a no conserved hypothetical protein 
3 SZOO0780t SEQ0083 no transposase 
4 SZOO1211 SEQ0202 yes putative exported protein 
5 SZOO1310 SEQ0213 yes putative mutator protein MutX 
6 SZ001811t SEQ2027 yes NUDIX hydrolase 
7 SZ001890 SEQ2018 yes AraC family regulatory protein 
8 SZOO2310t SEQ1968 no transposase 
9 SZOO2330t SEQ1966 no transposase 
10 SZ002560t SEQ1942 no integrase 
11 SZ003651t SEQ1824a no transposase 
12 SZ004200t SEQ1720 no transposase 
13 SZ004281t not present - hypothetical protein 
14 SZOO4441 SEQ1699 no putative exported protein 
15 SZOO4650t SEQ1677 no conserved hypothetical protein 
16 SZOO5080t not present - transposase 
17 SZOO5131t not present - conserved hypothetical protein 
18 SZ005140t SEQ1632 no conserved hypothetical protein 
19 SZOO5460 SEQ1598 yes putative ABC transporter, ATP-binding/permease protein 
20 SZOO5530t SEQ1590 no putative transposase 
21 SZOO5540t SEQ1589 no putative transposase 
22 SZOO5541t SEQ1588a no transposase 
23 SZOO5550 SEQ1588 yes putative lantibiotic leader peptide processing serine protease 
24 SZ005840 not present - putative exported protein 
25 SZ006070 not present - phosphate transport system protein PhoU 
26 SZOO6220t SEQ1528 no transposase 
27 SZOO6320t not present - putative membrane protein 
28 SZOO636ot SEQ1516 yes hypothetical protein 
29 SZOO6361t SEQ1518 no hypothetical protein 
30 SZOO6380 SEQ1514 yes hypothetical protein 
31 SZOO6410t SEQ1511 yes hypothetical protein 
32 SZOO7580t not present - replication initiator protein (on genomic island) 
33 SZOO7581t not present - conserved hypothetical protein 
34 SZ007600t not present - putative relaxase 
35 SZOO7660 not present - lantibiotic biosynthesis protein 
36 SZOO7710t SEQ1389 yes transposase 
37 SZOO7750 SEQ1387 no putative transposase 
38 SZOO7770 SEQ1385 no putative bacteriocin secretion protein 
39 SZ007780t SEQ1383 no putative bacteriocin transport/processing ATP-binding 
protein 
40 SZOO7790 SEQ1382 yes putative bacteriocin 
41 SZOO7810t SEQ1380 no putative membrane protein (bacteriocin associated) 
42 SZOO7970t SEQ1364 no putative uncharacterized protein 
43 SZ008000 SEQ1361 yes putative membrane protein 
44 SZ010201t SEQ1066 yes transposase 
45 SZ010361t not present - conserved hypothetical protein 
46 SZ010410t not present - conserved hypothetical protein 
47 SZ010430 not present - conserved hypothetical protein 
48 SZ011420t SEQ0943 no transposase 
49 SZ011830t SEQ0899 no transposase 
50 SZ012460 SEQ0771 yes putative membrane protein 
51 SZ012570t not present - conserved hypothetical protein 
52 SZ012580t not present - conserved hypothetical protein 
53 SZ012590t not present - conserved hypothetical protein 
54 SZ012620t SEQ0752 no putative conjugative transposon DNA recombination protein 
55 SZ012630t SEQ0752 no putative conjugative transposon DNA recombination protein 
56 SZ012640 SEQ0751 yes DNA-binding protein 
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57 SZ012660t not present - DNA topoisomerase 
58 SZ012670t not present - putative replication initiation protein 
59 SZ012900 not present - group II intron reverse transcriptase maturase 
60 SZ012921 SEQ0737 yes Putative conjugative transposon membrane protein 
61 SZ012940 SEQ0733 no putative conjugal transfer protein 
62 SZ014260 SEQ0595 yes arginine repressor 
63 SZ014360 SEQ0584 no putative transposase 
64 SZ014471t not present - conserved hypothetical protein 
65 SZ014721t not present - conserved hypothetical protein 
66 SZ015430t SEQ0511 no putative membrane protein 
67 SZ015420t SEQ0514 no conserved hypothetical protein 
68 SZ015440t SEQ0509b no putative transposase 
69 SZ015450t SEQ0509a no putative integrase 
70 SZ016340t SEQ0405 no putative hypothetical phage protein 
71 SZ016870 SEQ0346 yes acid phosphatase precursor LppC 
72 SZ017290t SEQ0308 yes conserved hypothetical protein 
73 SZ017330t not present - transposase 
74 SZ017561t not present - relaxase 
75 SZ017570 not present - group II intron-encoded protein 
76 SZ017580t not present - putative relaxase 
77 SZ017660 not present - conserved hypothetical protein 
78 SZ017840t not present - putative amidase 
79 SZ017850t not present - putative peptidase 
80 SZ017860 not present - conserved hypothetical protein 
81 SZ017890 not present - conserved hypothetical protein 
82 SZ017920 not present - TraG family protein 
83 SZ017970t not present - conserved hypothetical protein 
84 SZ017980t not present - conserved hypothetical protein 
85 SZ018020t SEQ1389 yes putative transposase 
86 SZ018030t SEQ1389 yes putative transposase 
87 SZ018031t SEQ2027 yes NUDIX hydrolase 
and 
SZ001811t 
88 SZ018820t SEQ2170 yes ABC transporter membrane protein 
89 SZ018970t SEQ2190 yes putative cell surface-anchored protein 
90 SZ019061 not present - phage hypothetical protein 
91 SZ019062t not present - phage hypothetical protein 
t indicates partial gene 
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Table A.3 Composition of chemically defined medium 
Component Concentration (gIL) 
Adenine Sulfate, 2H2O 0.020000 
DL-Alanine 0.100000 
L-Arginine, FB 0.100000 
L-Ac;paragine, Anhydrous 0.100000 
L-Aspartic Acid 0.100000 
Biotin 0.000200 
Calcium Chloride, Anhydrous * 0.005066 
D-Calcium Pantothenate 0.002000 
Cyanocobalamin 0.000100 
L-cystine, 2HCI 0.065200 
Dextrose, Anhydrous 10.000000 
Ferric Citrate * 0.003040 
Ferrous Sulfate, 7H20 * 0.005000 
Folic Acid 0.000800 
L-Glutamic Acid 0.100000 
L-Glutamine 0.200000 
Glycine 0.100000 
Guanine, HCI, H2O 0.020000 
L-Histidine, FB 0.100000 
Hydroxy L-Proline 0.100000 
L-Isoleucine 0.100000 
L-Leucine 0.100000 
L-Lysine, HCI 0.124900 
Magnesium Sulfate, heptahydrate * 0.700000 
Manganous Sulfate, H20 * 0.005850 
L-Methionine 0.100000 
Niacinamide 0.001000 
Beta-NAD, 3 H2O 0.002500 
Para-Aminobenzoic Acid 0.000200 
L-Phenylalanine 0.100000 
Potassium Phosphate, Dibasic, Anhydrous 0.200000 
Potassium Phosphate, Monobasic, Anhydrous 1.000000 
L-Proline 0.100000 
Pyridoxal, HCI 0.001000 
Pyridoxamine,2HCI 0.001000 
Riboflavin 0.002000 
L-Serine 0.100000 
Sodium Acetate, Anhydrous 2.712600 
Sodium Phosphate, Dibasic, Anhydrous 7.350000 
Sodium Phosphate, Monobasic, H20, ACS 3.195000 
Thiamine, HCI 0.001000 
L-Threonine 0.200000 
L-Tryptophan 0.100000 
L-Tyrosine, 2Na, 2H2O 0.144200 
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Table A.3 continued 
Component Concentration (gIL) 
Uracil 0.020000 
L-Valine 0.100000 
Composition of chemically defined medium (CDM) purchased in powder form from SAFC 
Biosciences. * Reagents from Sigma added separately. 
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Table A.4 Identity of S. equi and S. zooepidemicus isolates studied by Southern blot and 
peR 
Lane Species peR type or SeM ST StrainID Disease/Source Animal Year 
allele 
1 Se Dl, SeM-3 179 4047 Strangles Horse 1990 
2 Se SeM-9 179 7344 Strangles Horse 2003 
3 Se SeM-6 NA 7350 Strangles Horse 2003 
4 Se SeM-6 179 1350 Strangles Horse 2003 
5 Se SeM-II 179 7364 Strangles Horse 2003 
6 Se SeM-2 179 CF32 Strangles* Horse 1981 
7 Se SeM-5 179 B237325 Strangles Horse 2003 
8 Se SeM-l NA 6073 Strangles Horse 1998 
9 Se NA 179 8229 Strangles Dog 2004 
10 Sz Dill 23 H25 Lower respiratory Horse 2000 
II Sz Dill 23 H61 Upper respiratory Horse 2000 
12 Sz Dill NA D53 Lower respiratory Horse 2000 
13 Sz Dill 8 H8 Lower respiratory Horse 2000 
14 Sz DI/3 NA D24 Lower respiratory Horse 2000 
15 Sz DII4 51 B236074 Uterine infection/abortion Horse 2003 
16 Sz DII5 33 H50 Upper respiratory Horse 2000 
17 Sz DI/5 27 HI5 Lower respiratory Horse 2000 
18 Sz Dllu NA Dla Lower respiratory Horse 2000 
19 Sz DI/u NA D84 Upper respiratory Horse 2000 
20 Sz Dllu 49 B236378 Uterine infection/abortion Horse 2003 
21 Sz AliI I 7271 Uterine infection/abortion Horse 2003 
22 Sz AI/2 NA P22 Lower re.~piratory Horse 2000 
23 Sz AII2 NA BHS32 Lower respiratory Dog 2001 
24 Sz AII2 22 BHS53 Lower respiratory Dog 2001 
25 Sz AII3 30 H9 Lower respiratory Horse 2000 
26 Sz AII4 NA D36 Lower respiratory Horse 2000 
27 Sz AII4 13 B260863 Uterine infection/abortion Horse 2006 
28 Sz AI/4 91 BHS37 Lower respiratory (severe Dog 2001 
bronchopneumonia) 
29 Sz AI/4 I H70 Upper respiratory Horse 2000 
30 Sz AII5 NA B237156 Uterine infection/abortion Horse 2003 
31 Sz AI/5 47 BHS28 Lower respiratory Dog 2000 
32 Sz AII5 10 BHS41 Lower respiratory Dog 2001 
33 Sz NA 16 B24 7132 Upper respiratory Horse 2004 
34 Sz NA 5 B24 7159 Lymph node abscess Horse 2004 
35 Sz NA 54 B24 7155 Upper re.~piratory Horse 2004 
36 Sz NA 125 B24 7157 Upper respiratory Horse 2004 
37 Sz NA 17 B24 7158 Upper re.~piratory Horse 2004 
38 Sz NA 95 B247156 Upper respiratory Horse 2004 
39 Sz NA 48 B254433 Lymph node abscess Horse 2005 
40 Sz AIIA2 93 B237166 Uterine infection/abortion Horse 2003 
41 Sz AIIDI/5 55 B237163 Uterine infection/abortion Horse 2003 
42 Sz Bill 8 D40 Lower respiratory Horse 2000 
43 Sz BlI2 NA BHS23 Lower respiratory Dog 2000 
44 Sz BlI3 2 DI4a Lower respiratory Horse 2000 
45 Sz BlI4 123 BHS5 Lower respiratory Dog 1999 
46 Sz BlIu 86 H52 Upper respiratory Horse 2000 
47 Sz CIII 45 D56 Lower respiratory Horse 2000 
48· Sz ClI2 NA D88 Upper re.~piratory Horse 2000 
49 Sz ClI3 45 H51 Upper respiratory Horse 2000 
50 Sz ClIu NA D44 Lower respiratory Horse 2000 
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Table A.4 continued 
Lane Species PCR type or SeM ST StrainID Disease/Source Animal Year 
allele 
51 Sz C2IB21D2 NA D13 Lower respiratory Horse 2000 
52 Sz C214 6 SI3 Skin swab Dog 2002 
53 Sz C21u 4 B244389 Uterine infection/abortion Horse 2004 
54 Sz C21u 149 6618 Uterine infection/abortion Horse 2003 
55 Sz D2Iu 101 B242382 Uterine infection/abortion Horse 2004 
56 Sz DIID2/4 178 2958 Uterine infection/abortion Horse 2003 
57 Sz NA 58 B26 Tansey Nephritis Horse 2006 
58 Sz NA 96 B254763 Lymph node abscess Horse 2005 
59 Sz NA 46 B250061 Lymph node abscess Horse 2005 
60 Sz NA 50 B255405 Lymph node abscess Horse 2005 
61 Se SeM-6 NA 7063 Strangles Horse 2003 
62 Se SeM-7 179 1931 Strangles Horse 2004 
63 Se SeM-14 179 3156 Strangles Horse 2004 
64 Se SeM-IO 179 7140 Strangle.~ Horse 2003 
65 Se SeM-12 179 3154 Strangles Horse 2004 
66 Se NA NA VOOO9445 Bastard strangles Horse NA 
67 Se SeM-2 179 303 Strangles" Horse 1999 
68 Se SeM-2 179 SA Strangles" Horse 1999 
69 Se SeM-15 179 181063 Strangles" Horse 1999 
70 Sz Dill 23 H27 Lower respiratory Horse 2000 
71 Sz DIll 23 H30 Lower respiratory Horse 2000 
72 Sz Dill NA D91 Upper respiratory Horse 2000 
73 Sz Dill 23 H29 Lower respiratory Horse 2000 
74 Sz Dill 8 H22a Lower respiratory Horse 2000 
75 Sz DIll NA D96 Upper respiratory Horse 2000 
76 Sz DI/3 NA DIOa Lower respiratory Horse 2000 
77 Sz DI/5 9 H54 Upper respiratory Horse 2000 
78 Sz Dl/u NA PI5 Lower respiratory Horse 2000 
79 Sz Dllu NA DI9 Lower respiratory Horse 2000 
80 Sz Dllu 8 D2a Lower respiratory Horse 2000 
81 Sz Dllu 8 H49 Upper re.~piratory Horse 2000 
82 Sz AI/5 53 B24 7102.2 Lymph node abscess Horse 2004 
83 Sz AII5 5 B24 7043 Lymph node abscess Horse 2004 
84 Sz AI/5 5 B247325 Upper respiratory Horse 2004 
85 Sz Allu 4 B244388 Uterine infection/abortion Horse 2004 
86 Sz A2/3 14 B242519 Uterine infection/abortion Horse 2004 
87 Sz BI/2 3 D33 Lower respiratory Horse 2000 
88 Sz BII2 NA BHS2 Lower respiratory Dog 1999 
89 Sz D2/3 61 H40 Lower re.~piratory Horse 2000 
90 Sz D21u 101 B244996 Uterine infection/abortion Horse 2004 
91 Sz D21u 56 B233322 Uterine infection/abortion Horse 2003 
NA Information not available. Details of many of these isolates are also available on the online 
MLST database: http://pubmlst.orglszooepidemicus/. Accessed 23.02.09). * Isolates collected 
from outside the UK. 
344 
